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The goal of the research was to develop a Protein-Specific Properties Evaluation (PSPE) 
framework that would aid in the statistical evaluation of variables for predicting ranges of and 
prior probability distributions for protein crystallization conditions.  Development of such a 
framework is motivated by the rapid growth and evolution of the Protein Data Bank.  Features of 
the framework that has been developed include (1) it is an instantiation of the “scientific 
method” for the framing and testing of hypotheses in an informatics setting, (2) the use of hidden 
variables, and (3) a negative result is still useful. 
The hidden variables examined in this study are related to the estimated net charge (Q ) 
of the proteins under consideration.  The Q  is a function of the amino acid composition, the 
solution pH, and the assumed pKa values for the titratable amino acid residues.  The protein’s 
size clearly has a significant impact on the magnitude of the Q .  Therefore, two additional 
variables were introduced to mitigate this effect, the specific charge (Q ) and the average surface 
charge density (σ ). 
The principal observation is that proteins appear to crystallize at low values of Q  and σ .  
One problem with this observation is that “low” is a relative term and the frame of reference 
requires careful examination.  The results are sufficiently weak that no prospective predictions 
appear possible although information of this type could be included with other weak predictors in 
a Bayesian predictor scheme.  Additional work would be required to establish this; however that 
work is beyond the scope of the dissertation.  Although many statistically significant correlations 
 v 
among Q -related quantities were noted, no evidence could be developed to suggest they were 
anything other than those expected from the additional information introduced with the hidden 
variables. 
Thus, the principal conclusions of this PSPE analysis are that (1) Q /σ  and other Q -
related variables are of limited value as prospective predictors of ranges of values of 
crystallization conditions.  Although this is a negative result, it is still useful in that it allows 
attention to be directed into more productive avenues. 
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1.0  INTRODUCTION 
X-ray crystallography is the primary method of choice for modeling the three-dimensional (3D) 
structure of proteins and other biological macromolecules, such as deoxyribonucleic acid (DNA) 
and ribonucleic acid (RNA).  Determining the 3D structure of a protein can provide important 
details, such as its function and mode of action (how it works), and can aid in drug design and 
discovery (McPherson, 1999).  Currently, there are more than forty compounds used as drugs 
that have been discovered or identified using structural-based methods.  Many of these 
compounds have been approved or are undergoing clinical trials for the treatment of human 
disease; examples include drugs against HIV/AIDS (HIV proteases: Nelfinavir, Amprenavir, and 
Lopinavir), chronic myelogenous leukemia (Imatinib), and non-small cell lung cancer (Erlotinib; 
Congreve, et al., 2005). 
1.1 PROBLEM 
There are several steps involved in obtaining the 3D structure of a protein and breakdowns in this 
process can occur for any number of reasons.  Crystallizing the protein along with obtaining a 
soluble form of the protein are the major bottlenecks in the structure determination process.  
Growing a crystal suitable for X-ray diffraction studies can be very time consuming, costly, and 
difficult, as demonstrated by the low success rate.  Crystal growth is often problematic because 
of the large search space.  The experimenter has to determine the correct concentrations of the 
protein, salt(s), and buffer, as well as the temperature and pH.  Additionally, the optimal 
crystallization conditions appear to vary idiosyncratically from protein to protein raising the 
question:  What, if anything, can be predicted about the crystallization behavior before the fact 
and if so, how can that be used to facilitate the process? 
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The current 'state of the art' methods for crystallizing a protein consist of randomly 
searching the possible conditions, using an ordered search by combining all pairwise 
combinations of two or more solution variables at several levels each (grid screens), or using the 
solution conditions that have worked for other previously crystallized proteins (the sparse-matrix 
approach).  Because of the large amount of parameters to search and the usually limited amount 
of protein, researchers try to maximize the probability of obtaining a crystal by using the sparse-
matrix approach. Companies, such as Hampton Research, Molecular Dimensions, Emerald 
BioStructures, or Jena Bioscience, all market crystallization screens based on the sparse-matrix 
approach.  The sparse-matrix approach for initial crystallization screens is based on the 
assumption that whatever solution conditions that have previously succeeded in crystallizing 
proteins have a higher probability in crystallizing new target proteins, a one-size-fits-all 
approach.  These commercial screens are also available for special subclasses of proteins, such as 
membrane proteins or nucleic acids, and are relatively easy to use.  However, even with these 
methods, the success rate of crystallization remains quite low. 
The sparse-matrix method creates a somewhat repetitive set of conditions for several 
reasons.  First, certain areas of the search space are over sampled, such as the abundance of high 
molecular weight polyethylene glycols (PEG) in screens.  Second, a few of the experiments 
within a screen provide most of the crystallization success rate.  Page et al. (2003) demonstrated 
that removing 75% of 480 screening conditions would have no effect on the number of proteins 
crystallized in a study of 539 Thermotoga maritima proteins.  For these reasons, alternate 
methods need to be developed to condense screens even further to contain smaller subsets 
(Kimber et al., 2003; Page et al., 2003; Wooh et al., 2003; Page and Stevens, 2004). 
One such method to developing alternative screening strategies is to determine what 
characteristics of a protein make it amenable to the structural determination process.  
Researchers are realizing the importance of recording the conditions used to grow the crystals.  
The Protein Data Bank (PDB; Berman et al., 2000) is now recording many of these parameters, 
but most are still optional upon deposition of a new 3D structure.  Now with more available data 
due to funding for the Protein Structure Initiative (PSI) by the National Institute of General 
Medical Sciences (NIGMS) and a few independent researchers, such as John Rosenberg at the 
University of Pittsburgh, some plausible explanations can be explored in more detail.  These 
projects are collecting information about successes (where to search) as well as failures (where 
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not to search).  This dissertation developed a framework to frame and test hypotheses about 
protein crystallization behavior.  If the hypotheses are validated on a retrospective data set, they 
can be used to suggest regions in the crystallization search space that are more likely to result in 
the formation of crystals of the proteins under study. 
McPherson (1999) lists 36 parameters, 12 physical, 12 chemical, and 12 biochemical, 
which affect the outcome of crystallization experiments (Table 1.1).  Each of these variables has 
multiple levels and may be either continuous, such as concentration and pH, or discrete, such as 
precipitant and salt type.  Additionally, the interaction between these variables is not fully 
understood.  Although many of the variables in Table 1.1 are not typically examined, the 
possible combinations of all parameters would be extremely large and unmanageable with 
limited protein, time, labor, and cost. 
 
Table 1.1 Parameters influencing protein crystallization outcome. 
 
Physical Chemical Biochemical 
Temperature pH Isoelectric point 
Surfaces Precipitant Type Macromolecular stability  
Methodology Precipitant Concentration Source of Macromolecule 
Gravity Ionic Strength Ligands, inhibitors, effectors 
Pressure Specific Ions Proteolysis / Hydrolysis 
Time Degree of Supersaturation Chemical Modifications 
Vibrations / Sound  Macromolecular Concentration  Posttranslational modifications 
Electrostatic / Magnetic Fields Metal Ions Genetic Modifications 
Dielectric Properties of the Medium Reductive / Oxidative Environment Macromolecular Purity 
Viscosity of the Medium Cross-linkers/Polyions Aggregation State 
Homogeneous or Heterogeneous 
Nucleants 
Detergents / Surfactants / 
Amphophiles 
Inherent symmetry of the 
macromolecule 
Rate of Equilibration Non-macromolecular Impurities History of the sample 
* Taken from McPherson, 1999 
 
Unfortunately, most of these parameters in Table 1.1 are not recorded or in a format 
suitable for information extraction.  The conditions used to grow the crystals are starting to 
appear with more frequency in the macromolecular crystallographic information file (mmCIF), 
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but this information is voluntary and far from complete (Section 2.4).  Additionally, only 
successful conditions are reported within the PDB.  Negative examples would provide an 
additional wealth of information (Edwards et al., 2000; Rupp, 2003; Page and Stevens, 2004; 
Rupp and Wang, 2004), but are usually only reported within laboratory notebooks.  Knowing 
where not to search in the parameter space, would allow the researcher to focus more of his/her 
efforts on areas where crystallization is more probable.  Additionally, a large amount of protein 
would be required to screen all of these combinations, which would often not be available or cost 
effective due to the time and effort required for such a screening.  Therefore, this research 
focused on features that are sequence based and easy to calculate, such as molecular weight and 
isoelectric point, and do not require the use of any of the protein sample. 
1.2 SIGNIFICANCE 
The approaches currently used to grow crystals are costly and have low success rates.  For 
example, the estimated average cost of obtaining a single 3D protein structure is $100,000-
$125,000 (Burley and Bonanno, 2002; Uehling, 2005).  Coupled with success rates ranging from 
1-23% (Chayen and Saridakis, 2002; Lesley et al., 2002; Rupp and Wang, 2004; Couzin, 2005; 
Page et al., 2005; Walter et al., 2005) it is clear that an alternative method for selecting 
crystallization conditions needs to be developed.  This dissertation developed a hypothesis 
testing framework, the Protein Sequence-Properties Evaluation Framework (Chapter 4), which 
was used to demonstrate that most proteins do crystallize at a low estimated net charge, or more 
specifically a low estimated specific charge (Q ) and estimated average surface charge density 
(σ ).  One problem with this observation is that “low” is a relative term and the frame of 
reference requires careful examination.  The results are sufficiently weak that no prospective 
predictions appear possible although information of this type could be included with other weak 
predictors in a Bayesian predictor scheme.  Additional work would be required to establish this; 
however that work is beyond the scope of the dissertation. 
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1.3 THE APPROACH 
The goal of this research was to conduct a retrospective study to identify features within a 
protein’s primary sequence that can guide a protein crystallographer in designing and/or 
optimizing crystallization screens.  The proteins examined in this research were a non-redundant 
set from the Protein Data Bank (PDB), i.e. proteins that have been successfully crystallized.  The 
goal of the research was to develop a Protein-Specific Properties Evaluation (PSPE) framework 
that would aid in the statistical evaluation of variables for predicting ranges of and prior 
probability distributions for protein crystallization conditions. 
1.4 PROTEIN SEQUENCE-PROPERTIES EVALUATION FRAMEWORK 
The development of this framework is largely motivated by the rapid growth and evolution of the 
Protein Data Bank. The general framework was developed to test hypotheses about the solution 
conditions leading to the formation of protein crystals, the Protein Sequence-Properties 
Evaluation (PSPE).  This framework is an instantiation of the “scientific method” for the framing 
and testing of hypotheses in an informatics setting.  The goal was to identify protein features that 
could be used to suggest crystallization solution conditions that would result in an increased 
success rate of obtaining crystals.  Because the reported pH of crystallization ( crystpH ) is the 
most recorded solution parameter, the initial focus was on using the estimated charge of the 
protein to suggest solution pH ranges for crystallization, but with more information available, 
any environmental variable could be examined.  For example, based on the target protein’s 
estimated net charge, the probability of growing a crystal suitable for diffraction studies over a 
range of pH values can be calculated when given its protein sequence.  Although the PSPE 
framework was developed for the specific application of protein crystallization, it could be 
implemented in other areas of interest where researchers are trying to find or explain differences 
in protein behavior. 
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1.5 THESES 
The overall hypothesis that forms the basis for this work is that there are features present within 
a protein’s primary sequence that can guide a protein crystallographer to intelligently select 
experimental solution conditions that have a higher probability of generating crystals.  This 
would ideally lead to the development of more successful crystallization screens.  In this 
dissertation, the following theses are specifically developed and tested: 
First, it is hypothesized that the Protein Sequence-Properties Evaluation Framework can 
be used to frame and test hypotheses in-silico about variables that are believed to be important in 
protein crystallization.  These discoveries can then be used to predict ranges of solution 
Controllables in a probabilistic manner.  It is hypothesized that this general framework will 
result in more efficient crystallization screens. 
Second, based on the application of the PSPE framework to the examination of solution 
pH values of previously crystallized proteins, it is hypothesized that a protein’s Q  or σ  could 
be used to suggest solution pH ranges that have a higher probability of generating crystals 
suitable for diffraction studies.  This approach examines the distribution of both the Q  and σ  of 
previously crystallized proteins to suggest values for an independent dataset comprised of newer 
PDB entries.  These charge values are then translated into pH space using the target protein’s Q  
or σ  curves.  However, the mapping from charge space back into pH space is still an open 
research problem.  Additional experimental validation of these results would be extremely 
important. 
Third, it is hypothesized that ‘similar’ proteins crystallize under similar solution 
conditions, including those that result in similar charge values, in terms of both the Q  and σ .  
Groups of proteins are identified with the PSPE Framework, using binning or clustering 
algorithms, such as two-step clustering and self-organizing maps, to increase the accuracy of 
predicting the Q  and σ  ranges of target proteins.  The following protein features were 
examined to define proteins as being similar: the molecular weight, the estimated isoelectric 
point (pIest), and the Q  curve. 
Based upon the above theses, specific claims are made: 
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1. The goal of the research was to develop a Protein-Specific Properties Evaluation (PSPE) 
framework that would aid in the statistical evaluation of variables for predicting ranges of 
and prior probability distributions for protein crystallization conditions.  Development of 
such a framework is motivated by the rapid growth and evolution of the Protein Data 
Bank.  Features of the framework that has been developed include: 
a. It is an instantiation of the “scientific method” for the framing and testing of 
hypotheses in an informatics setting. 
b. The use of hidden variables, i.e. parameters which are analytic functions of 
quantities extracted from the database.  Note that one of the hazards of hidden 
variables is that they introduce additional information and care must be taken to 
ensure that “discoveries” based on the hidden variables are not simply reflections 
of that additional information. 
c. A negative result is still useful; i.e. the recognition that a variable has minimal 
utility in predicting ranges or probabilities of crystallization allows energy and 
attention to be focused elsewhere, where it may be more productively employed. 
2. The hidden variables examined in this study are related to the estimated net charge (Q ) 
of the proteins under consideration.  The Q  is a function of the amino acid composition, 
the pH of the solution and the assumed pKa values for the titratable amino acid residues 
in the protein.  Specific variables and observations include: 
a. The size of the protein clearly has a significant impact on the magnitude of the Q ; 
two additional variables were introduced to mitigate this effect: 
i. The specific charge (Q ) is the ratio of the Q  to the protein mass, 
expressed here in units of e/kDa (electron units of charge per kilo Dalton). 
ii. The surface charge density (σ ) is the ratio of the Q  to the estimated 
surface area of the protein; a convenient unit is me/nm2 (10-3 electron units 
of charge per square nm).  Although the estimation of surface area is 
difficult, σ  facilitates comparisons with other biologically relevant 
macromolecules. 
b. Additional Q -related quantities examined include: 
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i. The estimated isoelectric point (pIest), which is the pH at which the Q  is 
zero. 
ii. Measures of the shape of the titration curve which is either Q  or σ  
expressed as a function of pH. 
c. The principal observation of this study is that proteins appear to crystallize at low 
values of Q  and σ . 
i. One problem with this observation is that “low” is a relative term and the 
frame of reference requires careful examination. 
1. One frame of reference is provided by comparison to the known σ  
values for nucleic acids and phospholipid bilayers, whose surface 
charge densities are at least an order of magnitude greater than that 
of proteins. 
a. One problem with this frame of reference is that there is no 
pH at which proteins are as highly charged as nucleic acids. 
b. A more serious problem is that nucleic acids crystallize 
readily, demonstrating that high σ  is not a barrier to 
crystallization. 
2. Another frame of reference is in relation to the mean Q /σ  values 
at “physiological pH” of 7.4 ( 4.7=pHQ ); here, there is an 
approximately three-fold reduction in the mean of crystQ  vs. the 
mean of 4.7=pHQ . 
a. One problem with this frame of reference is that the pH 
reference value, 7.4, is questionable because many proteins 
function in physiological compartments where the pH is 
significantly different. 
b. A more serious problem is that the standard deviations of 
the two distributions are more than twice the shift between 
them.  The shift is statistically significant because of the 
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sample size, but cannot be used to make meaningful 
predictions about specific proteins. 
3. It should be noted that the preponderance of “domain knowledge” 
would be that the primary factors selecting low net charge are 
issues of protein folding and stability as well as issues of 
functionality. 
d. The results are sufficiently weak that no protein-specific prospective predictions 
appear possible although information of this type could be included with other 
weak predictors in a Bayesian predictor scheme.  Additional work would be 
required to establish this; however that work is beyond the scope of the 
dissertation. 
e. Although many statistically significant correlations among Q -related quantities 
were noted, no evidence could be developed to suggest they were anything other 
than those expected from the additional information introduced with the hidden 
variables (see 1b). 
3. Thus, the principal conclusions of this PSPE analysis are: 
a. Q /σ  and other Q -related variables are of very limited value as prospective 
protein-specific predictors of ranges of values of crystallization conditions. 
b. Probabilities based on these variables may prove useful in a Bayesian sense, 
although that has not been demonstrated at this time. 
c. Although this is a negative result, it is still useful in that it allows attention to be 
directed into more productive avenues. 
 
1.6 DISSERTATION OVERVIEW 
In Chapter 2, the current methods used to grow a crystal are discussed as well as other relevant 
research.  In Chapter 3, the estimated net charge is identified as an important variable that may 
be able to be predicted apriori for crystallization.  This analysis led to the development of the 
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Protein Sequence-Properties Evaluation (PSPE) Framework, which is presented in Chapter 4 
(Claim 1).  A specific application of the PSPE framework, identification of a low Q  and σ  
being important for crystallization, are described in Chapter 5.  In Chapter 6, various methods of 
clustering proteins by similarity are explored to improve upon the results in Chapter 5, which are 
used to generate solution pH priors for future proteins targeted for crystallization attempts.  
Several applications are presented in Chapter 7, which calculate the predicted pH ranges for 
crystallization for three proteins undergoing crystallization attempts in the Rosenberg Research 
Group (Department of Biological Sciences, University of Pittsburgh).  A Discussion of the 
results, methods, and limitations are presented in Chapter 8, while future research opportunities 
are discussed in Chapter 9.  The Python scripts written for this dissertation are found in 
Appendix A.  An examination of the solution pH values of commercial screens was examined in 
Appendix B., Next, an annotated example on how to use the information developed in this 
dissertation is demonstrated in Appendix C using three proteins from the test set.  Finally, the 
preliminary results of fitting a curve to the plot of pIest vs. crystQ  is presented in Appendix D, 
while the preliminary results of using a protein’s amino acid composition to suggest pH ranges 
for initial crystallization attempts using Linear Regression and Neural Networks is shown in 
Appendix E. 
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2.0  BACKGROUND 
Determining a protein’s three-dimensional (3D) structure to molecular level detail can provide a 
wealth of information for biomedical researchers.  The detailed 3D structure can give insight into 
a protein’s function at a broad level, mechanism of action at a narrow level, and possible binding 
partners, regardless if any of these are already known.  For example, molecular level detail can 
be used to determine the actual atoms from the amino acid residues involved in the active site of 
enzymes.  This knowledge can also be used to examine and predict the effects of mutations of 
these residues, which is an important aspect in understanding the effects of various diseases.  
Additionally, determining a biological macromolecule’s structure is a very important part of the 
drug design and discovery process, facilitating new treatments for disease and understanding of 
important biological processes. 
2.1 METHODS OF OBTAINING A PROTEIN’S 3D STRUCTURE 
There are several methods, both computational and experimental, that are used to determine the 
three-dimensional (3D) structure of biological macromolecules, primarily proteins and nucleic 
acids.  The computational approaches are based upon the target protein’s amino acid sequence 
and use no physical sample, but cannot provide the level of detail that experimental methods can 
unless there is a very high level of sequence similarity.  Even when a target protein has a 
sequence similarity of greater than 50% to proteins with a known three-dimensional structure, 
computational approaches, such as homology modeling, can only predict the structure to a 
comparable X-ray resolution limit of diffraction of 3.0 Angstroms (Å).  When high-level of 
molecular detail is required, such as that for enzymes, the computational approaches fail to 
provide enough detail and experimental approaches should be attempted (Burley and Bonanno, 
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2003).  Experimental methods are able to provide a much better level of molecular detail, often 
approaching the atomic level, ~1.2 Å.  
The experimental approaches require use of the actual protein sample.  Even though only 
a few milligrams of protein may be required, this small amount is very difficult and time-
consuming to obtain.  The primary experimental methods consist of X-ray diffraction and 
nuclear magnetic resonance (NMR) spectroscopy.  Although each of these different methods can 
each provide varying degrees of molecular detail of the structures, X-ray diffraction is the only 
one that can approach atomic level detail (McPherson, 2004). 
The general experimental steps involved in the structure determination process and their 
success rates are discussed in Section 2.2.  The protein’s solubility is discussed in Section 2.3, 
while the crystallization process and the methods commonly used to obtain crystals are described 
in Section 2.4.  Next, methods that can increase the probability of obtaining crystals for X-ray 
diffraction studies are discussed in Section 2.5.  Finally, the variables involved in the 
crystallization process are examined methods in Section 2.6. 
2.2 STRUCTURE DETERMINATION PROCESS 
There are several common steps involved in any experimental protein structure determination 
process undertaken in the laboratory, whether using X-ray diffraction or NMR.  The steps in 
order include target selection, cloning the protein, expressing the protein in a soluble form, and 
purifying it.  The ability to obtain a purified protein can fail in any of these steps.  Once a protein 
has been purified in sufficient quantities (milligrams), it can undergo the next step of the 
structural determination process, which is crystallization for the purposes of this dissertation 
(Section 2.4). 
The biggest failure rates in the structural determination process have been reported in the 
literature as either obtaining a soluble form of the protein (Christendat et al. 2000; Edwards et al. 
2000; Lesley et al. 2002; Yee et al., 2002; Goulding and Perry, 2003; Rupp, 2003a; Bourne et al., 
2004; Albeck et al., 2005) and/or determining the correct environmental conditions for 
crystallization (Chayen, 1999; Heinemann et al., 2000; Chayen, 2002; Chayen and Saridakis 
2002; Goulding and Perry, 2003; Bourne et al., 2004; Page and Stevens, 2004).  Temporal data 
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available from the Protein Structure Initiative’s database, TargetDB (Table 2.1, Westbrook et al., 
2003; http://targetdb.pdb.org/statistics/TargetStatistics.html), supports this observation.  Several 
large drop-offs in success rates are observed, such as attempting to obtain a soluble form of the 
expressed protein (47%) and trying to crystallize a purified protein (40%).  There is even less 
success in obtaining a crystal suitable to diffraction studies from a purified protein (20%).  When 
comparing the amount of proteins that have been cloned to those that have resulted in a 
diffraction quality crystal, a 4% success rate is observed. 
However, these results give an overestimate of the success rate, because many proteins 
are not selected as targets if they are predicted to be difficult to solve.  Proteins are often filtered 
from selection if they are predicted to be a transmembrane protein, a signal peptide, a coil-coil 
protein, a protein with low complexity, or a disordered protein.  These proteins often have a 
more difficult time proceeding through the steps of structure determination and crystallizing.  
Thus, the PDB may not be a true representative sample of the protein universe as described by 
SWISS-PROT, the database of the protein universe.  This is indeed the case, as the PDB contains 
an under abundance of transmembrane proteins, proteins with low complexity, signal sequences, 
and disordered regions.  Alternatively, the PDB contains an over abundance of enzymes and 
proteins with disulfide bonds or metal-binding sites (Peng et al., 2004).  It has been speculated 
that the proteins in the PDB are the ‘low hanging fruit’, meaning the soluble proteins that are 
relatively ‘easy’ to clone, express, purify, and crystallize.  This illustrates that new methods are 
needed to improve upon the success rates. 
In addition to being a difficult step, crystallization has been estimated as one of the most 
time consuming steps of the structural determination process (Table 2.1).  Using temporal 
information available from the TargetDB, Bourne et al. (2004) were able to calculate the mean 
time to complete each step of the structural determination process.  Cloning the target protein 
took 120 days on average, while expressing the protein required only approximately 25 days.  
After getting the protein expressed, it took an average of 75 days to purify the protein to 
sufficient quantities, which would also include obtaining a soluble form of the protein.  Once the 
protein was purified, it required a mean of 195 days to obtain a diffraction quality crystal (85 
days to get the protein crystallized with another 110 days to obtain a diffraction quality crystal).  
After obtaining a diffraction quality crystal, another 195 days on average were required to 
diffract and obtain the crystal structure.  Finally, another 130 days were required to analyze the 
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structure and deposit it into the PDB, which generally includes getting a publication on the 
solved structure.  The whole process from selecting a target to depositing the solved X-ray 
diffraction structure into the PDB took about 2 years on average.  Additionally, a large part of 
this time was devoted to the crystallization process, approximately 195 days.  Any method that 
can reduce the crystallization time would be of great benefit to the structural community. 
 
Table 2.1 The steps in the determination of the 3D structure of proteins and the success rates1. 
 
Status 
Total 
Number of 
Targets 
(%) Relative to 
Cloned Targets
(%) Relative to 
Expressed 
Targets 
(%) Relative to 
Purified 
Targets 
(%) Relative to 
Crystallized 
Targets 
Approximate Mean 
Time 
(Days) 2 
Cloned (C) 70,750 100 - - - 119 (C) 
Expressed (E) 41,501 59 100 - - 25 (C→E) 
Soluble (S) 19,382 27 47 - -  
Purified (P) 14,972 21 36 100 - 75 (S-P) 
Crystallized (X) 5,934 8 14 40 100 85 (P→X) 
Diffraction-quality 
Crystals (DC) 3,029 4 7 20 51 110 (X→DC) 
Diffraction (D) 2,579 4 6 17 43 110 (DC→D) 
Crystal Structure 
(CS) 2,384 3 6 16 40 85 (D→CS) 
NMR Assigned  1,150 2 3 8 -  
NMR Structure 1,065 2 3 7 -  
In PDB 3,056 4 7 20 35 130 (CS→PDB)  
110 (NMR→PDB)
Work Stopped 14,363 - - - -  
1 As determined for the Structural Genomics (SG) projects from the TargetDB on 05-19-2006  (Westbrook et al., 
2003) 
2 The approximate times for each step were estimated from Bourne et al. (2004). 
 
In an attempt to increase throughput, researchers have examined how a protein’s 
biophysical properties may be correlated to success (1=yes) or failure (0=no) at each step of the 
process, cloning, expression, solubility, purification, and crystallization.  The reason being that if 
 15 
a protein has a low probability of producing crystals, it should be removed.  In each step, the 
protein’s biophysical properties have significantly correlated with success or failure (Goh et al., 
2004).  The large amount of data being generated by the Structural Genomics (SG) groups has 
enabled such analysis as data mining to be undertaken.  Using the TargetDB, the status of each 
SG target protein is tracked.  This enables one to create a list of proteins that have succeeded or 
failed at each step.  In this dissertation, a protein’s biophysical properties are used to predict a 
solution pH range that has a higher probability of producing crystals. 
  As mentioned previously, there is often a bias beginning at the first step, selecting the 
protein targets for analysis.  Once a protein is selected for analysis, various expression systems 
(usually bacterial organisms) are used to get the protein expressed, i.e. made by the organism.  A 
variety of protein properties such as size, amino acid composition (Christendat et al., 2000; 
Braun et al., 2002; Goh et al., 2004; Luan et al., 2004), isoelectric point (pI; Braun et al., 2002; 
Goh et al., 2004), secondary structure composition (Christendat et al., 2000), the presence of 
particular protein domains, subcellular location (Braun et al., 2002), hydrophobicity (Goh et al., 
2004; Luan et al., 2004), signal sequence , and whether the protein is conserved across different 
organisms (Goh et al., 2004) have correlated with successful expression of the protein.  For 
example, as the size increases, there is a decrease in expression.  Of the amino acids shown to 
predict expression, the acidic amino acids, Glutamic acid and Aspartic acid, apparently play a 
major role (Christendat et al., 2000; Goh et al., 2004).  Although a protein may be expressed, it 
may not be of use if it is not soluble. 
Often proteins are expressed in an insoluble form and packaged into inclusion bodies by 
the cell.  The proteins placed in these vesicles are often the result of insoluble aggregates of 
misfolded or denatured proteins.  There are several reasons these insoluble masses may be 
formed.  When the host organism forms a foreign protein, it may lack the appropriate chaperone 
or binding partner necessary to properly fold the protein.  Additionally, bacteria cells lack the 
mechanism for post-translational modifications that may be required for eukaryotic proteins.  
However, there are several methods that are available to try to resolubilize the proteins located in 
the inclusion bodies, including adding a denaturing agent, such as urea.  An insoluble protein 
presents problems in terms of purification and the possibility of misfolding.  A variety of studies 
have been performed that have examined a protein’s biophysical properties and whether the 
protein is soluble or insoluble upon expression.  The composition of certain amino acids has 
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shown to be positively (Arginine, Glutamine, Glutamic acid, Isoleucine, and Leucine) or 
negatively (Asparagine, Cysteine, Glycine, Methionine, Phenylalanine, Proline, Serine, 
Threonine, and Tyrosine) correlated with solubility (Christendat et al., 2000; Luan et al., 2004; 
Idicula-Thomas et al., 2006; Idicula-Thomas and Balaji, 2005).  Many of these correlations seem 
logical such as positive correlation of Arginine, Glutamine, and Glutamic acid with solubility.  
These amino acids are polar or charged and can favorably interact with the water molecules in 
the liquid phase.  Similarly, the non-polar and hydrophobic residues would be expected to be 
negatively correlated with solubility.  Therefore, it was not unexpected that this was the case 
with Phenylalanine, Methionine, and Proline.  However, there were some correlations that did 
not appear to make sense, such as the positive correlation between solubility and Isoleucine and 
Leucine (both hydrophobic amino acids).  This was also observed with the negative correlation 
between solubility and Cysteine, Serine, Threonine, and Tyrosine. 
Additional features that are predictive of whether an over-expressed protein will be 
soluble (Yes/No) include the dipeptide (Idicula-Thomas et al, 2006) or tripeptide frequency 
(Idicula-Thomas and Balaji, 2005), and length (Goh et al., 2004).  Other variables that had a 
positive correlation with solubility include Aliphatic Index (Idicula-Thomas & Balaji, 2005; 
Idicula-Thomas et al, 2006), Instability Index (both the whole protein and the N-terminal region), 
the net charge (Idicula-Thomas et al, 2006), and the secondary structure (α-helices; Idicula-
Thomas and Balaji, 2005).  Similarly, other variables have a negative correlation with solubility 
including hydrophobicity (Christendat et al., 2000; Bertone et al., 2001; Bussow et al., 2004; 
Dyson et al., 2004; Luan et al., 2004;), the presence of a signal sequence, transmembrane helices 
(Luan et al., 2004), low complexity regions (Dyson et al., 2004), molecular weight (Dyson et al., 
2004), and secondary structure (β-sheets; Idicula-Thomas and Balaji, 2005). 
Once a protein is expressed in a soluble form, it is relatively easy to purify, assuming that 
the protein is tagged for easy purification.  Similar to the earlier steps, the ability to purify an 
expressed protein (Yes/No) has also been correlated with the protein's biophysical properties.  
Braun et al. (2002) examined the ability to purify human proteins in a bacterial expression 
system, Escherichia coli (E. coli).  They found that proteins with certain domains, like ras-like 
domains (n=15) or protein kinases (n=10) in their data set had an 80%+ success rate for 
purification, while proteins from the seven-transmembrane-domain-receptors (n=4), Ephrin 
(n=4), or tumor necrosis factor (TNF) domains (n=4) all failed the purification process.  In these 
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cases, the domains were defined using the Pfam database (Bateman et al., 2004).  Subcellular 
localization, as defined by Gene Ontology (GO; The Gene Ontology Consortium, 2000), was 
also found to correlate with propensity to purify.  Cytoskeleton (n=6) and DNA associated 
proteins (n=38) had a high probability of purifying (75%+), while integral membrane and 
extracellular proteins had a lower probability (25%) of purifying (Braun et al., 2002).  In a later 
study using decision trees and random forests, Goh et al. (2004) found decision rules based upon 
the amino acid composition of Aspartic acid + Glutamic acid, Asparagine + Glutamine, and the 
small hydrophobic residues (Glycine + Alanine + Valine + Leucine + Isoleucine), along with pI 
and proteins that are conserved across organisms predictive of the purification step.  Following 
the rules developed, a protein could be predicted as being able to be purified or not. 
Once a protein has been purified in sufficient quantities, crystallization attempts are 
performed.  Crystallization is considered the last step, at which a protein’s biophysical properties 
correlate with success, because once a ‘good’ crystal is obtained, it should just be a matter of 
analysis time to solve the 3D structure. 
Crystallization, which is the focus of this dissertation, also had biophysical properties 
associated with success or failure.  Similar to other steps in the process, the amino acid content 
was predictive of the propensity to crystallize (Christendat et al., 2000; Bertone, et al., 2001; 
Canaves et al., 2004; Goh et al., 2004).  This has been shown for both individual amino acids 
composition, such as Alanine, Asparagine, Aspartic acid, Tyrosine, Serine, and Methionine, and 
the cumulative composition of 'similar' amino acids, such as all charged residues, the acidic 
(Aspartic acid + Glutamic acid) and/or the basic residues, small hydrophobic residues (Glycine + 
Alanine + Valine + Leucine + Isoleucine).  This is especially true for the acidic and basic amino 
acids, which are the ones that have side chains that can be charged.  For example, Bertone et al. 
(2001) found that proteins with an Aspartic acid composition greater than 5% have a higher 
probability of crystallizing.  The correlation of the aliphatic amino acids, Alanine, Valine, 
Isoleucine, and Leucine, which give a measure of the protein’s stability (Aliphatic Index; Ikai, 
1980), with solubility, might also not be unexpected.  Proteins that are more stable might be 
hypothesized to crystallize more readily.  Conversely, Christendat et al. (2000) found that 
proteins with an Asparagine composition greater than 3.5% have a lower probability of 
crystallizing.  Canaves et al. (2004) found that acidic proteins, based on pI values 5.1-7.5, had a 
higher probability of crystallizing.  Additionally, they found that signal peptides, proteins with 
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transmembrane helices, those with a GRAVY value (hydrophobicity measure; Kyte and 
Doolittle, 1982) below –1.0 or above –0.1, or proteins with low complexity regions are less 
likely to crystallize.  The lower probability of the first three to crystallize is probably due to the 
presence of a significant number of hydrophobic residues within these proteins.  Proteins with 
regions of low complexity are another issue.  These proteins are generally non-globular and have 
mobile domains.  Low complexity proteins are often elongated, displaying extended coils and 
helical structures (Wootton, 1994).   
Differences were also found based on the protein's secondary structure and amino acid 
length.  Examining proteins whose structures have been solved by X-ray and NMR or NMR 
only, Valafar et al. (2002) concluded that proteins with β-sheets were less likely to crystallize 
than proteins with α-helices.  This was inferred by few protein structures with β-sheets being 
solved by both methods (Valafar et al., 2002).  Idicula-Thomas and Balaji (2005) also found that 
proteins with a higher occurrence of amino acids that have a propensity to form β-sheets 
displayed lower solubility.  Not surprisingly, the length of the protein was also correlated with 
propensity to crystallize (Christendat et al., 2000; Bertone et al., 2001; Canaves et al., 2004). 
Proteins with a sequence length <80 residues (short proteins) and >560 residues (long proteins) 
crystallize less frequently (Canaves et al., 2004).  Therefore, it was felt that similar biophysical 
properties might also indicate what solution conditions could lead to success, i.e. crystals. 
2.3 PROTEIN SOLUBILITY 
In order to proceed with crystallization attempts, the target protein should have a 
moderate level of solubility, usually ≥10 milligrams/milliliter (mg/ml).  A protein’s solubility is 
the maximum concentration in liquid phase in equilibrium with the solid phase as either a 
precipitate or a crystal, such that there is no net loss or gain of the solid phase.  The protein’s 
solubility is determined by its biophysical properties, the solvent, and the interactions between 
the two.  The protein’s solubility is a key factor in understanding its crystallization behavior.  
Currently, there are no methods to predict the solubility of a protein.  This can only be 
determined experimentally, which is tedious and requires the use of the protein sample. 
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2.3.1 Solute Properties 
The solubility of the solute (protein) is determined by its biophysical properties, 
including its hydrophobicity and net charge.  The hydrophobic amino acids (Alanine, Isoleucine, 
Leucine, Methionine, Phenylalanine, and Valine) fold into the interior of the protein to minimize 
contact with any polar (water) or charged (salts) solvent components.  This is believed to be a 
key factor in the folding of globular proteins.  Because of this, proteins with large stretches of 
hydrophobic regions, such as transmembrane proteins, generally have a low solubility.  In order 
to solubilize membrane proteins, researchers have to include a detergent in the solution to 
achieve maximal solubility.  While the hydrophobic residues tend to fold into the interior, the 
hydrophilic residues are found on the surface where they can interact with the solvent. 
The protein’s charge has been known to be a major determinant of its solubility.  There 
are certain residues on the proteins that can be protonated or deprotonated, such as the amino- 
and carboxyl-terminus, respectively.  Additionally, the side chains of the acidic (Aspartic acid, 
Glutamic acid, Cysteine, and Tyrosine) and basic residues (Histidine, Lysine, and Arginine) can 
take on a negative or positive charge, respectively.  The charge of these residues is largely 
controlled by the solution pH.  The solution pH gives a measure of the amount of free protons 
(H+) in the solution.  When there is an excess amount of H+ in the solution, the basic residues 
will pick up a proton and become positively charged.  Alternatively, when there is a low 
abundance of protons, the carboxyl groups of Glutamic acid and Aspartic acid will give up a 
proton and become negatively charged.  At neutral pH values, the acidic residues are negatively 
charged and the basic residues are positively charged.  These charged molecules then can form 
hydrogen bonds with the water molecules to neutralize the charge and shield nearby molecules 
from the charge.  The overall effect of the solution pH on a protein’s charge is observed by 
calculating an estimated titration curve. 
The estimated titration curve plots the proteins estimated net charge (Q ) as a function of 
the solution pH (Figure 2.1).  The point along the curve where the protein has a zero net charge 
is the pIest.  This curve is based upon the amino acid composition of the protein and is calculated 
using the Henderson-Hasselbach Equation (HHE; Equation 2.1).  The HHE uses model pKa 
values for each titratable residue, which represents the pH value where 50% of the residues 
would be charged and 50% would be uncharged.  Thus, a protein’s solubility can change 
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dramatically around the pKa values.  Additionally, a protein’s solubility is usually minimal at the 
pIest.  This is largely due to the reduction of repulsive electrostatic interactions between protein 
molecules.  Therefore, it was hypothesized that there would be a correlation between the pIest and 
the crystpH . 
 
 
Figure 2.1. An example estimated titration curve for PDB proteins 1A2N and 1AHP. 
 
When calculating the estimated titration curve, several assumptions are made, which may 
or may not be true.  The first assumption is that all like amino acids have the same pKa value. 
For example, all Aspartic acids have the same pKa value and 50% are negatively charged at a pH 
of 3.65, its pKa value.  Secondly, it is assumed that all titratable groups can be protonated or 
deprotonated.  This is not always the case, because not all charged amino acids are present on the 
surface.  Some charged amino acids are required to interact with other molecules, which 
requiring the residue to have a charged state, which may cause the pKa of that residue to shift 
several pH units.  The next assumption is that all charged groups are accessible, i.e. on the 
surface.  Finally, for the estimation of net charge it is assumed that the protein is monomeric, 
because until the structure is solved the residues located in the interface between molecules can 
not be known (Ries-Kautt and Ducruix, 1997; 1999).   
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It has long been hypothesized that there should be a correlation between the crystpH  and 
its pI, where its estimated net charge is zero.  This was for two main reasons: (1) a protein 
usually exhibits minimum solubility at its pI and (2) a low net charge lowers the probability of 
unfavorable electrostatic interactions between protein molecules (McPherson, 1999).  This was 
demonstrated in early protein solubility literature when crystalline pepsin (Northrop, 1930), 
crystalline hemoglobin (Green, 1931a), crystalline catalase (Sumner and Dounce, 1937), 
crystalline β-lactoglobulin (Gronwall, 1942), crystalline insulin (Fredericq and Neurath, 1950), 
and more recently with amorphous fibrinogen (Leavis and Rothstein, 1974), amorphous 
lysozyme (Shih et al., 1992), crystalline ovalbumin (Judge et al., 1996), and crystalline 
ribonuclease Sa (Shaw et al., 2001) all displayed a minimum solubility at their pI.  As the 
solution pH was moved away in either direction from the pI, the protein's solubility increased.  It 
is well known that crystallizing a protein requires a slow reduction in solubility for the protein to 
come out of solution as a well-ordered crystal. 
However, the hypothesized correlation between pIest and crystpH  has not been supported 
in practice or by the literature (McPherson, 1999; Page et al., 2003; Kantardjieff and Rupp, 
2004).  In a large scale structural genomics approach to protein crystallization, Page et al. (2003) 
attempted to crystallize 539 Thermotoga maritima open-reading frames (ORFs) that had been 
successfully cloned, expressed, and purified.  Of the 465 proteins that did crystallize (86% 
success rate), the correlation between pIest and crystpH  was quite low (r = 0.01).   
Meanwhile, Kantardjieff and Rupp (2004) took a data mining approach and examined 
9,596 proteins that had previously been crystallized from the PDB and similarly found a low 
correlation (r <0.10) between the pIest and crystpH .  Although this correlation was statistically 
significant, such a low correlation is unlikely to provide much information in determining initial 
crystallization conditions. 
2.3.2 Solvent Properties 
In addition to the protein’s biophysical properties, the solvent may interact with the 
protein or other solvent compounds to alter the protein’s solubility.  Solvent properties, such as 
pH, temperature, and ionic strength of the solution, play critical roles in determining the 
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protein’s solubility.  Water molecules form hydrogen bonds with the protein, which keeps the 
protein solvated.  While some solvent components act to increase the solubility, others act to 
decrease the solubility.  Alternatively, a compound may increase the solubility at one 
concentration, but decrease the solubility at another concentration.  This is the case with salts.  
Salts have been known to change the protein’s solubility, stability, and activity. 
The protein’s solubility can generally be increased with a low concentration of salt, a 
phenomenon called salting-in.  A low concentration of salt stabilizes the protein through non-
specific electrostatic interactions.  The salt ions act to shield the charge or bind to the protein, 
allowing the protein molecules to come closer together (decrease repulsion between protein 
molecules).  After the initial increase in solubility, additional salt will decrease the solubility 
(salting-out).  The decrease in solubility is mainly due to hydrophobic interactions caused by the 
competition of the salt ions and the protein for the solvent (water) to remain solvated.  This 
forces the protein molecules to interact with each other.  These protein-protein interactions are 
what eventually cause the protein to come out of solution, either as a crystal or a precipitate.  The 
particular effects of a salt vary depending upon the type of cation and anion. 
The effectiveness of a given salt to reduce the protein’s solubility is predicted to some 
degree by the Hofmeister series and the charge of the protein.  The Hofmeister series ranks the 
ability of different anions and cations to stabilize (salt-out) or destabilize (salt-in) proteins.  The 
cations rank NH4+ > K+ > Na+ > Cs+ > Li+ > Mg2+ > Ca2+ > Ba2+ in their efficiency to lower a 
protein’s solubility, regardless of the protein’s charge (Cacace et al., 1997; Ries-Kautt and 
Ducruix, 1999).  The effect of salts on a protein’s solubility is mainly driven by the anions.  
However, the effects are additive over all the ions in the liquid phase.  When considering the 
effect of the anions, the charge of the protein matters.  When the protein has a net negative 
charge, the ability of the anion to lower solubility follows the Hofmeister series, F- > PO43- > 
SO42- > CH3COO- > Cl- > Br- > I- > CNS-.  This is generally the case for acidic proteins, where 
the solution pH is above their pI and the net charge is negative.  However, when the protein has a 
net positive charge the Hofmeister series is reversed, often referred to inversion of the 
Hofmeister series.  This is usually the case with basic proteins, when the solution pH is below 
their pI, resulting in a net positive charge. 
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2.4 PROTEIN CRYSTALLIZATION 
Once a protein is available in a purified form, several experimental methods can be 
applied to determine its three-dimensional (3D) structure (Table 2.2).  The most widely used 
method as determined by the frequency of structures in the PDB remains X-ray crystallography 
(84.7%), while the second most popular method is Nuclear Magnetic Resonance (NMR) 
spectroscopy (14.7%).  Currently, these two methods account for 99.4% of the structures in the 
PDB.  An advantage of NMR over crystallography is that the molecule is studied in its native 
state in the liquid phase or within a membrane.  There is no need to grow a crystal, which is a 
difficult task as discussed throughout this dissertation.  However, NMR is limited in its ability to 
determine the structure of monomeric proteins <40 kilodaltons (kDa) in size or multi-meric 
proteins <60 kDa (Widmer and Jahnke, 2004), while there are no protein size limits for X-ray 
diffraction studies.  An additional drawback is that the protein studied needs to be highly soluble 
for NMR studies.  However, many proteins are not highly soluble as observed by the fraction of 
soluble proteins (47%) obtained from the expressed proteins in Table 2.1.  As a comparison to X-
ray diffraction, the length of data collection for NMR ranges from 45-60 days, while analysis 
takes an additional 6-12 months (Eisenstein et al., 2000).  This dissertation focuses primarily on 
protein crystallization and X-ray diffraction because of its popularity and widespread use among 
structural biologists.  However, it is hypothesized that similar methods and findings from this 
dissertation may be applied in the future to the other methods, such as NMR. 
In order to determine the X-ray structure of the protein, the purified protein has to first be 
crystallized.  This usually involves an undersaturated liquid phase and slowly creating a 
supersaturated state, where there is more protein present in the liquid phase than can be 
maintained in equilibrium (Section 2.3).  This leads to the formation of a solid phase, ideally in 
the form a large well-ordered crystal suitable for X-ray diffraction studies.  However, when the 
protein forms a solid phase, the formation of crystals is not the only possible result.  If the 
protein solution is very highly supersaturated, the protein may form an amorphous precipitate.  
Alternatively, the protein may undergo a phase transition as a shower of microcrystals or 
separate into a gel (liquid-liquid phase separation).  However, these negative results may still be 
informative.  For example, crystallization is often preceded by a liquid-liquid phase separation 
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(Section 2.5.2).  A slight adjustment in solution parameters around these regions of phase 
transitions (liquid-solid or liquid-liquid) may result in a large crystal. 
Typically, proteins are initially screened against 100’s to 1000’s of different solution 
conditions.  For instance, the Hauptmann Woodward Medical Research Institute (HWI) in 
Buffalo, New York typically screens each protein against 1,536 different solution conditions 
(Luft et al., 2003; http://www.hwi.buffalo.edu/).  These initial screens may lead to diffraction 
quality crystals or may indicate where follow-up experiments should be directed from the 
observation of some form of crystalline material (‘hits’) in a particular solution.  The realistic 
goal of the initial screen is to find areas in the crystallization search space where protein crystals 
are obtained and then further optimized for quality.  The follow-up experiments (optimization) 
usually narrow down the ranges/levels of two to three variables examined around the ‘hits,’ 
trying to produce one large good quality crystal, i.e. Grid screens. 
Historically, crystallization conditions were initially searched in a lab specific manner 
with individual researchers having their own preference for reagents and conditions.  This 
changed with the development of the sparse matrix crystallization screens by Jancarik and Kim 
(1991).  These screens were designed using conditions that had succeeded in crystallizing other 
proteins as compiled from the literature, initially sampling pH values approximately every 1.0 
unit from 4.5 to 8.5 (4.6, 5.6, 6.5, 7.5, and 8.5).  In this method, a large number of conditions are 
examined by varying the partial combinations of the concentrations and type of salt, buffer, and 
precipitants.  These screens caught on and were commercialized and are currently used by many 
researchers due to their ease of use and proven track record.  However, this approach is more of a 
‘one-size-fits all’ approach, assuming that all proteins will follow a similar pattern.  Since then, 
other researchers have developed and published their own sparse matrix screens (Doudna et al., 
1993; Cudney et al., 1994; Zeelen et al., 1994; Scott et al., 1995; Harris et al., 1995; Brzozowski 
and Walton, 2001; Radaev and Sun, 2002; Iwata, 2003; Majeed et al., 2003; Tran et al., 2004; 
Gao et la., 2005; Radaev et al., 2006). 
Others have taken a more mathematical/statistical approach to crystallization screen 
design.  These approaches typically design screens composed of an ordered selection from the 
experimental parameter space.  These approaches include the factorial and incomplete factorial 
experiments (Carter and Carter, 1979; Carter et al., 1988; Sedzik, 1995; Shieh et al., 1995), along 
with orthogonal arrays (Kingston et al., 1994), or Bayesian approaches (Hennessy et al., 2000).  
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The complete factorial experiment samples every combination of available parameters, which is 
typically not feasible in terms of time, cost, and protein volume.  The incomplete factorial takes 
an ordered subset of the complete factorial.  After coding the results, including the failures, 
statistical analysis is performed to identifying the important solution parameters that are involved 
in forming a high-quality crystal. 
Bayesian approaches examine the occurrences of each solution parameter in other 
proteins (Hennessy et al., 2000; Rupp and Wang, 2004).  Again, these proteins can have varying 
degrees of similarity to the protein of interest.  These successes are tabulated and used as priors 
to predict the probability of success for a new protein.  These probabilities can be combined over 
multiple features. 
Reducing the time spent in searching areas for crystallization conditions that are not 
likely to produce crystals would increase the chances of yielding a high quality crystal.  Focusing 
more attention on the areas that have a higher probability of yielding crystals can do this.  A 
unique approach for optimization was presented recently by DeLucas et al. (2003).  They used 
the results of incomplete factorial experiments and fed the coded results into a neural network, 
which was then used to predict the outcomes of experimental conditions not previously seen by 
the trained neural network.  The trained neural network correctly predicted crystallization 
conditions for the test set conditions in all cases.  This approach again shows the importance of 
negative examples, i.e. no crystals or the presence of phase transitions, which are used in training 
the neural networks. 
2.5 METHODS TO INCREASE THE PROBABILITY OF GROWING A CRYSTAL 
There are several methods that have been used to increase the probability of growing a crystal.  
The most widely used method is to simply use the crystallization solution conditions that have 
worked previously for other proteins (sparse-matrix approach; Section 2.5.1).  Another method 
used is to observe the protein’s phase behavior as a function of varying solution parameters, such 
as the protein and precipitating agent concentrations, which can then be used to create a phase 
diagram.  This diagram can then indicate what concentration values may be more suited for 
forming (nucleation) and growing crystals (Section 2.5.2).  Alternatively, the protein-protein 
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interactions in the liquid phase are measured using light scattering techniques (Section 2.5.3).  
Although these methods have proven useful for identifying the conditions that can lead to the 
formation of crystals, the creation of a phase diagram and light scattering studies are not 
routinely performed.  One reason is that these two methods require the use of the protein sample, 
which may be in short supply. 
2.5.1 Crystal Screens 
Since Jancarik and Kim’s original sparse matrix screen, others have developed more specific 
sparse matrix screens for RNA (Doudna et al., 1993; Scott et al., 1995 Golden et al., 1997), 
immunoglobulins (Harris et al., 1995), enzymes (Brzozowski & Walton, 2001), protein-protein 
complexes (Radaev & Sun, 2002; Radaev et al., 2006), and membrane proteins (Iwata, 2003).  
These studies and others demonstrated that particular classes of macromolecules have a 
preference for solution conditions that lead to successful crystallization (Samudzi et al., 1992; 
Farr et al., 1998; Hennessy et al. 2000; Jurisica et al., 2001; Gilliland et al. 2002; Kimber et al. 
2003; Goh et al., 2004; Rupp and Wang, 2004). The successful experimental conditions that have 
been used to grow the crystal can often be found in the literature, the Biological Macromolecule 
Crystallization Database (BMCD; Gilliland et al., 1994), or the PDB.  Most successful 
conditions are listed within the published article where the 3D structure was first described.  
However, it would take a huge amount of effort to obtain all of this information from free text, 
including a large amount not available in electronic format. 
Gary Gilliland, who manually extracted the information from the published literature into 
his notebook, originally created the BMCD in the late 1980’s, which had information on 600 
different biological macromolecules (Gilliland, 1988).  The BMCD contains detailed information 
on the conditions (solution and environmental) used to grow the crystals.  This effort has been 
abandoned as no new crystal entries have been deposited into the BMCD since 1997.  Since that 
time, the PDB has been including fields for crystallization solution parameters. 
However, the value of using the BMCD for crystallization screen design was shown in 
later studies.  Using the BMCD, certain classes or families of proteins were shown to have a 
tendency to crystallize under a more narrow range of environmental conditions (Samudzi et al., 
1992; Farr et al., 1998; Hennessy et al. 2000).  For example, Hennessey et al. (2000) found that 
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proteins they described as ‘ligand binding proteins’ and ‘enzymes’ had significantly different 
crystpH   distributions.  This prior knowledge is encoded as Bayesian priors and used to generate 
probability distributions for various solution parameters, including pH and temperature.  These 
probabilities are further combined over multiple crystallization variables as more data, both 
positive and negative, is collected.  The solution probabilities are then rank-ordered by the 
probability of successfully obtaining a crystal suitable for diffraction studies to suggest regions 
in the crystallization search space more likely to produce well-ordered crystals.  These rank-
ordered conditions can then be chosen for the initial crystallization attempts.  This is 
accomplished by selecting the conditions that have a higher probability in generating crystals.  
Even a collection of weak predictors is informative and can aid in crystallization design 
(Hennessy et al., 2000). 
Information on a limited number of crystallization parameters can also be found in the 
PDB.  Each structure within the PDB has a set of standard information collected, including a 
limited set of crystallization parameters, and put into a file, the macromolecular Crystallographic 
Information File (mmCIF), which provides standard annotations for data uniformity.  The 
experimental conditions that have been used to grow the crystal are starting to appear more 
frequently in the mmCIF files (Table 2.2); however, most are still optional (Bourne et al., 1997).  
The crystpH  is the most recorded crystallization parameter for PDB structures solved by X-ray 
diffraction, 21,602/26,995 (80%) on 11/14/2005.  The crystpH  is obtained from the 
__exptl_crystal_grow.pH field of the mmCIF file (Table 2.2a).  Other experimental parameters, 
such as the method and temperature, may be listed within the __exptl_crystal_grow or 
__exptl_crystal_grow_comp fields.  The __exptl_crystal_grow.detail field is in the form of free 
text, while the __exptl_crystal_grow_comp field contains more structured text components, such 
as the component name, concentration, and volume (Table 2.2b).  However, these fields are still 
optional and not highly populated. 
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Table 2.2 mmCIF (macromolecular Crystallography Information File) specifications for crystallization conditions 
(http://ndbserver.rutgers.edu/mmcif/). 
 
(a)  __exptl_crystal_grow 
 
Item Name Mandatory Code 
Example Entry 
_exptl_crystal_grow.crystal_id Yes 1 
_exptl_crystal_grow.apparatus No Linbro plates 
_exptl_crystal_grow.atmosphere  No Room air 
_exptl_crystal_grow.details  No  
_exptl_crystal_grow.method  No Hanging drop 
_exptl_crystal_grow.method_ref  No McPherson et al., 1988 
_exptl_crystal_grow.pH  No 5.5 
_exptl_crystal_grow.pressure  No  
_exptl_crystal_grow.pressure_esd  No  
_exptl_crystal_grow.seeding  No macroseeding 
_exptl_crystal_grow.seeding_ref  No Stura et al., 1989 
_exptl_crystal_grow.temp  No 298 
_exptl_crystal_grow.temp_details  No ? 
_exptl_crystal_grow.temp_esd  No  
_exptl_crystal_grow.time  No 2-4 days 
 
(b) __exptl_crystal_grow.comp fields 
 
Item Name Mandatory Code 
Example 
_exptl_crystal_grow.comp.conc No 0.1 ml 
_exptl_crystal_grow.comp.crystal_id Yes 1 
_exptl_crystal_grow.comp.details No in 3 mM NaAzide 
_exptl_crystal_grow.comp.id Yes 1 
_exptl_crystal_grow.comp.name No Acetic acid 
_exptl_crystal_grow.comp.sol_id No Solution A 
_exptl_crystal_grow.comp.volume No 0.1 ml 
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2.5.2 Phase Diagrams 
Another method that may guide the crystallographer to selecting solution conditions that have a 
higher probability of generating crystals, but is not yet common practice, is the creation of a 
phase diagram (solubility diagram; Odahara et al., 1994; Saridakis et al., 1994; Shaw Stewart and 
Khimasia, 1994; Galkin and Vekilov, 2001; Santesson et al., 2003; Saridakis and Chayen, 2003; 
Asherie, 2004; Collins et al., 2004; Saijo et al., 2005; Sommer and Larson, 2005; Vivares et al, 
2005).  A phase diagram typically displays the resulting phase (solid, liquid, etc.) of the target 
protein as a function of 2-3 solution parameters, often the protein’s concentration by the 
precipitating agent’s concentration. 
A phase diagram allows a researcher to determine the target protein’s solubility curve, 
which represents the border between undersaturation and supersaturation.  Along the solubility 
curve, the protein in the liquid phase is at equilibrium with the solid phase (precipitate or 
crystal).  In areas below the solubility curve (undersaturation), crystals will not form, because the 
protein is stable in the liquid phase.  However, in areas above the solubility curve, there is more 
protein in the liquid phase than the system can contain at equilibrium, which causes some of the 
protein to form a solid phase until equilibrium is reached.   
There are three areas of interest above the solubility curve, the precipitation, nucleation, 
and metastable zones.  At very high levels of supersaturation, precipitate will spontaneously 
form in the solution, the precipitation zone.  The nucleation zone occurs at slightly lower levels 
of supersaturation, where crystals will form (nucleate).  This is the area that needs to be found 
for successful crystallization.  Depending upon the level of saturation within this area, there 
could be a few or many crystal forming.  In the metastable zone, which is immediately above the 
solubility curve, crystals cannot form, but they can grow.  Knowledge of the supersaturation 
zones should increase the probability of generating protein crystals. 
From the various observations of phase transitions of the test protein, the borders between 
the saturation zones are assessed.  These observations can suggest areas of supersaturation that 
are more likely to generate crystals, i.e. where nucleation takes place.  Nucleation is usually 
preceded by the formation of a metastable liquid-liquid phase separation.  This involves the 
formation of a droplet that has a high protein concentration and the remaining solution that has a 
low protein concentration.  It is within this droplet that the nucleation of a crystal takes place 
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(Haas and Drenth, 1999).  Alternatively, regions where the protein is undersaturated (no 
observed phase separation) should be avoided, because these conditions are unlikely to yield 
crystals in a timely manner.  However, the creation of a phase diagram is tedious and requires the 
use of the protein sample, which may be in short supply. 
2.5.3 Light Scattering 
Light scattering techniques are another experimental method that is used as a pre-screening 
method and can explain protein crystallization behavior.  These methods measure the 
interactions of protein in the liquid phase and can indicate whether the solution in which a 
protein resides can produce crystals (Kam et al., 1978).  The two most popular methods are 
dynamic light scattering (DLS) and static light scattering (SLS).  For both of these methods, the 
scattering of light through the protein solution is measured using different protein concentrations 
at either a fixed (DLS) or different (SLS) scattering angles.  Due to their tedious nature and use 
of protein, which may be in short supply, these methods are not routinely performed prior to the 
initial crystallization attempts. 
Dynamic Light Scattering (DLS) measures the dispersity of the protein in the liquid 
phase.  Depending upon the amount of light scattered, this measurement gives an indication of 
the aggregation state of the protein molecules, indicating whether there are different sized protein 
aggregates.  If only one size aggregate is present (monodisperse), there is a higher probability of 
crystallization.  However, if more than one size of aggregate is present in the solution 
(polydisperse), crystals generally will not form.  Additionally, an interaction parameter is 
calculated which signifies whether the interactions between molecules are attractive (negative 
values) or repulsive (positive values).  This technique can also be used to test individual 
additives, whether they increase or decrease the aggregation, to give an idea whether the additive 
may promote crystallization (Veesler and Boistelle, 1999; Wilson, 2003). 
Another light scattering technique that has been used successfully to determine whether a 
solution can promote crystallization is Static Light Scattering (SLS).  SLS is used to measure the 
second virial coefficient (B22), which is a dilute solution parameter that gives a measure of the 
adhesive hard sphere potential between two protein molecules.  Similar to the measurement of 
polydispersity by DLS, negative B22 values indicate an attractive interaction between protein 
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molecules in the liquid phase, while positive values indicate a repulsive interaction.  George and 
Wilson (1994) measured the B22 of nine different proteins in solutions that grew crystals and 
discovered that using a wide range of precipitating agents, crystals formed only in a narrow 
region of slightly negative B22 values (-1x10-4 to – 8x10-4 moles*milliliters/gram2), the 
‘crystallization slot,’ where protein molecules are slightly to moderately attractive.  Interactions 
that are more negative have a greater probability of forming amorphous precipitate than crystals.  
There is also some variation within the crystallization slot, with fewer larger crystals being 
formed at the more positive end of the slot and many small crystals being formed at the more 
negative end (Wilson, 2003).  This method was also shown to work with membrane proteins 
(Hitscherich et al., 2000), a special subset of proteins that are difficult to crystallize. 
In addition to its use for predicting crystallization conditions, a correlation between B22 
and solubility was also demonstrated for a number of proteins, including lysozyme (Rosenbaum 
and Zukoski, 1996; George et al., 1997; Guo et al., 1999; Piazza and Pierno, 2000), ovalbumin 
(Guo et al., 1999; Demoruelle et al., 2002), and serum albumin (George et al., 1997; Demoruelle 
et al., 2002).  This correlation matches quite well between the ‘crystallization slot’ of B22 and the 
observed liquid-liquid phase separation (Haas and Drenth, 1999).  The second virial coefficient 
(B22) depends strongly on the solution pH and ionic strength (Haynes et al., 1992).  This method 
has been suggested to replace the direct measurements of solubility, which can often be 
laborious.  
2.5.4 This Dissertation 
Similar to the other methods discussed in Sections 2.5.1-2.5.3, this dissertation aims to increase 
the probability of forming a protein crystal in the initial screen.  However, unlike the creation of 
a phase diagram (Section 2.5.2) or using light scattering techniques (Section 2.5.3), the methods 
discussed here use no protein sample.  The methods used here are purely computational.  Any 
method that increases the probability of crystal formation, should decrease the time and cost of 
the structure determination process.  The unique approach presented here attempts to use protein 
sequence information to suggest the most likely pH regions, which if successful  should increase 
the probability of obtaining a crystal.  This is unlike the typical screening procedures, which 
generally use a one-size-fit all approach (Section 2.5.1).  The resulting knowledge can also be 
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used to gain insight into the crystallization process and explain the idiosyncratic nature of 
proteins (why some solution conditions are more effective at generating crystals for certain 
proteins than others). 
2.6 TYPES OF CRYSTALLIZATION VARIABLES 
In order to begin to understand the crystallization process, one must first understand the types of 
variables that are involved and are available.  McPherson (1999) lists thirty-six variables that are 
believed to play an important role in the crystallization process that were listed in Table 1.1.  
These variables are broken down further into two types of crystallization variables that will be 
examined and discussed, Givens/Features (Section 2.6.1) and Controllables (Section 2.6.2).  The 
results from any crystallization experiment are the Observables (Section 2.6.3).  Knowledge of 
these variables and their interactions should help in obtaining a desirable outcome, the formation 
of a crystal suitable for diffraction studies. 
2.6.1 Givens 
Givens refer to those variables that are known or can be estimated prior to any 
crystallization attempts.  Most of the features listed in the Biochemical section of Table 1.1 
would be considered Givens.  The Givens examined in this dissertation include Features about 
the protein and previously successful experimental conditions.  The Primary Given Feature for 
protein crystallization is the amino acid sequence, which is available from the PDB.  From a 
protein’s amino acid sequence, other biophysical properties can be calculated or estimated, such 
as the molecular weight, estimated titration curve, and the pIest, which are not present in the 
PDB, Hidden Features.  Determining the importance of each Feature in the crystallization 
process could lead to a better understanding of the process as a whole and could possibly be used 
for improving the success rate for future crystallization attempts. Currently, no one has 
demonstrated a useful correlation between a protein's biophysical properties (Features) and the 
specific solution conditions used for crystallization (Controllables), although several researchers 
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have suggested that there should be a link between the two (Heinemann et al., 2000; Kimber et 
al., 2003; Canaves et al., 2004; Rupp and Wang, 2004; Bussow et al., 2004).  However, there 
have been some recent studies showing that a protein's biophysical properties can give an idea as 
to whether a protein is amenable to each step in the structural determination process (Section 
2.2). 
2.6.2 Controllables 
Controllables refer to the variables that are manipulated in the experiment.  These include the 
pH, temperature, type of precipitating agent, and concentration.  A more complete list is found in 
the Physical and Chemical fields of Table 1.1.  As mentioned previously, most of these variables 
are not present within the major structural databases and are usually only found within individual 
laboratory notebooks.  The solution pH was the initial Controllable examined, because of its 
known importance to the crystallization process and being the most reported crystallization 
solution condition.  Because the solution pH largely controls the charge of the protein, as 
demonstrated by the estimated titration curve, the estimated net charge (Q ) and related variables 
(the estimated specific charge and estimated average surface charge density) can also be 
considered as Hidden Controllables.  If enough data was available in the PDB any Controllable 
can be examined. 
2.6.3 Observables 
Observables refer to the experimental observations resulting from the interactions of Features 
and Controllables, i.e. one experimental well/setup.  The results of a given experiment (i.e. well) 
could be in the form of success or failures, i.e. presence of crystal, 1=yes or 0=no or a more 
detailed crystal quality scale (Table 2.3), such as that suggested by Carter (1999).  Observables 
reported in the form of successes, as listed in the PDB, could include the resolution limit of 
diffraction (difflim), R factor, and the asymmetric unit composition (number of chains and the 
molecular weight), which may be different than the biological unit.  A good example is presented 
at the PDB website (http://www.rcsb.org/pdb/ biounit_tutorial.html) using hemoglobin, which 
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has a biological unit composed of four protein chains.  However, the crystal’s asymmetric unit 
can be composed of 1 biological unit (2HHB; four chains), 2 biological units (1HHO; eight 
chains), or a portion of a biological unit (1HV4; two chains).  Observations could also be 
recorded for failures, such as the presence or absence of precipitates or phase separation.  
Because it is readily available and its use as the primary indicator of quality, the difflim was the 
only observable examined in this dissertation.  The difflim is the closest resolution that two 
objects can be determined as different. 
The distribution of crystpH , crystQ , crystQ , and crystσ  for previously crystallized proteins 
would also be considered as Given Observables, because they are known or can be estimated 
prior to any crystallization attempts for a target protein.  The goal of this dissertation was to find 
variables from sequence information (Features ), such as the amino acid composition, molecular 
weight, and pIest, which are known apriori in the lab, to predict a pH range (Controllable) that 
will result in crystallization, crystpH  (Observable), which is not known apriori in the lab. 
 
Table 2.3 An example crystal quality scale for a given experiment result (well) as suggested by Carter (1999). 
 
Observation Score 
Cloudy/Amorphous Precipitate 1.0 
Gelatinous/Particulate Precipitate 2.0 
Oils 3.0 
Spherulites 4.0 
Needles 5.0 
Plates 6.0 
Prisms 7.0 
2.7 BACKGROUND SUMMARY 
Protein crystallization still remains the most common method of determining the 3D structure of 
biological macromolecules.  However, the crystallization process is a complex event that is not 
completely understood.  The conditions that lead to the successful crystallization of one protein 
have no effect on another protein.  Currently, most researchers try a one-size-fits-all approach to 
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identifying these solution conditions.  While occasionally successful, alternative methods need to 
be developed to increase the success rate of generating a crystal suitable for X-ray diffraction 
studies.   
Similar to other methods presented in Section 2.5, this dissertation aims to increase the 
probability of obtaining a protein crystal in the initial screen.  Unlike the other methods 
discussed in Sections 2.5.1-2.5.3 that use the protein sample to determine the solution conditions 
(Controllables) most likely to produce crystals, the unique approach presented here uses protein 
sequence information (Features) to suggest the most likely pH regions to result in the formation 
of a crystal.  Additionally, the approach presented in Chapter 4 is examined on several proteins 
from the test set (Appendix C) or target proteins whose structure remains to be solved (Chapter 
7).  The results also give some insight into the crystallization process by offering plausible 
explanations (Chapter 8).  For these reasons, the time and cost of the structure determination 
process should hopefully decrease. 
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3.0  INITIAL ANALYSIS OF THE PDB 
Within the last couple of years more reported crystallization data has been available in the 
Protein Data Bank (PDB), therefore a retrospective analysis was performed to retest the 
relationship between a protein’s estimated isoelectric point (pIest) and the reported pH of 
crystallization ( crystpH ).  The long held belief that the two would be related has stemmed from 
the fact that a protein generally has its minimum solubility at the pIest (Section 2.5.1).  Because 
protein crystallization requires the reduction of protein solubility, this seemed quite logical.  
However, previous attempts (McPherson, 1999; Page et al., 2003; Kantardjieff and Rupp, 2004) 
have found little evidence of this. 
 The solution pH is known to largely exhibit its effects of controlling the charge of the 
protein (causal relationship).  Because of this, the estimated net charge at the crystpH  ( crystQ ) was 
estimated using the protein’s amino acid sequence, the assumed pKa values of the titratable 
amino acid residues, and the crystpH .  From this information, the estimated titration curve is 
calculated and the crystQ  value inferred from the curve by setting QQcryst = , where the 
crystpHpH = .  Initially, it was hypothesized that there would be a linear relationship between 
crystQ  and protein Features, particularly the molecular weight and the pIest. 
In order to examine this relationship, groups of proteins were formed on the basis of their 
asymmetric unit molecular weight (MWau) or pIest.  Then the distributions of both Given 
Features (MWau and pIest) and Given Observables ( crystpH  and crystQ ) were examined between 
the groups to determine whether there are differences in the distribution of Given Observables, 
especially the estimated net charge of the protein, based upon a protein’s molecular weight or 
pIest.  The hypothesis was that the estimated net charge (Q ) of a target protein over the pH range 
(pH 1.0-14.0) can be used to guide researchers into selecting the solution pH ranges that are 
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more likely to result in crystallization.  This can theoretically be accomplished by setting the 
solution pH (Controllable) to a value that equals the Given Observable, crystpHpH = , by using 
the solution pH that results in the Q  (Hidden Controllable) being equal to the crystQ   (Hidden 
Observable), crystQQ = . 
3.1 METHODS 
The methods used here for Feature extraction, Feature construction, and case selection 
were incorporated into the Protein Sequence-Properties Evaluation Framework (Chapter 4).  For 
more information on the process, see Chapter 4.  Version #107 of the Protein Data Bank (January 
2004) contained information on 23,792 structures.  There were 14,468 structures in version #107 
of the PDB that had a crystpH  value.  After case selection, the original list structures was reduced 
to a final data set of 11,518 proteins, labeled PDB_v107.  The PDB_v107 data set was allowed to 
contain redundant proteins.  A second data set of non-redundant PDB entries was created using 
the non-redundant PDB (nrPDB; updated 02/03/04; Holm and Sander, 1998), as described in 
Section 4.6.3.  The final nrPDB_v107 data set contained 3,957 proteins. 
After the creation of both data sets, the PDB_v107 and nrPDB_v107, various features 
were calculated as described in Section 4.5.  The slope of the estimated titration curve at both the 
pIest and crystpH  was calculated, using the pH values 0.1 above and below the pIest and their 
corresponding charge values.  In an attempt to determine whether there is a bias in the data sets, 
the distributions of variables in both data sets were compared using a Kolmogorov-Smirnov (KS) 
test (Section 4.9).  After creating variables that were not present in the original data set, the 
intercorrelations among all variables were examined using Spearman's rho (non-parametric) 
correlations (Section 4.6).  
After examining the correlation among variables, several attempts were made to group 
proteins by similarity and then examine differences in crystallization behavior, crystpH  and crystQ  
values.  Here, proteins are described as ‘similar’ by displaying similar values of their MWau, pIest 
(Section 3.2.1), or estimated titration curves (Section 3.2.2).  First, all protein structures were 
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binned into groups using their MWau (Section 3.2.1.1) or pIest (Section 3.2.1.2).  Then the 
combined effects of each variable, MW group by pIest group, was examined (Section 3.2.1.3).   
Next, the ability to use the whole estimated titration curve, rather than one point along the 
curve (pIest), was used to suggest regions of the pH search space were explored (Section 3.2.2).  
The estimated titration curves were calculated for all proteins selected from the PDB in units of 
0.2 (Figure 3.1a; Section 4.5.3).  These estimated titration curves were then clustered using self-
organizing maps (SOMs; Kohonen, 2001; Section 4.7.2.2).  This unsupervised clustering method 
appeared to accurately cluster the groups as visually judged by the titration curves; however the 
clusters primarily separated the proteins by their molecular weight, as judged by either end of the 
estimated titration curve (pH 1.0 and pH 14.0).  In order to put all titration curves on the same 
scale, each Q  value along the titration curve was scaled by subtracting the minimum Q  value 
( minQ always at pH 14.0) and divided by the difference between the maximum Q  value ( maxQ  
always at pH 1.0) and minQ  (Equation 3.1).  Thus, a scaled titration curve has a maximum Q
~  
value of 1.0 and a minimum Q~  value at 0.0 (Figure 3.1b). This would in theory allow for all 
proteins to be equally compared, removing much of the molecular weight effect. 
Equation 3.1 
minmax
min~
QQ
QQQ −
−=   
One drawback of the traditional SOM algorithm is that the user has to pre-specify the 
number of clusters usually with no prior information.  This was not an issue if a dynamic SOM is 
used, which allows the data to determine the appropriate number of clusters.  For this procedure, 
the GSOM package (Hsu et al., 2003) was used (kindly provided by Art Hsu).  Growth is 
controlled by the within cluster error and a growth threshold. When the accumulated error value 
exceeds the growth threshold within a cluster, the cluster is split into two clusters. 
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Figure 3.1.The  (a) Q  or (b) scaled estimated net charge (Q~ ) curves for PDB proteins 200L and 1EXM. 
3.2 RESULTS 
Two data sets were created and examined in the Preliminary Results to determine the effects of 
bias in the Protein Data Bank (PDB).  The two data sets only differ in the amount of redundant 
proteins within each set.  The PDB_v107 data set allows for any level of redundant proteins, 
such as the many different lysozyme mutants present in the PDB.  The second data set, 
nrPDB_v107, addresses this issue by removing redundant protein structures with a sequence 
similarity of BLAST p-value <10-80, which reduced the data set by approximately 66% (3,957 
nrPDB_v107/11,518 PDB_v107). 
First, the variable distributions between the data sets were examined.  Several variables, 
including the slope of the titration curve at both the pIest and crystpH , and the slope of the scaled 
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titration curve (SS) at both the pIest and crystpH  had negatively skewed distributions.  The 
distribution of MWau was positively skewed.  Therefore, non-parametric correlations 
(Spearman's rho) and statistical measures (Kolmogorov-Smirnov Z test) were used for analyzing 
the data.  An α-level of 0.001 was used for significance to reduce spurious significant findings 
due to the large number of cases. 
The means and standard deviations (SD) of all variables are shown in Table 3.1.  While 
there appeared to be slight differences in the mean values between the data sets, the actual 
distributions of most variables were significantly different (p<0.001).  No differences in the 
distributions of crystQ  and the slope of the titration curves at both the pIest and crystpH  were 
found.  Additionally, there should not be any differences in the random variable and indeed there 
were not.  It was not clear why the slopes of the titration curves at both the pIest and crystpH  were 
not significantly different between the data sets, while scaling the slope resulted in a significant 
difference between data sets.  The differences may be due to the MWau and pIest distributions 
being significantly different.  A significant difference between difflim distributions was also 
found.  This is not unexpected, because the nrPDB_v107 data set is comprised of the 'best' non-
redundant structures from the PDB_v107 data set. 
 
Table 3.1 Comparing the PDB_v107 and nrPDB_v107 datasets. 
 
Data Set n  MWau b pIestb 
Slope at 
pIest  b 
SS at 
pIest b cryst
pH a 
Slope at 
crystpH
b 
SS at 
crystpH
b crystQ
b difflim a 
Random
Number
PDB_ 11,518 Mean 67.7 6.4 -14.5 -0.09 6.7 -9.0 -0.05 -5.3 2.12 0.01 
v107  SD 79.6 1.6 20.6 0.06 1.3 14.2 0.04 24.5 0.48 1.00 
nrPDB_ 3,957 Mean 65.1 6.3 -15.1 -0.09 6.7 -9.3 -0.05 -5.2 2.08 0.00 
v107  SD 82.9 1.7 21.6 0.06 1.3 15.4 0.05 25.6 0.51 1.02 
KS  Z 3.0 2.8 1.6 4.4 2.2 1.7 5.6 0.8 2.6 1.1 
Test c  p< 0.0001 0.0001 0.009 0.0001 0.0002 0.007 0.0001 0.485 0.0001 0.153 
a Extracted from the PDB  
b Calculated using sequence information 
c Variables distributions were considered as being significantly different if p <0.001 as determined by a KS Test. 
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The crystpH  histograms for both the PDB_v107 (n = 11,518) and nrPDB_107 (n=3,597) 
data sets are shown in Figure 3.2b.  From the histograms, a saw-tooth pattern was observed at 
approximately every 0.5 pH unit from pH 4.5-9.0.  There appears to be little differences between 
the two graphs except a larger peak at pH 4.5 for the PDB_v107 data set.  This is believed to be 
caused by the preponderance of lysozyme structures within the full data set.  Many of these 
proteins and their mutants had a crystpH  of 4.5.  The distribution of pIest also demonstrated 
interesting differences (Figure 3.2a).  Although these figures show many similarities, there are 
two points in the PDB_v107 data set that stand out, peaks at a pIest of 9.0 and 10.1.  These values 
correspond to the estimated pI values for hen egg white lysozyme and T4 lysozyme, respectively.  
It was thought that this would be a potential bias, so further analysis primarily focused on the 
nrPDB_v107 data set. 
After detecting a potential bias in the full data set, the intercorrelations were examined 
between the Given Features and the Given Observables for the nrPDB_v107 data set (Table 3.2).  
Givens refer to the variables that are known prior to any crystallization attempts in the lab 
(Section 2.6.1).  Such variables would include a protein's biophysical properties (MWau, pIest, 
slope of the estimated titration curve at the pIest, and the slope of the scaled titration curve at the 
pIest).  The Given Observables refer to the solution conditions that have succeeded in 
crystallizing proteins as reported in the PDB.  The primary Observable is the crystpH , which can 
also be used with the local Feature (primary amino acid sequence) to calculate some Hidden 
Features, such as the estimated net charge, slope of the titration curve, and scaled slope of the 
estimated titration curve, along with some Hidden Observables, such as the crystQ .  The 
resolution limit of diffraction (difflim) is an Observable, which is a quality outcome measure. 
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Table 3.2 The Spearman’s rho correlation values for the variables examined using the PDB_v107 data set (black 
font) or the nrPDB_v107 data set (red font). 
 
Variable MWau pIest 
Slope at 
pIest 
SSa at pIest crystpH  
Slope at 
crystpH  
SS a at 
crystpH  cryst
Q  difflim 
Random 
# 
MW (kDa)  -0.043 -0.692** 0.189** 0.092** -0.644** 0.084** -0.252** 0.357** -0.009 
pIest -0.134**  0.402** 0.524** 0.061 0.058 0.031 0.661** 0.017 -0.024 
Slope at pIest -0.674** 0.439**  0.510** -0.024 0.518** -0.007 0.440** -0.258** -0.012 
SS a at pIest 0.230** 0.439** 0.494**  0.074** -0.073** 0.071** 0.301** 0.078** -0.038 
crystpH  0.096** 0.046** -0.038** 0.069**  0.336** 0.566** -0.475** 0.049 0.003 
Slope at 
crystpH  
-0.644** 0.090** 0.479** -0.125** 0.312**  0.658** -0.018 -0.231** 0.009 
SS a at 
crystpH  0.084** -0.008 -0.049** 0.040** 0.538** 0.657**  -0.305** 0.048 -0.004 
crystQ  -0.290** 0.677** 0.459** 0.265** -0.483** -0.007 -0.323**  -0.086** -0.017 
difflim 0.391** -0.055** -0.275** 0.109** 0.067** -0.235** 0.078** -0.139**  -0.019 
Random # -0.008 -0.008 0.012 0.003 -0.001 0.010 0.006 0.000 0.008  
a SS = scaled slope, where the maximum and minimum values for the estimated titration curves were 1 and 0, respectively. 
b Any correlation greater than 0.20 or less than -0.20 is in bold, while any correlation greater than 0.5 or less than -
0.5 are additionally highlighted. 
** p-value <0.0001 
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(a) 
 
(b) 
 
 
Figure 3.2: The frequency distributions for (a) pIest and (b) crystpH  for both data sets. 
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The protein's MWau was highly correlated with measures based on the estimated titration 
curve, slope of the titration curve at both the pIest (r = -0.674) and the crystpH  (r = -0.644) as 
demonstrated in Table 3.2. 
3.2.1 Binning Proteins 
The PDB provides the amino acid sequence of all protein chains in the structure’s asymmetric 
unit.  From this list, various variables are calculated, including the MWau and the estimated 
titration curve, from which the pIest is obtained.  The effects of molecular weight (MWau) and 
pIest on the crystpH  were examined by grouping proteins with 'similar' values of each individual 
variable.  It was thought that proteins with 'similar' MW or pIest values would crystallize under 
similar conditions, including the solution pH.  Because the solution pH controls the protein’s Q , 
the estimated net charge at the crystpH  ( crystQ ) was also examined.  Due to differences in the full 
and non-redundant data sets’ distributions, only the nrPDB_v107 data set was used here.  
Scatterplots demonstrate the relationships between the MWau, the pIest, the crystpH , and the crystQ  
(Figure 3.3).  As previously demonstrated in Table 3.2, little correlation was found between 
MWau x crystpH  (Figure 3.3a) and pIest x crystpH  (Figure 3.3b).  However, a much stronger 
correlation was observed between MWau x crystQ  (Figure 3.3c).  Lower MW proteins had a crystQ  
distribution more tightly centered on zero.  As the proteins grew in size, the crystQ  values spread 
out in both the negative and positive directions.  An interesting pattern was also observed for the 
scatterplot of pIest x crystQ , which were also significantly correlated (Figure 3.3d).  Proteins with a 
pIest around 7.0 have a crystQ  near zero.  As the pIest increased, the crystQ  became more positive, 
while the crystQ  became more negative if the pIest decreased below 7.0.  A high correlation was 
also observed between crystpH  and crystQ  (Figure 3.3e).  Proteins with a high crystpH  are more 
negatively charged, while proteins with a lower crystpH  generally had a positive crystQ .  The 
interesting patterns of MWau and pIest with crystQ  indicated that these Features might be able to 
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predict more probable crystQ  values that result in the formation of crystals.  Therefore, various 
groups of proteins were formed based upon their MW and pIest values and differences were then 
examined in their crystQ  distributions. 
3.2.1.1 Binning by MW 
Proteins were binned into several groups based upon their MWau, pIest, or estimated titration 
curve.  The first method examined simply binning the nrPDB_v107 by their ln(MW) distribution 
into three groups, 'Small,' 'Average,' and 'Large.'  The ln(MW) distribution was chosen over the 
MW distribution, because the ln(MW) distribution was relatively normal compared to the highly 
skewed MWau distribution.  A protein was considered 'Average' if its ln(MW) value was within 
one standard deviation (SD) of the mean value based on all 3,957 proteins.  'Small' proteins were 
those with a ln(MW) value greater than 1 SD below the mean, while 'Large' proteins were those 
whose ln(MW) value was greater than 1 SD above the mean.   
When the nrPDB_v107 proteins were separated into three groups by their size, ln(MWau), 
no significant differences were observed in their pIest and random number distributions (Table 
3.3a).  The random number distribution, which served as an internal control, had no differences 
as expected.  Although no differences were found with the pIest distributions, significant 
differences were found between all slopes (scaled or not) of the estimated titration curves at both 
the pIest and crystpH .  Although pIest is not affected by the size of the protein, the shape of the 
titration curve is.  As the proteins grew larger, the slope at the titration curve at both the pIest and 
crystpH  became increasingly negative.  This also corresponds to different shaped scaled titration 
curves.  Because a larger protein can have more charged residues, they can take on a greater 
range of Q  values and hence crystQ  values, which were also significantly different between MW 
groups.  Differences were also found in the crystpH  and difflim distributions.  Smaller proteins 
were found to crystallize under significantly lower experimental pH conditions.  As the proteins 
grow larger, the difflim increased.  This last finding is well described in the literature and also 
served as an internal control.  Not finding this correlation would lead to more questions about the 
analysis. 
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The next method split the 'Small' and 'Large' proteins into an additional group each, 
creating five ln(MW) groups.  If the protein was greater than 2 SD below or above the mean 
ln(MW) value, the protein was labeled as 'Very Small' or 'Very Large,' respectively.  The five 
MW group results were very similar to that of the three MW groups (Table 3.3b).  Again, no 
differences were found in the distributions of the pIest or the random number.  The slopes at both 
the pIest and crystpH  were significantly different for each group, as the values become 
increasingly negative as the size increases.  This same pattern was also observed for the crystQ  
distributions.  Additionally, sporadic differences were observed in the slopes of the scaled 
titration curves at both the pIest and crystpH .  This led us to question whether the scaled titration 
curves were indeed removing the effects of molecular weight.  Similar effects of size on the 
difflim distributions were also observed with the 5 ln(MW) groups, with each group having a 
significantly different difflim distribution with the smaller proteins having a better difflim, i.e. 
lower values.  Now, it became apparent that the 'Very Small' proteins were the ones that had a 
low crystpH , 5.9±1.2.  All other groups had a mean crystpH  between 6.5-6.8.  There were also 
some slight differences between the other MW groups and the crystpH , with the 'Small' proteins 
reportedly crystallized at slightly more acidic conditions than the 'Average' or 'Large' groups. 
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Figure 3.3: Scatterplots of the nrPDB_v107 data showing the distributions of the  MW, pIest, crystpH , and crystQ . 
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Table 3.3 The mean and standard deviation (SD) of the examined variables for each of the nrPDB_v107 groups 
separated by their MWau into either (a) three or  (b) five groups. 
 
 (a)  3 MW groups 
 
MWau 
Group n  pIest 
Slope at 
pIest 
SS at 
pIest cryst
pH  Slope at 
crystpH  
SS at 
crystpH
b crystQ  difflim a 
Random 
Number 
Mean 6.4 A -4.5 A -0.12 A 6.4 A -2.5 A -0.06 A -0.5 A 1.8 A 0.0 A Small 656 
SD 2.0 3.3 0.08 1.4 2.5 0.06 6.8 0.4 1.0 
Mean 6.3 A -11.6 B -0.09 B 6.7 B -7.1 B -0.05 B -3.3 B 2.1 B 0.0 A Average 2,670 
SD 1.7 9.6 0.06 1.3 7.5 0.05 15.8 0.5 1.0 
Mean 6.1 A -40.6 C -0.07 C 6.8 C -25.6 C -0.05 C -17.9 C 2.4 C 0.0 A Large 631 
SD 1.3 41.5 0.05 1.2 30.0 0.04 53.1 0.6 1.0 
KW  x2 1.2 1354.2 118.7 28.6 1204.4 21.7 173.8 344.0 0.2 
Test  p< 0.539 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.918 
 
b) 5 MW groups 
 
MW 
Group n MWau pIest 
Slope at 
pIest 
SS at 
pIest cryst
pH  Slope at 
crystpH  
SS at 
crystpH   cryst
Q  difflim Random
Mean 6.5 A 6.3 A -2.4 A -0.10 A 5.9 A -1.4 A -0.07 AB -0.4 A 1.6 A 0.0 A Very 
Small 78 SD 1.0 1.9 2.1 0.09 1.2 1.5 0.06 4.2 0.5 1.1 
Mean 13.2 B 6.4 A -4.8 B -0.12 B 6.5 B -2.6 B -0.06 A -0.5 B 1.9 B 0.0 A 
Small 575 
SD 2.6 2.0 3.3 0.07 1.4 2.6 0.06 7.1 0.4 1.0 
Mean 47.2 C 6.3 A -11.6 C -0.09 C 6.7 C -7.1 C -0.05 B -3.3 C 2.1 C 0.0 A 
Avg. 2,674 
SD 22.5 1.7 9.6 0.06 1.3 7.5 0.05 15.8 0.5 1.0 
Mean 148.2 D 6.2 A -31.2 D -0.07 D 6.8 C -19.8 D -0.05 C -13.2 D 2.4 D 0.0 A 
Large 529 
SD 36.9 1.3 23.4 0.05 1.2 19.6 0.04 39.3 0.5 1.0 
Mean 445.3 E 6.0 A -90.0 E -0.07 D 6.8  BC -55.8 E -0.05 BC -43.1 E 2.6 E 0.0 A Very 
Large 101 SD 204.6 1.2 70.7 0.04 1.2 50.6 0.04 93.9 0.7 1.1 
KW  x2 2713.5 2.10 1393.9 126.1 45.2 1243.2 21.5 192.2 356.7 0.29 
Test p< 0.0001 0.717 0.0001 0.0001 0.0001 0.0001 0.0003 0.0001 0.0001 0.990 
Note: Groups labeled with different letters (A, B, C, D, or E) have significantly different distributions (p<0.01) as 
determined by a KS Test. 
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3.2.1.2 Binning by pIest 
A similar method of discretization was used for the protein’s pIest.  Initially, the general 
description of 'Acidic,' 'Neutral,' and 'Basic' proteins was taken from Ries-Kautt and Ducruix 
(1999).  Proteins were considered 'Neutral' if their pIest was between 6.0 and 8.0.  Those proteins 
with a pIest ≤ 6.0 were labeled 'Acidic,' while those with a pIest ≥ 8.0 were labeled 'Basic.'  As 
seen in Table 3.4, the majority of proteins were considered 'Acidic' (53.6%), while another 
sizable portion of proteins were 'Neutral' (26.7%).  Only a small portion of the proteins were 
labeled as 'Basic' (19.7%).  This was also observed in the Baseline pIest distribution (Figure 3.2a). 
 
Table 3.4 Discretization of the nrPDB_v107 proteins by their pIest. 
 
pIest 
Group 
n  MW 
Slope at 
pIest 
SS at pIest crystpH  
Slope at 
crystpH  
SS at 
crystpH  
crystQ  difflim 
Random 
Number 
Mean 70.0 A -20.3 A -0.12 A 6.6 A -10.3 A -0.06 A -14.6 A 2.1 A 0.0 A 
Acidic 2,122 
SD 91.2 26.5 0.06 1.3 17.7 0.05 26.2 0.5 1.0 
Mean 68.8 A -8.4 B -0.04 B 6.7 A -9.7 A -0.05 B 0.8 B 2.1 A 0.0 A 
Neutral 1,057 
SD 80.5 10.4 0.03 1.2 13.4 0.04 16.8 0.5 1.0 
Mean 46.7 B -9.8 C -0.09 C 6.7 A -5.8 B -0.05 C 12.4 C 2.0 A 0.0 A 
Basic 778 
SD 55.4 12.3 0.06 1.3 9.2 0.04 21.9 0.5 1.1 
KW  x2 103.2 660.8 1280.4 5.3 122.0 29.0 1629.3 7.6 1.7 
Test  p< 0.0001 0.0001 0.0001 0.072 0.0001 0.0001 0.0001 0.022 0.424 
Note: Groups labeled with different letters (A, B, or C) have significantly different distributions (p<0.01) as 
determined by a KW Test and followed by a KS Test if significantly differences were found. 
 
No statistically significant differences were observed in the crystpH , difflim, or random 
number distributions.  The 'Basic' proteins were also smaller, averaging only 47 kDa, while the 
'Acidic' and 'Neutral' proteins were considerably larger, ~70 kDa.  Differences were also 
observed in the slopes of the titration curves at both the pIest and crystpH .  The 'Acidic' proteins 
had a much steeper slope at the pIest than did the other two groups.  This might be expected as the 
pKa values of Aspartic Acid and Glutamic Acid are 3.65 and 4.25 respectively.  This causes the 
titration curves to decrease rapidly around these pH values.  Again, the differences in the titration 
curve carried over to the scaled titration curves, which were significantly different between all 
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pIest groups.  Finally, while no differences were observed in crystpH  distributions, significant 
differences in the crystQ  distributions were observed between each pIest group.  'Acidic' proteins 
were crystallized with a global net negative charge, while 'Basic' proteins were generally 
crystallized with a net positive charge.  Neutral proteins were crystallized with a net charge near 
zero, the isoelectric point.  This was not surprising given the different curves for these pIest 
groups.  A majority of the estimated titration curve was negative for 'Acidic' proteins, while 
'Basic' proteins had a large range of positively charged values.  This led us to investigate 
separating the proteins by their titration curve, rather than one point along the curve, the pIest. 
3.2.1.3 Binning by pI x MW  
After observing differences in variables based upon separation of proteins by their MW or pIest, 
proteins were separated into groups based upon the combination of their size and pIest.  For this 
analysis the three ln(MW) Groups (Section 3.2.1.1) and three pIest Groups (Section 3.2.1.2) were 
used.  The cross product, ln(MW) x pIest, resulted in the formation of 9 groups (Table 3.5).  The 
number of proteins in each group was quite variable, with the 'Average Acidic' group containing 
36% of the proteins and the 'Large Basic' group containing only 1.8%. 
For this analysis, only the crystpH  and crystQ  results are presented (Table 3.6).  Similar to 
the previous analysis, sporadic differences are observed in the crystpH  distributions among 
groups.  All groups based on a similar size, such as 'Small,' have similar crystpH  distributions 
regardless of the pIest group.  However, when the crystQ  distributions were examined, significant 
differences were found among all groups. This led us to believe that the crystQ  is an important 
crystallization variable that could be used for modeling solution pH conditions. 
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Table 3.5 Discretization of ln(MWau) and pIest variables within the nrPDB_v107 data set.  (a) The number and 
percentage of proteins in each group when each size group was crossed with each pIest group.   
 
ln(MWau) Bins   
pIest Bin  
Small Average Large 
Total 
Count 332 1424 366 2122 Acidic 
% of Total 8.4% 36.0% 9.2% 53.6% 
Count 152 713 192 1057 Neutral 
% of Total 3.8% 18.0% 4.9% 26.7% 
Count 172 533 73 778 Basic 
% of Total 4.3% 13.5% 1.8% 19.7% 
Count 656 2670 631 3957 Total 
% of Total 16.6% 67.5% 15.9% 100.0% 
 
 
Table 3.6 Discretization of ln(MWau) and pIest variables within the nrPDB_v107.  After detecting significant 
differences (p-value<0.01) with a KW test, a KS Test was performed pairwise for each MW x pIest Bin to detect the 
individual differences for 
crystpH  or crystQ  (shaded). 
 
 Small Acidic 
Average 
Acidic 
Large 
Acidic 
Small 
Neutral 
Average 
Neutral 
Large 
Neutral 
Small 
Basic 
Average 
Basic 
Large 
Basic 
Small 
Acidic 
 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 
Average 
Acidic 
0.001   0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 
Large 
Acidic 
0.005 0.719   0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 
Small 
Neutral 
0.258 0.005 0.003   0.0001 0.0001 0.0001 0.0001 0.0001 
Average 
Neutral 
0.0001 0.322 0.985 0.0002   0.0001 0.0001 0.0001 0.0001 
Large 
Neutral 
0.0002 0.0003 0.030 0.0001 0.004   0.0001 0.0001 0.0001 
Small 
Basic 
0.655 0.784 0.467 0.202 0.300 0.017   0.0001 0.0001 
Average 
Basic 
0.003 0.866 0.990 0.003 0.935 0.006 0.693   0.0001 
Large 
Basic 
0.034 0.115 0.507 0.006 0.461 0.896 0.170 0.385   
Note: The values presented are the p-values resulting from the KS Test. 
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3.2.2 Separating Proteins by their Estimated Titration Curve 
After determining that the slopes of the estimated titration curves were different for proteins 
separated by their MW or pIest, separating proteins by their titration curves was investigated.  For 
this method, Self-Organizing Maps (SOMs) were used (Kohonen, 2001).  For a more detailed 
explanation on SOMs, see Section 4.7.2.2.  The input into the SOM algorithm was a one-
dimensional vector for each protein representing the Q  values over a given range of pH values.  
This vector was composed of the Q  values every 0.2 pH units from 1.0-15.0.  Although a pH 
value of 15.0 is not possible, it was included so that the estimated titration curves were relatively 
flat at the end of the curve.  This was primarily due to the pKa value of Arginine, 12.48.   
Initial analysis on the estimated titration curve using SOMs basically separated the 
proteins by their MW.  The proteins were separated primarily by the initial or final values of the 
titration curve.  This led us to attempt to scale the titration curves, so each curve started at a Q  of 
1.0 and ended at a Q  of 0.0. 
Initially, the GSOM software was applied to the entire set of PDB proteins (PDB_v107) 
to cluster the estimated titration curves.  The algorithm was able to place all the proteins into a 
group of 61 clusters (Figure 3.4).  Proteins with an ‘Acidic’ pIest (pIest ≤ 6) were clustered near 
the top of the SOM, while proteins with a ‘Basic’ pIest (pIest ≥ 8) were clustered towards the 
bottom of the SOM.  Examples of some mean estimated curves from the clusters in Figure 3.4 
are shown in Figure 3.5a.  The crystpH  distributions of the ‘Acidic’ vs. ‘Basic’ proteins are 
shown in Figure 3.5b.  When the ‘Acidic’ and ‘Basic’ proteins were examined from Figure 3.5b, 
significant differences in crystpH  distributions were discovered.  This observation could lead to 
an experimental protocol such as that shown in Figure 3.6.   
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Figure 3.4: The resulting GSOM derived from the data distributed into 61 clusters. 
 
From the input of a target protein’s sequence, the estimated titration curve and the scaled 
titration curve are calculated.  The scaled titration curve would then be presented to the GSOM 
algorithm based on all proteins listed in the PDB_v107 data set.  The SOM algorithm then places 
the test protein into the cluster with the best matching curves.  This cluster or neighborhood of 
clusters could then be examined for the frequency of crystpH  values and used to intelligently 
guide the researcher for selecting pH ranges for their test protein. 
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Figure 3.5: (a) The GSOM Clusters closer together in space (Figure 3.4) have more similar estimated titration 
curves.  Clusters 28, 29, 59, and 60 are used for Group 1, while Clusters 24, 31, 33, and 54 are used for Group 2. (b) 
the 
crystpH  distributions of Group 1 and Group 2. 
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Figure 3.6 Expected flow of selecting solution pH conditions for a target protein. 
 
So far, differences were found in experimental conditions for protein structures based 
upon their size (MW) and pIest.  Another method to group proteins (SOMs) based on the 
estimated titration curve was also explored.  While exploratory, these novel findings warranted 
further analysis.  These findings have been examined in subsequent chapters by attempting to 
account for the size of the protein by dividing the estimated net charge by either the molecular 
weight in kilodaltons or estimated solvent accessible surface area in square nanometers to obtain 
an estimated specific charge curve or estimated surface charge density curve, respectively.  The 
translation from theory to the workbench will also be discussed. 
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3.3 CHAPTER SUMMARY 
A retrospective study was undertaken as an attempt to explain the behavior of proteins 
undergoing crystallization attempts.  The initial attempt focused on the crystpH , because it is the 
most widely reported experimental crystallization variable available in the Protein Data Bank 
(PDB).  The crystpH  values were obtained for proteins by extracting the information from each 
protein structure's mmCIF file.  Two data sets with different levels of redundancy were created 
from the available data in version #107 of the PDB.  The first data set consisted of all protein 
structures that had a crystpH  with some added constraints, such as the length being greater than or 
equal to 20 amino acids and removing all membrane proteins.  The PDB is known to contain a 
large amount of data on several well-studied proteins such as lysozyme. Therefore, the second 
data set removed all proteins with a sequence similarity greater than a BLAST p-value of 10-80.  
Next, the distribution of protein features and crystallization variables was examined between 
each data set. 
Statistically significant differences were observed for various Given protein Features and 
crystallization variables (Observables) between the two data sets.  Several of these could be 
explained by the abundance of redundant structures within the database.  Therefore, it was felt 
that the non-redundant data set would remove much of the selection bias. 
After choosing the non-redundant data set, the correlations between both the protein 
Features (MW and pIest) and the crystpH  were examined.  Similar to previous studies the crystpH  
was not correlated to the pIest of the proteins (r = 0.061).  Because the solution pH helps control 
the charge of the proteins, the estimated net charge (Q ) of the protein at the crystpH  ( crystQ ) was 
calculated and examined.  The thought was that crystQ  might be used as a proxy variable for the 
crystpH .  However, the crystQ  is obtained by calculating the estimated titration curve of the 
protein structure, which uses the amino acid sequence, the assumed pKa values of the charged 
residues, and the crystpH .  .  Because the crystQ  is calculated using these variables, it might be 
expected that there would also be a high correlation with these variables.  The crystQ  was found to 
have a positive linear relationship with the pIest (r = 0.661; p <0.0001; Figure 3.3d), which is also 
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obtained from the estimated titration curve.  However, crystQ  was found to have a negative linear 
correlation with crystpH   (r = -0.475; p <0.0001) and a negative non-linear correlation with 
ln(MW) (r = -0.252; p <0.0001).  From the estimated titration curve, various other shape features 
were obtained, such as the slope of the titration curve at both the pIest and crystpH .  Because the 
possible range of Q  values are dependent upon the amino acid composition and the size of the 
protein, an attempt was made to account for these differences by scaling each curve so that the 
maximum Q  value was 1.0 and the minimum Q  value was 0.0.  It was believed that this scaling 
would account for size differences.  However, the results here were inconclusive, as clear MW 
effects were still observed with the slopes of the scaled curves. 
After the intercorrelations of variables were examined, proteins were separated into 
subgroups by their MWau, pIest, or a combination of their MWau x pIest.  When proteins were 
separated into three or five groups by their ln(MW) values, the proteins labeled 'Small' had a 
slight shift in their crystpH  distributions to lower pH values (statistically significant).  When the 
MW groups were further separated into a 'Very Small' group, this group was found to have a 
much lower shift in crystpH  distributions than the 'Small' proteins.  While only slight statistical 
differences in the crystpH  distributions were seen in the ln(MW) groups, the crystQ  distributions 
of each group had statistically significant shifts in their distributions.  As proteins grew larger, 
the crystQ  distribution became much more negative.  Additionally, each group displayed a 
significant difference in their difflim distributions and the slopes of the titration curve at both the 
pIest and crystpH .  However, significant differences were still observed with the slopes of the 
scaled titration curves.  This indicated that scaling the titration curves did not remove all of the 
influence of molecular weight and hinted at a possible non-linear relationship. 
When proteins were separated into groups based upon their pIest, no differences were 
observed in the crystpH  distributions between groups.  However, when the crystQ  distributions 
were examined, large differences were observed among all groups.  This was also observed in 
the MWau x pIest groups.  Groups with the same size did not display significantly different 
crystpH  distributions, but every group had significantly different crystQ  distributions.  These 
findings confirmed previous analyses of failing to correlate a protein's pIest with the crystpH , but 
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it did offer a possible explanation to why this link could not be found.  Although proteins may 
crystallize under similar pH conditions, the underlying net charge of the proteins may be quite 
different.  This is seen in the different shapes of estimated titration curves.  While the crystpH  
cannot be predicted apriori, these results suggest that there are estimated net charge (Q ) values 
that have a higher probability of resulting in the formation of crystals. 
 After determining that protein crystallization behavior might be influenced by the 
magnitude of the estimated titration curve, proteins were clustered by their scaled estimated 
titration curve.  An unsupervised clustering algorithm, SOMs, was used to group proteins into 61 
clusters by their estimated titration curve.  ‘Acidic’ and ‘Basic’ proteins were at opposite ends of 
the SOM and had significantly different crystpH  distributions.  This indicated that rather than one 
point along the estimated titration curve, the pIest, the titration curve itself might be used for 
predicting solution pH ranges that are more probable or less probable in growing a protein 
crystal. 
 In conclusion, the size of the protein clearly has a significant impact on the magnitude of 
the crystQ .  When proteins were separated into groups on the basis of their MWau, pIest, or the 
estimated titration curve, significantly different crystQ  distributions were observed.  Based upon 
these observed differences, it was hypothesized that the crystQ  distribution of previously 
crystallized proteins might be used to select pH ranges that have a higher probability of 
generating crystals suitable for diffraction studies. 
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4.0  PROTEIN SEQUENCE-PROPERTIES EVALUATION FRAMEWORK 
When initial attempts are made at crystallizing a new target protein, researchers typically use 
commercially developed screens with little consideration towards the protein and its biophysical 
properties.  While many researchers believe that there are clues present within a protein's 
sequence that can serve as a guide to selecting appropriate solution conditions for crystallization, 
there are few examples within the literature on how to test and use this knowledge.  In this 
chapter, the development of the Protein Sequence-Properties Evaluation (PSPE) Framework was 
largely motivated by the rapid growth and evolution of the Protein Data Bank.  The PSPE 
framework can be used for examining any crystallization variable of interest, such as the solution 
pH, and correlating the variable of interest with biophysical properties of successfully 
crystallized proteins.  But rather than just a computational approach, searching for correlations 
without the generation of hypotheses, this framework merges the computational and 
experimental approaches, where a hypothesis is generated and then tested.  This is done by 
conducting a retrospective evaluation of the experimental data, in this case, the successful 
solution conditions used to grow protein crystals, which were available from the Protein Data 
Bank (PDB).  It is hypothesized that the Protein Sequence-Properties Evaluation Framework can 
be used to frame and test hypotheses in-silico about variables that are believed to be important in 
crystallization.  If successful, these findings should increase our understanding of the 
crystallization process and provide a standard for developing more successful crystallization 
screens for other variables in addition to the solution pH.  
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4.1 PSPE FRAMEWORK 
The Protein Sequence-Properties Evaluation (PSPE) framework developed in this dissertation is 
presented in Figure 4.1, as both (a) a general framework and (b) the specific framework used in 
this dissertation.  While the PSPE framework was specifically applied to the area of protein 
crystallization, this framework could also be applied to other biological problems, where 
differences in protein behavior are observed, but not explained.  An example of another future 
application in another unrelated field would be the prediction of antigenic activity of short 
peptide sequences.  This would be useful for immunologist predicting the immune response to 
pathological organisms and their proteins.  The identification of proteins that exhibit an immune 
response may lead to the development of treatments and vaccinations against the organisms, an 
important area in human health. 
In this dissertation, the PSPE framework was used in an attempt to limit the solution pH 
ranges examined in initial crystallization screens.  However, this framework could be used for 
determining differences in any of the crystallization experimental variables.  Similar to the 
scientific method, the first step in the framework involves developing a testable hypothesis 
(Section 4.2).  Rather than performing actual experiments and collecting data, a list of proteins 
that match any constraints are obtained from the Protein Data Bank (PDB; Section 4.3).  The 
available data that can be obtained apriori (Givens) include the Primary Feature (amino acid 
sequence) and Primary Observable (reported pH of crystallization; crystpH ; Section 4.4).  After 
obtaining the reduced list of protein structures, various Hidden Features are calculated (Section 
4.5).  From the Primary Feature and other relevant information available within the database, a 
reduced list of non-redundant structures is created (Section 4.6).  The distribution of these 
Features for subpopulations of proteins may be modeled in their ability to predict ranges of the 
Observable values ( crystpH , crystQ , crystQ , and crystσ ; Sections 4.7 and 4.8). The model's abilities 
to predict a range for a Controllable by setting the values equal to the Observables is then tested 
on an independent test set (Section 4.9).  These models may be applied in the future for 
determining more probable solution conditions that will result in crystallization for new target 
proteins.  
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Figure 4.1 The (a) general and (b) specific applications of the Protein Sequence-Properties Evaluation (PSPE) 
framework as discussed in this dissertation. 
4.2 DEVELOPMENT OF A HYPOTHESIS 
Similar to the scientific method, the first step in the framework that is proposed is to identify a 
problem of interest and develop a testable hypothesis.  For this project, hypotheses were framed 
based upon physical reasons for correlations between a protein’s biophysical properties and 
crystallization Observables. The next step would be to perform experiments and collect the data.  
If the hypothesis is true, the correlations should be seen in the data.  In the example application, a 
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retrospective study was conducted with no actual experiments being performed.  The initial 
hypothesis developed in Chapter 3 was that the crystpH  could be predicted using a protein’s pIest. 
As mentioned earlier, this seemed logical and with more 3D protein structures available, 
this hypothesis was tested.  Although the results showed no useful relationship between the two 
variables, another relationship between a Hidden Observable, the crystQ , and the pIest proved 
promising.  The hypothesis was that the crystQ  could be used as a proxy variable for predicting 
the most probable crystpH  ranges.  This explanation also seemed plausible based on physical 
chemistry, because the solution pH largely exhibits its influence on the protein’s ionizable 
residues.  The crystQ  values are not available in any database and had to be estimated using 
sequence and crystpH  information.  However, it should be mentioned that a negative result is still 
useful; i.e. the recognition that a variable has minimal utility in predicting ranges or probabilities 
of crystallization allows energy and attention to be focused elsewhere, where it may be more 
productively employed. 
4.3 FEATURE EXTRACTION & EVOLVING DATABASE 
The next step involved in the framework was to obtain a set of protein structures.  Because the 
application involved using protein structures that had been successfully crystallized to select 
conditions for future proteins undergoing crystallization attempts, the PDB (Berman et al., 2000; 
Section 4.3.1) was used as the source of proteins.  The PDB (http://www.rcsb.org/pdb/) is the 
repository for 3D biological macromolecular structures (proteins and nucleic acids).  Because all 
the information required could not be found in the PDB, several related databases (nrPDB, 
Sections 4.3.2; and PDB-REPRDB, Section 4.3.3) were also used to augment the information for 
this dissertation.  All these databases are continually evolving as new three-dimensional (3D) 
structures are deposited into the PDB.  These new instances provide a rich source of test cases 
for models developed prior to their deposition (Section 4.9). 
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4.3.1 Protein Data Bank (PDB) 
The Protein Data Bank (PDB) collects and organizes all information regarding the 3D structure 
of biological macromolecules.  The PDB is updated on a weekly basis.  During each update, 
structures may be added or removed.  When structures are removed, they are generally replaced 
by a better example of the structure, i.e. better resolution.  The list of structures to use as the 
training set was downloaded from the PDB on October 5th, 2004.  A newer set of structures was 
obtained and downloaded a year later in November, 2005 to use as a test set (see Section 4.9 for 
more details). 
The PDB contains many instances of redundant structures, where two or more sequences 
share a high level of similarity.  This high level of redundancy has the potential to bias any 
analysis of the PDB.  The most common example of redundancy is the case of mutations, where 
two sequences differ by a single amino acid.  For example, a PDB search for 'T4 lysozyme' using 
the method of X-ray diffraction returned 408 structures (02/01/2005).  The exact same search 
retrieved 419 structures nine months later (11/22/2005).  Other examples of redundancy include 
the same protein unbound or bound to another protein or ligand, which creates a new PDB entry.  
For example, sperm whale myoglobin is present in the PDB in both the oxygenated (PDB ID: 
1A6M) and deoxygenated (PDB ID: 1A6N) form.  The only difference between these structures 
is a bound oxygen atom.  These redundant structures may bias the analysis if they are present in 
a large amount; therefore, a non-redundant data set of structures was created. 
4.3.2 Non-Redundant PDB (nrPDB) 
In order to deal with the issue of redundancy in the Protein Data Bank (PDB), the National 
Center for Biotechnology Information (NCBI) created the non-redundant Protein Data Bank 
(nrPDB; http://www.ncbi.nlm.nih.gov/Structure/VAST/nrpdb.html).  From this list, subgroups of 
PDB structures with varying degrees of non-redundancy could be selected (Table 4.1).  The 
nrPDB, which is updated approximately once a month, operates at the chain level when 
considering redundancy. However, this dissertation focused at the structural level.  Because each 
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structure may be composed of multiple chains, there needed to be a conversion to the structural 
level.  For example, a structure can have different chains in different non-redundant groups. 
Using the methods of Holm and Sander (1998), the nrPDB compares all chains within the 
PDB pairwise using the BLAST algorithm (Altschul et al., 1997).  Using one of the four levels of 
redundancy, the chains are clustered by their sequence similarity and then ranked (Table 4.1).  
The rankings are based on structural quality using factors such as resolution, percentage of 
residues of unknown amino acid type, incomplete coordinate data, missing data, and incomplete 
side-chain coordinates.  The nrPDB automatically removes chains less than 20 amino acid 
residues.  In some cases, if a mutant structure has a higher ranking than does the native structure, 
the native structure may be manually placed higher if it is of comparable quality.   
 
Table 4.1 Four levels of varying redundancy based on sequence similarity are available from the nrPDB. 
 
BLAST p-value Stringency 
10e-7 Most 
10e-40 
10e-80** 
↓ 
100% sequence identity Least 
** Level of redundancy used in this dissertation 
4.3.3 PDB-REPRDB 
The Representative Protein chains from the PDB database (PDB-REPRDB; 
http://www.cbrc.jp/pdbreprdb-cgi/reprdb_menu.pl) was created to provide a list of representative 
protein chains from the PDB (Noguchi and Akiyama, 2003).  The PDB-REPRDB is updated 
every 2-4 months.  The 'best' representative structure are prioritized by the user based on 9 
features, most of which are the same as the nrPDB, such as resolution, R-factor, number of chain 
breaks, and missing data.  One of the key features used in this database was the ability to easily 
identify membrane proteins for removal from the training and test sets.  The user can also filter 
out mutants, complexes, and fragments, which cannot be easily accomplished by the PDB 
(Section 4.3.1) or nrPDB (Section 4.3.2). 
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4.4 EXTRACTION OF PRIMARY FEATURES 
The Primary Feature or protein Given (amino acid sequence and composition) was obtained 
from the PDB.  The PDB provides a list of all sequences found in the structure’s asymmetric unit 
at ftp://ftp.rcsb.org/pub/pdb/derived_data/pdb_seqres.txt.  This list is in FASTA format (Figure 
4.2) for all structures present within the PDB, regardless of method (X-ray, NMR, etc.) and type 
(protein or nucleic acid).  Each sequence within the file has the PDB ID, chain id, molecular 
type, amino acid length, description, and the chain sequence reported.  This file was parsed into 
structural units (summation of chains) using Biopython (Chapman and Chang, 2000).  A Python 
(Version 2.3) script (Appendix A) was written to parse this file into individual PDB structures, 
grouping all chains into one sequence, while documenting all -NH3 and -COOH termini for 
specific Hidden Feature construction (estimated titration curve calculation).  Hidden Features 
were constructed if the structures contained only proteins, so all structures with nucleic acids or -
HET Groups (either protein-HET or nucleic-HET groups) were removed. 
After obtaining the list of protein structures, knowledge of the Primary Observable 
( crystpH ) had to be assessed from the PDB.  If a protein did not have a crystpH  listed it had to be 
removed from the data sets.  The structures that had a crystpH  (Primary Observable) could be 
queried at the PDB website using the 'SearchFields' option or examining each protein's 
macromolecular Crystallographic Information File (mmCIF) (exptl_crystal_grow_ph field).  The 
crystpH  values of structures were queried and downloaded from the PDB website on 11/29/04.  
Several structures had crystpH  values that were invalid (i.e. greater than 14).  These were 
manually examined in the mmCIF file and the structures were removed if their crystpH  was listed 
as 0 or greater than 14.  On 11/29/2004, there were 16,129 out of 24,118 (67%) PDB structures 
that had a crystpH  value listed.  More recently (04/05/2005), 20,468 / 30,205 (68%) PDB 
structures reported a crystpH .  In order to calculate the Hidden Observable ( crystQ ) only structures 
that had a valid crystpH  could be used. 
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 Figure 4.2 An example of sequences in FASTA format in the pdb_seqres.txt file. 
4.5 HIDDEN FEATURE AND CONTROLLABLE CONSTRUCTION 
The Primary Feature (AAau) and Primary Observable ( crystpH ), both Givens, were then used to 
calculate various Hidden Features and Hidden Observables that were not present within the 
original database (PDB).  The Hidden Features were initially chosen based on their ability to be 
easily calculated from a protein’s primary sequence and their possible significance for 
crystallization.  These Features included the asymmetric unit molecular weight (MWau; Section 
4.5.1), estimated solvent accessible surface area (AS; Section 4.5.2), pIest, and the estimated 
titration curve (Section 4.5.3).  Because the solution pH is known to affect the charged state of 
amino acid residues, various Hidden Observables were calculated based on the crystpH , 
including the crystQ , crystQ , and crystσ  (Section 4.5.4).  The hypothesis was that these variables or 
combinations of these Features would be predictive of the Primary or Hidden Observables at 
which crystals were grown (Figure 4.3a and d).  Note that one of the hazards of hidden variables 
>1eil_A mol:protein length:292 2,3-Dihydroxybiphenyl 1,2-Dioxygenase 
SIERLGYLGFAVKDVPAWDHFLTKSVGLMAAGSAGDAALYRADQRAWRIAVQPGELDDLAYAGLEVDDAAALERM 
ADKLRQAGVAFTRGDEALMQQRKVMGLLCLQDPFGLPLEIYYGPAEIFHEPFLPSAPVSGFVTGDQGIGHFVRCV 
PDTAKAMAFYTEVLGFVLSDIIDIQMGPETSVPAHFLHCNGRHHTIALAAFPIPKRIHHFMLQANTIDDVGYAFD 
RLDAAGRITSLLGRHTNDQTLSFYADTPSPMIEVEFGWGPRTVDSSWTVARHSRTAMWGHKSVRGQR 
>1ein_A mol:protein length:269 Lipase 
EVSQDLFNQFNLFAQYSAAAYCGKNNDAPAGTNITCTGNACPEVEKADATFLYSFEDSGVGDVTGFLALDNTNKL 
IVLSFRGSRSIENWIGNLNFDLKEINDICSGCRGHDGFTSSWRSVADTLRQKVEDAVREHPDYRVVFTGHSLGGA 
LATVAGADLRGNGYDIDVFSYGAPRVGNRAFAEFLTVQTGGTLYRITHTNDIVPRLPPREFGYSHSSPEYWIKSG 
TLVPVTRNDIVKIEGIDATGGNNQPNIPDIPAHLWYFGLIGTCL 
>1ein_B mol:protein length:269 Lipase 
EVSQDLFNQFNLFAQYSAAAYCGKNNDAPAGTNITCTGNACPEVEKADATFLYSFEDSGVGDVTGFLALDNTNKL 
IVLSFRGSRSIENWIGNLNFDLKEINDICSGCRGHDGFTSSWRSVADTLRQKVEDAVREHPDYRVVFTGHSLGGA 
LATVAGADLRGNGYDIDVFSYGAPRVGNRAFAEFLTVQTGGTLYRITHTNDIVPRLPPREFGYSHSSPEYWIKSG 
TLVPVTRNDIVKIEGIDATGGNNQPNIPDIPAHLWYFGLIGTCL 
>100d_A mol:nucleic length:10 DNA/RNA Chimeric Hybrid Duplex (5'-R(Cp*)-D(C 
CCGGCGCCGG 
>100d_B mol:nucleic length:10 DNA/RNA Chimeric Hybrid Duplex (5'-R(Cp*)-D(C 
CCGGCGCCGG 
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is that they introduce additional information and care must be taken to ensure that “discoveries” 
based on the hidden variables are not simply reflections of that additional information. 
4.5.1 Molecular Weight 
The protein's MWau in kilodaltons (kDa) was calculated from the amino acid sequence of 
all asymmetric unit chains (AAau) listed in the seqres.txt file.  The MW values used for the amino 
acids are shown in Table 4.2.  When calculating the MWau, a water molecule (18.02 Daltons) had 
to be subtracted for every peptide bond. It is important to note that the protein’s asymmetric unit 
may be composed of one or more biological units.  The biological unit is the protein's functional 
biological form, which may consist of a single (monomer) or multiple chains (dimer, trimer, or 
greater), which may be identical (homo-) or different (hetero-) in amino acid sequence.  
However, the functional protein may or may not be known apriori.  For this analysis, it was 
assumed that the asymmetric unit was known prior to any crystallization attempts.  
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Table 4.2 The amino acid MW and pKa values used in this dissertation (Nelson and Cox, 2000). 
 
   pKa Value 
Abbreviation Amino Acid MW (Da) -NH3 Term. -COOH Term. Side Chain 
A (Ala) Alanine 89.09 9.69 2.34 - 
C (Cys) Cysteine 121.15 10.28 1.96 8.18 
D (Asp) Aspartic Acid 133.10 9.60 1.88 3.65 
E (Glu) Glutamic Acid 147.13 9.67 2.19 4.25 
F (Phe) Phenylalanine 165.19 9.00 1.83 - 
G (Gly) Glycine 75.07 9.60 2.34 - 
H (His) Histidine 155.16 9.17 1.82 6.00 
I (Ile) Isoleucine 131.17 9.68 2.36 - 
K (Lys) Lysine 146.19 8.95 2.18 10.53 
L (Leu) Leucine 131.17 9.60 2.36 - 
M (Met) Methionine 149.21 9.21 2.28 - 
N (Asn) Asparagine 132.12 8.80 2.02 - 
P (Pro) Proline 115.13 10.96 1.99 - 
Q (Gln) Glutamine 146.15 9.13 2.17 - 
R (Arg) Arginine 174.20 9.04 2.17 12.48 
S (Ser) Serine 105.09 9.15 2.21 - 
T (Thr) Threonine 119.12 9.62 2.11 - 
V (Val) Valine 117.15 9.62 2.32 - 
W (Trp) Tryptophan 204.23 9.39 2.38 - 
Y (Tyr) Tyrosine 181.19 9.11 2.20 10.07 
 
4.5.2 Estimated Solvent Accessible Surface Area and Surface Charge Density 
Previous work has shown that a protein's solvent accessible surface area (AS) was proportional to 
its molecular weight raised to the power of a constant, b, where b ranged between 0.73 and 0.76.  
This was demonstrated for both monomeric (Chothia, 1975; Janin, 1976; Teller, 1976; Miller et 
al., 1987a) and oligomeric proteins (Miller et al., 1987b; Janin et al., 1988).  For a sphere, the 
surface area would be proportional to the density to the power of two-thirds (0.67).  However, 
proteins are not spherically shaped, having a convoluted shape with many cavities.  Therefore, 
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the exponent needs to be adjusted for the shape, with the exponent giving a measure of the shape 
complexity.  To estimate the AS several assumptions were made.  First it was assumed that the 
protein’s estimated mean surface charge density ( crystσ ) was relatively constant, being 
proportional to the crystQ /AS.  The finding by Barlow and Thornton (1986) that the surface charge 
density of proteins was relatively constant made this assumption reasonable.  However, AS had 
to first be approximated by the data. 
To estimate AS, it was assumed that the protein’s crystσ  was proportional to crystQ , 
)*/()( bcrystcryst MWaQ=σ .  In order to test this hypothesis, the MW was first plotted against the 
absolute values (abs) of crystQ  for all proteins in the training set.  Then, the best empirical least 
squares fit of bcryst MWaQabs )(*)( =  was calculated using the power law.  If the hypothesis was 
correct, this empirical fit should be similar to that estimated previously by Chothia, Miller, and 
Janin.  The absolute value of crystQ  was taken due to the large number of negative crystQ  values.  
Additionally, it should not matter whether the charge is positive or negative, just that crystσ  is 
proportional to the molecular surface area. 
Next, the σ  based upon the crystQ  divided by our AS estimation ( oursσ ) above was 
plotted against the σ  that was calculated using the AS equation developed for monomers by 
Miller et al. (1987a), where AS=6.3*MW0.73 ( millerσ ).  The resulting linear fit of 
cm oursmiller += σσ *  gives the scale factor for converting our estimate of AS to more closely 
resemble the empirical fit of AS previously developed by Miller et al.  Although, many of the 
protein structures in the training set are not monomers, Miller et al.’s equation was used as an 
initial starting point for examining the effects of AS on protein crystallization.  Similar to crystQ , 
crystQ  and crystσ  were obtained from the Q  and σ  curves respectively, using the crystQQ =  or 
crystσσ =  values of the solution where the crystpHpH = . 
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4.5.3 Estimated Titration Curves and Estimated Isoelectric Point (pIest) 
Each protein's estimated titration curve was calculated using the HHE (Equation 2.1), the 
asymmetric unit amino acid sequence (AAau), the assumed pKa values for the titratable amino 
acid residues, and the pH range from 1.0 to 14.0 every 0.1 pH unit where n was the number of 
each type of charged residue, either positive (Histidine, Lysine, and Arginine) or negative 
(Cysteine, Aspartic acid, Glutamic acid, and Tyrosine; Ries-Kautt and Ducruix, 1997; 1999).  
The point along the curve where the protein has zero net charge is the pIest.  This equation 
accounts for every C-terminus and N-terminus amino acid in the complex or chain.  The pKa 
values of the amino acids are the model pH values where the residues are 50% ionized.  The pKa 
values (Nelson and Cox, 2000) used in all calculations are shown in Table 4.2.  It was previously 
demonstrated that pIest values were generally in good agreement with experimentally measured 
values (Patrickios and Yamasaki, 1995). 
The availability of a large amount of experimental data within the PDB warranted a 
reinvestigation of the link between the pIest and crystpH  (Chapter 5).  Although experimental 
conditions used to grow the crystals are not required for depositing structural information into 
the PDB, the conditions are beginning to be reported more frequently.  The most reported 
experimental condition used to grow the crystals is the crystpH  (now available for 16,000+ 
structures).  Because the solution pH controls the Q  (Figure 4.3e), the crystQ  distribution was 
also examined to determine if it could be used as a predictor of solution pH ranges leading to 
successful crystallization.  The Q  is a function of the amino acid composition, the pH of the solution, 
and the assumed pKa values for the titratable amino acid residues in the protein.  From examining 
estimated titration curves (Q  plotted as a function of pH), it was observed that the Q  could 
remain relatively constant over a wide range of pH values.  Alternatively, the Q  could change 
drastically over a small range of pH values, especially near the pKa values of the charged 
residues. 
Rather than one point along the estimated titration curve, the pIest, it was hypothesized 
that the whole titration curve may be more predictive for initial experimental design and 
optimization (Chapter 6).  Additionally, the location on the estimated titration curve at which 
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crystals appear should dictate a finer (areas with a steep slope) or broader search (areas with a 
relatively flat slope) of pH ranges. 
4.5.4 Hidden Variables 
From the protein’s amino acid sequence (charged amino acid composition) and the 
solution pH, the protein’s Q  is estimated (Hidden Controllable).  This is done by calculating the 
protein’s estimated titration curve (Section 4.5.3).  Then the crystQ  (Hidden Observable) is 
obtained from the estimated titration curve by assigning the QQcryst =  where the solution 
crystpHpH = .  Because the Q  is dependent upon its amino acid content and size, a larger protein 
can have a wider range of possible Q  values due to the presence of more charged residues.  
Therefore, an attempt was made to adjust for variations in size, surface area, and Q  by 
calculating either the estimated specific charge (Q ) or the estimated surface charge density (σ ), 
which both are also considered as Hidden Controllables.  The Q  is the ratio of the Q  to the 
protein mass, expressed here in units of electrons (e)/kDa.  The σ  is the ratio of the Q  to the AS 
of the protein; a convenient unit is millielectrons (me)/nm2 (10-3 electron charges per square nm).  
Although the estimation of surface area is difficult, σ  facilitates comparisons with other 
biologically relevant macromolecules.  An example of a Q  curve is shown in Appendix C, 
Figure C.2b.  The crystQ  and crystσ  (Hidden Observables) were obtained from the Q  and σ  
curves the same way as previously mentioned for crystQ .  One of the hazards of using hidden 
variables is that they introduce additional information and care must be taken to ensure that 
“discoveries” based on the hidden variables are not simply reflections of that additional 
information. 
Barlow and Thornton (1986) have shown that the surface charge density varied little 
among proteins, where they defined the surface charge density as the number of charged residues 
per surface contact area in Å2.  For the current study, the AS would have to be estimated without 
the solved 3D structure (Section 4.5.2).  Additionally, the σ  that was examined in this study was 
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defined as Q  /AS.  It was hypothesized that the Q  and σ  of crystallized proteins ( crystQ  or 
crystσ ) would be relatively constant. 
Because the solution pH controls the protein's charge (Figure 4.3e), the crystQ , crystQ , and 
crystσ  were examined to determine if any of these Hidden Observables could be used as a 
predictor of the solution pH ranges leading to successful crystallization (Figure 4.3f).  From the 
crystpH  listed within the PDB, the crystQ  could be estimated using the HHE (Equation 2.1).  The 
pH controls the Q  by controlling the amount of protons (H+) available in the solution.  A large 
amount of protons will cause Lysine, Arginine, and Histidine to become positively charged.  
Alternatively, a small amount of protons in solution will cause the deprotonation of Glutamic 
acid, Aspartic acid, Cysteine, and Tyrosine.  Therefore, the crystQ  was hypothesized to be a proxy 
variable for crystpH  and was used as the outcome variable (Figure 4.3f). 
 
 
Figure 4.3 Can a protein's biophysical properties (Features) be used to predict crystallization conditions 
(Observables)?  
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4.6 CASE SELECTION 
For the initial investigations, only non-redundant, non-membrane proteins were chosen and 
nucleic acids, membrane proteins, structures with poor resolution, and peptides were excluded.  
It was expected that nucleic acids would behave quite differently than would proteins for 
crystallization, because nucleic acids are more charged than proteins.  Additionally, membrane 
proteins are a special case of proteins, which are generally difficult to crystallize, requiring 
special conditions.  Finally, the PDB contains a large amount of redundancy.  Two proteins that 
differ in a single amino acid are different entries.  The same protein from two different 
organisms can also be present in the database.  Identification of these instances and their removal 
should eliminate a potential source of bias. 
4.6.1 Macromolecular Type and Method  
The seqres.txt file identified whether the structure contained proteins and/or nucleic acids.  This 
was found within the mol:xxx description field, where xxx is 'protein,' 'protein-het,' 'nucleic,' or 
'nucleic-het.'  The '-het' indicated the presence of an 'X' within the sequence, which codes for an 
unknown amino acid or nucleic acid.  The unspecified group complicates calculation of the 
Hidden Features, so any structure with an 'X' within its sequence (protein-het or nucleic-het) was 
removed.  Additionally, any structures with an amino acid length less than 20 were removed. 
While the seqres.txt file does not contain the experimental method of structure 
determination, another file (entries.idx) found at http://pdbbeta.rcsb.org/robohelp/FTP_Server/ 
ftp_derived_data_index.htm does.  The tab-delimited entries.idx file contains a column for 
experiment type.  Possible experiment types include X-ray Diffraction, NMR, Electron 
Microscopy, Synchrotron X-ray Diffraction, Neutron Diffraction, Fiber Diffraction, 
Fluorescence Transfer, and Theoretical Models.  The number of structures within the PDB 
solved by each method is listed in Table 4.3.  X-ray diffraction remains the current method of 
choice, and generally provides the most molecular detail.  Due to possible differences between 
methods, structures not solved by X-ray diffraction were removed.  An additional constraint on 
the resolution limit of diffraction (difflim) was imposed, a difflim ≤ 3.0 Angstroms (Å).  At a difflim 
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greater than 3.0 Å, detailed information about the 3D structure is lost.  Therefore, a difflim of 3.0 
Å was set as the high threshold. 
 
Table 4.3 Method of structure determination as listed in the PDB (11/14/2005) 
 
Method Frequency 
X-ray Diffraction 28,535 
NMR 4,919 
Synchrotron Diffraction 32 
Electron Microscopy 55 
Neutron Diffraction 17 
Fiber Diffraction 24 
Theoretical Model 2 
Fluorescence 1 
Total 33,585 
 
4.6.2 Membrane Proteins 
Membrane proteins are a special case of proteins.  They are inherently difficult to crystallize, 
because they require the presence of a detergent or lipid bilayer in order to achieve solubility.  A 
protein has to have a certain level of solubility in order to crystallize.  Therefore, all structures 
containing membrane proteins were removed.  Membrane proteins were identified in three ways.  
The first method was to directly search the PDB website using the keyword “membrane protein”, 
which retrieved 718 structures on 11/14/2005.  The second method flagged 360 structures that 
were listed as being membrane proteins in the PDB-REPRDB (Noguchi and Akiyama, 2003; 
http://www.cbrc.jp/pdbreprdb-cgi/reprdb_menu.pl) on 11/16/05.  The final method examined the 
'header field' in the 'entries.idx' file available from the PDB.  Using this file, membrane proteins 
were identified with a search for '*membrane*', which resulted in 405 structures being labeled as 
membrane proteins.  A conservative approach was then used in which a structure was discarded 
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if any of the three methods identified the structure as having a membrane protein chain (862 
structures).  There appeared to be some time delay for entries among the differing sources.  A 
Venn diagram showing the overlap between the three methods is shown in Figure 4.4 (updated 
November 16, 2005). 
 
 
 
 Figure 4.4 The Venn-diagram showing the frequency of proteins being identified as membrane proteins. 
4.6.3 Redundancy 
The PDB contains many instances where structures are different by a single amino acid mutation 
or by the source species.  These multiple instances, which may number into the hundreds, were 
thought to be a potential source of bias for any analysis.  For example, a PDB search for 'T4 
lysozyme' using the method of X-ray diffraction returns 419 structures (11/22/2005).  In order to 
account for similar sequences, a non-redundant (BLAST p-value of 10-80 similarity) data set was 
created.  The list of non-redundant PDB entries was created using the PDB and the nrPDB 
(Holm and Sander, 1998) at the NCBI 
(http://www.ncbi.nlm.nih.gov/Structure/VAST/nrpdb.html).  Chains with a low similarity score 
(BLAST p-value of 10-80) were selected that had the highest structural quality as identified 
within the nrPDB database (Section 4.1.2) with a crystpH .  
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4.7 STATISTICAL MODEL BUILDING 
First, the distributions and descriptive statistics of all variables were examined to determine 
normality. As appropriate, transformations were performed on the raw data in order to 
approximate normal distributions.  Next, the intercorrelations between all Features and 
Controllables were calculated in order to detect multicollinearity among variables. 
First, zero-order correlations (Spearman’s rho) were examined between the Given 
Features (Primary and Hidden) and Given Observables (Primary and Hidden).  Features that 
were significantly correlated with a Given Observables ( crystpH , crystQ , crystQ , or crystσ ) might be 
able to predict that Observable.  A significant correlation among Observables indicated a 
relationship of the variables that may allow the substitution of one of the correlated Observables 
for prediction purposes, i.e. proxy variables.  Finding the Features that are predictive of a 
Observable may allow for predicting initial crystallization conditions for that Observable. 
The initial hypothesis was that the estimated net charge of the protein can be used as a 
proxy variable for selecting the solution pH ranges for screen design.  The solution pH has long 
been known to play a primary role for crystallization conditions.  The solution pH controls the 
amount of protons present in solution, which may protonate or deprotonate the charged amino 
acids.  Previous research has failed to identify a relationship between a Feature and the crystpH  
(Observable). 
The second hypothesis was that there are groups of structures within the PDB, which 
display different Primary ( crystpH ) or Hidden Observable ( crystQ , crystQ , and crystσ ) distributions 
that can be used for suggesting crystallization conditions on new test proteins.  Various methods 
were examined for grouping structures by 'similarity,' including simple binning (Section 4.7.1) 
and unsupervised clustering methods (Section 4.7.2). 
4.7.1 Creation of Groups by Binning 
One method to group structures was by binning on the basis of a Primary (AA composition) or 
Hidden Feature (MWau or pIest; Chapter 6).  The groups could be created by multiple methods, 
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such as dividing structures into an even number per group, for example, by using quartiles or 
deciles.  Alternatively, the mean or median of a variable could be used to split structures into two 
groups, such as a median split.  Groups could also be broken down by the distance from the 
mean using the standard deviation (SD).  These methods might also be based on prior knowledge 
(supervised) to create separation points, if available. 
For example, proteins were split into groups by their molecular weight using the distance 
from the mean value.  Because the MWau distribution is highly skewed, the MWau values were 
transformed by taking the natural log (ln) of all MWau values, which resulted in a relatively 
normal distribution.  The mean±SD of the ln(MWau) distribution was then used to create three or 
five groups of proteins.  For discretizing the three ln(MWau) groups, all proteins within 1 SD of 
the mean ln(MWau) were labeled ‘Average.’  Those proteins whose ln(MWau) was either greater 
than 1 SD below or above the mean were labeled as ‘Small’ and ‘Large,’ respectively.  When 
proteins were further separated into five groups, the 'Small' and 'Large' groups were split into a 
'Very Small' and 'Very Large' group, by considering whether the ln(MW) value was 2+ SD 
below or above the mean ln(MWau) value. 
A similar method of discretization was used for the protein’s pIest.  Proteins whose pIest 
was less than or equal to 6.0 were labeled as ‘Acidic.’  Proteins with a pIest greater than or equal 
to 8.0 were labeled as ‘Basic,’ while the remaining proteins were considered as ‘Neutral,’ 6.0 < 
pIest < 8.0 (Chapter 3).  This discretization based on pIest follows the description of Ries-Kautt 
and Ducruix (1999).  After determining differences between the three pIest bins (Chapter 3), the 
‘Acidic’ and ‘Basic’ groups were further broken down into ‘Very Acidic’ and ‘Very Basic’ 
groups.  Thus, the pIest range of both the ‘Acidic’ and ‘Basic’ groups was reduced to 5.0 < pIest ≤ 
6.0 and 8.0 ≤ pIest < 9.0, respectively.  The ‘Very Acidic’ group had a pIest ≤ 5.0, while the ‘Very 
Basic’ group had a pIest ≥ 9.0.  However, binning might not represent the optimal separation of 
proteins, as proteins with a 0.1 pIest difference, such as 6.0 and 6.1, may be grouped with proteins 
that have a 0.9 lower pIest (5.1) or a 1.8 higher pIest (7.9).  Therefore, an alternative strategy was 
also examined, unsupervised clustering. 
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4.7.2 Creation of Groups by Unsupervised Clustering 
Other methods of grouping were also examined, including various unsupervised clustering 
algorithms (two-step clustering and self-organizing maps).  These clustering methods were used 
to group structures by multiple Features, creating a feature vector (Chapter 6).  After the 
unsupervised clusters were formed, Spearman's correlation values were examined among the 
variables to determine what Features were associated with the groupings.  It was hypothesized 
that unsupervised clustering would result in a higher accuracy than binning. 
4.7.2.1 Two-Step Clustering 
Two-step clustering (2Step), as its name suggests, consists of two steps, pre-clustering and 
clustering (Chiu et al., 2001).  An additional positive feature was that the two-step clustering 
algorithm could handle either continuous or categorical variables.  The algorithm assumes that 
the continuous variables are normally distributed and independent.  However, the algorithm is 
relatively robust to violations of normality and independence. 
In the first step, the data are converted into a cluster feature tree.  This involves an initial 
pass through the data to cluster similar items (x).  Various statistics are used to represent the 
clusters, such as the number of items, the mean, and variance of each continuous feature.  
Starting from the root node, each item is passed to the child node with the minimum distance to 
the item.  Once a leaf node is reached, the algorithm determines whether the item is within a 
threshold distance from the leaf node.  Two distance measures can be used for each step, log-
likelihood or Euclidean distance.  If the distance between the leaf node and item x is below a 
threshold distance, x is placed within the leaf and the leaf's attributes are recalculated.  If the x's 
distance from the leaf node is greater than the threshold, it forms a new leaf node.  This results in 
a much smaller data set. 
The second step uses agglomerative hierarchical cluster analysis with the log-likelihood 
function (Equation 4.1) to place items in the set number of clusters (J).  For each item's (x) 
feature vector (θj), the probability of the item belonging to cluster Cj was determined, P(xi|θj).  
The item is assigned to the cluster with the maximum likelihood contribution (Equation 4.2), 
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where lCj is the log-likelihood contribution from cluster Cj. P(xi|θj) is the probability density 
function of x being in cluster Cj, and θj is the feature vector. 
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4.7.2.2 Self-Organizing Maps 
Another unsupervised clustering algorithm, self-organizing maps (SOMs), was examined.  
SOMs have previously been used to solve many biological problems, such as clustering protein 
families from sequence (Ferran et al., 1994; Andrade et al., 1997), prediction of a proteins 
structural class from amino acid composition (Cai et al., 2000), prediction of genes (Mahony et 
al., 2003), and classification of crystallization drop images (Spraggon et al., 2002).  A self-
organizing map (SOM; Kohonen, 2001) is considered a 2D non-linear projection of high-
dimensional data, composed of an X by Y matrix of neurons (mx,y; Figure 4.5).  The SOM 
compresses the multi-dimensional data into the 2D feature space, while preserving the spatial 
relationship between the data.  Items in the dataset that are more similar are placed closer 
together in the 2D space, thus preserving the spatial relationship between items. 
Each item (n) could be represented by a vector (v) of 1 to i features (f), which could be 
composed of a combination of Primary (amino acid composition) and/or Hidden (MWau, pIest, 
and estimated titration curve) Features.  Each item vector (vn=[f1, f2,..., fi]), has its distance, 
usually Euclidean, measured to each mx,y's feature vector (mx,y=[f1, f2,..., fi].  The neuron with the 
minimum distance (Equation 4.3) to the input vector is the Best-Matching Unit (BMU), c.  Next, 
the BMU's feature vector is recalculated to more closely resemble the input vector.  Additionally, 
the BMU's neighboring neuron's feature vectors may also be adjusted to a lesser degree.  Each 
item vector is presented to the SOM algorithm over a given number of iterations.  The mx,y 
feature vectors are then adjusted by their contents with a decreasing weight after each iteration.  
Equation 4.3 }{minarg , yxi
i
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Figure 4.5 The SOM algorithm presents each feature vector, v, composed of i features (f) to each neuron's feature 
vector, mx,y. 
 
4.7.3 Comparison of groups within each clustering technique 
After splitting all training set protein structures into groups, statistical differences in the Hidden 
Features, such as the pIest or MWau, and Observables ( crystpH , crystQ , crystQ , and crystσ ) 
distributions were examined, using nonparametric tests (Section 4.10).  If significant differences 
in Observable distributions were observed among groups, a model was developed to predict the 
Observable given the protein Features.  Significant differences or correlations (Spearman rank) 
in Hidden Features among groups indicated that these Hidden Features might be used to predict 
any Primary or Hidden Observable that was significantly different between groups. 
4.7.4 Modeling with Gaussians 
The ability to model the Primary ( crystpH ) or Hidden Observable ( crystQ , crystQ , or crystσ ) 
distributions with Gaussians was also examined for each grouping method.  Using the observed 
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mean, Gaussians (Equation 4.4) were fit to (a) all structures Observable distributions and then 
(b) each group (i) individually, where yi = observed value within group i; iµ  = mean of group i; 
iσ  = standard deviation (SD) of group i.  The best-fit Gaussian was determined by minimizing 
the residual sum of square (RSS) between the observed and the predicted values (Equation 4.5).  
The value of the SD was adjusted in small increments (0.01 units) in order to determine the best-
fit SD (SDbf) with the minimum RSS.   
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After determining the best-fit Gaussian, the number of proteins within 1 SDbf for both the 
training and test sets was calculated.  In order to compare all groups within a given grouping 
method, a common SD for all groups was chosen based on examining the SDbf of all groups 
(rounding the decimal off to the tenths). 
4.7.5 Comparing Binning to Clustering 
The ability of each method to suggest ranges of the output variable (Primary or Hidden 
Observable) on an independent test set was used to compare methods (see Section 4.8) using 
predictive accuracy as a performance measure. 
4.7.6 Determining the optimal number of clusters 
After comparing the unsupervised clustering techniques to binning in the previous section, the 
number of clusters was allowed to vary.  Rather than arbitrarily setting the number of clusters, 
the question was asked, "How many clusters are there within the data?"  Both 2Step clustering 
and SOMs were able to answer this question, because the algorithms have established methods to 
predict the ‘correct’ number of clusters. 
 82 
As mentioned in Section 4.7.2.1, the 2Step algorithm can predict the number of clusters 
in a dataset.  The algorithm computes either the Schwarz's Bayesian Criterion (BIC; Schwarz, 
1978) or Akaike Information Criterion (AIC; Akaike, 1983) to choose the number of clusters.  A 
large drop off in the information criterion tells the algorithm what the 'correct' number of clusters 
should be. 
 
 
 
Figure 4.6 The Supervised SOM algorithm for determining the dimensions of the best-fit self-organizing map. 
 
Alternatively, there are several SOM algorithms that have the ability to determine the 
‘correct’ number of clusters, including the GSOM algorithm, which was used in the Preliminary 
Results (Section 3.2.2).  Additionally, the Supervised SOM algorithm (Figure 4.6) was 
developed to determine the optimum SOM dimensions (i.e. number of clusters).  Initially a 2x2 
SOM was initialized with the maximum number of clusters set to 16.  Sixteen would be the 
maximum number of groups if the structures were binned by their pIest every 0.5 units from 4.0-
12.0.  Starting with an initial 2x2 SOM, each dimension of the SOM was increased one at a time 
starting with the x-dimension, i.e. the next SOM investigated would be 3x2.  It was observed that 
if the x-dimension increased and the y-dimension stayed at 2, a one-dimensional SOM resulted, 
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with no structures in the 2nd y-dimension.  Therefore, the x-dimension of the SOM was allowed 
to increase above 8, where an 8x2 would theoretically allow for sixteen groups.  With the y-
dimension staying at 2, the x-dimension was allowed to increase to a maximum value of 16.  The 
stopping criterion was finding clusters that did not differ significantly from each other in their 
crystQ  distributions. 
4.7.7 Comparing Among All Grouping Methods 
The ability of all methods to predict either the Primary ( crystpH ) or Hidden ( crystQ  or crystσ ) 
Observable on an independent test set was used to rank the different methods.  The number of 
test set structures whose Observable value was within a predicted range (accuracy) was 
calculated for each group in both the training and test sets. 
4.8 TRANSLATION OF HIDDEN CONTROLLABLE INTO PRIMARY 
CONTROLLABLE SEARCH SPACE 
If the protein structures in the test set follow a similar pattern observed in the training set, 
calculating a protein's estimated titration curve can theoretically be used for selecting pH ranges 
for crystallization attempts.  Each protein exhibits a unique titration curve based upon its charged 
amino acid composition and MW (Appendix C; Figure C.1).  It should be noted that proteins 
with different sequences, but the same charged amino acid compositions and similar molecular 
weights, may produce the same results.  Some predictions may be of little use, due to relatively 
long flat regions along the titration curve in the most probable crystQ  ranges.  However, some 
predictions will narrow the pH search space to a narrow pH range (≤ 1 pH unit).  Three methods 
are discussed in this paper for estimating the ),|( PDBQQpHpHP crystcryst ==  over a pH range 
for the test set: (1) calculating the middle 50% confidence interval, (2) calculating a probability 
distribution, and (3) the Charge Range Test. 
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4.8.1 Confidence Interval Calculation 
For the first method, a confidence interval (CI) was calculated from an Observable ( crystpH , 
crystQ , or crystσ ) distribution of each cluster for the middle 50% (CI50) of proteins.  For example, 
the quartiles of the distribution were calculated for each group.  The middle two quartiles (>25% 
and <75%) were used as the middle 50% range.  These calculations form a CI for the predictions.  
The CI50 bracketed a specific Controllable range for each group where there would be an 
estimated 50/50 chance that similar new protein structures would have a Observable value in this 
range (Figure 4.7a).  This range can then be applied to target proteins to select an initial 
Controllable range for crystallization attempts (Figure 4.7b). 
The test set was used to determine if proteins not seen in the training set would follow a 
similar pattern.  If the test set was representative of similar structures, 50% of them should fall in 
the CI50.  If less than 50% of the test proteins fall in the CI50 of the training set structures, this 
method would not be useful for prediction.  The CI can be adjusted to make the distributions 
tighter (decrease the CI) or broader (increase the CI) depending upon the desires of the 
individual researcher.  For example, the CI67 could be used to represent all structures within 1 SD 
of the mean Observable value. 
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Figure 4.7 From a group’s (a) distribution of a Hidden Controllable, the CI50 is calculated, and (b) applied to a test 
protein’s Q  curve to bracket a Primary Controllable range. 
4.8.2 Probability distribution calculation 
Based upon the amino acid sequences of the proteins in the training set (Given Features) and 
their crystpH  (Given Observable), the crystQ  frequencies (Given Hidden Observables) can be 
calculated and use to estimate the )|( dataQQP cryst=  (Figure 4.8a). These probabilities were 
calculated every 0.1 unit between -2.0 and +2.0 e/kDa by dividing the frequency of crystQ  
occurrence within each group by the number of proteins in that group.  The range from -2.0 to 
+2.0 was chosen based on the observed crystQ  distributions for proteins in the training set with 
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few proteins have a crystQ  above or below this range.  The probabilities for crystQQ =  were then 
directly mapped onto the pH space, guiding selection of pH ranges for a test protein sequence 
(Figure 4.8c).  The probability of success for a given Q  value was calculated from the training 
dataset for (1) all proteins and (2) for each group (Figure 4.8a). 
An estimated specific charge curve (Q  vs. pH) can be calculated for any given protein 
sequence (Figure 4.8b).  Every pH value has a Q  value associated with it for a given protein.  
However, the same Q  value can be associated with many pH values as seen from the titration 
curve in Figure 4.8b.  The conditional probabilities are then calculated that a particular pH value 
over the selected range is the crystpH  given the database (PDB) and that the Q  is the crystQ , 
),|( PDBQQpHpHP crystcryst == .  These pseudo-probabilities were calculated for every 0.5 pH 
units from 4.0-10.0.  This narrow range was chosen because few structures have a crystpH  
outside this range (< 2%).  The 0.5 steps in pH prediction were based upon the saw-tooth pattern 
in the crystpH  distribution.  This resulted in thirteen calculated probabilities for 
),|( PDBQQpHpHP crystcryst == .  Because long stretches of the titration curve can have similar 
Q  values, the probabilities often added up to more than 100%.  The probabilities were 
standardized to 100% by dividing each probability value by the total relative probability for that 
protein. 
The most probable regions of the pH space (Controllable) could then be observed and a 
decision made as to where to set the pH values for the initial crystallization screens.  Because 
proteins denature at the extreme pH ranges and the fact that few proteins crystallized at these 
ranges, probabilities were calculated over the pH range of 4.0 to 10.0 in 0.5 unit increments.  The 
increments can be made coarser or finer.  Alternatively, there could be a threshold, where only 
pH values that have a greater probability than the threshold are searched.  The threshold can be 
raised or lowered accordingly.  For this study, a threshold of 10% was used for high probability, 
8-10% as low probability, and less than 8% as no better than a random pH selection.  If one of 
the thirteen crystpH  probability values were chosen randomly, a success rate of 7.7% would 
theoretically be observed.  The other threshold value of 10% was arbitrarily chosen based on 
inspection of many probability distributions.  If a 10% threshold is applied to the distribution in 
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Figure 4.8c, an initial pH range of 6.0-7.5 is suggested for crystallization attempts.  The pH 
values of <5.0 or >7.5 have a probability no better than random (.06) and comprise 38% of the 
commercial screens with a listed pH.  This would account for a significant reduction (62%) in 
experimental conditions.  Additionally, other informative probability distributions could be 
obtained if we conditioned on more than just the crystQ , for example, by using information related 
to the slope of the titration curve at the crystpH .
1 
 
 
 
Figure 4.8 Creating a 
crystpH  probability distribution from (a) a crystQ  distribution and (b) a test protein's Q  curve to 
obtain (c) ),|( PDBQQpHpHP crystcryst == . 
                                                 
1 An alternative method for generating probabilities is to calculate the derivative of the estimated titration curve and 
then take the product of its absolute value and its frequency.  This calculation would result in a different shape of the 
probability distribution and would alter all of the findings of the subsequent analyses. 
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4.8.3 Charge Range Test 
Because the CI50 range can be quite different between groups, a third method was developed, the 
Charge Range Test.  This method simply uses the crystQ  or crystσ  values (Hidden Observables) 
for all training set proteins and examines the percentage of proteins within a given range of the 
mean (Figure 4.9).  The ranges examined were every ±0.1 Q  or ±10 σ  values up to the 
calculated standard deviation (SD).  The frequency counts were converted to percentages and 
used as pseudo-probabilities.  The observed percentage indicated the probability that a new 
protein structure would crystallize within the given Q  or σ  range (Controllable).  This allowed 
for a more fair comparison among grouping methods, which may have widely different CI50 
ranges. 
 
 
Figure 4.9 The Charge Range Test calculates the percentage of proteins within a given interval of the groups mean 
crystQ  value, (a) Mean±0.0, (b) Mean±0.1, (c) Mean±0.2, and Mean±0.3. 
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4.9 CREATION AND USE OF TEST SET 
The PDB is updated weekly with new structures.  A newer nrPDB version (11/07/2005) was 
used to create a test set.  Using the same framework (Figure 4.1b), the Primary Feature and 
Observables were obtained from the PDB (Sections 4.3-4.4).  Hidden Features were created as 
in Section 4.5 and cases selected (Section 4.6) to create a non-redundant test set of 1,246 proteins 
that had a low sequence similarity, BLAST p-value < 10-80, to the proteins in the original training 
set.  The test set proteins were then used in the statistical models developed from the training set 
in Section 4.7 to predict a Q  or σ  range (Hidden Controllable).  These ranges could then be 
translated back into the Primary Controllable search space (Section 4.8).  The ability of the 
original training set to predict the Observables, Primary ( crystpH ) or Hidden ( crystQ  or crystσ ), for 
these new proteins was then examined as validation for the methods of analysis.  When 
comparing two different methods, the method that predicted the test set proteins more accurately 
was the better model. 
4.10 STATISTICAL ANALYSIS 
After groups of structures were formed, statistical measures were performed in order to 
determine if there were any significant differences (p<0.01) between the Primary ( crystpH ) and 
Hidden ( crystQ ) Observables among the groups (Conover, 1999).  When there were more than 
two groups, a Kruskal-Wallis test (a nonparametric ANOVA) was first performed to determine 
whether there were any significant differences in the location or shape of the distributions.  For 
the Kruskal-Wallis (KW) test, the individual observations were first ranked from 1 to N, where 
N was the total number of observations.  The ranks were then summed, Ri, for each group, i.  
The test statistic, TKW, was computed from Equation 4.6, where the sample variance (S2) was 
computed from Equation 4.7.  The number of groups was represented by k.  The chi-square 
distribution was then used for the determination of the null distribution of TKW.  The null 
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hypothesis was that all groups' distributions were identical with a given significance level 
α<0.01.  If TKW was greater than the 1-α null distribution value, the null hypothesis was rejected. 
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If significant differences (p<0.01) were found between the distributions, a Kolmogorov-
Smirnov (KS) test was performed pair-wise to locate the individual differences in the location 
(means or median) and/or shape of the distributions (variance) between groups.  The two-sided 
KS-test compared the vertical distance between the two empirical distributions.  The test 
statistic, TKS, was the largest absolute difference between the two distributions, S1 and S2 
(Equation 4.8).  Similar to the KW tests, the null hypothesis was that the two groups' 
distributions were identical at an α of 0.01.  If TKS was greater than the 1-α null distribution 
value, the null hypothesis was rejected (Conover, 1999). A nonparametric test was chosen 
because of the large differences in size and variance between the groups and independence from 
the assumption of normality. SPSS (Chicago, IL) version 13.0 was used for all analysis. 
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4.11 CHAPTER SUMMARY 
The PSPE framework presented here was applied to the PDB to gain insight into the solution pH 
requirement for protein crystallization; however, it could be used for other analyses of biological 
sequences, structures, or folds.  Often a certain representative subset of sequences or structures is 
desired for analysis, such as one member of a certain protein family.  Biological databases often 
contain multiple instances of these biological molecules.  There are many reasons for this, such 
as differences in the source organism or biological mutants.  While these instances are very 
important, usually they are not needed for a specific analysis.  A researcher may often just 
require one representative sequence with special constraints.  The analysis presented here was a 
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good example of just needing one representative sequence/protein, while requiring the protein to 
have a crystpH .  The PSPE general framework could be applied to the whole protein universe 
(UniProt; Apweiler et al., 2004), protein families (Pfam, Bateman et al., 2004), or protein folds 
(SCOP, Murzin et al., 1995; CATH, Orengo et al., 1997).  Additionally, the framework could be 
applied to the prediction of signal peptides (Bendtsen, 2004), disordered peptides (Jones and 
Ward, 2003; Oldfield et al., 2005), or even prediction of Major Histocompatability Complex 
(MHC) binding peptides to T-cell epitopes (Zhu et al., 2006, Guan et al., 2006}. 
While the crystpH  was the most reported crystallization parameter reported in the PDB, 
there are many other variables to which this method could be applied (see Table 1.1 in Chapter 
1).  For more potential future applications in the area of protein crystallization, see Chapter 9.  In 
the next chapter the PSPE Framework is applied to test the hypothesis that a protein’s Q  or σ  
values can be used to select solution pH ranges that have a higher probability of resulting in the 
formation of a well-ordered crystal. 
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5.0  A SPECIFIC APPLICATION OF THE PROTEIN SEQUENCE-PROPERTIES 
EVALUATION (PSPE) FRAMEWORK 
In the previous chapter, the Protein Sequence-Properties Evaluation (PSPE) framework was 
developed to analyze differences in crystallization behavior of proteins.  Meanwhile, the initial 
analysis of the Protein Data Bank (PDB) presented in Chapter 3 demonstrated a weak link 
between the crystpH  and the pIest.  However, the estimated net charge at the crystpH  ( crystQ ) 
demonstrated some potential use as an Observable, being highly correlated to both a Given 
Feature (pIest) and a Primary Observable ( crystpH ).  Additionally, the crystQ  distributions 
displayed more statistically significant differences between MWau or pIest groups than did the 
crystpH  distributions.  Therefore, it was hypothesized that the specific charge (Q ) and estimated 
surface charge density (σ ) of previously crystallized proteins could be used to suggest solution 
pH ranges with a higher probability of success (i.e. crystals) for new target proteins. 
The previous results also indicated MWau and pIest effects on crystallization conditions.  
In this chapter, using a newer version of the PDB (October 20004) with more training set cases 
and a larger independent test set (November 2005), attempts were made to account for the MW 
effects in the calculation of crystQ , by calculating the Q  at the crystpH  ( crystQ ).  The crystQ  was 
computed by dividing crystQ  by the MWau to obtain the crystQ  values in electrons/kilodalton 
(e/kDa).  Similarly, the estimated average surface charge density ( crystσ ) was calculated by 
dividing crystQ  by the estimated solvent accessible surface area (AS) to obtain the crystσ  values in 
millielectrons/square nanometer (me/nm2). 
The hypothesis examined in this chapter was that the crystQ  and crystσ  can be used to 
guide researchers to intelligently select the initial pH ranges for screening attempts.  Instead of 
using the crystQ , the crystQ  and crystσ  were calculated in an attempt to account for size effects.  
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Because both of these variables are largely controlled by the solution pH, any models developed 
could be used to determine the most probable crystpH  ranges for initial screen design. 
5.1 METHODS 
The training set was composed from PDB structures downloaded on October 5th, 2004, while the 
test set was downloaded on November 7, 2005.  The Primary Feature, amino acid sequence, was 
obtained from the seqres.txt file as described in Section 4.4.  The crystpH  values (Primary 
Observable) were queried and downloaded from the PDB in November 2004 (Section 4.4). 
Next, several Hidden Features and Observables were calculated as described in Section 
4.5, such as the asymmetric unit molecular weight (MWau) (Section 4.5.1), AS (Section 4.5.2), 
and the estimated titration curve (Section 4.5.3).  From the estimated titration curve and the 
crystpH , both the pIest and crystQ  were obtained.  By dividing each Q  value along the estimated 
titration curve by the MWau, the Q  was calculated.  From this Q  curve, the crystQ  was obtained 
similarly to crystQ  (Section 4.5.4).  For the σ  curve, the correct equation for AS had to be 
determined, as described in Section 4.5.2.  Once the AS values are calculated, each Q  value 
along the estimated titration curve was divided by the AS to obtain an σ  value in me/nm2.  The 
σ  value along the curve where the crystpHpH =  becomes the crystσ  (Section 4.5.4). 
Individual cases were selected with the applied filters and constraints as described in 
Section 4.6.  The final training set consisted of 4,114 non-redundant protein structures 
(nrPDB10.04.05).  The final test set used for this dissertation was created as described in Section 
4.9.  The final test set contained 1,246 non-redundant protein structures that had a low sequence 
similarity to the training set proteins. 
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5.2 RESULTS (DEVELOP STATISTICAL MODELS) 
5.2.1 Calculation of Accessible Surface Area (AS) and Average Surface Charge Density 
(σ ) 
Because a protein's accessible surface area was found to be proportional to its molecular weight 
(Chothia, 1975; Janin, 1976; Teller, 1976; Miller et al., 1987ab; Janin et al., 1988), attempts were 
made to adjust for variations in size (standardize), surface area, and net charge by dividing the 
estimated net charge, Q , by either the protein's MWau or AS to obtain the Q  or σ , respectively.  
To estimate the AS, several assumptions were made.  First, the protein’s crystσ  was assumed to be 
relatively constant, being proportional to the crystQ /AS.  The finding by Barlow and Thornton 
(1986) that the surface charge density of proteins was relatively constant made this assumption 
reasonable.  However, the AS had to first be approximated by the data.  In order to do this, a least 
squares fit of the absolute value (abs) of crystQ  = a*(MW)
b was performed, which resulted in 
Equation 5.1.  The correlation of the abs( crystQ ) and MWau was r = 0.664 (Pearson) or r = 0.525 
(Spearman’s rho), with both being highly significant, p<0.0001. 
 
Equation 5.1 806.0)(*3476.1)( aucryst MWQabs =  
 
The scatter-plot of the ln(MWau) by ln(abs( crystQ )) is shown in Figure 5.1.  From the 
linear regression line (r2 = 0.264; p<0.0001), Equation 5.2 was devised.  Removing the natural 
logs resulted in Equation 5.3.  This was basically the same result as the least squares fit in 
Equation 5.1.  Next, the σ  using Equation 5.3 for the AS ( oursσ ) was plotted against the millerσ , 
which uses the equation for the AS determined by Miller et al. (1987a).  This was done in order 
to determine the scale factor to more accurately represent AS using the actual values (Figure 5.2).  
From the graph, the linear regression equation was calculated to be Equation 5.4.  From this 
equation, a scale factor of 2.108 was used to convert our estimation of the AS ( oursSA . ) more 
closely to the observed and estimated AS values calculated for monomers by Miller et al. 
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(1987a), millerSA . .  The plot of the oursSA .  versus millerSA .  is shown in Figure 5.3.  Thus, our 
calculation of the AS for very large proteins may be slightly off.  Although many of the protein 
structures were not monomers, this was felt to be a close approximation.  After determining the 
appropriate equation for the calculation of the crystσ , the analysis of crystallization variables 
continued. 
 
 
 
Figure 5.1 Plot of the ln(MW) against the ln(abs(
crystQ )). 
 
Equation 5.2 298.0)ln(*806.0))(ln( += aucryst MWQabs    
Equation 5.3 806.0)(*3472.1)( aucryst MWQabs =  
Equation 5.4 810.1*108.2 += millerours σσ  
 
Thus, a crystQ  of 0.1 e/kDa corresponds to 1 (positive) charge per 5,240-6,231 Å
2 for a 
monomeric protein.  Although the surface area involved in lattice contacts can be quite variable, 
the 'typical' lattice contact in a protein crystal buries 570 Å2 (Janin and Rodier, 1995) or 
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approximately 4.2% of the surface (Valdar and Thornton, 2001), which are both much smaller 
values. 
 
 
 
 
Figure 5.2  Plotting the millerσ  versus oursrσ  to determine the scale factor. 
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Figure 5.3 Our estimation of the AS ( oursSA . ) plotted against that of Miller et al. (1987a), millersSA . . 
5.2.2 Analysis of Variables  
The analyses originally focused on the crystpH  (Primary Observable) because it was the most 
widely reported experimental condition in the PDB and it is considered to be one of the most 
important crystallization variables (McPherson, 1999).  The training set’s crystpH  frequencies (n 
= 4,114) and percentages are shown in Table 5.1 with the crystpH  values rounded off to the 
tenths.  Ninety-seven percent of the training set proteins had a crystpH  within a pH range of 4.0-
9.0.  Most of the proteins, 98.5%, fell within reported buffer pH (4.0-9.5) of the crystallization 
screens listed in Appendix B.  If this range is expanded another 0.5 pH units in each direction, 
pH 3.5-10.0, 99.3% of the training set proteins fell within this range.  The histogram of the 
crystpH  values used in this study is shown in Figure 5.4a, which was very similar to that found 
earlier in Chapter 3, using a smaller data set.  From the figure, a saw-tooth pattern was observed 
at approximately every 0.5 pH unit from pH 4.5-9.0.  Two additional spikes were also present at 
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pH values of 4.6 and 5.6.  When these values were compared to the reported buffer pH values 
listed in 18 different screens from four commercial companies, an overlap was observed 
(Appendix B). 
 
Table 5.1 The Training Set's 
crystpH values. 
 
pH Frequency Percent pH Frequency Percent pH Frequency Percent 
1.5 1 0.02 5.4 29 0.70 8.1 12 0.29 
2.0 2 0.05 5.5 145 3.52 8.2 29 0.70 
2.4 1 0.02 5.6 157 3.82 8.3 19 0.46 
2.5 2 0.05 5.7 19 0.46 8.4 18 0.44 
3.0 7 0.17 5.8 50 1.22 8.5 256 6.22 
3.2 2 0.05 5.9 12 0.29 8.6 9 0.22 
3.3 2 0.05 6.0 255 6.20 8.7 5 0.12 
3.4 2 0.05 6.1 19 0.46 8.8 9 0.22 
3.5 7 0.17 6.2 37 0.90 8.9 3 0.07 
3.6 1 0.02 6.3 32 0.78 9.0 54 1.31 
3.7 1 0.02 6.4 40 0.97 9.1 4 0.10 
3.8 8 0.19 6.5 493 11.98 9.2 7 0.17 
3.9 4 0.10 6.6 17 0.41 9.3 2 0.05 
4.0 45 1.09 6.7 32 0.78 9.4 3 0.07 
4.1 2 0.05 6.8 69 1.68 9.5 15 0.36 
4.2 40 0.97 6.9 18 0.44 9.6 2 0.05 
4.3 11 0.27 7.0 394 9.58 9.7 2 0.05 
4.4 13 0.32 7.1 17 0.41 9.8 1 0.02 
4.5 92 2.24 7.2 58 1.41 10.0 5 0.12 
4.6 191 4.64 7.3 34 0.83 10.1 1 0.02 
4.7 18 0.44 7.4 76 1.85 10.2 1 0.02 
4.8 33 0.80 7.5 526 12.79 10.5 4 0.10 
4.9 9 0.22 7.6 50 1.22 10.6 2 0.05 
5.0 141 3.43 7.7 13 0.32 10.7 2 0.05 
5.1 16 0.39 7.8 47 1.14 11.2 1 0.02 
5.2 38 0.92 7.9 13 0.32 Total 4114 100.00 
5.3 27 0.66 8.0 280 6.81   
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Figure 5.4 (a) The 
crystpH  distribution of the training set proteins.  (b) The scatter plot of the pIest vs. crystpH . 
 
This observed overlap has several interpretations, two of which are discussed here.  The 
first interpretation would suggest that researchers may not be optimizing the crystals produced 
from the initial screens and that many crystals deposited within the PDB may be further 
improved (i.e., better resolution) by finely exploring the solution pH.  The sparse matrix screens 
used by the commercial companies were originally designed to determine the initial conditions 
for nucleation, which would then be explored in more detail by further experiments 
(optimization).  For example, the researcher may want to examine the pH every 0.05-0.1 units 
when optimizing conditions as suggested by McPherson (1995).  A second possible 
interpretation would be that crystallization is relatively insensitive to pH.  If the protein’s ability 
to crystallize is relatively insensitive to a pH change of ±0.3 units, then there is no reason not to 
round to the nearest 0.5 pH unit.  However, the nature of the pH influence on crystallization may 
be protein-specific.  Some proteins crystallize over a wide range of pH (1-2 pH units); others 
crystallize under a narrow range (Cox and Weber, 1988).  When initial crystals (‘hits’) are found, 
the slope of the estimated titration curve in the vicinity of the ‘hit’ should be examined.  If the 
curve is steep, then a fine pH search may be mandatory.  This would be especially important 
around the pKa values of the charged amino acids (Table 4.2), where a small change in solution 
pH can have a large effect on a protein's charge, solubility, and ability to crystallize. 
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Next, the Spearman’s correlations between the crystpH  and the other variables were 
examined.  While statistically significant (p <0.001; Table 5.2), there was little correlation (r = 
0.059) between the pIest and crystpH  (Figure 5.4b).  This low correlation was similar to those 
previously reported by Page et al. (2003), r < 0.01, and Kantardjieff and Rupp (2004), r < 0.10.  
Due to the large number of proteins (4,114), even small correlations can become statistically 
significant.  Similar statistically significant, but low correlations (Table 5.2) with the crystpH  
were also observed with the MWau (r = 0.088; p <0.001), AS (r = 0.088; p<0.001), and difflim (r = 
0.036; p <0.022).  As a control, a random number with a mean of 0.0 and standard deviation of 
1.0 was generated for each protein and used for comparison of correlations.  No correlation was 
observed between crystpH  and the random number (r = 0.013; p <0.393).  While this lack of 
correlation with the random number was reassuring, we still believe that there is little 
information that can be exploited from the low, but statistically significant correlation ( crystpH  
vs. pIest) in the sense of guiding future crystallization efforts. 
Due to the lack of correlation between the crystpH  and pIest, the analysis was expanded to 
include the protein’s estimated net charge ( crystQ ), estimated specific charge ( crystQ ), and 
estimated average surface charge density ( crystσ ) at the crystpH .  The distributions of the crystQ , 
crystQ , and crystσ  for all training set proteins were all relatively normal and are shown in Figure 
5.5b-d.  The crystQ  distribution was slightly negative with a mean of -4.9 and a standard deviation 
of 25.2.  This slightly negative value may be due to the preponderance of proteins with a pIest < 
7.0 (Figure 5.5a).  With a mean crystpH  of 6.6, most of these proteins would be negatively 
charged to varying degrees.  The protein’s crystQ  was also highly correlated with the pIest (r = 
0.659; p <0.001) and crystpH  (r = -0.482; p <0.001; Table 5.2).  However, it should be noted that 
the crystQ  is calculated as a function of the crystpH , so this high correlation might be expected.  
The protein’s MWau had a stronger association with the crystQ  (r = -0.251; p <0.001) than did the 
crystpH  (r = 0.088; p <0.001).  There was also a significant but weak correlation between the 
crystQ  and difflim (r = -0.085; p <0.001).  As the proteins increased in size, the crystQ  and difflim 
also increased.  This was expected, because as the size increases, the number of charged amino 
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acids should increase, unless there is a significant change in the amino acid composition.  With a 
greater number of charged amino acids, the protein can have a greater range of possible Q  
values.  The correlation between the molecular weight and difflim (r = 0.323; p <0.001) is well 
known, with smaller proteins generally displaying better resolutions.  These correlations were 
similar to those observed in the earlier analysis in Chapter 3 (Table 3.2). 
Accounting for the size of the protein by dividing crystQ  by MWau, resulted in a weaker 
relationship between the crystQ  (e/kDa) and MWau (r = -0.095; p <0.001) and difflim (r = -0.024; p 
<0.118; Table 5.2).  Figure 5.5c showed that the protein’s crystQ  distribution was concentrated 
around a mean of zero (-0.1±0.4), the isoelectric point.  Similar to the crystQ , a stronger 
correlation was also found between the pIest and  crystQ  (r = 0.746; p <0.001) than was found 
between the pIest and crystpH  (r = 0.059).  This was not surprising given that a protein's charge 
can remain relatively constant over a wide range of pH values.  Additionally, the crystQ  was 
highly correlated with the crystpH  (r = -0.475; p <0.001). 
Because of the known relationship between a protein’s molecular weight and its 
accessible surface area, the estimated average surface charge density in me/nm2 ( crystσ ) was also 
examined.  The strength of other variable’s correlations with the crystσ  appeared to be in between 
those with the crystQ  and crystQ .  For example, the correlations of the crystσ  with pIest (r=0.737; 
p<0.001) and MWau (r = -0.134; p <0.001) were between the correlations of the crystQ  and crystQ  
with those same variables (Table 5.2).  This finding was also observed for the correlation among 
crystallization parameters examined.  The crystσ  was more correlated with the crystQ  (r = 0.944) 
than crystQ  (r = -0.912).  The correlation between the crystσ  and crystQ  was also very high (r = 
0.995).  This indicated that the crystQ  was a good approximation of the mean surface charge 
density, crystσ .  With only slight differences in the strength of their correlations, attempts were 
made to predict both a crystQ  and crystσ  interval for test set proteins. 
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Figure 5.5 The distributions of (a) the pIest, (b) crystQ , (c) crystQ , and (d) crystσ .  
 
These results have several possible explanations, two of which are discussed here.  One is 
that these correlations might be expected, because the estimated net charge variables (pIest, crystQ , 
crystQ , and crystσ ) are all calculated as a function of the solution pH, so the correlation to crystpH  
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might be expected.  A second interpretation would be that while the pIest and MWau cannot 
predict the crystpH  ranges for crystallization attempts, they might be able suggest values for 
crystQ  or crystσ  (proxy variables for the crystpH ), which are determined by the amino acid 
composition and the pH of the mother liquor. 
 
Table 5.2 Spearman's rho correlations among the training set’s Features and Controllables.   
 
Variable pIest MWau AS  crystpH  crystQ  crystQ  crystσ  difflim Random 
pIest 1.000 - - - - - - - - 
MWau -0.062** 1.000 - - - - - - - 
AS -0.062** 1.000 1.000 - - - - - - 
crystpH  0.059** 0.088** 0.088** 1.000 - - - - - 
crystQ  0.659** -0.251** -0.251** -0.482** 1.000 - - - - 
crystQ  0.746** -0.095** -0.095** -0.475** 0.912** 1.000 - - - 
crystσ  0.737** -0.134** -0.134** -0.483** 0.944** 0.995** 1.000 - - 
difflim 0.006 0.323** 0.323** 0.036 -0.085** -0.024 -0.038 1.000 - 
Random 0.006 0.004 0.004 0.013 -0.005 -0.006 -0.006 0.025 1.000 
** p-value < 0.001 
 
The crystQ  and crystσ  distributions indicate that proteins appear to crystallize at low values 
of Q  and σ .  One problem with this observation is that “low” is a relative term with no frame 
of reference.  One frame of reference is to compare the known σ  values for nucleic acids and 
phospholipid bilayers, whose σ  values are at least an order of magnitude greater than that of 
proteins.  However, there are no pH values at which proteins are as highly charged as nucleic 
acids.  Because nucleic acids readily crystallize, a high σ  is not a barrier for crystallization.  
Another frame of reference is in relation to the mean Q  or σ  values at a “physiological pH” of 
7.4 ( 4.7=pHQ ).  The mean crystpH  is 6.6, which is 0.8 pH units less than “physiological pH” 
(Table 5.3).  Therefore, the  Q  and σ  values at the crystpH  would be expected to be lower, i.e. 
less negative.  Indeed they are, with a mean crystQ  of -0.06 e/kDa, which is approximately three-
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fold lower than the 4.7=pHQ  mean (-0.17 e/kDa).  The distributions (Figure 5.6) are significantly 
different as judged by a Student’s t-test (p<0.0001).  However, it should be noted that many 
proteins function in physiological compartments where the pH is significantly different.  A more 
serious problem is that the standard deviations of the two distributions are more than twice the 
shift between them.  The shift is statistically significant because of the sample size, but cannot be 
used to make meaningful predictions about specific proteins 
 
Table 5.3 Comparing the 
crystQ  and 4.7=pHQ  values. 
 Mean SD SE 
crystQ  -0.06 0.39 0.01 
4.7=pHQ  -0.17 0.34 0.01 
 
 
 
Figure 5.6 Comparing the 
crystQ  and 4.7=pHQ  distributions. 
5.2.3 Analysis of the Test Set  
Attempts were made to verify any findings on an independent test set of 1,246 proteins from 
more recent entries in the PDB (November 2004 thru November 2005).  In order to remove 
potential bias, these proteins were filtered to maintain a low sequence similarity (BLAST p-value 
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<10-80) to the proteins in the training set.  First, the variable distributions of proteins between the 
training and test sets were compared (Table 5.4).  The proteins were similar in all aspects, except 
molecular weight, between the two data sets.  The proteins in the test set had a significantly 
larger MWau distribution (65.0±69.0 kDa) than did those proteins in the training set (61.2±74.9 
kDa).  A similar effect was observed with AS, which was estimated using the MWau.  Given the 
advances in technology, it might not be too surprising that the newer proteins were slightly larger 
than those present in the training set, which consisted of previously crystallized proteins from the 
inception of the PDB.  After concluding that the two data sets were similar enough, especially in 
the crystallization Observables, methods were developed using the training set proteins to predict 
the crystpHpH =  ranges for the test set proteins, the probability that the Primary Controllable 
(solution pH) would equal the Primary Observable ( crystpH ). 
 
Table 5.4 The mean and SD for all examined variables. 
 
Data Set n  pIestb MWau b AS b crystpH
a 
crystQ
b 
crystQ
b crystσ  b difflim a Random Number 
Train 4,114 Mean 6.34 61.2 90.9 6.64 -4.88 -0.06 -17.2 2.02 0.02 
  SD 1.69 74.9 80.6 1.30 25.19 0.39 101.5 0.44 1.00 
Test 1,246 Mean 6.36 65.0 96.4 6.65 -2.89 -0.03 -10.3 2.03 0.02 
  SD 1.63 69.0 76.2 1.36 28.19 0.36 98.9 0.42 0.97 
KS  Z 1.07 2.78 2.78 0.71 2.03 1.16 1.14 0.89 0.490 
Test  p< 0.206 0.0001 0.0001 0.689 0.001 0.138 0.151 0.410 0.972 
a Extracted from the PDB 
b Calculated using sequence information 
5.2.4 Developing and Testing Models on the Independent Test Set  
 Each protein exhibits a unique titration curve based upon its amino acid sequence; therefore, 
these curves may result in protein-specific predictions.  Some proteins are likely to be less 
affected by pH due to relatively long flat regions along the estimated titration curve in the most 
probable crystQ  ranges.  Even the identification of such proteins should aid in screen design.  
Alternatively, some predictions will narrow the pH search space to a narrow pH range (< 1 pH 
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unit).  The three methods discussed in Section 4.8 for estimating the  
),|( PDBQQpHpHP crystcryst ==  or ),|( PDBpHpHP crystcryst σσ ==  over a pH range for the 
test set are examined here. 
5.2.4.1 Confidence Interval  
First, the fifty percent confidence intervals (CI50) were calculated (Section 4.8.1) for all 
crystallization Observables examined, the crystpH , crystQ , crystQ , and crystσ , for the training set 
proteins (Table 5.5).  The CI50 for the crystpH  suggested that a pH range of 5.6 to 7.5 should be 
searched for all proteins.  Fifty-seven percent of the proteins in the training set were observed to 
crystallize within this pH range, while forty-nine percent of the test set proteins crystallized 
within this range.  More than 50% of the training set proteins were present in the CI50 due to the 
erratic crystpH  distribution.  Approximately 46% of the commercial screens examined in 
Appendix B had a buffer pH value within this range (5.6-7.5).  However, it should be noted that 
an additional 15% of the screens did not mention the solution pH.  Searching pH values only in 
this range (5.6-7.5) would result in a narrow pH sparse matrix screen, offering little insight into 
the crystallization process and more than likely miss many of the proteins that are difficult to 
crystallize. 
While the crystpH  distribution offered little direct insight into the crystallization process, 
the solution pH exhibits its effects on the protein by controlling the protonation and 
deprotonation of the charged amino acid residues.  Therefore, the estimated net charge of 
crystallized proteins was also examined.  As mentioned previously, all the estimated net charge 
variable distributions ( crystQ , crystQ , and crystσ ) were centered near zero, the isoelectric point 
(Figure 5.5b-d).  To determine which variable performed best, the frequency of the test set 
proteins within the training set protein’s CI50 was examined.  While 50% of the training set 
proteins had a crystQ  between –11.82 and +4.73, only 44.9% of the test set proteins crystQ  values 
fell within this range.  After attempting to account for the size of the protein by dividing the 
estimated net charge by the MWau, 48.2% of the test set proteins had a crystQ  value between the 
training sets CI50, –0.25 and +0.14 e/kDa.  Although there was a small difference between the 
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training (50.6%) and the test set’s crystQ  CI50 results (1.8%), it was felt that this was not 
significant given the sample size and round off effects.  A slightly lower percentage of the test 
set proteins, 46.6%, had a crystσ  that fell within the CI50 of the training set, -0.73 to +0.38 
me/nm2.  This slight decrease in the test set compared to the crystQ  CI50 results may be due to 
errors in the calculation of AS, which may increase in larger proteins.  Unless, a more accurate 
calculation of AS can be easily performed, it is thought that the crystQ  values are more likely to 
yield better results.  These results suggest that if a new protein was crystallized, there would be 
an approximately 50% chance that the crystpH  would result in the protein having a crystQ  value 
between –0.25 and +0.14 e/kDa.  Assuming that the Q -related variables (Hidden Observables) 
can be used as proxy variables for the crystpH  (Primary Observable), examining the net charge 
variables allows for a more detailed insight into the crystallization process than simply 
examining the solution pH values. 
 
Table 5.5 The CI50 values and ranges for the Observables. 
 
Variable Low Value High Value Range 
% of Training 
Set 
% of Test Set % Difference 
crystpH  5.6 7.5 1.9 57.2 49.1 8.1 
crystQ  -11.82 4.73 16.54 50.0 44.9 5.1 
crystQ  -0.25 0.14 0.39 50.0 48.2 1.8 
crystσ  -73.07 37.96 111.03 50.0 46.6 3.4 
5.2.4.2 Probability Distribution 
The generation of probability distributions was discussed in Section 4.8.2.  For this method a 
probability distribution was estimated based upon the relative frequency of proteins with a 
particular value for a Given Observable.  This can be performed for any of the Observables 
examined, the crystpH , crystQ , crystQ , or crystσ .  As a reminder, any of the Hidden Observables can 
then be theoretically translated back into the pH search space (Primary Controllable).  From the 
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probability distribution, the researcher can choose any threshold for selecting pH values to search 
for crystallization. 
crystpH   
If a 10% threshold is applied to the crystpH  frequency distribution in Figure 5.7a, an 
initial pH range of 6.5-7.5 is suggested for all crystallization attempts.  This would eliminate 
44% of all screening conditions, not including those conditions where no pH value is listed.  This 
would allow for a significant reduction in experimental conditions.  However, this approach 
would likely miss the crystallization conditions of many proteins and is therefore not 
recommended. 
crystQ  
The crystQ  relative frequency distribution was calculated every 5 e units from -60 e to +60 
e (25 values).  Assuming every Q  value has an equal probability, a ‘Random’ value of 4% 
would result.  Based upon the crystQ  relative frequency distribution, a threshold of 10% was 
initially selected (Figure 5.7b).  This would suggest a Q  range of -5 e to +5 e for all proteins.  
Each protein’s estimated titration curve is then examined to determine what pH values result in a 
Q  of -5 e to +5 e. 
crystQ  
The Q  probabilities were calculated every 0.1 unit between -2.0 and +2.0 e/kDa by 
dividing the relative frequency of crystQ  by the number of proteins in that Q  group.  The range 
from -2.0 to +2.0 e/kDa was chosen based on the observed crystQ  relative frequency distributions 
for structures in the training set (Figure 5.7c).  For this study, a threshold of 10% was used for 
high probability, 6-10% as average probability, and less than 6% as no better than a random pH 
selection.  The 10% threshold value was arbitrarily chosen based on inspection of many 
probability distributions. 
crystσ  
The σ  range chosen was -200 to +200 every 10 me/nm2 increments, which resulted in 41 
values.  Assuming all the σ  values have an equal probability of succeeding in growing a crystal, 
a 0.024 (1/41) probability was used as ‘Random.’  There were no σ  values that are greater than 
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10%.  In fact, the highest relative probability of the 41 values was 5.6% (Figure 5.7d).  
Therefore, a cut off of 4% was chosen as the threshold.  This would translate into any pH value 
that resulted in the protein having a σ  value of -70 to +20 me/nm2. 
 
 
 
Figure 5.7 Observable distributions with arbitrary threshold probabilities. 
 
For any of the Observable distributions, the researcher is free to choose any relative 
probability threshold cutoff.  This information can then be translated back into the pH search 
space (Primary Controllable) by matching the Q  values along the estimated titration curve 
(Hidden Controllable) with the relative probability distributions in Figure 5.6b as discussed in 
Section 4.8.2.  Similarly, the Q  or σ  values along the specific charge or surface charge density 
curves can inherit the probabilities of the previously crystallized proteins in Figures 5.7c and 
5.7d.  The pH values with the highest probabilities can then be selected for the initial screen 
design. 
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5.2.4.3 Charge Range Test 
Due to potential differences in CI50 ranges among different methods of grouping proteins 
by similarity, a third method was developed to compare models, the Charge Range Test (Section 
4.8.3).  This method examines the percentage of proteins that had crystallized within a given Q  
or σ  range.  The initial ranges were chosen based upon the group’s mean and standard deviation 
(SD).  Then the percentage of proteins within a given range of the mean value was calculated for 
both the training and test sets.  For example, the Q  values examined were ±0.1 to ±0.3 e/kDa of 
the mean and ±10 to ±100 me/nm2 for σ  values.  The resulting model with the most test set 
proteins within a given Controllable range has the highest accuracy.  Thus, the Observable 
variable with highest accuracy should be used in future analyses.  The results are shown in Table 
5.6. 
From this table, it can be observed that approximately 40% of the training set proteins 
crystallized within ±0.1 of the mean value.  A slightly lower percentage of test set proteins 
crystallized within the same range.  When a slightly larger range (±0.2) was used, an increase of 
~20% was observed in both the training and test sets.  Finally, when an Q  range of ±0.3 was 
used, 72% of the tests set proteins were captured within this range, an increase of about 12% 
over the ±0.2 results. 
 When the σ  values were examined, a much smaller percentage of proteins were found 
within the lower ranges examined, < 40%.  Once the Mean±40 was reached, similar percentages 
of proteins to the Q  ranges were observed.  It should be noted that the σ  SD for all training set 
proteins was ±102.  An increase of 5-10% is observed for every ±10 me/nm2 , with a gradual 
reduction in the number of proteins captured within the ranges.  Because of possible errors in the 
estimation of σ , it was felt that all future Charge Range Test results would focus on using the 
specific charge (Q ) as the measure of charge.  Once Q  values are determined, these values can 
be converted to σ  by estimating the AS as was done here. 
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Table 5.6 The Baseline Charge Range Test results for the 
crystQ  and crystσ .  
 
Q    σ    
Q  Range Training Set Test Set σ  Range Training Set Test Set 
Mean ±0.1 40.4 37.5 Mean ±10 11.1 9.5 
Mean ±0.2 60.1 59.6 Mean ±20 20.6 17.7 
Mean ±0.3 73.1 71.8 Mean ±30 29.7 27.0 
Mean ±0.4 81.8 81.1 Mean ±40 38.1 35.8 
   Mean ±50 45.9 41.4 
   Mean ±60 53.7 50.0 
   Mean ±70 59.6 58.7 
   Mean ±80 65.6 64.6 
   Mean ±90 71.0 68.3 
   Mean ±100 75.0 72.6 
5.3 CHAPTER SUMMARY 
In this chapter, a specific application of the PSPE framework (Chapter 4) was presented and 
applied to the Protein Data Bank (PDB).  This application was meant to gain insight into the 
solution pH, the estimated specific charge (Q ), and the estimated average surface charge density 
(σ ) required for the crystallization of proteins.  For this analysis, the Primary Observable 
( crystpH ) was obtained from the PDB and the Hidden Observables ( crystQ  and crystσ ) were 
calculated using the Primary Observable and Primary Feature (amino acid sequence) for a non-
redundant set of PDB proteins.  While the crystpH  was not statistically correlated to any protein 
Feature, the Hidden Observables were.  However, uncertainty remains, because the Hidden 
Observables ( crystQ  and crystσ ) are calculated from both protein Features and the Primary 
Observable ( crystpH ).  Therefore, the high correlations among variables may be expected.  Thus, 
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the hypothesis that the Protein Sequence-Properties Evaluation Framework can be used to frame 
and test hypotheses in-silico about variables that are believed to be important in crystallization 
appears inconclusive. 
Based upon the observation that the crystQ  appeared to be a possible proxy variable for the 
crystpH  (Chapter 3), it was hypothesized that a protein’s crystQ  or crystσ  values could be used as 
proxy variables for the crystpH  and thus used for identifying solution pH ranges (Primary 
Controllable) with a higher probability of generating crystals.  Regardless, a key observation was 
that the Q  and  σ  distributions were low centered on zero.  Also, there was a statistically 
significant, but weak correlation between the pIest and crystpH , which was similar to previous 
studies.  However, much stronger correlations were observed between the other Hidden 
Observables and the Features.  Of particular interest were the Feature’s correlations with the 
crystQ  and crystσ .  These two Hidden Observables were much more correlated to the pIest, another 
charge derived variable, while removing much of the correlation to the MWau that the crystQ  
displayed.  This observation has two possible interpretations.  The first is that although many 
statistically significant correlations among the Q -related quantities were noted, no evidence 
could be developed to suggest they were anything other than those expected from the additional 
information introduced with the hidden variables (Features and Observables).  The second 
interpretation would be that the pIest might suggest estimated charge values, whether the crystQ , 
crystQ , or crystσ , that have a higher probability in generating crystals, which can then be translated 
back into pH space.  However, the second interpretation cannot be proven at this time. 
Based on the second hypothesis, three methods were examined to use previously 
crystallized proteins to suggest a crystpH  range for target proteins using the target protein’s Q  
curve.  All methods were tested on an independent test set of 1,246 proteins.  The first method 
calculated the middle 50% confidence interval (CI50) of all Observables ( crystpH , crystQ , crystQ , 
and crystσ ) and examined the frequency of the test set proteins that fell within that range.  In 
theory, 50% of the test proteins should also fall within that range.  Indeed, all of the Observables 
capture approximately 50% of the test cases.  The smallest difference observed between the 
number of proteins within the Observable’s CI50 range for the training and test sets of proteins 
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was with crystQ  followed by crystσ .  Therefore, it was felt that these estimates of Q  and σ  could 
be used to estimate the probability of success over the pH ranges. 
The next method used the relative frequencies of the Observables to calculate a pseudo-
probability distribution.  A researcher can then choose a desired threshold for selecting initial 
solution pH ranges.  While the crystpH  probabilities based upon the relative frequencies result in 
the same initial pH values for all proteins, the values of the Hidden Observables translate into 
more specific pH conditions.  This is accomplished using the protein’s Q  or σ  curve and 
matching the probabilities to the pH values that result in the particular crystQQ =  or crystσσ =  
value along the curve.  Although the same Q  and σ  probability thresholds are used for each 
protein, the translation of these Hidden Observables into the pH search space (Primary 
Controllable) may result in quite different pH ranges for each protein. 
For the final method, the Charge Range Test was devised to be a hybrid of the previous 
two methods.  The researcher simply uses the mean crystQ  value ±0.1, ±0.2, or ±0.3 e/kDa to 
select the crystQ  ranges for initial crystallization attempts.  This method allows for a more fair 
comparison among methods, which may have quite variable CI50 ranges.  Similar to the previous 
method, a relative probability could be estimated for a protein crystallizing in this range based 
upon the relative frequency distribution of the proteins for that particular crystQQ =  or crystσσ =  
range. 
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6.0  GROUPING PROTEINS BY SIMILARITY 
In Chapter 4, the Protein Sequence-Properties Evaluation (PSPE) Framework was developed to 
examine differences in protein sequence derived properties (Primary or Hidden Features) or 
experimental variables (Primary or Hidden Observables) between two or more groups of 
proteins.  The PSPE Framework was implemented in Chapter 5 to determine the relative 
importance of the estimated specific charge ( crystQ ) and estimated average surface charge density 
( crystσ ) in protein crystallization.  Two possible interpretations were derived.  The first 
interpretation was that no direct evidence was obtained to suggest the observed correlations 
among these variables was anything other than those expected, because these Hidden 
Observables ( crystQ  and crystσ ) were calculated from the protein Features and the Primary 
Observable ( crystpH ). The second interpretation was that the Hidden Observables ( crystQ  and 
crystσ ) may the potential to be utilized for initial crystallization screen design, particularly in the 
selection of the solution pH ranges (Primary Controllable) with a higher likelihood of success 
(crystals).  This alternative hypothesis is used for this chapter.  Therefore, the crystQ  or crystσ  
became the Observables of interest and other protein Features were examined in their ability to 
predict these two variables.  In this chapter, several methods, including binning and unsupervised 
clustering, were used to group proteins by similarity.  It was hypothesized that there are groups 
of ‘similar’ proteins that crystallize under similar conditions.  Similarity was determined by 
using the values of a single variable (binning by MWau, or, pIest) or a Feature vector (Q or σ  
curves). 
Binning by the Hidden Features was the simplest approach to grouping proteins by 
similarity and was examined first, (Section 6.1).  After grouping protein structures, differences in 
distributions were examined for the Observables, crystpH , crystQ , crystQ , and crystσ .  If significant 
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differences were observed between the distributions of experimental variables, the groups were 
further examined for pairwise differences.  Attempts were then made to predict the Observable 
ranges from the test set, using the CI50 Test (Section 6.1.2) and the Charge Range Test (Section 
6.1.3).  After binning was used to separate proteins into groups by a Hidden Feature (MWau or 
pIest), two unsupervised clustering techniques were then examined to determine their ability to 
separate the proteins into groups by using a Feature vector, the Q or σ  curves (Section 6.2).  
Finally, the distributions of the Hidden Observables appeared relatively normal in Chapter 5, so 
attempts were made in Section 6.3 to model the Q  distributions with Gaussians. 
6.1 BINNING 
Binning involved selecting a single protein sequence Feature and determining cutoff points for 
group separation.  Two main features frequently used to describe proteins are the molecular 
weight (MW) and pIest.  Additionally, these Features are thought to play an important role in the 
crystallization process.  Therefore, initial attempts focused on separating proteins based upon 
their MWau or pIest.  The number of cut points could be arbitrary (MWau) or based upon some 
limited domain knowledge (pIest).  As a control, the proteins were also randomly grouped. 
The first binning technique used the protein’s size, MWau, to group proteins.  To 
determine the cutoff points for group separation, the distribution was first examined.  The 
distribution of MWau was positively skewed with no obvious points of separation (Figure 6.1a).  
The MWau values were therefore transformed by taking the natural log (ln) of the MWau values, 
ln(MWau), in order to make the distribution appear more symmetric (Figure 6.1b).  Similar to the 
Preliminary Results in Section 3.2.1.1, the proteins within one standard deviation (SD) of the 
mean ln(MWau) were labeled as 'Average' (n = 2758).  All proteins less than 1 SD below the 
mean ln(MWau) were labeled 'Small' (n = 689), while proteins greater than 1 SD above the mean 
were labeled 'Large' (n = 667). 
Another Feature typically used to describe a protein is its pIest, the solution pH where a 
protein exhibits an Q  of zero.  As mentioned previously, researchers had speculated a high 
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correlation between a protein's pIest and its crystpH .  It was expected that proteins would have a 
higher probability of crystallizing at or near their pIest for reasons already discussed. 
The pIest distribution for all proteins is shown in Figure 6.1c.  Similar to other studies, 
which examined the proteomes of various organisms from Archaea bacteria, Bacteria, and 
Eukaryotes (Urquhart et al., 1998; Van Bogelen et al., 1999; Schwartz et al. 2001), a bimodal 
distribution was observed for pIest, where a much greater percentage of 'Acidic' (pI ≤ 6) proteins 
than either 'Basic' (pI ≥ 8) or 'Neutral' (6 < pI < 8) proteins was observed.  In order to examine 
the effects of pIest differences among proteins, the pIest was first discretized.  Unlike molecular 
weight, some knowledge could be applied to the separation of proteins by pIest.  Ries-Kautt and 
Ducruix's (1999) descriptions of 'Acidic' (pI < 6), 'Basic' (pI > 8), and 'Neutral' (6 < pI < 8) were 
initially used in the Chapter 3.  However, due to the large amount of proteins and the significant 
differences found earlier, a finer sampling of pIest was used.  Proteins with a pIest ≤ 5 were 
labeled as ‘Very Acidic’ (n = 976), 5 < pIest ≤ 6 labeled as 'Acidic' (n = 1188), 8 ≤ pIest < 9 as 
'Basic' (n = 564), and those pIest ≥ 9 as ‘Very Basic’ (n = 448).  All remaining proteins with a 
pIest between 6 and 8 were labeled as ‘Neutral’ (n = 938). 
The third and final binning technique examined random groups.  For this method, all the 
proteins in the training set were randomly assigned to one of five groups.  To do this, each 
protein was assigned a random number from a distribution with a mean of 0.0 and a standard 
deviation of one. The proteins were then rank ordered by the random number and divided into 
five equal groups. 
Differences in the distribution of Features (pIest, MWau, and AS), Observables ( crystpH , 
crystQ , crystQ , crystσ , and difflim), and the random variable were examined within each binning 
method, using a Kruskal-Wallis (KW) test with an α of 0.01 (Section 4.10). The hypothesis was 
that proteins with different MW or pIest would behave differently in crystallization attempts.  In 
particular, larger proteins would crystallize over a broader range of charge, because of the greater 
range of possible Q  values.  It was also hypothesized that binning by pIest, would increase the 
accuracy of the modeling methods on the test set, because each group would have its own crystQ  
or crystσ  range. 
 117 
 
 
 
Figure 6.1 The Baseline distributions of the (a) MWau, (b) ln(MWau), and (c) pIest. 
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6.1.1 Variable Distributions 
6.1.1.1 Molecular Weight Bins 
A KW test was used to determine if the three ln(MWau) groups had significantly different (p 
<0.01) distributions of Observables ( crystpH , crystQ , crystQ , crystσ , and difflim) and Features, pIest 
or ln(MWau).  No significant difference was observed for either the pIest or random number 
distributions (Table 6.1; Figure 6.2a).  However, significantly different distributions were 
observed for the ln(MWau), difflim, crystpH , crystQ , crystQ , and crystσ  (Figure 6.2b-g).  To find out 
where the individual differences were in the distributions, a Kolmogorov-Smirnov (KS) test was 
performed on the groups pairwise using an α of 0.01.  The 'Small' proteins had a significantly 
lower crystpH  distribution, than did the 'Average' or 'Large' groups.  In particular, there were a 
greater percentage of 'Small' proteins that crystallized with a pH between 4.0-4.5.  The larger two 
groups of proteins had a greater percentage of proteins that crystallized between a pH of 7.0-8.0. 
As the proteins grew larger, their crystQ  distribution grew wider, but was still centered on 
a Q  of zero electron units of charge (e).  The 'Small' MWau proteins had a crystQ  distribution that 
was more tightly centered on zero (Figure 6.2c).  The mean crystQ  for 'Small' proteins was 
slightly negative, -0.4±6.8 electron units of charge (e).  The 'Average' proteins were slightly 
more negative than the 'Small' proteins at -3.1±15.6 e, while the 'Large' proteins were much more 
negatively charged, -17.0±51.8 e (Table 6.1).  This was not surprising given that larger proteins 
can have more charged amino acids, thus giving them a greater possible charge range.  
Therefore, attempts were made to take account for the size of the proteins by dividing the crystQ  
by either the protein’s MWau or AS to obtain crystQ  and crystσ , respectively. 
Previous research has shown that a protein's surface area is proportional to its MW 
(Chothia, 1975; Teller, 1976; Miller et al., 1987ab; Janin et al., 1988).  While there may be more 
charged residues on the surface of larger proteins, they should have approximately the same 
average surface charge density as smaller proteins.  While having widely different crystQ  
distributions, the crystQ  (Figure 6.2b) distributions were much more similar to each other, varying 
in degrees of kurtosis.  However, all three ln(MWau) groups were still significantly different from 
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each other, although less so.  This was also demonstrated by all size groups displaying a similar 
mean crystQ  and a low but still significant Spearman's correlation between the MWau and crystQ , r 
= -0.095, p <0.0001.  The crystσ  distributions were more different than the crystQ  distributions (Figure 
6.2g), but still much less different than the crystQ  distributions.  This may be due to differences in 
the calculation of AS for ‘Small’ versus ‘Large’ proteins.  It was expected that there would be 
larger errors in the estimation of AS for ‘Large’ proteins, because of more complex shapes.  
Therefore, it was felt that the crystQ  may result in a better estimation of surface charge density. 
Additional significant differences were observed in the ln(MWau) and difflim distributions 
(Figure 6.2e-f).  The 'Small' proteins had a significantly better (i.e. lower) difflim than did both 
the 'Average' and 'Large' proteins.  Similarly, the 'Average' proteins had a better difflim than did 
the 'Large' proteins.  This was also expected, because there was a moderate correlation between 
the MWau and difflim in the training set, r = 0.323, p <0.0001.  The ln(MWau) was used to 
separate proteins; therefore, all groups had significantly different values. 
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Figure 6.2: The distribution of (a) pIest, (b) crystQ , (c) crystQ , (d) crystpH , (e) ln(MWau), (f) difflim, and (g) crystσ  for the 
MWau Bins. 
 
Table 6.1 The mean and SD of the training set proteins separated by their (a) ln(MWau), (b) pIest, or (c) random 
group numbers. 
(a) 
ln(MWau)   Features Observables Random 
Group n  pIest b ln(MWau)b crystσ  crystQ b crystQ b crystpH a difflim a Number 
Mean 6.5 A 2.45 A -9.1 A 0.0 A -0.4 A 6.4 A 1.83 A 0.01 
Small 689 
SD 2.0 0.30 125.2 0.6 6.8 1.4 0.43 0.98 
Mean 6.4 A 3.69 B -15.9 B -0.1 B -3.1 B 6.7 B 2.02 B 0.02 
Average 2,758 
SD 1.7 0.46 96.1 0.4 15.6 1.3 0.42 1.00 
Mean 6.1 A 5.07 C -30.6 C -0.1 C -17.0 C 6.8 B 2.25 C 0.04 
Large 667 
SD 1.3 0.45 94.4 0.3 51.8 1.2 0.42 0.99 
KW  x2 3.56 2837.0 36.1 13.1 167.8 28.7 290.7 0.43 
Test  p< 0.169 0.0001 0.0001 0.001 0.0001 0.0001 0.0001 0.805 
Mean 6.3 3.71 -17.2 -0.1 -4.9 6.6 2.02 0.02 
Total 4,114 
SD 1.7 0.87 101.5 0.4 25.2 1.3 0.44 1.00 
(b) 
   Features Observables Random
pIest Bin n  pIest b MWau b crystσ  crystQ b crystQ b crystpH a difflim a Number
Mean 4.5 A 56.3 A -108.0 A -0.4 A -19.3 A 6.5 A 2.0 A 0.04 
Very Acidic 976 
SD 0.4 83.5 99.8 0.4 29.3 1.4 0.4 1.02 
Mean 5.5 B 74.2 B -39.8 B -0.1 B -10.3 B 6.7 B 2.1 B 0.00 
Acidic 1,188 
SD 0.3 80.2 63.5 0.2 22.5 1.2 0.5 1.00 
Mean 6.6 C 661 C 5.7 C 0.0 C 0.3 C 6.7 B 2.1 BC 0.00 
Neutral 938 
SD 0.4 72.2 61.9 0.2 20.0 1.2 0.4 0.97 
Mean 8.2 D 52.9 A 48.3 D 0.2 D 7.8 D 6.7 B 2.0 AC 0.06 
Basic 564 
SD 0.4 64.7 60.8 0.3 14.4 1.2 0.4 0.98 
Mean 9.7 E 37.8 D 110.5 E 0.4 E 14.7 E 6.7 AB 2.0 AC 0.05 
Very Basic 448 
SD 0.5 44.1 86.4 0.3 19.3 1.4 0.4 1.02 
x2 3894 236.7 2128 2170 1784 20.0 27.6 2.0 KW 
Test c p< 0.0001 0.0001 0.0001 0.0001 0.0001 0.0005 0.0001 0.744 
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 (c)  
Random   Features Observables Random 
Group n  pIest b MWau b crystσ  crystQ b crystQ b crystpH a difflim a Number 
Mean 6.3 57.4 -15.69 -0.05 -3.9 6.6 1.99 -1.38 
A 
RG 1 823 
SD 1.7 65.8 106.19 0.41 22.7 1.3 0.43 0.46 
Mean 6.3 66.0 -17.4 -0.06 -5.7 6.6 2.04 -0.51 
B 
RG 2 823 
SD 1.7 87.8 102.43 0.39 30.1 1.3 0.46 0.17 
Mean 6.3 60.7 -17.14 -0.06 -4.8 6.6 2.01 0.03 
C 
RG 3 823 
SD 1.6 74.4 97.601 0.38 23.4 1.3 0.44 0.14 
Mean 6.4 58.8 -19.12 -0.06 -5.4 6.7 2.02 0.54 
D 
RG 4 823 
SD 1.7 71.8 101.11 0.40 23.3 1.3 0.44 0.17 
Mean 6.4 63.3 -16.41 -0.06 -4.6 6.6 2.05 1.42 
E 
RG 5 822 
SD 1.7 72.9 100.21 0.38 25.7 1.3 0.44 0.47 
x2 0.5 10.9 1.4 1.2 2.7 3.1 7.6 3947 
KW Test c 
p< 0.970 0.028 0.853 0.877 0.602 0.545 0.106 0.0001 
a Extracted from the PDB 
b Calculated using asymmetric unit sequence information 
c Degrees of freedom of 4 
Note: Groups labeled with different letters (A, B, C, D, or E) have significantly different distributions (p <0.01) as 
determined by a KS Test. 
6.1.1.2 pI Bins 
After the proteins were separated by their pIest, their group frequencies were compared to those 
of the ln(MW) bins (Table 6.2).  While all pIest bins had approximately 67±3% in the 
ln(MW)=‘Average’ group, the distribution of ‘Large’ and ‘Small’ proteins was not equally 
divided among the five pIest bins.  The proteins at either end of the pIest range (‘Very Acidic,’ 
‘Basic,’ and ‘Very Basic’) had a much greater percentage of ‘Small’ proteins than ‘Large’ 
proteins.  The ‘Neutral’ proteins had a slightly greater percentage of ‘Large’ proteins, while the 
‘Acidic’ proteins had a much greater percentage of ‘Large’ proteins.  These differences may be 
due to the technology bias in isolating and purifying slightly acidic and neutral proteins (using 
more standardized methods). 
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Table 6.2 Cross-tabulation of the proteins separated using either binning by the pIest or ln(MWau).  
 
 ln(MWau) Bin  % 
pIest Bin Small Average Large Total Total 
Very Acidic 218 (22.3) 635 (65.1) 123 (12.6) 976 (100) 23.7 
Acidic 114 (9.5) 815 (68.6) 259 (21.8) 1188 (100) 28.9 
Neutral 130 (13.9) 627 (66.8) 181 (19.3) 938 (100) 22.8 
Basic 118 (20.9) 368 (65.2) 78 (13.8) 564 (100) 13.7 
Very Basic 109 (24.3) 313 (69.9) 26 (5.8) 448 (100) 10.9 
Total 689 2758 667 4114 100.0 
% Total 16.7 67.0 16.2 100.0 
Note: The percentage of proteins in each row is shown in parentheses. 
 
Next, differences in the distribution of the Observables ( crystpH , crystQ , crystQ , and crystσ ) 
were examined among the pIest groups, using a KW test with an α of 0.01.  When significant 
differences were found, a KS test was performed pairwise to determine where the individual 
differences occurred between groups.  Similar to the ln(MWau) bins, there were some group 
differences in the crystpH  distributions.  The 'Very Acidic' proteins had a greater percentage of 
proteins that crystallized at a pH 4.0-4.5 than the other pIest groups (Figure 6.3a).  The remaining 
groups had no significant differences in their crystpH  distributions.  The crystpH  distributions 
among the pIest bins were spread wide over the pH range, generally between pH of 4 and 10 with 
varying degrees of smoothness.  This broad range corresponded to the recommended range to 
search as suggested by other researchers (Gilliland, 1997; Farr et al., 1998; Kantardjieff and 
Rupp, 2004).  All distributions had an average of 6.5-6.8, while exhibiting their peaks between a 
crystpH  of 6.5-7.5. 
The distribution of the crystQ  among the five pIest groups is shown in Figure 6.3c.  The 
KW test indicated that there were statistically significant differences among the populations.  
The KS test demonstrated that all groups had significantly different pairwise crystQ  distributions 
(Table 6.3).  The 'Neutral' group of proteins was centered on a crystQ  of zero, the pIest.  As the 
protein’s pIest deviated from 'Neutral', the distributions shifted.  When the pIest decreased, the 
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crystQ  distribution became more negative, and when the pIest increased, the crystQ  distribution 
became more positive. 
When the proteins were binned by their pIest, a KW test indicated differences in crystQ  
distributions.  The pairwise KS test demonstrated that all five crystQ  distributions were 
significantly different from each other (Figure 6.3b).  This was expected because the crystQ  and 
crystQ  variables were highly correlated, r = 0.912, p <0.0001.  The probability of successful 
crystallization was higher for an 'Acidic' protein when the crystQ  was slightly negative.  The crystQ  
distribution shifted towards a more negative value for 'Very Acidic' proteins.  'Basic' proteins 
were more likely to crystallize when the crystQ  was slightly positive, with 'Very Basic' proteins 
having a higher mean crystQ .  The 'Neutral' protein's crystQ  distribution was centered on zero, the 
pIest.  Similar results were observed for the crystσ  (Figure 6.3g).  Again, because the proteins were 
separated by a Q -related variable, the pIest, it might be expected that the distributions of the other 
Q -related Observables ( crystQ , crystQ , and crystσ ) would therefore also be significantly different. 
After demonstrating that binning proteins by their pIest resulted in significantly different 
crystQ , crystQ , and crystσ  distributions, the distribution of the difflim and MWau were examined.  
The KW test indicated that there were significant differences in both distributions.  Few pairwise 
differences were found in the distribution of the difflim (Figure 6.3f).  The 'Very Basic', 'Basic', 
and 'Very Acidic' proteins had difflim distributions that were slightly lower than the 'Acidic' 
group.  Additionally, the 'Very Basic' proteins were significantly smaller, averaging <40 kDa, 
than were the other four groups, which averaged 50+ kDa (Figure 6.4e).  The 'Acidic' proteins 
were significantly larger than the other groups were.  Additionally, the 'Neutral' proteins were the 
next largest group and significantly larger than the remaining three groups.  In general, all of 
these distributions were very rough with several sharp points. 
 125 
 
 
Figure 6.3 The distributions of the (a) pIest, (b) crystQ , (c) crystQ , (d) crystpH , (e) ln(MWau), (f) difflim, and (g) crystσ  for 
the proteins binned by their pIest. 
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6.1.1.3 Random Bins 
As seen in Table 6.6, no variable besides the one used to form the groups (random number) had 
significantly different distributions as determined by a KW test.  The distributions of the MWau 
and ln(MWau) were approaching statistical significance, which partially justifies the use of an α 
of 0.01.  After examining the distribution of variables among the five random groups, the ability 
of each group to predict the crystQ  was examined. 
After examining differences in protein Features and Observables between the ln(MWau), 
pIest, and random groups, the ability of these groups to predict a range of Q  values for 
crystallization was tested on the same independent test set used in Chapter 5.  The same methods 
used in Chapter 5 were used here, the CI50 test (Section 6.1.2) and the Charge Range Test 
(Section 6.1.3).  These results were then compared to the results in Chapter 5, where no 
subgroups were formed (Baseline), to determine whether separating proteins by molecular 
weight had a positive effect, i.e. increased predictive power. 
6.1.2 CI50 Test 
The Q  interval that captured the middle 50% (CI50) of the proteins in each ln(MWau) group is 
shown in Table 6.3.  Approximately, 0.3-0.6 Q  units were needed to capture the middle 50% of 
the proteins.  The 'Large' and 'Average' proteins had tighter crystQ  distributions (Figure 6.2b), 
thus displaying a smaller crystQ  range to capture the middle 50%.  The CI50 range for the 
'Average' proteins was the same as Baseline in Chapter 5, -0.25 to 0.14 Q  units.  The overall 
accuracy as judged by the amount of test set proteins within the CI50, was slightly lower than 
when modeled on all proteins, 46.6% versus 48.2%.  The 'Small' test set proteins had an accuracy 
of 48.9% on the test set proteins, while the 'Large' proteins decreased to 45.5%.  These findings 
indicated little to no improvement in crystQ  predictions when separating proteins on the basis of 
their MWau.  However, it remained unclear whether molecular weight along with other variables 
could improve prediction. 
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Although the CI50 analysis gave an indication on how well the test set fits any model 
developed on the training set, it failed in not taking into account the different Q  ranges required 
to obtain the CI50.  For example, the CI50 ranges for the MWau bins (Table 6.3) were quite 
different among groups.  The CI50 range for the 'Small' proteins (0.61) was 2x that of the 'Large' 
proteins (0.28).  However, the number of proteins within the CI50 of the 'Small' proteins (49%) 
was greater than those in the 'Large' proteins, 45.5%.  These results were misleading, giving the 
appearance that the 'Small' proteins captured the information better.  Therefore, another 
procedure (Charge Range Test) was developed in which the number of proteins within a Q  
range of the group mean was examined in Section 6.1.3. 
The results of the CI50 Test for proteins grouped by their pIest are shown in Table 6.3.  
Approximately 50% of the training set proteins were found in the CI50 of both, the binning by 
pIest and the Baseline group.  However, the CI50 crystQQ =  range, 0.34, was 0.13-0.15 larger than 
the 'Acidic', 'Neutral', and 'Basic' groups.  When the test set proteins were examined, the ‘Very 
Acidic’ and ‘Very Basic’ bins had more proteins within the CI50 range than the other groups.  
However, when the CI50 ranges were examined, this test again proved misleading as a much 
smaller CI50 range was used for the ‘Acidic,’ ‘Neutral,’ and ‘Basic’ bins.  Additionally, based on 
the cumulative results, it appeared that ln(MWau) binning outperformed pIest binning, 46.6% 
versus 43.9%.  Again, when the CI50 ranges are compared for the ln(MWau) and pIest bins, there 
was often a larger range for the ln(MWau) bins.  For these reasons, the CI50 test would not be 
examined in further clustering methods (Section 6.2). 
The CI50 Test results from randomly grouping the proteins are shown in Table 6.3.  All 
five groups had a similar low, high, and Q  range, which was very similar to using all proteins as 
one group (Baseline; Chapter 5).  Approximately 50% of the training set proteins were found in 
each group’s CI50, as expected.  The amount of test set proteins within each random group’s CI50 
was slightly variable, ranging from 46-52%.  Using the random groups also gave an indication of 
the error on the test set.  This method was a pseudo-five fold cross-validation, which gave an 
error of ±2.2%.  With a larger sample size, all groups may be less variable and more distributed 
around 50%.  The cumulative average for the random groups, 48.6% was again very similar to 
that obtained with the Baseline group, 47.8%, and well within the 2.2% error identified with the 
random groups. 
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Table 6.3 The CI50 Q  ranges for the protein separated by their MWau, pIest, and random number values along with 
the CI50 results.   
 
Training Set CI50 Range % Proteins in CI50 
MWau Cluster 
Low Q  High Q  Q  Range Training Set Test Set 
Small -0.32 +0.29 0.61 50.1 48.9 
Average -0.25 +0.14 0.39 50.0 46.6 
Large -0.24 +0.04 0.28 50.2 45.5 
MW Cum %    50.1 46.6 
Very Acidic -0.55 -0.21 0.34 50.0 52.5 
Acidic -0.25 -0.06 0.19 50.0 42.0 
Neutral -0.07 0.13 0.20 50.1 34.6 
Basic 0.06 0.27 0.21 50.0 45.6 
Very Basic 0.18 0.59 0.41 50.0 52.7 
pI Sum Total    50.0 43.9 
RG 1 -0.26 +0.16 0.42 50.2 51.8 
RG 2 -0.24 +0.13 0.37 50.2 46.3 
RG 3 -0.24 +0.15 0.39 50.2 48.1 
RG 4 -0.26 +0.13 0.39 50.2 47.1 
RG 5 -0.26 +0.13 0.40 50.1 49.7 
RG Sum Total    50.2 48.6±2.2 
Baseline -0.25 +0.14 0.39 50.0 47.8 
6.1.3 Charge Range Test 
For this method, a Q  range was selected around the group's mean crystQ  value for the training set 
proteins and the amount of proteins within the given range was then examined on both the 
training and test set data.  The widths of the ranges chosen were Mean±0.1, Mean±0.2, and 
Mean±0.3 based on the results in Section 5.2.4.3.  Using all proteins as one group, these ranges 
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were able to capture approximately 40%, 60%, and 70% of both the training and test set proteins.  
By calculating the percentage of proteins within a given range, this method allowed for easy 
comparison between groups or methods of separating proteins. 
When the overall Charge Range Test results of the ln(MWau) binning were compared to 
the results of Baseline in Chapter 5, no differences in the Q  results were observed (Table 6.4).  
However, when each group was examined individually, some differences became more apparent 
(Figure 6.4).  These differences seemed more in line with the actual group crystQ  distributions 
(Figure 6.2b) than with the CI50 results.  The group of 'Large' proteins performed the best on both 
the training and test sets.  This was not to surprising given that the 'Large' proteins had the 
tightest crystQ  distribution (Figure 6.2b).  When a Mean±0.1 range was applied, 48.6% of the 
'Large' proteins in the test set fell within the range.  This was approximately 11% better than 
Baseline (37.5%).  While the 'Large' proteins performed better, the 'Small' proteins performed 
much worse.  At the same Mean±0.1 interval, only 28.3% of the 'Small' proteins were captured.  
While having a greater range of possible net charge values ( crystQ ; Figure 6.2c), the 'Large' 
proteins actually had a tighter estimated specific charge distribution ( crystQ ).  This observation 
was the opposite of the hypothesis that the large proteins would have a greater range of possible 
charge values for crystallization.  Thus it appears that 'Small' proteins can be crystallized over a 
greater Q  range than can the 'Large' proteins, that were more constrained to lower Q  values, 
near the pIest.  A possible reason for this may be the possible electrostatic repulsion between 
large proteins when the Q  or σ  is higher.  Another possible explanation would be that other 
molecules present in the solution, such as salts, might aid in dissipating/shielding the charges of 
the 'Small' molecules.  However, this could not be examined with the current data set due to the 
unavailability of this information for many of the proteins in the PDB and would offer a possible 
future endeavor. 
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Figure 6.4 (a) The Charge Range Test results (a) between methods (cumulative percent) or (b) within grouping 
method, Baseline and ln(MWau) binning for proteins in the test set. 
 
The results of the Charge Range Test for the pIest bins is shown in Table 6.5.  When the 
amount of proteins whose crystQ  fell within a given Q  range were examined and compared to 
those obtained with Baseline, the pIest binning method appeared to perform much better, contrary 
to the CI50 results.  At every Q  range for both data sets, binning by pIest increased the 
cumulative percentage of proteins captured within the Q  range by 12-15% (Figure 6.5a). 
When each pIest group was examined individually, some groups were more effective than 
others in capturing the crystQ  of the test set (Figure 6.5b).  Again, the effectiveness mimicked the 
calculated crystQ  distributions of each group in Figure 6.3b.  When examining the CI50 results, the 
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'Very Acidic' proteins in the test set were captured 58% of the time, which was a very good 
result.  However, the CI50 Q  range for ‘Very Acidic’ proteins was much larger than most of the 
other pIest bins (Table 6.4).  The percentages of proteins within ±0.1 to ±0.2 Q  units of the mean 
crystQ  value were 10-25% better than no binning for all groups except the 'Very Basic' group.  
The 'Very Basic' proteins had a lower accuracy than did the Baseline group until the Mean±0.3 
Q  unit width, where they were more accurate than the Baseline group. 
 
Table 6.4 The Charge Range Test results for the proteins separated by their ln(MWau) and compared to Baseline. 
 
Training Set Small Average Large Cum%  
N=4,114 N=689 N=2,758 N=667 MWau Bins Baseline 
Mean ±0.1 28.3 40.4 52.3 40.3 40.4 
Mean ±0.2 43.4 60.8 74.7 60.1 60.1 
Mean ±0.3 55.7 74.2 86.2 73.1 73.1 
Test Set Small Average Large Cum%  
N=1,246 N=139 N=887 N=220 MWau Bins Baseline 
Mean ±0.1 23.7 35.9 48.6 36.8 37.5 
Mean ±0.2 45.3 59.5 69.5 59.7 59.6 
Mean ±0.3 54.0 71.8 80.0 71.3 71.8 
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Figure 6.5 (a) The Charge Range Test results for the proteins separated by their pIest or Baseline. (b) The within pIest 
bin comparison to the Baseline group using the test set proteins. 
 
The Charge Range Test was designed to provide a more fair comparison of clusters than 
the CI50 test, which does not take into account the variable crystQ  CI50 ranges.  The frequency of 
proteins within a given Q  range for random groups (RG) of proteins was also examined.  The 
Charge Range Test result for the training set proteins in the random clusters is shown in Figure 
6.6 and Table 6.6.  Although there was some variation among the percentages of training set 
proteins within each Q  interval, all random groups were within 5% of each other at all levels.  
When the cumulative percentage of the training set proteins within each interval was compared 
to the Baseline group, they were exactly the same.  As demonstrated in Table 6.3, each RG and 
the Baseline group had the same crystQ  mean and standard deviation, -0.1±0.4 e/kDa.  Therefore 
it was no surprise that the test set proteins Charge Range Test results for the random groups and 
the Baseline group were the same.  This was similar to a five-fold cross-validation. 
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Table 6.5 The Charge Range Test results for the proteins separated by their pIest and compared to Baseline. 
 
Training Set 
Very 
Acidic 
Acidic Neutral Basic 
Very 
Basic 
Cum. % pI 
Bins 
Baseline 
Mean ±0.1 42.6 58.2 67.5 56.7 34.2 53.8 40.4 
Mean ±0.2 63.5 79.4 83.3 82.1 60.9 74.9 60.1 
Mean ±0.3 75.9 89.6 90.0 89.7 81.0 85.5 73.1 
Test Set 
Very 
Acidic 
Acidic Neutral Basic 
Very 
Basic 
Cum. % pI 
Bins 
Baseline 
Mean ±0.1 47.1 48.9 54.6 53.2 33.3 49.0 37.5 
Mean ±0.2 69.6 77.5 74.3 77.8 56.6 73.0 59.6 
Mean ±0.3 81.3 87.7 83.5 87.1 86.0 85.1 71.8 
 
 
 
 
Figure 6.6 Comparing Baseline and random clusters to bracket the 
crystQ  value of both the training and test sets.  
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Table 6.6 The Charge Range Test results for the proteins randomly grouped and compared to Baseline.   
 
Training Set RG 1 RG 2 RG 3 RG 4 RG 5 
Cum. % Random
Group* 
Baseline 
Mean ±0.1 37.1 41.6 43.6 40.2 39.4 40.4±2.4 40.4 
Mean ±0.2 57.1 61.6 60.4 61.1 60.5 60.1±1.8 60.1 
Mean ±0.3 70.6 74.2 73.1 74.2 73.2 73.1±1.5 73.1 
Test Set RG 1 RG 2 RG 3 RG 4 RG 5 
Cum. % Random
Group 
Baseline 
Mean ±0.1 37.5 37.5 37.5 37.5 37.5 37.5 37.5 
Mean ±0.2 59.6 59.6 59.6 59.6 59.6 59.6 59.6 
Mean ±0.3 71.8 71.8 71.8 71.8 71.8 71.8 71.8 
* mean±SD 
6.1.4 Binning Summary 
As a reminder, the results presented in this section assume that the Q -related Observables 
( crystQ , crystQ , and crystσ ) can be used as proxy variables for the crystpH .  When previously 
crystallized protein structures were binned into groups based on their MWau or pIest, statistically 
significant differences were observed in their Observable variable distributions ( crystpH , crystQ , 
crystQ , and crystσ ).  Using either method of binning, few pairwise differences were observed in 
the crystpH  distributions.  However, when the distributions of the crystQ , crystQ , and crystσ were 
examined, using either method of binning, statistically significant differences were found 
between all groups pairwise.  When proteins were randomly grouped into five clusters, no 
differences were found between group distributions for any Feature, or Observable.  After 
examining for differences in variables within binning techniques, the ability of the individual 
bins to predict a Q  interval that captured the crystQ  of an independent test set was examined. 
Two methods of comparing the results were examined and compared, calculating a 50% 
confidence interval (CI50) and the Charge Range Test.  Although the CI50 demonstrated some 
value in comparing the proteins within the grouping method, comparison among different 
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methods proved more difficult, because of varying Q  CI50 intervals for each group.  This led to 
the development of the Charge Range Test, which calculated the frequency (percentage) of 
proteins within a given Q  interval around the group's mean crystQ .  Using the same Q  interval 
to compare methods allowed for a more fair comparison among the different methods of 
grouping protein structures.  Therefore, all future methods would only examine the Charge 
Range Test values. 
Binning by the MWau had little advantage over using all proteins as one group in the 
overall Charge Range Test.  However, when the MWau groups were examined individually, the 
'Large' proteins were more tightly distributed around a crystQ  of zero.  This resulted in a better 
Charge Range Test, more proteins within a given Q  interval, than the other two ln(MWau) Bins 
('Small' and 'Average') and the Baseline group.  One interpretation would be that negative 
electrostatic forces are more detrimental for larger proteins than smaller proteins.  This may 
simply be due to more charged amino acids.  'Small' proteins were found to crystallize over a 
larger Q  range than did either the 'Average' or 'Large' proteins.  This might be due to shielding 
of the charges by other solution parameters, such as salts.  As such, the Charge Range Test 
wasn't as accurate for this group ('Small') when compared to the other two groups. 
Although no overall improvement in the Charge Range Test was found when binning by 
ln(MWau), the same was not true for separating proteins into pIest Bins.  Binning by pIest had a 
significant improvement (12-15%) on both the between method (pIest vs. Baseline) and within 
method results.  Each pIest Bin, except the 'Very Basic' Bin, had a significant improvement over 
the Baseline group.  This may be explained by the high correlation between a protein's pIest and 
the crystQ .  Therefore, when predicting a protein’s estimated specific charge, proteins should be 
separated into pIest Bins, rather than using all proteins as one group. 
When proteins were grouped into five random groups, there were some differences 
observed in the individual results for the training set proteins.  However, each random group had 
the same mean and standard deviation, which led to the same Charge Range Test results for all 
groups on the test set proteins.  The cumulative percentage of crystQ  values within a given Q  
interval was the same as that observed for using all proteins as one group, Baseline.  This result 
ended up being a pseudo-five-fold cross-validation, which gave an estimated error for the Charge 
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Range Test of 2.2%.  While the number of clusters was set rather arbitrarily in each binning 
method, there was no reason to believe that these methods were the optimal method of grouping 
proteins by similarity.  Therefore, other unsupervised methods of grouping proteins by similarity 
were also explored in the next section. 
6.2 UNSUPERVISED CLUSTERING 
In the previous section, successfully crystallized proteins were grouped by either their MWau or 
pIest.  Although significant differences were found in these group's distributions of Observables, 
the crystpH , crystQ , crystQ , and crystσ , the number of groups actually present in the data was 
unknown.  The number of pIest groups was initially chosen based upon some limited domain 
knowledge (Ries-Kautt and Ducruix, 1999), while the number of ln(MWau) groups was chosen 
rather arbitrarily. 
In this section, rather than arbitrarily setting cutoff points for ln(MWau) or using limited 
domain knowledge (pIest), two unsupervised clustering algorithms were used to group proteins by 
the similarity of their estimated specific charge curves (Q  plotted against pH), where similarity 
is judged by the Q  values over a given range and interval of pH.  Instead of one point along the 
Q  curve to group proteins (binning by pIest), the ability of a larger section of the Q  curve to 
separate proteins was examined.  This section builds upon the preliminary results in Chapter 3, 
Section 3.2.2, where proteins were grouped by their scaled estimated titration curve using the 
GSOM algorithm.  However, instead of using the whole estimated titration curve or the scaled 
titration curve (pH 1.0-14.0), a portion (pH 4.0-10.0) of the Q  curve was used.  It was 
hypothesized that using the Q  curve would result in better separation of groups than using one 
point on the curve, binning by pIest.  With more knowledge available, the unsupervised clustering 
algorithms should more accurately group proteins than did binning as determined by the Charge 
Range Test.  A one-dimensional vector of Q  values every 0.2 pH units 4.0-10.0 (31 values) was 
used as the input for each clustering algorithm.  This range was chosen, because few proteins 
(~1.3% of the training set) were crystallized outside of this pH range, as demonstrated by the 
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crystpH  distributions in Chapters 3 & 5.  Also, pH values above and below this range may have 
denaturing effects on the native protein.  It was hypothesized that there would be statistically 
significant differences in the distribution of protein Features and Observables between the 
different clusters.  Initially, a subset of five was the initial arbitrary number chosen.  There could 
be more or less number of groups, but it was hypothesized that there would be a greater number 
of subgroups than five. 
Two unsupervised clustering algorithms (two-step clustering and self-organizing maps) 
were used to compare the binning techniques in the previous section (Section 6.1) with an 
unsupervised approach.  The first method, two-step clustering, has the ability to determine the 
'optimum' number of clusters by examining the information criteria of the clusters as they are 
formed (for more details see Section 4.7.2.1).  First, the number of groups was set to five for 
each unsupervised method to compare with results from binning by pIest.  Then the 2Step 
algorithm was allowed to determine the optimal number of clusters.  Similarly, the initial 
application of the self-organizing map (SOM) algorithm used five clusters.  Then the Supervised 
SOM algorithm was used to determine the number of clusters (Section 4.7.2.2). 
Initially, each clustering method was compared to binning by pIest by examining the pIest 
distribution of the clusters to determine how the unsupervised clustering algorithms separated the 
proteins into different clusters.  Then various protein Features and Observable distributions were 
examined for differences within the clustering method and between clustering methods.  The 
ability to separate proteins into the maximum number of groups with different statistically 
significant Observable distributions was the goal of using the unsupervised clustering 
techniques.  Once this could be done, modeling the distributions with Gaussians was examined 
for predictive purposes and to determine which of the methods worked best in separating the 
proteins (Section 6.3). 
6.2.1 Two-Step Clustering 
The two-step clustering algorithm (2Step) of Chui et al. (2001) was available in SPSS 
14.0/Clementine 8.0.  To compare the two-step clustering algorithm to the initial supervised 
clustering method (Binning by pIest), the number of clusters was initially fixed at five (Section 
6.2.1.1).  Next, the 2Step clustering algorithm was allowed to choose the 'optimum' number of 
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clusters (Section 6.2.1.2).  It was not known apriori how many clusters would be found present in 
the data, but it was hypothesized that the number would be larger than five due to the large 
number of protein structures examined. 
6.2.1.1 Two-Step with 5 Clusters 
The distribution of proteins within the 5 two-step (2Step5) clusters was compared to the 
frequency distribution of proteins within the pIest Bins (Section 6.1.1.2) in Table 6.7.  The mean 
Q  curves for each cluster are shown in Figure 6.7.  The 2Step algorithm grouped the 'Very 
Acidic' and 'Acidic' proteins in 2Step5 Clusters 2 and 5, while 2Step5 Cluster 1 contained most of 
the proteins with a 6.0 ≤ pIest ≤ 9.0 (46% of the data; Table 6.7; Figures 6.8a).  Two of the 
clusters (1 and 2) contained ~80% of the proteins, which demonstrated that most of the proteins 
could be placed into two groups, while the proteins with the more extreme pIest values were 
placed in the remaining three groups.  2Step5 Cluster 4 contained only 2% of the proteins, which 
were the most acidic proteins (pIest='Very Acidic') with a mean (±SD) pIest of 3.7±0.3.  2Step5 
Cluster 5 contained most of the proteins with a 4.0 ≤ pIest ≤ 5.0.  The remaining ‘Acidic’ 
proteins, 5.0 ≤ pIest ≤ 6.0, were grouped in 2Step5 Cluster 2.  The 'Very Basic' proteins were 
placed in 2Step5 Cluster 3 along with few of the 'Basic' proteins.  The 2Step clustering algorithm 
appeared to be able to use more information present within the Q  curve to group 'similar' 
proteins. 
Additionally, there were also significant differences in the MWau and ln(MWau) 
distributions between clusters, that may partially explain some of the overlap between pIest 
values (Table 6.8; Figure 6.8a).  The clusters (3 and 4) with the extreme pIest values had a smaller 
mean MWau (<32 kDa).  Sporadic differences were also observed with the difflim and crystpH  
distributions (Figure 6.8d).  Although only slight differences were observed in crystpH  
distributions, every cluster had significantly different crystQ , crystQ , and crystσ distributions (Figure 
6.8bc).  This mirrored the findings using pIest Binning. 
Using five clusters, the 2Step algorithm was able to separate the proteins into distinct 
groups as demonstrated by their Q  curves.  Each cluster exhibited a distinct distribution for the 
Hidden Observables ( crystQ , crystQ , and crystσ ).  However, similar to Binning by pIest, each cluster 
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did not have a unique crystpH  distribution, again demonstrating the potential for using Hidden 
Observable ( crystQ , crystQ , and crystσ ) distributions and the Hidden Controllables (Q , Q , or σ ) 
for modeling purposes. 
 
Table 6.7 Cross-tabulation of the clusters generated by pIest Binning and two-step clustering with five clusters 
(2Step5). 
 
 Binning by pIest  % Mean 
Cluster Very Acidic Acidic Neutral Basic Very Basic Total Total pIest 
2Step5 1 2 383 887 501 121 1894 46.0 7.0 
2Step5 2 549 788 48 1 0 1386 33.7 5.2 
2Step5 3 0 0 2 62 327 391 9.5 9.6 
2Step5 4 78 0 0 0 0 78 1.9 3.7 
2Step5 5 347 17 1 0 0 365 8.9 4.4 
Total 976 1188 938 564 448 4114 100.0 6.3 
% Total 23.7 28.9 22.8 13.7 10.9 100.0   
Mean pIest 4.5 5.5 6.6 8.2 9.7 6.3   
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Table 6.8 The variable descriptors (mean and SD) for each of the 2Step5 clustering groups separated by their 
estimated specific charge curves from pH 4.0-10.0. 
 
2Step5   Features Observables Random 
Cluster n  pIest MWau crystσ  crystpH  crystQ  crystQ  difflim Variable 
Mean 7.0 A 66.3 A 14.2 A 6.7 A 0.1 A 1.4 A 2.05 A 0.03 A 
1 1894 
SD 1.1 74.8 59.2 1.2 0.2 18.2 0.43 0.98 
Mean 5.2 B 70.4 A -56.4 B 6.6 AB -0.2 B -14.1 B 2.04 A 0.02 A 
2 1386 
SD 0.5 87.0 69.6 1.3 0.2 26.9 0.46 1.00 
Mean 9.6 C 31.6 B 124.3 C 6.7 AB 0.5 C 15.2 C 1.96 AC 0.00 A 
3 391 
SD 0.7 33.1 92.2 1.5 0.4 20.4 0.44 1.03 
Mean 3.7 D 20.0 C -282.0 D 6.3 B -1.2 D -23.8 D 1.74 B -0.03 A 
4 78 
SD 0.3 20.7 113.7 1.4 0.5 26.8 0.38 1.04 
Mean 4.4 E 40.6 D -125.7 E 6.4 B -0.5 E -20.1 E 1.96 C -0.02 A 
5 365 
SD 0.3 46.0 92.9 1.4 0.3 28.6 0.44 1.02 
KW  x2 3264 401 1999 21.4 2064 1479 56.0 1.5 
Test  p< 0.0001 0.0001 0.0001 0.0003 0.0001 0.0001 0.0001 0.833 
Note: Groups labeled with different letters (A, B, C, D, or E) have significantly different distributions (p<0.01) as 
determined by a KS Test. 
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Figure 6.7 The mean Q  curves for each (a) pIest Bin and (b) 2Step5 Cluster. 
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Figure 6.8 The 2Step5 distributions of (a) pIest, (b) crystQ , (c) crystQ , (d) crystpH , (e) ln(MWau), (f) difflim, and (g) crystσ .  
6.2.1.2 Charge Range Test 
After demonstrating the ability of the 2Step algorithm to cluster the proteins into distinct groups 
by their Q  curve similarity, the Charge Range Test was performed on the clusters and compared 
to Baseline and pIest Binning.  Because there were no differences in the Charge Range Test 
between Baseline, ln(MWau) binning, and Random Binning, the latter two were not reported here 
(see Section 6.1.3).  There was an obvious improvement in the amount of proteins captured by 
the Charge Range Test when comparing the cumulative percentage versus Baseline at all levels 
(Table 6.9; Figure 6.9a).  A 14% increase in the Charge Range Test results over Baseline was 
observed at all levels.  When compared to the pIest Bin Charge Range Test results, 2Step 
clustering resulted in no improvement at the low intervals, Mean±0.1 and Mean±0.2, and a 
slightly better result at the Mean±0.3 level (+4%).  Because of simplicity and ease of calculation, 
along with similar Q  range results, pIest binning should be used over 2Step clustering with 5 
clusters.  However, it was not known what the ‘optimal’ number of clusters should be, which 
was examined in the next section (Section 6.2.1.3). 
 
Table 6.9 The Charge Range Test for each 2Step5 cluster and that of the Baseline group (Chapter 5). 
 
Training Set 
2Step5 1 
N=1894 
2Step5 2 
N=1386 
2Step5 3 
N=391 
2Step5 4 
N=78 
2Step5 5 
N=365 
Cum. % 
2Step5 
Baseline 
Mean ±0.1 51.1 59.9 33.0 29.5 43.3 51.2 40.4 
Mean ±0.2 78.6 78.6 56.8 37.2 59.5 74.0 60.1 
Mean ±0.3 92.6 88.2 73.9 46.2 75.1 86.9 73.1 
Test Set 
2Step5 1 
N=587 
2Step5 2 
N=424 
2Step5 3 
N=128 
2Step5 4 
N=9 
2Step5 5 
N=98 
Cum. % 
2Step5 
Baseline 
Mean ±0.1 48.0 56.8 32.8 44.4 48.0 49.4 37.5 
Mean ±0.2 72.6 76.4 60.2 55.6 72.4 72.5 59.6 
Mean ±0.3 90.1 88.2 75.8 77.8 81.6 87.2 71.8 
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Next, the clusters within the 2Step5 method were compared (Figure 6.9b).  2Step5 
Clusters 1 and 2, the most populated clusters, both had a significant improvement at all levels 
over the Baseline group.  2Step5 Cluster 4 had the fewest training (n=78) and test (n=9) set 
proteins.  This group appeared to capture the small ‘Very Acidic’ proteins, and had a lower 
Charge Range Test score than did all other groups within method and between methods 
(Baseline and pIest Bins).  Similarly, 2Step5 Cluster 3 represented the ‘Very Basic’ proteins and 
also had an accuracy below that of the Baseline group.  These two groups represented more 
extreme cases and there was difficulty predicting the Q  range.  Thus, the cumulative percentage 
of protein structures captured by Charge Range Test was much more accurate at all levels.  
However, the 2Step5 clustering method performed no better than did binning by pIest.  A slight 
improvement of 4% was observed at the Mean ±0.3 interval.  The next step was to attempt to use 
the 2Step clustering algorithm’s ability to determine the number of clusters present within the 
data. 
 
 
 
Figure 6.9 (a) The cumulative Charge Range Test results for 2Step5 clustering and Baseline (BL).  (b) The 
breakdown of each 2Step5 cluster compared to Baseline on the test set proteins. 
6.2.1.3 Determining the Optimum Number of Clusters 
After demonstrating that protein structures could be separated by their Q  curves, the next step 
was to determine how many clusters were present within the data.  For this step, the 2Step 
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algorithm was allowed to choose the optimal number of clusters based upon Schwarz's Bayesian 
Information Criteria (BIC; Schwarz, 1978) using maximum likelihood distance. 
 
Table 6.10 The optimal number of clusters chosen by the 2Step algorithm was six, using BIC and maximum 
likelihood distance. 
 
Number of 
Clusters 
BIC 
BIC 
Change a 
Ratio of BIC 
Changes b 
Ratio of Distance 
Measures c 
1 -174512    
2 -203369 -28856.6 1.000 1.478 
3 -222729 -19359.9 0.671 2.816 
4 -229271 -6542.5 0.227 1.069 
5 -235360 -6088.7 0.211 1.310 
6 -239884 -4524.3 0.157 2.947 
7 -241078 -1194.3 0.041 1.206 
8 -241981 -902.6 0.031 1.021 
9 -242854 -873.2 0.030 1.055 
10 -243655 -800.6 0.028 1.055 
11 -244387 -731.7 0.025 1.650 
12 -244627 -240.2 0.008 1.234 
13 -244723 -96.6 0.003 1.092 
14 -244768 -45.0 0.002 1.297 
15 -244685 83.3 -0.003 1.003 
a The changes are from the previous number of clusters in the table. 
b The ratios of changes are relative to the change from the two cluster solution. 
c Compares the distance measures between the current and  previous number of clusters. 
 
The 2Step algorithm determined that the optimal number of clusters for the training data 
was six using BIC analysis (2Step6; Table 6.10).  The Q  curves of each protein cluster are 
shown in Figure 6.10.  When compared to the 2Step5 clusters, the 2Step6 Clusters split 2Step5 
Clusters 1 (mean pIest of 7.0) into 2Step6 Clusters 4 (mean pIest of 6.2) and 5 (mean pIest of 8.4).  
There was also some other rearrangement of proteins, but there was a group of proteins with the 
same mean pIest as in the 2Step5 Clusters (Table 6.11). 
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The BIC analysis resulted in six clusters with 2Step clustering.  Although similar to the 
2Step5 clusters, the addition of the extra cluster still maintained the statistically significant 
differences observed in the pIest and the Hidden Observable distributions of crystQ , crystQ , and 
crystσ  (Table 6.12; Figure 6.11a-c,g).  The crystpH  distributions displayed few differences; with 
the most acidic cluster (2Step6 Cluster 1) having lower crystpH  distributions than clusters 4 and 
5, which had a smaller percentage of proteins that crystallized at pH 4-4.5 (Figure 6.11d).  
Varying differences were also observed with the MWau and difflim distributions (Figure 6.11e-f).  
Only 2Step6 Clusters 3 and 4 had similar MWau distributions.  All other Clusters had MWau 
distributions that were significantly different from one another.  The 2Step6 clusters with the 
extreme pIest distributions (Clusters 1 and 6) had significantly lower mean difflim values (1.8 and 
1.9 Å, respectively) than the other clusters which averaged 2.0-2.1 Å.  No differences were 
observed in the random number distributions. 
 
Table 6.11 Cross-tabulation of the 2Step clustering results using 5 (2Step5) or 6 clusters (2Step6). 
 
2Step6 2Step5 Cluster  % 
Cluster 1 2 3 4 5 Total Total 
Mean 
pIest 
1 0 0 0 78 5 83 2.0 3.7 
2 0 129 0 0 360 489 11.9 4.5 
3 14 1215 0 0 0 1229 29.9 5.2 
4 1143 42 0 0 0 1185 28.8 6.2 
5 737 0 178 0 0 915 22.2 8.4 
6 0 0 213 0 0 213 5.2 9.8 
Total 1894 1386 391 78 365 4114 100.0 6.3 
% Total 46.0 33.7 9.5 1.9 8.9 100.0  
Mean pIest 7.0 5.2 9.6 3.7 4.4 6.3  
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Table 6.12 The variable descriptors (mean and SD) for each of the 2Step6 clustering groups separated by their Q  
curves from pH 4.0-10.0. 
 
2Step6   Features Observables Random 
Cluster n  pIest MWau crystσ  crystQ  crystQ  crystpH  difflim Variable 
Mean 3.7 A 20.1 A -276.0 A -1.2 A -23.5 A 6.3 A 1.8 A -0.05 A 
1 83 
SD 0.3 20.6 115.0 0.5 26.3 1.4 0.4 1.03 
Mean 4.5 B 46.8 B -118.2 B -0.4 B -21.4 B 6.5 AB 2.0 BD 0.00 A 
2 489 
SD 0.4 57.1 89.8 0.3 30.8 1.4 0.4 1.02 
Mean 5.2 C 70.8 C -52.5 C -0.2 C -13.1 C 6.6 AB 2.0 BC 0.03 A 
3 1229 
SD 0.5 88.5 67.5 0.2 25.8 1.3 0.5 1.00 
Mean 6.2 D 73.9 C -4.3 D 0.0 D -2.1 D 6.7 B 2.1 C 0.01 A 
4 1185 
SD 0.6 84.3 55.6 0.2 20.5 1.2 0.4 0.95 
Mean 8.4 E 51.1 D 49.8 E 0.2 E 7.8 E 6.7 B 2.0 BD 0.07 A 
5 915 
SD 0.9 50.6 58.2 0.2 13.8 1.3 0.4 1.01 
Mean 9.8 F 28.4 E 160.2 F 0.7 F 17.9 F 6.7 AB 1.9 D -0.07 A 
6 213 
SD 0.8 31.4 95.0 0.4 20.6 1.5 0.4 1.03 
KW x2  3542 389.5 2187 2244 1716 15.4 73.7 5.3 
Test p< 0.0001 0.0001 0.0001 0.0001 0.0001 0.009 0.0001 0.379 
Note: Groups labeled with different letters (A, B, C, D, E, or F) have significantly different distributions (p<0.01) as 
determined by a KS Test. 
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Figure 6.10 The mean Q  curves for each 2Step6 cluster. 
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 150 
Figure 6.11 The 2Step6 distributions of (a) pIest, (b) crystQ , (c) crystQ , (d) crystpH , (e) ln(MWau), (f) difflim, and (g) 
crystσ . 
6.2.1.4 Charge Range Test 
The 2Step6 results of the Charge Range Test are shown in Table 6.12.  Similar to the 2Step5 
results (Table 6.9), the 2Step6 results demonstrated significant improvement over the Baseline 
group at all levels (Figure 6.12a).  While the 2Step5 results showed little to no cumulative 
improvement over the pIest Bin results, allowing the 2Step algorithm to select the number of 
clusters (6 clusters; 2Step6) resulted in a 4-5% improvement over both the pIest Bin (Table 6.5) 
and 2Step5 results (Table 6.9) at all ranges.  Therefore, this would seem to represent a more 
optimal separation of proteins. 
After examining the cumulative 2Step6 results, the focus turned to the results within the 
method (Figure 6.12b).  2Step6 Clusters 1 and 6 represented the extremely acidic and basic 
proteins, respectively.  Similar to previous results with pIest binning, these extreme cases had 
lower prediction accuracy than the Baseline group.  These two clusters performed poorly on both 
the training and test sets.  2Step6 cluster 2 performed similar to the Baseline group at all levels, 
although slightly better at the Mean±0.3 level.  At the Mean±0.3 level, 2Step6 Clusters 3-5 all 
approached 90% accuracy in selecting the correct Q  range for crystallization, which was similar 
for the ‘Acidic,’ ‘Neutral,’ and ‘Basic’ pIest groups.  A Q  range of Mean±0.1 or Mean±0.2 
seems to maximize the performance over the Baseline method, +17%. 
 151 
Table 6.13  The Charge Range Test results for each 2Step6 cluster and Baseline (Chapter 5). 
 
Training Set 
2Step6 1 
n=83 
2Step6 2 
n=489 
2Step6 3 
n=1229 
2Step6 4 
n=1185 
2Step6 5 
n=915 
2Step6 6 
n=213 
Cum. %
2Step6 
Baseline 
Mean ±0.1 28.9 39.3 63.1 64.2 58.6 30.5 57.2 40.4 
Mean ±0.2 37.3 60.7 81.0 86.1 81.5 50.7 77.7 60.1 
Mean ±0.3 45.8 77.9 89.2 93.3 90.2 70.4 87.4 73.1 
Test Set 
2Step6 1 
n=12 
2Step6 2 
n=132 
2Step6 3 
n=386 
2Step6 4 
n=365 
2Step6 5 
n=286 
2Step6 6 
n=65 
Cum. %
2Step6 
Baseline 
Mean ±0.1 33.3 44.7 58.8 57.5 53.8 36.9 54.4 37.5 
Mean ±0.2 41.7 63.6 78.5 82.2 79.0 58.5 76.7 59.6 
Mean ±0.3 58.3 81.1 88.3 90.7 88.8 78.5 87.6 71.8 
 
 
 
 
Figure 6.12 Comparison of (a) cumulative or (b) individual Charge Range Test results between 2Step6 clustering and 
Baseline. 
6.2.2 Self-Organizing Maps (SOMs) 
The self-organizing map (SOM) algorithm (Kohonen, 2001) usually requires the user to set the 
number of clusters apriori.  The number of clusters may be set arbitrarily or by using some 
domain knowledge.  Usually, the SOM clusters are a two-dimensional projection of a 
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multidimensional dataset with each cluster represented by an x and y value.  The number of 
clusters within such a SOM equals x * y.  Alternatively, there are a few dynamic SOM 
algorithms that allow the data to determine the number of clusters.  One example was the GSOM 
algorithm (Hsu et al., 2003), which was described in Chapter 3.  A dynamic SOM measures the 
error within a cluster and when this error reaches a threshold, another cluster is added adjacent to 
the best-fit node (see Section 4.7.2.2). 
Initially, a 5x1 SOM (SOM5x1) was chosen to compare the results with binning by the pIest 
(Section 6.1).  This size SOM would result in a maximum of five clusters with a spatial 
relationship between each cluster.  Cluster 1 would be more similar to Cluster 2 than to Cluster 
3.  The input vector was the Q  values of the Q  curve from 4.0-10.0 every 0.2 pH units, the 
same values used in the previous section, 2Step clustering.  The self-organizing map (SOM) 
algorithm was implemented using Clementine 8.0 (SPSS, Chicago, IL). 
The default settings were used for the first Learning Phase (growing), the learning rate decay 
(linear), neighborhood (2), initial eta (0.3), and cycles (20).  The second Learning Phase 
(smoothing) had a neighborhood of 1, an initial eta of 0.1, and 150 cycles. 
The next step was to determine the optimum SOM dimensions (i.e. number of clusters).  Two 
methods were attempted, a dynamic SOM and the Supervised SOM algorithm developed in 
Section 6.2.3.  The dynamic SOM package used was the same one used in the Preliminary 
Results (Section 3.2.2), GSOMPak 1.0 Beta, kindly provided by Art Hsu (Hsu et al., 2003).  
Similar growth and smoothing parameters to those used in the initial SOM analysis in 
Clementine were used.  The initial spread factor was set to 0.1 (the lowest setting), which should 
result in the fewest number of clusters.  After the initial attempt with the GSOM package, a 
smaller amount of cycles was used for the smoothing phase (50) in an attempt to reduce the 
number of clusters in the final model. 
6.2.2.1 SOM with 5 Clusters 
Initially, five clusters were chosen to allow easy comparison to binning by the pIest (Section 6.1.) 
and the other unsupervised clustering method, 2Step Clustering (Section 6.2.1).  These clusters 
were created by using a 5x1 SOM (SOM5x1).  The proteins within the SOM5x1 clusters were first 
compared to binning by pIest and then the other unsupervised clustering algorithm. 
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In the initial analysis (Section 6.1.1.2), the proteins were divided into 5 bins based upon 
the proteins pIest values, 'Very Acidic' (pIest ≤ 5.0), 'Acidic' (5.0 < pIest ≤ 6.0), 'Neutral' (6.0 < pIest 
< 8.0), 'Basic' (8.0 ≤ pIest < 9.0), and 'Very Basic' (pIest ≥ 9.0).  These pIest cut point values were 
determined with some limited domain knowledge and it was unknown if there were better ways 
to group the data.  The unsupervised SOM algorithm broke up proteins differently with each 
group containing 14-30% of the proteins (Table 6.14).  The resulting frequencies may not be 
surprising given the preponderance of 'Acidic' and 'Neutral' proteins in the training set.  The 
SOM split the two acidic pIest groups (pIest ≤ 6.0) into 3 clusters (Clusters 2-4) and combined 
most of the 'Basic' and 'Very Basic' proteins (pIest ≥ 8.0) into Cluster 0.  The majority of 'Acidic' 
proteins fell into Cluster 2, along with a sizable amount in Cluster 3.  The 'Very Acidic' proteins 
were divided between Clusters 3 and 4.  All SOM5x1 groups contained some proteins labeled as 
'Neutral'; however, the majority of these proteins fell in Clusters 1 and 2.  The percentage of 
proteins within each group was more balanced than observed with the pIest Binning where 10-
14% of the proteins were found in each of the 'Basic' and 'Very Basic' pIest Groups.  The 'Very 
Acidic', 'Acidic', and 'Neutral' pIest groups each had approximately 25% of all the training set 
proteins.  The mean Q  curves for each SOM5x1 cluster are shown in Figure 6.13.  These curves, 
especially the SOM5x1 Clusters 0 and 4, were much closer together than were those obtained 
using 2Step clustering (Figure 6.7 and 6.10).  This could be explained by these clusters having a 
larger proportion of proteins (14-20%) than did the most acidic and basic 2Step clusters (2-10%). 
 
 
Figure 6.13 The SOM5x1 cluster’s mean Q  curves. 
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Table 6.14 Cross-tabulation of the SOM5x1 clusters vs. the (a) pIest bins or (b) 2Step5 clusters. 
 
(a) pIest Bin  % Mean 
Cluster Very Acidic Acidic Neutral Basic Very Basic Total Total pIest 
SOM5x1 0 0 0 52 328 441 821 20.0 9.0 
SOM5x1 1 0 31 561 226 7 825 20.1 7.0 
SOM5x1 2 65 844 296 9 0 1214 29.5 5.7 
SOM5x1 3 387 274 24 1 0 686 16.7 5.0 
SOM5x1 4 524 39 5 0 0 568 13.8 4.4 
Total 976 1188 938 564 448 4114 100.0 6.3 
% Total 23.7 28.9 22.8 13.7 10.9 100.0  
Mean pIest 4.5 5.5 6.6 8.2 9.7 6.3  
 
(b) 2Step5 Cluster  % Mean 
Cluster 1 2 3 4 5 Total Total pIest 
SOM5x1 0 431 0 390 0 0 821 20.0 9.0 
SOM5x1 1 824 0 1 0 0 825 20.1 7.0 
SOM5x1 2 639 575 0 0 0 1214 29.5 5.7 
SOM5x1 3 0 686 0 0 0 686 16.7 5.0 
SOM5x1 4 0 125 0 78 365 568 13.8 4.4 
Total 1894 1386 391 78 365 4114 100.0 6.3 
% Total 46.0 33.7 9.5 1.9 8.9 100.0  
Mean pIest 7.0 5.2 9.6 3.7 4.4 6.3  
 
 
As mentioned previously, SOMs should preserve the spatial relationship between 
clusters, i.e. clusters that share borders or are closer together in space (1D or 2D) are more 
closely related to each other.  For this analysis, Cluster 0 should be most closely related to 
Cluster 1, while most different from Cluster 4.  This could be observed by either the Q  curves 
(Figure 6.13) or the mean pIest values of each cluster.  Meanwhile, there are no defined 
relationships between 2Step clusters.  These relationships may be inferred from each cluster's 
mean pIest value or by calculating the distance between clusters on the mean crystQ  values. 
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This was indeed the case, where Cluster 0 was composed of 'Very Basic' proteins (mean 
pIest of 9.0) and Cluster 4 is composed of 'Very Acidic' proteins (mean pIest of 4.4).  Table 6.15 
shows the Mean±SD of the variables examined, including the pIest, MWau, crystpH ,  crystQ , crystQ , 
crystσ , difflim (Å), and the random variable.  All five groups had significantly different 
distributions of the pIest (Figure 6.14a), crystQ  (Figure 6.14c),  crystQ  (Figure 6.14b), and crystσ  
(Figure 6.14g).  Although there were significant differences in the distributions of the  pIest, there 
were overlaps between all groups (Figure 6.14a).  Clusters 0 and 1 had fairly broad pIest 
distributions, while the others are more tightly distributed.  In contrast, binning by the pIest 
resulted in no overlaps of the pIest.  Clearly, the SOM algorithm was picking up other differences 
between the Q  curves.  Using a portion of the Q  curves (pH 4.0-10.0) separated the data 
differently, regardless of the unsupervised clustering method (SOMs or Two-Step Clustering). 
The crystQ  distributions (Figure 6.14b) were very similar to those obtained when binning 
proteins by their pIest, where all the distributions appeared relatively normal.  This was another 
difference between the SOMs and the other unsupervised clustering method (2Step Clustering).  
The most acidic and basic clusters in the 2Step clustering method displayed crystQ  distributions 
that were very erratic (Figures 6.8b and 6.11b) due to the smaller amount of proteins in these 
groups.  There was also an interesting peak in the crystQ  distribution of Cluster 4, which had a 
spike near the pIest.  Similar to the crystQ , the other measures of charge ( crystQ  and crystσ ) also 
appeared relatively normal with varying degrees of noise. 
While some statistical differences in the crystpH  and difflim distributions did exist between 
the SOM5x1 clusters, most seem quite trivial for use in the laboratory ( crystpH ) or determining 
quality (difflim).  The clusters all had crystpH  means ranging from pH 6.4-6.7.  The distribution of 
the crystpH  is shown in Figure 6.14c.  Cluster 4 had more proteins that crystallized under acidic 
conditions, especially pH 4.0, than did the other groups, while less at pH 6.0.  Again, this lack of 
difference in the crystpH  demonstrated the utility of using Q  values for prediction rather than pH 
values.  The distribution of difflim was also found to be statistically different, but lacking any 
great differences as all groups had an average difflim of 1.9-2.0 Å.  Finally, no statistical 
differences were observed in the random number distributions. 
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Table 6.15 The variable descriptors (mean and SD) for each of the SOM5x1 groups separated by their estimated 
specific charge curves from pH 4.0-10.0. 
 
SOM5x1   Features Observables Random 
Cluster n  pIest MWau crystσ  crystQ  crystQ  crystpH  difflim Variable 
Mean 9.0 A 42.5 AB 85.8 A 0.3 A 11.4 A 6.7 AB 2.0 AC 0.05 A 
0 821 
SD 0.9 44.7 82.6 0.3 16.6 1.3 0.4 1.01 
Mean 7.0 B 66.6 AC 15.9 B 0.1 B 2.6 B 6.7 A 2.0 AB 0.03 A 
1 825 
SD 0.7 75.2 55.3 0.2 20.7 1.2 0.4 0.96 
Mean 5.7 C 75.6 BC -25.5 C -0.1 C -7.4 C 6.7 A 2.1 B 0.01 A 
2 1214 
SD 0.5 83.6 59.7 0.2 20.4 1.2 0.4 1.00 
Mean 5.0 D 67.6 AC -63.3 D -0.2 D -15.3 D 6.5 AB 2.0 AB 0.02 A 
3 686 
SD 0.5 92.5 70.0 0.2 27.2 1.3 0.4 0.99 
Mean 4.4 E 42.1 C -140.3 E -0.6 E -21.3 E 6.4 B 1.9 C 0.00 A 
4 568 
SD 0.5 53.9 109.6 0.5 30.2 1.4 0.4 1.03 
x2  3551 327 2128 2185 1694 19.3 43.3 1.2 
KW Test 
p<  0.0001 0.0001 0.0001 0.0001 0.0001 0.0007 0.0001 0.879 
Note: Groups labeled with different letters (A, B, C, D, or E) have significantly different distributions (p<0.01) as 
determined by a KS Test. 
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Figure 6.14 The SOM5x1 cluster distributions of the (a) pIest, (b) crystQ , (c) crystQ , (d) crystpH , (e) ln(MWau), (f) difflim, 
and (g) 
crystσ . 
6.2.2.2 Charge Range Test 
After demonstrating the ability to separate proteins into unique groups by their Q  curves, the 
ability to correctly capture the crystQ  of an independent test set was examined.  The SOM5x1 
clusters displayed an obvious improvement over Baseline (Table 6.16; Figure 6.15a).  An 
approximate 13% increase was observed in the cumulative percentage of test set proteins 
bordered at all levels.  When the Charge Range Test values were examined within cluster, 
striking differences were observed among clusters.  The most acidic (SOM5x1 4) and basic 
(SOM5x1 0) protein clusters did not perform as well as the middle three clusters, although they 
performed similarly or better than the Baseline group.  There were little differences between the 
SOM5x1 clusters, the 2Step5 clusters, and the pIest Bins.  The 2Step6 clusters performed slightly 
better (3%) than the SOM5x1 clusters at the Mean±0.2 and Mean±0.3 levels, but 7% better at the 
Mean±0.1 level.  Therefore, it is recommended to use the 2Step6 clustering over SOM5x1 clusters. 
 
Table 6.16 The Charge Range Test results for each SOM5x1 cluster and the Baseline values (Chapter 5). 
 
Training Set 
SOM5x1 0 
n=821 
SOM5x1 1 
n=825 
SOM5x1 2 
n=1214 
SOM5x1 3 
n=686 
SOM5x1 4 
n=568 
Cum. % 
SOM5x1 
Baseline 
Mean ±0.1 41.2 58.1 66.9 55.4 32.0 53.3 40.4 
Mean ±0.2 65.8 85.2 84.4 79.7 57.4 76.3 60.1 
Mean ±0.3 80.4 93.8 92.1 90.4 65.7 86.2 73.1 
Test Set 
SOM5x1 0 
n=263 
SOM5x1 1 
n=246 
SOM5x1 2 
n=373 
SOM5x1 3 
n=223 
SOM5x1 4 
n=141 
Cum. % 
SOM5x1 
Baseline 
Mean ±0.1 36.1 50.8 55.2 53.4 34.0 47.6 37.5 
Mean ±0.2 66.9 74.0 79.6 77.6 61.7 73.4 59.6 
Mean ±0.3 81.0 93.1 88.2 87.9 72.3 85.8 71.8 
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Figure 6.15 (a) The Charge Range Test results (a) between methods (cumulative percent) or (b) within grouping 
method, SOM5x1 and Baseline for proteins in the test set. 
6.2.3 Supervised SOM 
The second SOM method to determine the optimum number of clusters was developed for this 
particular purpose, the supervised SOM.  The goal was to determine the maximum number of 
clusters, which all displayed significantly different distributions of an Observable, crystQ  in this 
case.  The crystQ  distribution was chosen because of the differences observed between the pIest 
bins in Section 6.1.1.2.  As shown in all the previous examples, there were much larger 
differences observed in the crystQ  distributions than in the crystpH  distributions.  The hypothesis 
was that the optimum number of clusters would perform better at modeling the crystQ  
distributions for prediction on an independent test set as judged by the Charge Range Test. 
Initially, a 2x2 SOM (SOM2x2) was created and incrementally increased in one dimension at 
a time until either a single non-statistically significant difference was found between any two 
cluster’s crystQ  distributions, as determined by a KS test, or the number of clusters reached 16 
(Section 4.7.6).  Sixteen clusters would be the maximum number of groups if the proteins were 
binned by their pIest every 0.5 pH units from 4.0-12.0.  Starting with an initial SOM2x2, each 
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dimension of the SOM was increased one at a time starting with the x-dimension, i.e. the next 
SOM investigated would be SOM3x2. 
Although the initial use of the GSOM algorithm in Chapter 3 seemed promising, the 
implementation with the new training set proved otherwise.  The GSOM applied to the PDB 
version #107 data set (n = 11,518) had a size of 61 clusters, which was large, but manageable.  
The attempts on the non-redundant data set (nrPDB10.04.05) produced 993 clusters using the same 
parameters as in the SOM5x1. The effort to analyze 1000 clusters would be quite time consuming.  
One difference between the analyses was that the current input Feature vector only used the Q  
curve from pH 4.0-10.0, while the initial analysis used the estimated titration curve from 1.0-
15.0.  The number of epochs (passes through the data) was then decreased in an attempt to 
decrease the overall size, but this had little to no effect on the overall size (1023 clusters).  
Although there is the possibility that there are actually several hundred distinct clusters in this 
small subsection of the protein universe, this method was abandoned for the time being. 
The supervised SOM algorithm proved more manageable than the dynamic SOM.  After 
some initial SOM analysis, it was observed that if the x-dimension increased and the y-dimension 
stayed at 2, no proteins were found in the 2nd y-dimension, creating a one-dimensional SOM.  
For example, a 4x2 SOM could have 8 possible clusters to populate.  As it turned out, one 
dimension was not populated, resulting in only 4 populated clusters.  Therefore, the x-dimension 
of the SOM was allowed to increase above 8, where a SOM8x2 would theoretically allow for 
sixteen groups.  With the y-dimension remaining at 2, the x-dimension was allowed to increase to 
a maximum value of 16.  Therefore, the strategy was altered so the SOM size could increase to 
16x2, because the 2nd dimension would not be populated, resulting in only 16 clusters.  
Additionally, only minor differences were observed between the cluster assignments (2% of the 
proteins; 80/4114) in the one dimensional and two-dimensional SOM cluster assignments, such 
as between a 5x1 and 5x2 SOM. 
Table 6.17 demonstrated that the 'optimum' SOM dimension was a 14x2 SOM (SOM14x2).  
When a 15x2 SOM (SOM15x2) was produced, there was a non-significant pairwise difference 
between clusters as determined by a KS test.  When the 2nd dimension began to populate in the 
SOM3x3, non-significant differences in crystQ  distributions were immediately observed between 
clusters.  One possible explanation was that a one-dimensional (1D) vector was used as input.  
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The differences in the 1D vector may not be able to be captured in the second dimension.  Thus, 
the 1D vector was better represented in 1D space, which also allowed for an easier interpretation. 
The SOM14x2 splits each SOM5x1 cluster into 3-4 additional clusters each with overlaps 
between the adjacent SOM5x1 clusters (Table 6.18).  The 'Very Acidic' proteins are grouped more 
towards SOM14x2 Cluster 0, while the 'Very Basic' clusters are more concentrated toward 
SOM14x2 Cluster 13.  The terminal clusters (0-1 and 12-13) had the fewest number of proteins 
and tended to be of smaller size with the most extreme pIest values and the widest crystQ  
distributions (Figure 6.17).  These terminal clusters also contained proteins with better 
resolution, which may be related to their small size.  Each SOM14x2 cluster displayed 
significantly different distributions of pIest and crystQ , although some clusters may have the same 
mean value (Table 6.19).  Many differences were also observed in the crystQ  distributions, with 
overlapping distributions occurring towards each terminal end of the SOM14x2.  SOM14x2 Clusters 
0 and 1 had significantly lower crystpH distributions than did several other clusters.  The MWau 
and difflim distributions also displayed a complex pattern of differences. 
 
 
 
Figure 6.16 The mean Q  curves for each SOM14x2 cluster. 
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Table 6.17 Determining the optimum SOM dimension using the supervised SOM algorithm in Section 4.7.6.  For 
comparison, the number of non-significant (NS) pairwise differences in the 
crystQ  and crystpH  distributions between 
SOM clusters was also reported.   
 
# of Clusters - NS Pairwise SOM 
Dimensions 
(x*y) 
# of Possible 
Clusters 
# of Empty 
Clusters 
# Possible 
Pairwise 
Comparisons crystQ
 crystQ  crystpH  
2x2 4 3  - - - 
3x2 6 3 3 0 0 3 
4x2 8 4 6 0 0 5 
5X2 10 5 10 0 0 8 
6x2 12 6 15 0 1 12 
7x2 14 7 21 0 1 16 
8x2 16 8 28 0 1 22 
9X2 18 9 36 0 3 30 
10x2 20 10 45 0 3 38 
11x2 22 11 55 0 6 45 
12x2 24 12 66 0 6 56 
13x2 26 13 78 0 9 68 
14x2 28 14 91 0 6 78 
15x2 30 15 104 1 10 91 
3x3 9 0 36 1 3 35 
4x3 12 0 66 1 6 63 
 
 
 
Figure 6.17 The distribution of the 
crystQ  for each SOM14x2 cluster in the training set. 
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Table 6.18 Cross-tabulation of the SOM5x1 and SOM14x2 Clusters.  
 
SOM5x1 Cluster  SOM14x2 
Cluster 0 1 2 3 4 Total 
% 
Total 
0 0 0 0 0 95 95 2.3 
1 0 0 0 0 122 122 3.0 
2 0 0 0 0 245 245 6.0 
3 0 0 0 165 106 271 6.6 
4 0 0 5 381 0 386 9.4 
5 0 0 295 112 0 407 9.9 
6 0 0 354 28 0 382 9.3 
7 0 51 355 0 0 406 9.9 
8 0 216 201 0 0 417 10.1 
9 0 350 4 0 0 354 8.6 
10 178 202 0 0 0 380 9.2 
11 336 6 0 0 0 342 8.3 
12 150 0 0 0 0 150 3.6 
13 157 0 0 0 0 157 3.8 
Total 821 825 1214 686 568 4114 100.0 
% Total 20.0 20.1 29.5 16.7 13.8 100.0  
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Table 6.19 The variable descriptions for each of the SOM14x2 clusters. 
 
SOM14x2 Features Controllables  Random 
Cluster pIest MWau crystσ  crystQ  crystQ  crystpH  difflim Number 
0 Mean 3.8 A 22.3 A -270.6 A -1.2 A -25.3 A 6.4 AB 1.8 A -0.06 A 
 SD 0.3 23.4 114.7 0.5 28.7 1.4 0.4 1.05 
1 Mean 4.3 B 28.7 B -132.8 B -0.5 B -17.9 BC 6.1 A 1.9 AB 0.01 A 
 SD 0.4 25.0 105.7 0.4 25.5 1.5 0.4 1.00 
2 Mean 4.6 C 46.9 C -109.6 C -0.4 C -19.6 BC 6.5 AC 2.0 BCF -0.01 A 
 SD 0.4 54.7 83.4 0.3 28.9 1.4 0.4 1.03 
3 Mean 4.8 D 66.8 D -88.1 D -0.3 D -21.3 AB 6.6 BC 2.0 CD 0.02 A 
 SD 0.4 100.0 70.6 0.2 33.3 1.3 0.5 1.02 
4 Mean 4.9 E 70.4 DE -63.5 E -0.2 E -15.1 C 6.6 BC 2.0 BDE 0.08 A 
 SD 0.3 89.6 65.5 0.2 27.1 1.2 0.4 0.98 
5 Mean 5.3 F 74.3 DE -44.7 F -0.2 F -12.1 D 6.7 BC 2.0 BDEF 0.06 A 
 SD 0.3 84.4 60.0 0.2 24.6 1.2 0.5 1.03 
6 Mean 5.8 G 68.3 DE -30.5 G -0.1 G -8.2 E 6.7 C 2.1 CDE -0.07 A 
 SD 0.5 73.4 70.4 0.3 20.4 1.3 0.5 0.97 
7 Mean 6.1 H 75.0 DE -10.3 H 0.0 H -4.9 F 6.7 BC 2.1 CDE 0.02 A 
 SD 0.5 90.5 64.7 0.2 23.6 1.2 0.4 1.00 
8 Mean 6.2 I 77.0 E -2.8 I 0.0 I -1.4 G 6.7 BC 2.1 D 0.01 A 
 SD 0.5 78.7 52.6 0.2 18.9 1.2 0.4 0.93 
9 Mean 7.1 J 66.6 DE 13.7 J 0.0 J 3.0 H 6.7 BC 2.0 BCF 0.01 A 
 SD 0.7 81.5 42.5 0.1 16.6 1.2 0.4 0.97 
10 Mean 8.0 K 59.2 D 35.6 K 0.1 K 6.6 I 6.7 C 2.0 BCF 0.06 A 
 SD 0.8 55.5 51.0 0.2 14.4 1.2 0.4 1.01 
11 Mean 8.6 L 45.3 C 60.8 L 0.2 L 9.3 J 6.7 C 2.0 BCF 0.10 A 
 SD 0.8 46.7 60.8 0.2 15.2 1.2 0.4 1.02 
12 Mean 9.4 M 35.0 B 100.3 M 0.4 M 13.5 K 6.5 AC 2.0 BCF 0.02 A 
 SD 0.6 41.8 65.3 0.3 17.2 1.4 0.5 1.02 
13 Mean 10.0 N 24.9 B 175.9 N 0.7 N 18.2 L 6.8 BC 1.9 AF -0.10 A 
 SD 0.7 18.5 97.4 0.4 19.9 1.5 0.4 1.00 
x2 3742 479 2258 2319 1773 33.2 81.7 13.0 KW Test 
(df=13) p < 0.0001 0.0001 0.0001 0.0001 0.0001 0.002 0.0001 0.447 
Note: Groups labeled with different letters (A-N) have significantly different distributions (p<0.01) as determined 
by a KS Test. 
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6.2.3.1 Charge Range Test 
The next step was to examine each cluster's Charge Range Test results and compare the 
cumulative results with Baseline and the 2Step clustering methods.  Large improvements in the 
Charge Range Test values were seen in all levels when compared to Baseline (Table 6.20; Figure 
6.18a).  The cumulative results show a +20% at the Mean±0.1 and Mean±0.2 levels for the test 
set proteins.  These were followed by a +15% increase at the Mean±0.3. 
When the individual differences within clusters were examined, there was a striking 
increase in accuracy at the low Q  levels, such as the Mean±0.1 (Figure 6.18b).  For example, at 
the Mean±0.1 Q  level, four clusters had accuracy above 65%.  This was an improvement of 
over 30% in accuracy over Baseline.  While some individual clusters at the Mean±0.1 level in 
other methods produced 60% values, none exceeded 60%.  Again, the clusters at either end of 
the 14x2 SOM had lower values, which were composed of ‘Very Acidic’ or ‘Very Basic’ 
proteins.  However, these terminal clusters still produced accuracy levels comparable to Baseline 
(~35%). 
 
Table 6.20 The Charge Range Test results for each SOM14x2 cluster and the Baseline (Chapter 5) values. 
(a) Training Set 
SOM14x2 
Clusters 
n Mean ±0.1 Mean ±0.2 Mean ±0.3 
0 95 25.3 37.9 47.4 
1 122 18.9 39.3 65.6 
2 245 38.0 64.9 82.9 
3 271 53.5 78.6 87.1 
4 386 64.0 86.8 92.0 
5 407 75.4 85.5 89.9 
6 382 62.0 78.5 87.7 
7 406 45.6 78.6 89.2 
8 417 71.0 89.2 94.2 
9 354 82.5 90.7 95.5 
10 380 69.7 86.8 93.2 
11 342 64.0 80.7 86.8 
12 150 47.3 70.0 86.7 
13 157 31.2 54.1 72.6 
 166 
Cum. % 
SOM14x2 
4,114 59.6 78.9 87.7 
Baseline 4,114 40.4 61.8 73.1 
(b) Test Set    
SOM14x2 
Clusters 
n Mean ±0.1 Mean ±0.2 Mean ±0.3 
0 14 28.6 35.7 50.0 
1 21 23.8 47.6 71.4 
2 67 46.3 67.2 85.1 
3 99 45.5 74.7 85.9 
4 116 64.7 81.9 88.8 
5 126 68.3 86.5 94.4 
6 116 44.8 75.9 86.2 
7 134 44.8 76.1 85.8 
8 133 63.2 85.7 92.5 
9 92 73.9 84.8 89.1 
10 109 61.5 76.1 90.8 
11 114 65.8 80.7 88.6 
12 70 44.3 58.6 85.7 
13 35 42.9 65.7 77.1 
Cum. % 
SOM14x2 
1,246 56.0 77.0 87.7 
Baseline 1,246 37.5 59.6 71.8 
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Figure 6.18 The Charge Range Test results (a) between methods (cumulative percent) or (b, c) within grouping 
method, SOM14x2 and Baseline for proteins in the test set. 
6.2.4 Summary of Unsupervised Clustering Results 
Similar to binning, the results in this section are based on the assumption that the Q -related 
Observables can be used as proxy variables for the crystpH .  Using unsupervised clustering on a 
protein's Q  curve, demonstrated improved benefits over using all proteins as one group 
(Baseline; Chapter 5).  These methods increased the cumulative predictive percentage of crystQ  
by 10-20% over Baseline.  An even more significant increase could often be found when 
examining the individual differences within each clustering technique.  This demonstrated that 
there are groups of proteins in the known protein space that behave similarly in crystallization 
attempts.  However, clusters with more extreme Q  curves, as judged by very high or very low 
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pIest values, did not perform as well in the Charge Range Test.  Using the findings presented here 
should increase the number of proteins that yield crystals.  This could be done by decreasing the 
sampling at the pH values where proteins are not likely to crystallize and increasing the sampling 
in the pH search space where proteins are likely to crystallize. 
These results also reaffirmed the observation in Chapter 5 that knowledge of a protein's 
Q  values over a given pH range could be used to potentially increase the probability of 
obtaining a crystal suitable for diffraction studies.  Few differences were found in the distribution 
of crystpH  between clusters within any method of grouping, binning or unsupervised clustering.  
Many more differences were found with the crystQ , crystQ , and crystσ  distributions.  Additionally, 
these results demonstrated that there is knowledge present within a protein's sequence that can be 
used for the selection of solution pH ranges for initial crystallization screen design. 
6.3 MODELING crystQ  DISTRIBUTIONS WITH GAUSSIANS 
In this section, attempts were made to model the crystQ  distributions with Gaussians.  If 
the crystQ  distributions could be fit by Gaussians, this would allow one to easily compare the 
crystQ  distributions between groups and methods, which would permit the identification of the 
‘best’ method of grouping proteins by similarity.  Knowledge of the crystQ  distributions would 
also allow for simple prediction of probabilities over ranges of Q  values, )|( dataQQP cryst= . 
 
Equation 6.1 2
2
( )
21( )
2
x
f x e
µ
σ
σ π
− −
=
 
, where x = observed crystQ  value, µ= mean crystQ  value, and σ  = SD (observed or best-fit SD) 
The crystQ  distributions in Chapter 5 and the previous sections (6.1-6.2) appeared as 
though they could be fit relatively well with Gaussians (Equation 6.1).  However, the groups 
with the most extreme Q  curves (lowest and highest mean pIest values) often displayed erratic 
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crystQ  distributions.  In this section, attempts were made to model the crystQ  distributions of two 
grouping methods with Gaussians. 
The best fit Gaussian was chosen by minimizing the residual sum of square error (RSS; 
Equation 6.2) between the observed values (Yi) and the Gaussian predicted crystQ  values (Ŷi).  
The value of the standard deviation (SD) was varied by 0.01 crystQ  units in order to determine the 
SD with the minimum RSS. 
Equation 6.2. ( )∑
=
−= N
i ii
YYRSS
1
ˆ  
After determining the best-fit Gaussian, the number of proteins within 1 SD of the best-fit 
curve for both the training and test sets was calculated.  Then, in order to compare all groups, a 
common SD for all groups was chosen based on using the best fit SD of all proteins (rounding 
off to tenths).  Gaussians (Equation 6.1) were initially fit to all training set proteins (Baseline; 
Section 6.3.1).  After examining the calculated and observed distributions for all proteins, the 
crystQ  distributions for each 2Step6 cluster was calculated (Section 6.3.2).  These values then 
were compared to Baseline (Section 6.3.1). 
6.3.1 Baseline (All Proteins) 
Initially, a Gaussian was fit to the Baseline crystQ  distribution using the observed mean and SD of 
-0.06 and 0.39, respectively (Figure 6.19).  The Gaussian calculated based upon the observed SD 
fit fairly well, RSS of 0.0056.  However, when the SD was allowed to vary, the best-fit SD was 
0.30, with a RSS of 0.0017.  The Gaussian with the best-fit SD fit the data very well (Table 
6.19), with 72.5% of the training set proteins falling within 1 SD of the observed mean crystQ  
value.  A similar amount of the test set proteins fell within 1 SD of the mean, 73%.  These 
values, ~73%, were slightly more than would be expected from the portion of cases found within 
1 SD of a normal distribution (67%).  There were also slightly more proteins whose crystQ  value 
was 1+ SD above the mean (~17%) than were 1+ SD below the mean crystQ  value (~11%). 
After demonstrating that a Gaussian could be fit to the crystQ  distribution of all training 
set proteins, the ability to fit a Gaussian to the clustering results was examined.  The two-step 
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clustering method with six clusters (2Step6; Section 6.2.1.3) was used as the example for 
comparison. 
 
 
 
Figure 6.19 The Baseline crystQ  distribution along with the Gaussians calculated from the observed and best-fit SD.  
 
Table 6.21 The Baseline crystQ  range for the best-fit Gaussian of the training set proteins and the percentage of 
proteins within 1, 1-2, or 2+ SD of the mean crystQ  for both the training and test sets.  
 
Grouping Low crystQ  Value High crystQ  Value
% Within Range 
(Train) 
% Within Range 
(Test) 
2+ SD Below - -0.8 3.4 1.8 
1-2 SD Below -0.7 -0.5 7.3 7.1 
Within 1 SD -0.4 0.2 72.5 73.0 
1-2 SD Above 0.3 0.5 11.0 12.5 
2+ SD Above 0.6 - 5.8 5..6 
6.3.2 2Step Clustering 6 Clusters 
In the previous section, a Gaussian was fit to the crystQ  distribution of all proteins in the training 
set.  In this section, the Baseline Gaussian was compared to Gaussians that were fit to each 
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cluster of the 2Step6 results, the optimal number of clusters as determined by 2Step clustering; 
Section 6.2.1.3. 
The observed crystQ  distributions of 2Step6 Clusters 1 and 6 were not as smooth as the 
other clusters.  These clusters were also the ones with the fewest number of proteins within them, 
representing the proteins with the extreme pIest values.  The observed frequency distributions 
along with the calculated Gaussians from the observed and best-fit SD are pictured in Figure 
6.20a-f.  Figure 6.20g shows all of the 2Step6 best-fit Gaussians in one figure for comparison. 
Table 6.22a shows the difference between the observed SD and the best-fit SD.  There 
are varying degrees of differences.  For instance, 2Step6 Cluster 1 had an observed and best-fit 
SD that was the same.  The other best-fit SDs differed from the observed SDs by 0.03-0.07 crystQ  
units.  Next the amount of proteins that fell within 1 SD of the best-fit Gaussian were calculated 
and compared to the Baseline Gaussian in Section 6.3.1. 
The amount of proteins within 1 SD of the best-fit Gaussian ranged from 68-86% of the 
proteins within the cluster Table 6.22a.  Overall, 81% of the proteins clustered by the 2Step 
algorithm fell within 1 SD of the best-fit Gaussians.  This was an overall improvement of 9% 
over the best-fit Gaussian on the Baseline group in the previous section, which had 72.5% of the 
proteins within 1 SD of the best-fit Gaussian.  However, this may be a little misleading, because 
the best-fit SD of all proteins was 0.30, while those in the 2Step6 distributions ranged from 0.16-
0.52.  This was the same problem with the CI50 test that led to the development of the Charge 
Range Test.  In order for a more fair comparison, the amount of proteins within a common SD of 
±0.2 or ±0.3 was calculated for each 2Step6 cluster and the Baseline group. 
When a common SD was used for all clusters, an even more pronounced difference was 
observed between the 2Step6 clusters and the Baseline group (Table 6.22b).  An overall 
improvement of 15-18% was observed for the 2Step6 clustering method.  Several of the 2Step6 
clusters with the tight distributions had ~80% and ~90% of their proteins within ±0.2 and ±0.3 
e/kDa units of the group mean, respectively.  Again the 2Step6 clusters with the more extreme Q  
curves, fewer proteins, and those with a larger best-fit SD (Clusters 1 and 6) did not perform as 
well as the other clusters.  However, this was expected because these clusters involved proteins 
with more extreme Q  curves and fewer representative cases. 
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Figure 6.20 Modelling each 2Step6 cluster with a Gaussian (a-f).  The best-fit crystQ  Gaussian for each cluster was 
then shown in (g). 
 
 173 
Table 6.22 The mean , observed SD, and best-fit SD of crystQ  for each 2Step6 cluster. The percentage of proteins 
within 1 SD of the best-fit crystQ  Gaussian was calculated for (a) each Cluster or (b) a common SD based on the 
best-fit crystQ  Gaussian on all proteins (Baseline). 
 
(a) 
Cluster N Mean crystQ  Observed SD Best-Fit SD 
% Within 1 SD  
of Best-Fit 
2Step6 1 83 -1.22 0.52 0.52 67.5 
2Step6 2 489 -0.44 0.33 0.26 77.9 
2Step6 3 1229 -0.18 0.24 0.18 81.0 
2Step6 4 1185 -0.01 0.19 0.16 86.1 
2Step6 5 915 0.19 0.22 0.18 81.5 
2Step6 6 213 0.66 0.39 0.32 70.4 
Cumulative Total 4114 - - - 81.4 
Baseline 4114 -0.06 0.39 0.30 72.5 
 
(b) Percent of proteins within a common SD of ±0.2 or ±0.3 
 
2Step6 
Cluster 
Common SD 
% Within 
Common SD 
(0.2) 
Common SD
% Within 
Common SD
(0.3) 
2Step6 1 ±0.2 37.3 ±0.3 45.8 
2Step6 2 ±0.2 60.7 ±0.3 77.9 
2Step6 3 ±0.2 81.0 ±0.3 89.2 
2Step6 4 ±0.2 86.1 ±0.3 93.3 
2Step6 5 ±0.2 81.5 ±0.3 90.2 
2Step6 6 ±0.2 50.7 ±0.3 70.4 
2Step6 Total ±0.2 77.7 ±0.3 87.4 
Baseline ±0.2 59.3 ±0.3 72.5 
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6.3.3 Modeling Summary 
The two examples presented above demonstrated the ability to accurately model the crystQ  
distributions with Gaussians.  The Gaussians were originally calculated based upon the mean and 
standard deviation (SD) of the training set’s observed crystQ  frequency distribution.  Next, the SD 
was allowed to vary to determine the best-fit Gaussian by minimizing the residual sum of 
squares.  In all but one case examined (6/7) the best-fit Gaussian had a lower SD (0.02-0.07 
e/kDa units) than that calculated from the frequency distribution.  Similar to earlier sections, a 
significant improvement over Baseline was observed when proteins were grouped by their Q  
curves.  The resulting Gaussians could then be used to eliminate the erratic peaks (spikes) and 
valleys in the frequency distributions of the proteins with the more extreme estimated titration 
curves.  This should result in a more accurate prediction of the crystQ . 
6.4 CHAPTER SUMMARY 
In Chapter 5, two possible interpretations of the Q -related Observables were discussed.  One 
interpretation was that, because these Q -related Observables were derived from both the protein 
Features and the Primary Observable ( crystpH ), there should be a high correlation between the 
variables.  The other interpretation, although inconclusive, was that the Q -related Observables 
( crystQ  and crystσ ) could be used as proxy variables for the Primary Observable ( crystpH ).  The 
results of this chapter are based on the second interpretation.  Therefore, if the first interpretation 
is correct, the results of this section are meaningless. 
In Chapter 5, the distributions of both the crystQ  and crystσ  were shown to be relatively 
normal, while displaying a high correlation to both Features and the Primary Observable.  
Several methods were also discussed on how to use this information for estimating a pH range 
that has a higher probability in generating crystals.  Then, it was hypothesized that there are 
groups of proteins that can be identified, which display similar crystallization behavior.  By 
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identifying these subgroups, the accuracy of capturing the crystQ  within a narrow range of Q  
values can be improved over using all proteins as one group, Baseline.  In this chapter, several 
methods were used to group proteins by similarity, both supervised and unsupervised.  The first 
methods examined were supervised, based upon binning the proteins by their MWau, pIest, or 
randomly grouping the proteins (Section 6.1.1).  Binning by the natural log transformed 
asymmetric unit molecular weight, ln(MWau), had no additional effect on the crystQ  prediction 
compared to Baseline.  Similarly, the randomly picked groups of proteins resulted in a similar 
level of accuracy to Baseline (Sections 6.1.2-6.1.3).  However, when proteins were separated by 
their pIest, a 12-14% improvement was observed in the Charge Range Test predictions of the 
crystQ  on an independent test set (Table 6.5).  This improvement was not equally split among all 
the pIest groups.  The models developed on proteins with moderate pIest values, 5.0-9.0, 
performed better than those proteins with the extreme pIest values, pIest < 5.0 or pIest > 9.0.  One 
reason for this is the shape of the distributions.  Those subgroups with a moderate pIest are highly 
populated with a relatively normal distribution.  However, there are fewer cases of proteins in the 
extreme pIest groups and the crystQ  distributions are very sporadic.  A more detailed look into the 
crystallization conditions of these proteins may be warranted to determine if other molecules are 
present in the solution to neutralize the charge. 
Because the pIest represented only one point along the Q  curve, unsupervised clustering 
techniques (Section 6.2) were examined for grouping proteins with similar Q  curves from pH 
4.0-10.0 in 0.2 pH unit intervals.  Each clustering algorithm examined, Two-Step Clustering 
(2Step) and Self-Organizing Maps (SOMs), could have the number of clusters specified apriori 
or have the algorithms determine the ‘correct’ number of clusters.  Initially, five clusters were 
examined and compared to pIest binning, which resulted in five groups.  Similar to pIest binning, 
these two algorithms were able to improve prediction accuracy over the Baseline group.  
However, five clusters resulted in no improvement over the pIest binning, as judged by the 
Charge Range Test.  When the algorithms were allowed to select the number of clusters for the 
training set, six were chosen for 2Step and fourteen for SOMs.  These clusters resulted in a slight 
improvement of 4-5 percent over pIest binning (Table 6.23).  Thus, the unsupervised clustering 
methods, which used a portion of the Q  curve from pH 4.0-10.0, should be used over pIest 
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binning for selecting Q  ranges that have a higher probability in generating crystals.  These 
ranges can then be translated into more specific pH ranges. 
 
Table 6.23 The Charge Range Test summaries for (a) the training or (b) test set proteins.   
 
(a)         
 crystQ  Baseline 
ln(MWau) 
Bins 
pIest 
Bins 
Random 
Clusters 
2Step5 2Step6 SOM5x1 SOM14x2 
Mean ±0.1 40.4 40.3 54.0 40.4±2.4 51.2 57.2 53.3 59.6 
Mean ±0.2 60.1 60.1 74.6 60.1±1.8 74.0 77.7 76.3 78.9 
Mean ±0.3 73.1 73.1 84.8 73.1±1.5 86.9 87.4 86.2 87.7 
 (b)         
 crystQ  Baseline 
ln(MWau) 
Bins 
pIest 
Bins 
Random 
Clusters 
2Step5 2Step6 SOM5x1 SOM14x2 
Mean ±0.1 37.5 36.8 49.0 37.5 49.4 54.4 47.6 56.0 
Mean ±0.2 59.6 59.7 73.0 59.6 72.5 76.7 73.4 77.0 
Mean ±0.3 71.8 71.3 83.1 71.8 87.2 87.6 85.8 87.7 
Note: The numbers in the cells represent the percentage of correct 
crystQ  within a range of the group mean crystQ . 
 
In the final section, attempts were made to model the crystQ  distributions with Gaussians 
(Section 6.3).  Gaussians were shown to fit the crystQ  distributions very well for both the Baseline 
group and each 2Step6 cluster.  Again, the clusters with extreme mean pIest values could not be 
represented by a Gaussian as well.  Using Gaussians will remove the peaks and valleys in the 
distributions and allow the prediction of the crystQ  over any given Q  range. 
In conclusion, it appears that ‘similar’ proteins can be identified, which crystallize under 
similar Q  ranges.  Here, ‘similarity’ among proteins was based upon the Q  curves, either one 
point along the curve (pIest) or a section of the curve (pH 4.0-10.0).  The belief is that using the 
successful solution conditions from ‘similar’ proteins should increase the probability of 
generating crystals suitable for diffraction studies over the current one-size-fits-all approach.  
There may be other Hidden Features that can further breakdown the proteins into groups with 
tighter crystQ  distributions, some of which are discussed in Chapter 9.  In the next chapter, an 
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example application using three target proteins undergoing crystallization attempts in the 
Rosenberg Lab (Department of Biological Sciences, University of Pittsburgh) is presented. 
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7.0  EXAMPLE OF APPLICATION 
In this chapter, annotated examples are presented for three proteins, which are currently 
undergoing crystallization attempts in the Rosenberg Lab (Department of Biological Sciences) at 
the University of Pittsburgh.  These proteins are α-Synuclein, Neuroblastoma apoptosis-related 
RNA binding protein (NAPOR-1), and Ultraviolet-damaged DNA-binding protein (UV-DDB).  
Currently, these proteins have failed to yield well-formed crystals suitable for X-ray diffraction 
studies.  The steps involved in the process of selecting the most probable pH regions to set up 
experiments and recommendations are presented. 
With the Protein Sequence-Properties Evaluation (PSPE) Framework developed in 
Chapter 4, these three proteins provided an opportunity for a real-world application.  In Section 
7.1, the protein sequences were examined and various parameters calculated that are used by the 
PSPE framework.  These proteins were then matched to 'similar' proteins that have been 
successfully crystallized and deposited in the PDB as discussed in Chapter 6 (Section 7.2).  After 
determining the best-matching group of proteins, prior probabilities were generated for the range 
of the Q  values, ),|( 05.04.10nrPDBGroupQQP cryst= , that are most likely to result in the 
formation of a crystal (Section 7.3).  These ),|( 05.04.10nrPDBGroupQQP cryst=  probabilities were 
then translated back into the pH space, ),,|( 05.04.10nrPDBGroupQQpHpHP crystcryst == , where 
the knowledge could be used directly in the lab.  With this knowledge in hand, a researcher 
should theoretically increase the probability of growing a well-ordered protein crystal.  This can 
be done by increasing the amount of experiments in pH areas more likely to generate crystals, 
while decreasing the experiments in areas not likely to grow crystals. 
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7.1 EXAMPLE PROTEINS 
All three of these proteins have implications for human health in development or disease.  α-
Synuclein is found primarily in the pre-synaptic nerve terminals in the brain.  This 14.5 kDa 
protein has been associated with plaque formation in neurodegenerative diseases, such as 
Alzheimer's (Jakes et al., 1994; Giasson et al., 2000) and Parkinson's disease (Giasson et al., 
2000; Shimura et al., 2001; Zarranz et al., 2004). 
NAPOR-1, which can also be found in the brain, has been linked to the early 
development and differentiation of the central nervous system.  NAPOR-1 is involved in post-
transcriptional regulation, i.e., turning on/off other gene products.  This protein was induced 
during apoptosis (programmed cell death), which is an important part of the nervous system 
development (Choi et al., 1999; Levers et al., 2002). 
The UV-DDB complex is composed of two chains, one small (48 kDa) and one large 
(127 kDa) subunit.  People with an inheritable defect of this gene, called xeroderma 
pigmentosum, have a predisposition for skin cancer.  When a cell's DNA is damaged from 
ultraviolet radiation, the tumor suppressor gene, p53, normally induces the expression of UV-
DDB.  UV-DDB is then involved with the nucleotide excision repair of the damaged DNA 
(Hwang et al., 1999; Rapic-Otrin et al., 2002).  If this process is not working, the result could be 
the development of cancer. 
 
Table 7.1 Three proteins within the Rosenberg Lab that are undergoing crystallization trials. 
 
Protein 
Number of 
subunits 
AA 
Length 
MW 
(kDa) 
pIest 
α-Synuclein 1 140 14.5 4.4 
NAPOR-1 1 490 52.3 8.6 
UV-DDB 2 1567 174.8 6.0 
 
The sequences of these proteins are shown in Figure 7.1, while some sequence derived 
parameters are displayed in Table 7.1.  These proteins are quite different in terms of molecular 
weight (MW), ranging in size from 14.5-174.8 kDa, and a pIest, ranging from 4.4-8.6.  UV-DDB 
is the largest of the three and consists of two subunits, one large subunit composed of 1140 
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amino acids and one small subunit composed of 427 amino acids.  Both α-Synuclein and 
NAPOR-1 consist of one protein subunit. 
 
  
 
Figure 7.1 Sequences in FASTA format for (a) α-Synuclein, (b) NAPOR-1, and (c) UV-DDB 
(a) α-Synuclein, monomeric, SwissProt P37840 
>sp|P37840|SYUA_HUMAN Alpha-synuclein 
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVT
GVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA 
 
(b) NAPOR-1, monomeric, SwissProt Q9UL67 
>tr|Q9UL67|Q9UL67_HUMAN Neuroblastoma apoptosis-related RNA binding 
protein - Homo sapiens (Human). 
MNGALDHSDQPDPDAIKMFVGQIPRSWSEKELKELFEPYGAVYQINVLRDRSQNPPQSKGCCFVTFYTRKAA
LEAQNALHNIKTLPGMHHPIQMKPADSEKSNAVEDRKLFIGMVSKKCNENDIRVMFSPFGQIEECRILRGPD
GLSRGCAFVTFSTRAMAQNAIKAMHQSQTMEGCSSPIVVKFADTQKDKEQRRLQQQLAQQMQQLNTATWGNL
TGLGGLTPQYLALLQQATSSSNLGAFSGIQQMAGMNALQLQNLATLAAAAAAAQTSATSTNANPLSTTSSAL
GALTSPVAASTPNSTAGAAMNSLTSLGTLQGLAGATVGLNNINALAVAQMLSGMAALNGGLGATGLTNGTAG
TMDALTQAYSGIQQYAAAALPTLYSQSLLQQQSAAGSQKEGPEGANLFIYHLPQEFGDQDILQMFMPFGNVI
SAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQAMNGFQIGMKRLKVQLKRSKNDSKPY 
 
(c) UV-DDB, p127 (large subunit), SwissProt Q16531 (1140 AA) 
>sp|Q16531|DDB1_HUMAN DNA damage binding protein 1 (DDB p127 subunit) 
(DDBa) (UV-damaged DNA-binding protein 1) (UV-DDB 1) 
MSYNYVVTAQKPTAVNGCVTGHFTSAEDLNLLIAKNTRLEIYVVTAEGLRPVKEVGMYGKIAVMELFRPKGE
SKDLLFILTAKYNACILEYKQSGESIDIITRAHGNVQDRIGRPSETGIIGIIDPECRMIGLRLYDGLFKVIP
LDRDNKELKAFNIRLEELHVIDVKFLYGCQAPTICFVYQDPQGRHVKTYEVSLREKEFNKGPWKQENVEAEA
SMVIAVPEPFGGAIIIGQESITYHNGDKYLAIAPPIIKQSTIVCHNRVDPNGSRYLLGDMEGRLFMLLLEKE
EQMDGTVTLKDLRVELLGETSIAECLTYLDNGVVFVGSRLGDSQLVKLNVDSNEQGSYVVAMETFTNLGPIV
DMCVVDLERQGQGQLVTCSGAFKEGSLRIIRNGIGIHEHASIDLPGIKGLWPLRSDPNRETDDTLVLSFVGQ
TRVLMLNGEEVEETELMGFVDDQQTFFCGNVAHQQLIQITSASVRLVSQEPKALVSEWKEPQAKNISVASCN
SSQVVVAVGRALYYLQIHPQELRQISHTEMEHEVACLDITPLGDSNGLSPLCAIGLWTDISARILKLPSFEL
LHKEMLGGEIIPRSILMTTFESSHYLLCALGDGALFYFGLNIETGLLSDRKKVTLGTQPTVLRTFRSLSTTN
VFACSDRPTVIYSSNHKLVFSNVNLKEVNYMCPLNSDGYPDSLALANNSTLTIGTIDEIQKLHIRTVPLYES
PRKICYQEVSQCFGVLSSRIEVQDTSGGTTALRPSASTQALSSSVSSSKLFSSSTAPHETSFGEEVEVHNLL
IIDQHTFEVLHAHQFLQNEYALSLVSCKLGKDPNTYFIVGTAMVYPEEAEPKQGRIVVFQYSDGKLQTVAEK
EVKGAVYSMVEFNGKLLASINSTVRLYEWTTEKELRTECNHYNNIMALYLKTKGDFILVGDLMRSVLLLAYK
PMEGNFEEIARDFNPNWMSAVEILDDDNFLGAENAFNLFVCQKDSAATTDEERQHLQEVGLFHLGEFVNVFC
HGSLVMQNLGETSTPTQGSVLFGTVNGMIGLVTSLSESWYNLLLDMQNRLNKVIKSVGKIEHSFWRSFHTER
KTEPATGFIDGDLIESFLDISRPKMQEVVANLQYDDGSGMKREATADDLIKVVEELTRIH 
 
UV-DDB, p48 (small subunit), SwissProt Q02466 (427 AA) 
>sp|Q92466|DDB2_HUMAN DNA damage binding protein 2 (Damage-specific DNA 
binding protein 2) (DDB p48 subunit) (DDBb) (UV-damaged DNA-binding 
protein 2) (UV-DDB 2) 
MAPKKRPETQKTSEIVLRPRNKRSRSPLELEPEAKKLCAKGSGPSRRCDSDCLWVGLAGPQILPPCRSIVRT
LHQHKLGRASWPSVQQGLQQSFLHTLDSYRILQKAAPFDRRATSLAWHPTHPSTVAVGSKGGDIMLWNFGIK
DKPTFIKGIGAGGSITGLKFNPLNTNQFYASSMEGTTRLQDFKGNILRVFASSDTINIWFCSLDVSASSRMV
VTGDNVGNVILLNMDGKELWNLRMHKKKVTHVALNPCCDWFLATASVDQTVKIWDLRQVRGKASFLYSLPHR
HPVNAACFSPDGARLLTTDQKSEIRVYSASQWDCPLGLIPHPHRHFQHLTPIKAAWHPRYNLIVVGRYPDPN
FKSCTPYELRTIDVFDGNSGKMMCQLYDPESSGISSLNEFNPMGDTLASAMGYHILIWSQEEARTRK 
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7.2 IDENTIFICATION OF SIMILAR PROTEINS 
All three methods (CI50, Charge Range Test, and Probability Distributions) are presented to 
predict solution pH ranges that are more likely to result in the crystallization of these test 
proteins.  All of these methods are currently based on some aspect of the protein's Q  curve.  In 
this chapter, each prediction method is examined using: (1) Baseline (Chapter 5) and (2) binning 
by the pIest (Chapter 6, Section 6.1). 
For the Baseline method, it was assumed that there are no subgroups of proteins and all 
proteins are modeled as one group.  Therefore, the Baseline crystQ  frequency distribution (Figure 
5.5c) was used to predict solution pH ranges.  This is accomplished by matching each Q  value 
along the protein’s Q  curve to the corresponding crystQ  frequency distribution of successfully 
crystallized proteins, )|( 05.04.10nrPDBQQP cryst= . 
The second method assumes that there are groups of proteins that display similar 
crystallization behavior, as demonstrated in Chapter 6.  The simplest method of grouping 
proteins uses the protein’s pIest to assign the protein to one of five groups (pIest Bins), 'Very 
Acidic,' 'Acidic,' 'Neutral,' 'Basic,' and 'Very Basic.'  The pIest is just one point along the 
estimated titration curve (or Q  curve) where the estimated net charge is equal to zero.  The Q  
probabilities, ),|( 05.04.10nrPDBpIQQP estcryst= , are then generated from the frequency of the 
crystQ  values for the successfully crystallized protein structures based on all proteins (Baseline) 
or groups of proteins with similar pIest or Q  curve values. 
7.3 PREDICTING THE PH RANGES 
The hypothesis was that proteins with similar Q  curves should crystallize under similar pH 
ranges.  Although different proteins may have the same )|( 05.04.10nrPDBQQP cryst=  priors based 
on belonging to the same group of proteins, the pH probabilities may be quite different.  This is 
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due to the translation of Q  back into pH space.  The three methods discussed in Chapter 4 were 
used to estimate the crystpH  range, 50% confidence intervals (CI50), Charge Range Test, and 
crystpH  probability distribution.  Generally, all methods are complementary within a given 
method of grouping, but may differ between grouping methods, such as binning by pIest and 
2Step clustering. 
Based upon the amino acid sequences in Figure 7.1, the Q  curves were first calculated 
for all three proteins (Figure 7.2).  Then the crystQ  priors were then chosen based on either all 
proteins as one group (Baseline) or binning the proteins by their pIest (supervised) and were then 
compared in their prediction of )|( 05.04.10nrPDBQQP cryst= .  These )|( 05.04.10nrPDBQQP cryst=  
values were then translated into the pH space, where the information could be directly used in 
the laboratory, ),|( 05.04.10nrPDBQQpHpHP crystcryst == . 
 
 
 
Figure 7.2 The Q  curves for α-Synuclein, NAPOR-1, and UV-DDB. 
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7.3.1 α-Synuclein 
The first clustering method discussed was binning proteins based upon their pIest.  α-Synuclein 
was labeled as 'Very Acidic' (pIest ≤ 5) with a pIest of 4.4.  The )|( 05.04.10nrPDBQQP cryst=  
distribution was chosen based on the proteins in the training set, 
)'_',|( 05.04.10 AcidicVerypInrPDBQQP estcryst == .  The 976 ‘Very Acidic’ proteins in this group 
generally crystallized with a negative charge with a mean crystQ  value of -0.4 e/kDa.  For the 
actual crystQ  distribution, see Figure 6.3b in Chapter 6.   
The first method examined, creates a confidence interval (CI) for the target protein based 
upon the middle 50% of the training set proteins within a group (CI50).  This CI50 range was then 
applied to the estimated titration curve of α-Synuclein to find the pH ranges that would result in 
a 50% chance of the crystpH  being within that range if a crystal was produced. 
The crystQ  CI50 for Baseline was -0.3 to +0.1 e/kDa, while the CI50 for ‘Very Acidic’ 
proteins ranged from -0.6 to -0.2 e/kDa (Table 6.3).  Figure 7.3 shows the CI50 for α-Synuclein 
as determined by using the pIest = 'Very Acidic' proteins.  When these Q  values are translated 
back into the pH search space, a pH range of 4.3-4.9 (Baseline) or 4.7-8.4 (pIest Bins) is 
suggested for the initial screens.  The very narrow pH range (4.3-4.9) for the Baseline group is 
most likely due to the fact that α-Synuclein is classified as a ‘Very Acidic’ protein.  The 
Baseline method was shown not to work as well with proteins with extreme pIest values, pIest ≤ 
5.0 or pIest ≥ 9.0, which are not well represented by the ‘average’ protein in the Baseline group.  
However, when the ’Very Acidic’ proteins were used for priors, a much broader pH range is 
suggested for initial screens, 4.7-8.4.  Based on the solution pH distribution of commercial 
screens (Appendix B; Table B2), 30% of the conditions can be removed from screening, because 
they have a solution pH that falls outside of this range (5.0-8.0).  This would allow the researcher 
more flexibility in testing other conditions. 
The second method uses the results from the Charge Range Test of each grouping method 
to estimate a probability of crystallization for the pH range that results in a Q  value within the 
group’s Mean crystQ ±0.1 to crystQ ±0.2.  The mean crystQ  value for the ‘Very Acidic’ proteins was 
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-0.4 e/kDa.  The pH values that result in a Q  of -0.4±0.1 e/kDa will have the same probability of 
crystallizing as that of the ‘Very Acidic’ proteins from Section 6.1.3.  When these crystQ  values 
are translated back into the pH search space, a pH range of 4.8-5.8 (Mean±0.1) or 4.7-8.4 
(Mean±0.2) is suggested for α-Synuclein (Table 7.2).  The probability that the crystpH  will fall 
within these ranges is 47% and 70%, respectively. 
 
 
 
Figure 7.3 The Q  curve with CI50 interval and crystpH  probability distribution for α-Synuclein. 
 
The next approach aimed at predicting a Q  range for crystallization calculates a 
probability of each Q  value from -2.0 to +2.0 e/kDa.  These probabilities can then be carried 
over to the pH space by matching values along the estimated titration curve, 
),|( 05.04.10nrPDBQQpHpHP crystcryst == . 
  The pH probability distribution calculated for α-Synuclein is shown in Figure 7.3.  
When examining the probability curve, a spike in probability is observed around a pH of 5.0-5.5 
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for α-Synuclein.  This spike is missed in the both the CI50 and Charge Range Test results, which 
do not show local maxima values.  For example, all values between the CI50 lines are equally 
probable.  It can be inferred from the Charge Range Test results that the mean crystQ  value has 
the highest probability and as the Q  moves away from the mean value, a decrease in probability 
can be expected.  However, the Charge Range Test does not indicate how much of a loss in 
probability can be expected as the Q  moves away from the mean.  For the pH probability 
distribution a greater than 10% threshold was used as a high probability.  The 10% probability 
threshold cutoff suggests an acidic pH range for both the Baseline group (4.5-5.0) and the pIest 
bins (5.0-5.5). 
 
Table 7.2 Suggested pH ranges for initial crystallization attempts of the three test proteins based on either Baseline 
or pIest Binning.  
 
 α-Synuclein NAPOR-1 UV-DDB 
Method pHLow pHHigh Prob.2 pHLow pHHigh Prob.2 pHLow pHHigh Prob.2 
CI50 Baseline 4.3 4.9 50.0 6.4 10.3 50.0 5.2 9.0 50.0 
CI50 pIest Bins 4.7 8.4 50.0 4.6 8.0 50.0 6.3 9.0 50.0 
Charge Range 
Test, pIest 
Mean±0.1 
4.8 5.8 42.6 4.6 8.0 56.7 5.7 8.2 58.2 
Charge Range 
Test, pIest 
Mean±0.2 
4.7 8.4 63.5 4.3 9.1 82.1 5.2 9.0 79.4 
10% Prob.1 - 
Baseline 
4.5 5.0 44.0 9.5 9.5 11.3 6.5 8.0 46.6 
10% Prob.1- 
pIest 
5.0 5.5 44.0 6.5 8.0 50.9 6.5 9.0 83.3 
1 10% Prob. = probability distribution with a 10% threshold for cut-off 
2 Probability based on the training set proteins within the group 
 
All three methods chosen to predict a solution pH range, generally agree that an acidic 
pH range (5.0-6.0) would be more likely to crystallize α-Synuclein.  It is also expected that the 
pIest Bins will give a more accurate prediction of crystpH  than the Baseline group.  This is 
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primarily due to the very acidic pIest of α-Synuclein, 4.6, which would not represent an ‘average’ 
protein in the Baseline group.  Finally, the calculation of the crystpH  probability distribution can 
detect local maxima, which the other two methods cannot. 
7.3.2 NAPOR-1 
Based upon its pIest (8.6), NAPOR-1 was assigned to the 'Basic' group (8 ≤ pIest < 9).  The mean 
(±SD) pIest and crystQ  of the 564 'Basic' proteins was 8.2±0.4 and +0.2±0.3 respectively. 
Figure 7.4 shows the Q  curve for NAPOR-1 and the CI50 range for the pIest=‘Basic’ 
proteins, +0.06 to +0.27.  For this protein, different crystQ  CI50 ranges are predicted by each 
method, Baseline (-0.25 to +0.14 e/kDa) and pIest Bins (+0.06 to +0.27 e/kDa).  Therefore, these 
Q  ranges will predict quite different pH ranges for NAPOR-1, as shown in Table 7.2.  When 
these Q  values are translated into the pH search space, the crystQ  CI50 range for Baseline 
suggests a Neutral-Basic pH range for crystallization, 6.4-10.3.  The 'Basic' pIest Bin suggests a 
Q  range from pH 4.6-8.0.  Similar to α-Synuclein, it is expected that the ‘Basic’ proteins would 
represent more similar proteins to NAPOR-1 than using all proteins. 
Using the Mean±0.1 Q  range for pIest=‘Basic’ proteins, a pH range of 4.6-8.0 is also 
suggested (Table 7.2).  The estimated probability of NAPOR-1 crystallizing in this pH range is 
53% based on the results in Section 6.1.3.  This will reduce the number of screen conditions 
searched by 23.4% (Table B.2).  When the Q  range is increased to Mean±0.2, a larger pH range, 
4.3-9.1, is suggested, along with an increased probability (78%) of crystallization.  However, it 
should be noted that only 2.5% of the crystallization screens have a solution pH reported to be 
outside of this range.  Therefore, it appears that the Mean±0.2 Q  provides little benefit for 
NAPOR-1. 
 187 
 
 
Figure 7.4 The Q  curve with CI50 interval and crystpH  probability distribution for NAPOR-1. 
 
Using a 10% probability threshold, the Baseline group predicts only one pH value above 
the 10% threshold, pH 9.5 (Table 7.2).  As discussed previously in the CI50 section, this appears 
unlikely given the ‘Basic’ nature of NAPOR-1.  The pIest=‘Basic’ pH distribution predicts a 
relatively narrow solution pH range, 6.5-8.0 (Figure 7.4), which will reduce the crystallization 
conditions searched by 55.6%. A 51% probability for ),|( 05.04.10nrPDBQQpHpHP crystcryst ==  
is predicted for this range.  This will allow more extensive searches in more likely crystallization 
regions.  Again some local maxima ),|( 05.04.10nrPDBQQpHpHP crystcryst ==  values (pH 6.5-
8.0) are not visually obvious with the crystQ  CI50 and Charge Range Test methods, but could be 
displayed with the probability distribution. 
These results suggest different pH ranges depending upon the method used to group the 
structures.  Binning by the pIest predicts a wider pH range from either 4.6-8.0 (CI50 and Charge 
Range Test) to 6.5-8.0 (Probability distribution).  A local maximum was again observed using 
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the probability distributions, ),|( 05.04.10nrPDBQQpHpHP crystcryst == . Based upon these 
results, initial crystallization attempts for NAPOR-1 should focus on a narrow pH range of 6.5-
8.0.  The solution pH could be expanded to 4.6-8.0 if enough protein is available. 
7.3.3 UV-DDB 
UV-DDB was labeled 'Acidic' with a pIest of 5.95, which straddles the pIest binning border 
between the 'Acidic' (5.0 < pIest ≤ 6.0) and 'Neutral' (6.0 < pIest < 8.0) protein groups.  For this 
protein, a more specific pH range of 5.0-7.0 may be more appropriate as ‘similar’ proteins. 
The CI50 range (Figure 7.5) for both methods was very similar, -0.25 to +0.14 e/kDa for 
Baseline and -0.25 to -0.06 e/kDa for the pIest = ‘Acidic’ Bins.  When these values are transferred 
into the pH search space, similar pH ranges will be predicted for UV-DDB with the Baseline 
method predicting a slightly large pH range (pH 5.2-9.0) than the pIest=’Acidic’ Bin (pH 6.3-9.0; 
Table 7.2). 
Using the Mean±0.1 crystQ  range for pIest=‘Acidic’ proteins, a pH range of 5.7-8.2 is 
suggested (Table 7.2).  The estimated probability of UV-DDB crystallizing in this pH range is 
49% based on the Test Set results in Section 6.1.3.  This will reduce the number of screen 
conditions searched by 39% (Appendix B, Table B.2).  When the Q  range is increased to mean 
crystQ ±0.2, a larger pH range, 5.2-9.0, is suggested, along with an increased probability of 
crystallization, 78%.  However, only 10% of the crystallization screens have a solution pH 
reported to be outside of this range.  This reduction will slightly reduce the initial conditions to 
search. 
When the crystpH  probability distribution was examined (Figure 7.5), two peaks in 
probability were a little more pronounced, pH 7.5 and 8.0.  Each of these pH values had a 
),|( 05.04.10nrPDBQQpHpHP crystcryst == over 15%.  The probability values for 6.5-7.0 are 
slightly lower than 15%, but still well above the 10% threshold.  The Baseline group suggests a 
slightly more narrow pH range, 6.5-8.0, than the pIest=’Acidic’ Bin, pH 6.5-9.0. 
All methods predict that UV-DDB is more likely to crystallize when the pH ranges from 
6.5-8.0 with slight variations, down as low as pH 5.2 and as high as pH 9.0.  Generally, these pH 
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values are the ones most sampled by the commercial screens.  However, this information does 
suggest that crystallization attempts should be at a solution pH greater than 5.5.  This would 
remove a subset of acidic conditions (9.2%) and allow the researcher to focus their efforts a little 
more. 
 
 
 
Figure 7.5 The Q  curve with CI50 interval and crystpH  probability distribution for UV-DDB. 
7.4 CHAPTER SUMMARY 
The three methods discussed in Chapter 5, namely 50% Confidence Intervals (CI50), Charge 
Range Test, and crystQ  probability distributions, were used to predict a solution pH range for 
crystallization of three proteins currently undergoing structural determination in the laboratory of 
Dr. John Rosenberg (Department of Biological Sciences, University of Pittsburgh), α-Synuclein, 
NAPOR-1, and UV-DDB.  The goal is to predict the solution pH ranges that have a higher 
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probability of resulting in crystallization for the target protein given the protein’s amino acid 
sequence. 
This is accomplished by estimating the protein’s Q  curve from the amino acid sequence 
and then matching the Q  values along the curve to the crystQ  values of previously crystallized 
proteins, )|( 05.04.10nrPDBQQP cryst= .  These probabilities can then be transferred into the pH 
search space by using the protein’s Q  curve, ),|( 05.04.10nrPDBQQpHpHP crystcryst == .  In 
addition to comparing the three different methods of predicting the crystpH  ranges, two different 
methods of grouping proteins by similarity were compared.  The Baseline grouping method did 
not consider subgroups of proteins, i.e. all proteins were considered equal.  The second method 
used pIest Binning (Section 6.1.1.2) to separate proteins into groups. 
 The Baseline approach assumes that there are no subgroups of proteins and that all 
proteins can be assigned probabilities based on a one-size-fits-all approach.  Binning by the pIest 
assumes that proteins with a similar pIest can be used to improve the prediction over Baseline.  
As a result, when the target protein has a pIest in the ‘Acidic’ to ‘Basic’ range, close to the overall 
mean pIest (6.3±1.7), the predictions are generally not widely different from that obtained by the 
Baseline method.  However, as the target protein’s pIest moves farther away from the overall pIest 
mean, the probability differences can be quite different (Figure 7.6). 
For example, the proteins α-Synuclein (pIest = 4.4; Figure 7.6a) and NAPOR-1 (pIest =8.6; 
Figure 7.6b) have pIest values that are quite different than the training set’s mean pIest of 6.3.  As 
a result the pH values with the highest probabilities using Baseline are much closer to the 
protein’s pIest., because the Baseline crystQ  values with the highest probabilities are close to the 
pIest, mean crystQ  of -0.1 e/kDa.  When the predictions are based on the matching the pIest bin, 
there is large shift towards a more neutral pH where there are more negative (α-Synuclein) or 
positive (NAPOR-1) Q  values.  These Q  values were shown to have a higher probability in 
crystallizing ‘Acidic’ and ‘Basic’ proteins, more closely representing the groups mean crystQ  
values (-0.4 e/kDa for ‘Acidic’ and +0.2 e/kDa for ‘Basic’ proteins; Figure 6.3; Table 6.1b). 
 Alternatively, when the target protein has a pIest value that is closer to the mean pIest value 
of the Baseline group (pIest = 6.3), there isn’t as much as a shift in probability values when 
comparing Baseline to the pIest Binning.  This was demonstrated with the target protein UV-DDB 
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(pIest = 5.95; Figure 7.6c).  There is a shift in pH probability values for UV-DDB, but there may 
be an additional problem binning UV-DDB by the pIest.  UV-DDB has a pIest of 5.95, which is 
right at the pIest separation point for ‘Acidic’ and ‘Neutral’ proteins (pIest = 6.0).  A better 
estimate of the crystpH  probability may be obtained if all proteins within ±1.0 pIest units are used 
to estimate the probability (5.0 ≤ pIest < 7.0).  This remains an area of future research in case 
selection of ‘similar’ proteins, i.e. case-based reasoning. 
 As demonstrated with all three target proteins, each method of predicting the pH range 
for crystallization attempts are relatively complimentary, which they should be, because they are 
all based upon the same set of proteins.  However, there are some differences between the 
methods.  For example, the CI50 will suggest a crystpH  range, but it gives equal probability 
among all pH values within the range.  The Charge Range Test method can give a more accurate 
prediction by using the various levels of Q , ±0.1, ±0.2 for the selection of appropriate ranges.  
The probabilities obtained using this method also may be less than or greater than 50%.  This 
method does have its problems, because there may be differences in the crystpH  probabilities 
below or above the mean crystQ  value, such as between Mean-0.1 e/kDa and Mean+0.1 e/kDa.  
The Charge Range Test method may therefore miss some areas of local maximum probability.  
Therefore, it is felt that the probability distribution method will allow the researcher to make the 
most intelligent choice based upon any other limitations, such as a limited amount of protein. 
The ),|( 05.04.10nrPDBQQpHpHP crystcryst ==  calculations may result in  crystpH  
distributions from which any local maxima values can be determined.  Of the three proteins 
examined, α-Synuclein was predicted to have a very narrow pH range of high probability, 5.0-
5.5 (44%).  A wider pH range of 4.5-8.0 also has a higher probability than randomly searching 
the pH space, but less than the 10% threshold probability.  A more neutral pH is suggested for 
the basic NAPOR-1 (pIest = 8.6), pH 6.5-8.0.  This range is estimated to have a 51% chance of 
capturing the crystpH .  A slightly larger pH range, 6.5-9.0, is suggested for the slightly acidic 
UV-DDB (pIest = 5.95).  An increase in the crystpH  probability for this range is also observed, 
83.3%.  However, the lack of crystallization of these proteins might be due to something other 
than the solution pH, because previous attempts with commercial screens have failed.  Other 
methods for translating back to the pH space might yield different probability distributions, 
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which could be explored in future work.  Finally, the crystpH  probabilities can be calculated over 
a narrow (pH 4.0-10.0) or broad (pH 1.0-14.0) range of pH values with narrow (0.1) or broad 
(0.5) pH intervals.  For some proteins, the results will significantly reduce the pH values that 
should be searched, as with α-Synuclein, while other predictions will have little effect in 
reducing the pH search space. 
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Figure 7.6 Comparing Baseline results with pIest Binning, to estimate ),|( 05.04.10nrPDBQQpHpHP crystcryst == for the 
three example proteins. 
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8.0  DISCUSSION 
Protein crystallization remains a major bottleneck for structural biologist, because of the 
idiosyncratic behavior of the proteins in solution.  Currently, there are few, if any, rules for the 
selection of solution pH conditions for crystallization and the success rates are quite low.  The 
initial results in Chapter 3 indicated that separating proteins into groups based upon their 
estimated isoelectric point (pIest) or estimated titration curve may allow the researcher to 
intelligently select solution pH ranges that have a higher probability in generating crystals, while 
at the same time removing those pH ranges that have little chance of success.  These results led 
to the development of a framework for identifying protein features and solution conditions that 
are related to successful crystallization. The Protein Sequence-Properties Evaluation (PSPE) 
framework was created (Chapter 4) to aid in the statistical evaluation of variables for predicting 
ranges of and prior probability distributions for protein crystallization conditions.  Development 
of such a framework was largely motivated by the rapid growth and evolution of the Protein Data 
Bank.  Because the crystpH  is the most widely reported experimental variable for crystallization 
and the solution pH can largely control the protein’s charge, various charge variables, including 
the specific charge ( crystQ ) and average surface charge density ( crystσ ; Chapter 5) were estimated 
and their distributions examined in previously crystallized proteins.  The principal observation of 
this study was that proteins appear to crystallize at low values of crystQ  and crystσ .  This 
framework, while tested only on the solution pH and related charge variables ( crystQ , crystQ , and 
crystσ ), could be used in theory to identify any other crystallization variables (Section 8.1).  
Using a retrospective approach, the models developed in Chapters 5 and 6 were then tested and 
validated on an independent test set of more recent entries to the Protein Data Bank (PDB; 
Section 8.2).  The possible success of this approach will hopefully lead to a more thorough 
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reporting of other crystallization solution parameters (Section 8.3), including a more accurate 
reporting of the crystpH  (Section 8.4). 
Many assumptions were made for the calculation of a protein’s estimated net charge from 
the crystpH .  With some modifications to these algorithms, a more accurate estimation of the 
crystQ  and crystσ  can be performed (Section 8.5).  While the current results can be largely 
explained by physical chemistry, a more accurate calculation should increase the predictive 
power of the models and increase our understanding of the crystallization process (Section 8.6).  
With a more thorough understanding of the process, crystallization screens can be designed, 
which should  improve upon the current low success rates (Section 8.7). 
8.1 PSPE FRAMEWORK 
The PSPE framework for identifying protein crystallization solution conditions based upon a 
protein’s biophysical properties was developed in Chapter 4.  The PSPE framework is an 
instantiation of the “scientific method” for the framing and testing of hypotheses in an 
informatics setting.  This ‘easy’ framework was developed for testing hypotheses for explaining 
differences in protein behavior in crystallization screens.  Initially, the framework was applied to 
proteins as one large group and indicated that the Q  and σ  may be possible proxy variables for 
the crystpH  (Chapter 5).  However, when proteins were separated into groups based upon similar 
biophysical properties (Features) that can be calculated prior to any crystallization attempts, an 
improvement was observed in the prediction of the estimated specific charge ranges for growing 
protein crystals (Chapter 6). 
Previous research has failed to correlate the pIest to the crystpH .  The PSPE framework 
was used to identify Features and Hidden Controllables (Q , Q , and σ ), which could 
potentially be used to select solution pH ranges that have a higher probability of generating 
crystals.  This can be done by using a protein’s amino acid sequence to first calculate the 
protein’s estimated titration curve.  From the estimated titration curve, the Q  and σ  curves can 
be obtained by dividing the estimated net charge of the protein by either the MWau or AS, 
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respectively.  Based upon the crystQ  values of previously crystallized proteins, the Q  and σ  
values of the target protein might be used to guide the researcher in selecting pH values that have 
a higher probability in forming crystals.  Combined with other information, this knowledge could 
help lead to the development of protein-specific screens.  Using this knowledge should increase 
the probability of generating crystals of suitable quality for diffraction studies by removing 
conditions not likely to result in crystals, while increasing the sampling in areas more likely to 
result in crystals. 
It is also important to discuss the limitation of the PSPE Framework.  The main limitation 
is that the PSPE Framework was tested on one example, identification of the Q  and σ  as 
possible proxy variables for the crystpH .  This can be considered one example, because these 
variables are close approximations of each other, Spearman’s rho of 0.995.  However the major 
limitation is that this observation needs experimental validation.  Another limitation is that the 
PSPE Framework is currently not automated. This can be accomplished; however, there is still 
the need for a highly involved user.  The framework cannot automatically find hidden variables, 
hypotheses have to be developed and tested.  Finally, another limitation is the availability of 
training and test set data.  A researcher will likely need to generate new data sets from the PDB 
with each hypothesis.  The dynamic nature of the database (continually evolving) also presents 
an interesting challenge as new protein structures are added with some others being replaced. 
8.2 TEST SET VALIDATION 
In order to validate any models or predictions, the solution pH ranges for crystallization were 
predicted on newer entries to the PDB.  Alternatively, cross-validation can be used, which would 
also give an estimate of the prediction error.  Due to a high level of bias present in the PDB, a 
non-redundant set of proteins should be used for both the training and test sets.  Because the 
PDB is an evolving database, the models can be updated as more 3D structures are solved.  This 
process can also be automated.  However, the ideal validation would be the actual crystallization 
of target proteins.  This experimental validation would demonstrate the value of recording more 
experimental parameters. 
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8.3 RECORD MORE INFORMATION 
Similar to Peat et al. (2005), the present results suggest that researchers should include more 
standardized information when depositing structures in the PDB.  This information would then 
be accessible in the mmCIF files for future analysis on the requirements for growing crystals.  
For example, if a commercial screen is used to grow the crystals, the screen and the well solution 
details should be listed.  Biliverdin Reductase A (PDB ID: 1LC3) was a good example where 
Emerald Screen Wizard-I, condition 27 was used to grow the crystal.  This information was 
found in the _exptl_crystal_grow.pdbx_details field of the mmCIF file.  There are occurrences in 
the PDB where this happens, but very infrequently.  With more information available, data 
mining may lead to an increase in the success rates (Luft et al., 2003; Walter et al., 2005).  
Additionally, researchers will be more likely to understand the conditions, including solution pH, 
which are required for the formation and growth of protein crystals suitable for diffraction 
studies. 
8.4 REPORTED PH OF CRYSTALLIZATION 
The saw-tooth pattern in the crystpH  distribution strongly suggests that very few researchers are 
measuring the actual solution pH.  Although commercial companies may report the pH of the 
buffer in their screens, it was demonstrated that the actual pH of the solution may be quite 
different (0.5-5.0 pH units) from the buffer listed or between the supplier's matched conditions 
(Bukrinsky et al., 2001; Wooh et al., 2003).  Recently, Hampton Research published a list of the 
measured pH values of their well solutions.  Although, many values were close to the pH of the 
buffer, some were quite different (Appendix B). 
Additionally, these pH values are also often only appropriate for the well solution and not 
the protein solution.  When making the protein solution, typically the well solution is mixed 
50/50 with the protein solution, which may contain a different pH with different buffers than the 
well solution.  This interaction between the reservoir and protein solutions may shift the solution 
pH at setup.  Additionally, the solution pH can also drift during the crystallization process.  This 
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would especially be systematic for reservoir solutions that are very acidic or very basic.  Here the 
protein solutions are more likely to be buffered towards the neutral and hence shift the pH in that 
direction.  These effects would broaden the Q and σ  distributions, i.e. adding to the variance. 
Therefore, the pH of the well and protein solution should be listed separately.  Based on current 
understanding, the crystpH  present in the PDB is most often the pH of the well solution.  A more 
accurate reporting of the protein solution’s pH will allow a better estimate of the net charge of 
the protein. 
8.5 LIMITATIONS WITH THE ESTIMATION OF NET CHARGE 
Experimental titration curves are rarely measured due to the time and effort required to obtain 
the required information.  Detailed pKa measurements are generally not attempted until 
functional and structural information has accumulated, suggesting an interesting phenomenon.  
Computational methods of determining the pKa values all require detailed structural knowledge.  
However, Q  can be estimated using the HHE (Equation 2.1).  The pKa values used in most 
calculations are model values that have been determined from the isolated amino acid, which are 
generally quite accurate (Yang et al., 1993).  It should be noted that there is some variation, 
depending upon the source.  Differences in model pKa values can be as large as 0.9 units for the 
same group.  However, these average values are relatively accurate for surface exposed residues.  
Additionally, some sources model every amino acid’s –NH3 and –COOH terminus as one value, 
such as Accelrys’ GCG package, while others have individual values for each amino acid, such 
as that used in this dissertation (Nelson and Cox, 2000).  Therefore, some differences may exist 
when computing the titration curves using different sources for model pKa values. 
Additionally, assumptions are made when calculating the estimated titration curves.  The 
first assumption was that all like amino acids have the same pKa value, which is not the case.  
Local environmental effects may cause significant shifts in pKa values of individual residues.  
The amino acids with large observed pKa shifts are often those that are important functionally or 
structurally.  In a study of 24 crystallized proteins with known pKa values determined by NMR 
spectroscopy, the pKa values for the carboxyl groups of Aspartic acids averaged 3.9 in acidic (pI 
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< 5) and 3.1 in basic proteins (pI > 8).  It was also observed that Aspartic acid residues with 
extreme pKa values (>5.5) were often found in the active sites or ligand binding sites (Forsyth et 
al., 2002).  For example, as the protein becomes more acidic, there is an increasing tendency for 
the negative charges to cluster, which is electrostatically unfavorable, thus raising their pKa 
values.  These effects are likely to be systematic. 
The second assumption made when estimating the titration curve was that all charged 
residues are accessible.  However, this is also known not to be the case.  Currently, there is no 
way to determine apriori which residues are located on the surface, which is why the term 
'estimated' titration curve is used.  It might be possible to more closely estimate the number of 
charged amino acids on the surface, by adjusting for surface amino acid propensity prior to 
calculating estimated titration curve.  For example, most Lysine, Glutamic acid, Aspartic acid, 
and Arginine residues are located on the surface of both monomeric (Miller et al., 1987a; Tsai et 
al., 1997) and oligomeric proteins (Janin et al., 1988), while over 50% of the Histidine, Cysteine, 
and Tyrosine residues are located in the interior.  In addition to adjusting for surface propensity, 
if the protein is an oligomer, adjustments for the protein-protein interface amino acid propensity 
can also be made (Janin et al., 1988, Tsai et al., 1997) of oligomeric proteins prior to calculating 
estimated titration curve.  These are possible areas for future study. 
Charged amino acids are often found in serendipitous clusters, which bind ions, thus 
altering/shielding the charge.  This reduces the net charge of the protein, which decreases the 
possible unfavorable electrostatic interactions between protein molecules allowing them to come 
into closer contact.  Functional ion binding sites typically involve clusters of charged residues, 
e.g. cations, which are typically bound by several acidic groups.  For example, the active site of 
inositol monophosphatase (PDB id: 2BJI; a homo-dimer) binds three Mg2+ ions.  These three 
Mg2+ ions in each dimer are bound to the side chains of Glu70, Asp90, Asp93, and Asp220 (Gill 
et al., 2005).  Negative ions can also be found bound to residues, however, they are usually 
involved in neutralizing positive charge.  For example, lysozyme can bind four Cl- ions 
(Retailleau et al., 1997).  Binding of ions, whether positively or negatively charged, may shift the 
estimated titration curve and pI (Green, 1931b; Retailleau et al., 1997).  This complicates the 
calculation of the crystQ  and crystσ , because there is currently no method to estimate the amount 
of ions that will bind apriori.  Therefore, ion-binding effects are likely to be systematic as well. 
 200 
However, it should be mentioned that the solution pH is not the only method of 
controlling the net charge.  For example, nucleic acids are significantly more charged than are 
proteins, yet still manage to crystallize.  Therefore, the protein’s charge shouldn’t be a barrier for 
crystallization.  The nucleic acid crystallization literature describes many reagents for dealing 
with this strong negative charge, ranging from small divalent cations, such as Mg2+, to small 
polyamines, such as spermine and putrascein, and including specialized reagents, such as cobalt 
hexamine.  These reagents provide the necessary counter ions to neutralize the negative charge 
and help stabilize the structures for crystallization (Dock-Bregeon et al., 1999). 
Due to difficulties estimating the AS, the crystQ  values appear to be a better variable to 
model than the crystσ .  The Q  values can be transformed into theσ  values by taking the 
molecular weight to the appropriate power (Section 5.2).  The AS can also be adjusted for the 
predicted number of chains in the biological/asymmetric unit.  Adjustments could also be made 
when considering the chains in the complex, whether they involve permanent, transient, or 
crystal contacts.  Each type of contact buries a different amount of surface area on average with 
the permanent complexes burying the most and the crystal contacts burying the least (Jones and 
Thornton, 1996; Carugo and Argos, 1997; Dasgupta et al., 1997; Valdar and Thornton, 2001; 
Bahadur et al., 2003).  Therefore, the primary amino acid sequence, particularly the composition 
of the charged amino acids, may play a critical role in suggesting pH ranges for obtaining 
crystals.  The kinds of systematic effects discussed previously can be corrected for empirically 
by examining the crystpH  values of proteins with similar amino acid composition, e.g. by pI 
binning.  This would be especially worthwhile when designing the initial screens for a new 
protein. 
8.6 PHYSICAL SIGNIFICANCE OF SPECIFIC CHARGE AND SURFACE 
CHARGE DENSITY 
The distributions of both the crystQ  and crystσ  of previously crystallized proteins were examined.  
While the crystQ  is a relatively clean number, which is well characterized thermodynamically 
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(specific charge), it does not provide the best explanative value for the problem.  However, the 
crystσ  has a more explanative value and allows for comparison to other charged biological 
models that crystallize, such as nucleic acids, but the calculations are based on a lot of 
interpretations and are rather soft.  Errors in the estimation of the AS may propagate when the 
crystσ  is calculated due to uncertainties in the calculation of surface area.  This would be more 
problematic for large proteins.  These issues may lead to a decrease in the accuracy of the 
predicted crystpH  range.  Therefore, both the crystQ  and crystσ  were examined and how they relate 
to proteins with known 3D structures. 
The distribution of the crystQ  and crystσ  around the pIest (Figures 5.5) indicated that these 
proteins are close to neutral, electrostatically.  It is likely that the crystallization process naturally 
selects for a low charge to limit negative electrostatic interactions between molecules, allowing 
them to come into close proximity to form crystal lattice contacts.  An alternative hypothesis 
would be that the low charge is a consequence of natural selection for function and/or stability.  
The crystQ  distributions were normally distributed and could be fit with a Gaussian (Section 6.3).  
A high correlation (0.995) between the two variables was also observed.  Thus, a low Q  is 
equivalent to a low σ .  For comparison purposes, 0.1 e/kDa corresponds to one excess positively 
charged amino acid out of 91 amino acids, assuming an average molecular weight of 110 Daltons 
per amino acid. So the original idea of crystallizing around the isoelectric point was not far off.  
However, a low crystQ  or crystσ  does not necessarily translate into a crystpH  being close to the 
pIest.  This is partially due to the shape of the protein’s estimated titration curve. 
However, there was a theoretical difficulty with the idea of crystallizing at the pI.  The 
more charged residues a protein has on its surface, the higher the probability of unfavorable 
electrostatic interactions between molecules, which will not allow the molecules to come into 
close contact and form crystals (Ries-Kautt and Ducruix, 1999).  Global electrostatic effects are 
problematic because they are necessarily long range.  Electrostatic forces are quickly damped in 
high dielectric aqueous media, particularly so in the presence of a high salt concentration.  It was 
therefore felt that electrostatics would be more important locally for crystallization i.e. between 
residues at (or near) lattice contacts especially between residues on different equivalent 
molecules (Tardieu et al., 2001). 
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The principal observation of this study is that proteins appear to crystallize at low values 
of Q  and σ .  One problem with this observation is that “low” is a relative term and the frame of 
reference requires careful examination. One frame of reference is provided by comparison to the 
known σ  values for nucleic acids and phospholipid bilayers, whose surface charge densities are 
at least an order of magnitude greater than that of proteins at their crystpH .  One problem with 
this frame of reference is that there is no pH at which proteins are as highly charged as nucleic 
acids. A more serious problem is that nucleic acids crystallize readily, demonstrating that a high 
σ  is not a barrier to crystallization. Another frame of reference is in relation to the mean Q /σ  
values at “physiological pH” of 7.4  ( 4.7=pHQ ); here, there is an approximately three-fold 
reduction in the mean of crystQ  vs. the mean of 4.7=pHQ .  One problem with this frame of 
reference is that the pH reference value, 7.4, is questionable because many proteins function in 
physiological compartments where the pH is significantly different.  A more serious problem is 
that the standard deviations of the two distributions are more than twice the shift between them.  
The shift is statistically significant because of the sample size, but cannot be used to make 
meaningful predictions about specific proteins.  It should be noted that the preponderance of 
“domain knowledge” would be that the primary factors selecting low net charge are issues of 
protein folding and stability as well as issues of functionality. 
It is interesting to note that in two studies (Dasgupta et al., 1997; Bahadur et al., 2003) 
that 4/5 of the most frequent residues found at crystal contacts were Aspartic acid, Glutamic 
acid, Lysine, and Arginine, which have side chains that can be ionized.  A low crystQ  or crystσ  is 
consistent with the electrostatic effects being primarily local.  Here it is argued that a low crystQ  
or crystσ  implies a low probability of like charges in close proximity across a lattice contact.  
Even though the crystQ  and crystσ  can be largely controlled by the solution pH, there are other 
solution parameters involved. 
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8.7 APPLICATION TO SCREEN DESIGN 
The above findings in possible combination with other case-based reasoning (Hennessy et al., 
2000; Jurisica et al., 2001) and Bayesian methods (Hennessy et al., 2000; Rupp and Wang, 2004) 
may help lead to the development of more successful crystallization screens.  Historically, 
crystallization conditions were initially searched in a lab specific manner.  This changed with the 
development of the sparse matrix crystallization screens by Jancarik and Kim (1991).  Designed 
using conditions that had succeeded in crystallizing other proteins, this screen initially sampled 
pH values approximately every 1.0 unit from 4.5 to 8.5 (4.6, 5.6, 6.5, 7.5, and 8.5).  Using this 
method, a large number of conditions are examined by varying the partial combinations of the 
concentrations and type of salt, buffer, and precipitants.  These screens caught on and were 
commercialized and are currently used by many researchers due to their ease of use and proven 
track record. 
Since Jancarik and Kim’s original sparse matrix screen, others have developed more 
specific sparse matrix screens for particular classes of biological molecules, such as RNA 
(Doudna et al., 1993; Scott et al., 1995), immunoglobulins (Harris et al., 1995), enzymes 
(Brzozowski and Walton, 2001), protein-protein complexes (Radaev and Sun, 2002; Radaev et 
al., 2006), and membrane proteins (Iwata, 2003).  These studies and others demonstrated that 
particular classes of macromolecules have a preference for solution conditions that lead to 
successful crystallization (Samudzi et al., 1992; Farr et al., 1998; Hennessy et al. 2000; Jurisica 
et al., 2001; Gilliland et al. 2002; Kimber et al. 2003; Goh et al., 2004; Rupp and Wang, 2004).  
For example, Hennessey et al. (2000) found that ligand binding proteins and enzymes had 
significantly different crystpH  distributions. 
This prior knowledge can be encoded as Bayesian priors and used to generate probability 
distributions for various solution parameters, including the solution pH.  These probabilities can 
be further combined over multiple crystallization variables as more data are collected to suggest 
regions in the crystallization search space more likely to produce well-ordered crystals.  Even a 
collection of weak predictors can be informative and aid in crystallization design (Hennessy et 
al., 2000). 
The present results support the idea of using prior knowledge to improve the probability 
of generating crystals from an initial screen.  From an amino acid sequence, an estimated 
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titration curve can be easily calculated.  This curve can then be translated into a Q or σ  curve 
by taking the protein’s MW or AS into account.  The crystQ  or crystσ  frequency distributions of the 
successfully crystallized proteins can then be used to suggest a pH range for the target protein(s).  
This can be accomplished by matching the pH values that result in a crystQQ =  or crystσσ =  
value that has a high probability of generating a crystal.2  However, careful consideration should 
be given to counter ions and other means of achieving neutrality, in addition to the solution pH, 
when the protein is highly acidic or basic.  Several examples demonstrating possible scenarios 
for crystallizing a test protein are presented in Appendix C. 
A protein from the test set, 1LRH (Auxin-Binding Protein 1), was used in the example.  
1LRH was an example where the predicted crystpH  range was extremely accurate.  The CI50 
range for crystQQ =  was -0.25 to +0.14 e/kDa, which results in a 50/50 chance that the crystQ  will 
fall within this range.  When translated back into pH space, a pH range of ~4.8-6.0 was 
suggested for initial crystallization attempts, while the crystpH  was 5.5.  When such narrow 
distributions are predicted, a focused pH search (5.0-6.0) for the initial crystallization attempts is 
suggested. 
Some proteins, such as UDP-N-Acetylglucosamine Enolpyruvyl Transferase (Figure 2.1; 
PDB id: 1A2N), have long flat portions along the estimated titration curve where the charge 
changes very slowly over a wide range of pH values.  If a protein crystallizes in this flat region, 
it may be relatively insensitive to the solution pH and therefore crystallize over a wide range of 
pH values, all of which result in a similarly charged protein.  If the protein crystallizes in an area 
of rapidly changing charge, near the pKa values of the charged amino acids, then it may be 
highly sensitive to manipulation of solution pH.  If a crystal produces a ‘hit’ in this region, a 
finer search of pH conditions would be suggested.  These methods may be relatively effective in 
limiting the range of pH values searched in an initial crystallization screen.  Alternatively, there 
may little reduction in pH space.  When a significant reduction is observed in the pH range, the 
researcher will have greater flexibility in searching other parameters, such as the salt or 
precipitating agent, while using the same number of experiments. 
                                                 
2 The findings and interpretation could differ based on the way these probabilities were propagated. 
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8.8 CONCLUSION 
The goal of the research was to develop a Protein-Specific Properties Evaluation (PSPE) 
framework that could aid in the statistical evaluation of variables for predicting ranges of and 
prior probability distributions for protein crystallization conditions.  Development of such a 
framework was motivated by the rapid growth and evolution of the Protein Data Bank.  Features 
of the framework that has been developed include: (1) it is an instantiation of the “scientific 
method” for the framing and testing of hypotheses in an informatics setting, (2) the use of hidden 
variables, i.e. parameters which are analytic functions of quantities extracted from the database, 
and (3) a negative result is still useful; i.e. the recognition that a variable has minimal utility in 
predicting ranges or probabilities of crystallization allows energy and attention to be focused 
elsewhere, where it may be more productively employed. 
The hidden variables examined in this study were related to the estimated net charge (Q ) 
of the proteins under consideration.  The Q  is a function of the amino acid composition, the pH 
of the solution, and the assumed pKa values for the titratable amino acid residues.  The size of 
the protein clearly has a significant impact on the magnitude of the Q .  Therefore, two additional 
variables were introduced to mitigate this effect.  The first variable was the estimated specific 
charge (Q ), which is the ratio of the Q  to the protein mass, expressed here in units of e/kDa.  
The second variable was the estimated surface charge density (σ ), which is the ratio of the Q  to 
the estimated surface area of the protein; a convenient unit is me/nm2.  Although the estimation 
of surface area is difficult, σ  facilitates comparisons with other biologically relevant 
macromolecules.  Additional Q -related quantities examined included the isoelectric point (pI), 
which is the pH at which the Q  is zero, and measures of the shape of the titration curve, which is 
either Q  or σ  expressed as a function of the pH. 
The principal observation of this study is that proteins appear to crystallize at low values 
of Q  and σ .  One problem with this observation is that “low” is a relative term and the frame of 
reference requires careful examination.  One frame of reference is provided by comparison to the 
known σ  values for nucleic acids and phospholipid bilayers, whose σ  values are an order of 
magnitude greater than that of proteins.  One problem with this frame of reference is that there 
are no pH values at which proteins are as highly charged as nucleic acids.  A more serious 
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problem is that nucleic acids crystallize readily, demonstrating that high σ  is not a barrier to 
crystallization. 
Another frame of reference is in relation to the mean Q /σ  values at “physiological pH” 
of 7.4 ( 4.7=pHQ ).  Here, there is an approximately three-fold reduction in the mean of crystQ  (-0.6 
e/kDa) vs. the mean of 4.7=pHQ  (-0.17 e/kDa).  One problem with this frame of reference is that 
the pH reference value, 7.4, is questionable because many proteins function in physiological 
compartments where the pH is significantly different.  A more serious problem is that the 
standard deviations of the two distributions are more than twice the shift between them.  The 
shift is statistically significant because of the sample size, but cannot be used to make 
meaningful predictions about specific proteins.  It should be noted that the preponderance of 
“domain knowledge” would be that the primary factors selecting low net charge are issues of 
protein folding and stability as well as issues of functionality. 
The results are sufficiently weak that no protein-specific prospective predictions appear 
possible although information of this type could be included with other weak predictors in a 
Bayesian predictor scheme.  Additional work would be required to establish this; however that 
work is beyond the scope of the dissertation.  Although many statistically significant correlations 
among Q -related quantities were noted, no evidence could be developed to suggest they were 
anything other than those expected from the additional information introduced with the hidden 
variables. 
Thus, the principal conclusions of this PSPE analysis are: (1) the Q /σ  and other Q -related 
variables are of limited value as prospective protein-specific predictors of ranges of values of 
crystallization conditions, (2) probabilities based on these variables may prove useful in a 
Bayesian sense, although that has not been demonstrated at this time, and (3) although this is a 
negative result, it is still useful in that it allows attention to be directed into more productive 
avenues. 
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9.0  FUTURE RESEARCH 
The initial work presented here focused on the reported solution pH of crystallization ( crystpH ) 
for several reasons.  The first reason was that the crystpH  was the most reported crystallization 
parameter reported in the PDB.  The second reason was that the solution pH has long been 
known to be one of the primary variables responsible for crystallization.  The solution pH 
exhibits its primary influence by controlling the estimated net charge of the protein.  For this 
dissertation, the Controllables were assumed to be independent variables.  However, this is not 
the case as there are many types of interactions between the parameters, both known and 
unknown. 
It was hypothesized in this dissertation that the Protein Sequence-Properties Evaluation 
Framework (PSPE) could be used to identify other important relationships between Observables 
and Features.  There remain a lot of possible variables to examine (see Table 1.1 in Chapter 1); 
some are discussed in Sections 9.1-9.3.  Additionally, other types of analyses can be examined, 
including multiparametric methods to examine the interactions among variables (Section 9.4), 
provided enough data is available (see Section 8.1). 
In addition to other types of analyses, the same methods used here with some minor 
modifications might be able to be used to further increase the predictive range results (Section 
9.5).  Adjustments could be made to the calculation of estimated titration curves, such as 
adjusting for the propensity of the amino acid being found on the surface or at a protein-protein 
interface.  Although the methods discussed within this dissertation might lead to an increase of 
the success rates of obtaining protein crystals, actual experimental verification is essential and 
should be explored further (Section 9.6). 
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9.1 OTHER CRYSTALLIZATION CONTROLLABLES AND OBSERVABLES 
This analysis focused on the solution pH, but any of the other Controllables could be examined 
and analyzed if sufficient information is present as crystallization Observables.  Although more 
information is accumulating on the crystallization conditions (Observables), much of it is in the 
form of free text.  This presents some problems due to all the possible lexicons.  For example, 
Peat et al. (2005) examined the precipitating agents used as listed in the PDB and found over 30 
possible terms for “ammonium sulfate,” many of which are misspellings or abbreviations.  There 
would also be the possibility to develop methods to extract the information from the original 
research articles, but that would be an even greater challenge. 
The temperature at which crystals grew is the next most reported variable and can now be 
queried from the PDB.  The reported temperature is currently available (5/26/2006) for 57% of 
the crystal structures solved by X-ray diffraction (19,723/34,578).  However, the bias in 
temperature selection is much greater than pH.  Most researchers examine temperature effects at 
either room temperature (20 or 25 oC) or in a cold room/refrigerator (4 oC).  Although the 
reporting of temperature is supposed to be in degrees Kelvin, there are many instances where the 
temperature is clearly in degrees Celsius, values of 4, 18, and 20. 
9.2 OTHER PROTEIN FEATURES 
In addition to analyzing other Observables, the effects of other Features can also be examined.  
Other Features that may prove valuable are measures of hydrophobicity, Aliphatic Index 
(stability), and Disorder.  Because these Features are also based on sequence information, they 
may also be correlated to sequence-based Observables, such as the Q -related Observables 
examined in this dissertation.  Additional variables such as the predicted secondary structure 
composition, i.e. Helix and Sheet, and subcellular location may also prove useful to include.  As 
mentioned earlier in Section 2.2, these variables have correlated with success (0=’No’ or 
1=’Yes’) of the structure determination process.  Therefore, it would be expected that their 
values may indicate what crystallization conditions to use. 
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Another factor that may influence the ability of the protein to crystallize is the source of 
the protein.  The source of each protein chain found in the PDB is available from PDBeast at 
http://www.ncbi.nih.gov/Structure/PDBEAST/pdbeast.shtml.  It should be noted that there may 
be multiple sources for each crystallized complex.  It is hypothesized that there may be 
differences in protein behavior based upon the Kingdom (Archaea, Bacteria, Eukaryota, or 
Virus). 
Previous work has also suggested that certain subclasses of proteins crystallize under 
different conditions.  Analysis could include identification of protein families, as defined in Pfam 
(Bateman et al., 2004), proteins with similar function, as defined by Gene Ontology (GO; The 
Gene Ontology Consortium, 2000), and other biological macromolecules.  Although these 
analyses may prove fruitful, preliminary work on the identification and frequencies need to be 
developed. 
9.3 OTHER BIOLOGICAL MACROMOLECULES 
This analysis focused only on forming crystals from non-membrane proteins.  There is no reason 
to believe that these methods could not be applied to NMR studies or membrane proteins.  
Sparse-matrix screens have been devised for membrane proteins, demonstrating that membrane 
proteins also have areas in the crystallization search space that have higher probabilities of 
generating crystals.  Analysis on membrane proteins can even include predicting type of 
detergent if enough information is available. 
The PSPE framework should also work with nucleic acids or DNA/RNA-protein 
complexes.  Similar to membrane proteins, sparse-matrix screens have also been developed for 
these particular classes of biomacromolecules.  It would be hypothesized that nucleic acids or 
these complexes may display similar crystallization behavior that sets them apart from other 
biological macromolecules even though the charged nature of nucleic acids may complicate 
analysis. 
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9.4 OTHER ANALYSIS METHODS 
Indications are that the primary sequence composition may be used to predict the Q  ranges that 
are more likely to result in the crystallization of a protein.  Binning and two unsupervised 
clustering methods were used to group proteins by similarity.  Although each method has shown 
promise there is no reason to believe that there may be better methods available for analysis.  
One method that should be more thoroughly explored is case-based reasoning, which has 
previously been shown to be useful for selecting crystallization conditions (Hennessey et al., 
2000; Jurisica et al., 2001).  Other methods that predict a single Observable value can be 
explored, such as Linear Regression, Neural Networks, and Decision Trees.  Preliminary results 
for Linear Regression and Neural Networks are discussed in Appendix E.  These analyses can be 
explored using the Charge Range Test and compared to the methods described in this 
dissertation. 
9.5 CORRECTION FACTORS 
 
Several modifications were discussed in Chapter 8 that could be explored to improve prediction 
of the crystQ  ranges, which can then be translated into the crystpH .  An example would be to make 
adjustments in the calculation of estimated titration curves for the amino acid’s propensity for 
surface or protein-protein interface.  Modification can also be made based on whether the 
multimeric proteins are homo-oligomeric or hetero-oligomeric proteins.  Other adjustments in 
charge can also be made for the binding of metal ions (positive charge), some of which would be 
known apriori, such as the binding of iron to hemoglobin.  Removal of the extreme cases 
(outliers) and using the next best example in the nrPDB may also slightly increase the prediction 
accuracy. 
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9.6 EXPERIMENTAL VERIFICATION 
A critical factor for validation would be the actual crystallization of a target protein that has 
proved difficult to crystallize.  Another possible form of validation would be to take some 
proteins from the PDB with low quality measures (poor resolution, r-factors, etc.) and attempt to 
improve quality by recrystallizing them using the predictions made using the models developed 
in this dissertation.  The quickest way to do this would be pre-selecting proteins that have narrow 
regions of high probability.  Finally, experiments can be performed using proteins that crystallize 
over a wide range of pH values.  The actual titration curves can be determined and the slopes of 
the titration curve where the protein crystallizes can be examined. 
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APPENDIX A: Python Scripts 
PYTHON SCRIPTS 
# The purpose of this program is to identify PDB ids and ALL OF THEIR SUBUNITS/CHAINS 
# and calculate some parameters based on protein sequence - amino acid counts, pKa curves, estimated pI 
# slope at the theoretical pI 
 
#copyright 2004 David S. Dougall and University of Pittsburgh, Pittsburgh, PA 15260 
 
import re, string, os 
from Bio import Fasta 
class PDB:  # create a class PDB that represents one PDB entry 
 def __init__(self, id, subunit, type, length, sequence): 
  self.id = id 
  self.subunit = subunit 
  self.type = type 
  self.length = length 
##  self.description = description 
  self.sequence = sequence 
  self.ala = 0  #ALA ALANINE 
  self.cys = 0  #CYS CYSTEINE 
  self.asp = 0  #ASP ASPARTIC ACID 
  self.glu = 0  #GLU GLUTAMIC ACID 
  self.phe = 0  #PHE PHENYLALANINE 
  self.gly = 0  #GLY GLYCINE 
  self.his = 0  #HIS HISTIDINE 
  self.ile = 0  #ILE ISOLEUCINE 
  self.lys = 0  #LYS LYSINE 
  self.leu = 0  #LEU LEUCINE 
  self.met = 0  #MET METHIONINE 
  self.asn = 0  #ASN ASPARAGINE 
  self.pro = 0  #PRO PROLINE 
  self.gln = 0  #GLN GLUTAMINE 
  self.arg = 0  #ARG ARGININE 
  self.ser = 0  #SER SERINE 
  self.thr = 0  #THR THREONINE 
  self.val = 0  #VAL VALINE 
  self.trp = 0  #TRP TRYPTOPHAN 
  self.tyr = 0  #TYR TYROSINE 
  self.x = 0   #Xaa Unknown AA 
  self.total = 0   
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  self.pos_charge = 0 # lysine + histidine + arginine 
  self.neg_charge = 0 # aspartic acid + glutamic acid + cysteine + tyrosine 
  self.abs_charge = 0 # absolute value of charge i.e. neg + pos charge (sum of charges) 
  self.mw = 0.0  # molecular weight (kDa) 
  self.start = ''  # start = first amino acid 
  self.end = ''  # end = last amino acid 
  self.pi = 0  # estimated pI 
  self.slope_pi = []  # pk curve slope at the pI 
  self.pk_list = []  # create an empty list to store net charge values ph 1-13 by 0.2 
  self.protein = 0  # binary flag for type = protein 
  self.protein_het = 0 # binary flag for type = protein-het 
  self.nucleic = 0  # binary flag for type = nucleic 
  self.nucleic_het= 0 # binary flag for type = nucleic-het 
  self.asa = 0.0  # solvent accessible surface area 
  self.num_chains = 1 # number of chains in the asymmetric unit 
   
 def sequence_parser(self): 
  # this subroutine will parse the biological sequence (i.e. amino acids) 
  # COUNT ALL OF THE 20 AMINO ACIDS IN THE SEQUENCE 
  # also added flags for molecular type 
  if curPDB.type == 'protein': 
   curPDB.protein = 1       
 # type = protein present in PDB entry 
  elif curPDB.type == 'protein-het': 
   curPDB.protein_het = 1  # type = protein-het present in PDB entry 
  elif curPDB.type == 'nucleic': 
   curPDB.nucleic = 1  # type = nucleic present in PDB entry 
  elif curPDB.type == 'nucleic-het': 
   curPDB.nucleic_het = 1  # type = nucleic-het present in PDB entry 
  if (curPDB.protein or curPDB.protein_het):  # parse only types of protein or protein-het  
   aa_list = ['A', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'K', 'L', 'M', 'N', 'P', 'Q', 'R', 'S', 'T', 'V', 'W','Y', 'X'] 
   # list of amino acids 
   self.ala = string.count(self.sequence, 'A')  #ALA ALANINE 
   self.cys = string.count(self.sequence, 'C')  #CYS CYSTEINE 
   self.asp = string.count(self.sequence, 'D')  #ASP ASPARTIC ACID 
   self.glu = string.count(self.sequence, 'E')  #GLU GLUTAMIC ACID 
   self.phe = string.count(self.sequence, 'F')  #PHE PHENYLALANINE 
   self.gly = string.count(self.sequence, 'G')  #GLY GLYCINE 
   self.his = string.count(self.sequence, 'H')  #HIS HISTIDINE 
   self.ile = string.count(self.sequence, 'I')  #ILE ISOLEUCINE 
   self.lys = string.count(self.sequence, 'K')  #LYS LYSINE 
   self.leu = string.count(self.sequence, 'L')  #LEU LEUCINE 
   self.met = string.count(self.sequence, 'M')  #MET METHIONINE 
   self.asn = string.count(self.sequence, 'N')  #ASN ASPARAGINE 
   self.pro = string.count(self.sequence, 'P')  #PRO PROLINE 
   self.gln = string.count(self.sequence, 'Q')  #GLN GLUTAMINE 
   self.arg = string.count(self.sequence, 'R')  #ARG ARGININE 
   self.ser = string.count(self.sequence, 'S')  #SER SERINE 
   self.thr = string.count(self.sequence, 'T')  #THR THREONINE 
   self.val = string.count(self.sequence, 'V')  #VAL VALINE 
   self.trp = string.count(self.sequence, 'W')  #TRP TRYPTOPHAN 
   self.tyr = string.count(self.sequence, 'Y')  #TYR TYROSINE 
   self.x  = string.count(self.sequence, 'X')    #Xaa   ANY AA 
 
   self.total = self.ala + self.cys + self.asp + self.glu + self.phe + self.gly +\ 
    self.his + self.ile + self.lys + self.leu + self.met + self.asn +\ 
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    self.pro + self.gln + self.arg + self.ser + self.thr + self.val + \ 
    self.trp + self.tyr + self.x 
   self.pos_charge = self.lys + self.his + self.arg  # lysine + histidine + arginine 
   self.neg_charge = self.asp + self.glu + self.cys + self.tyr # aspartic acid + glutamic 
acid + cysteine + tyrosine 
   self.mw = (self.ala*89.09 + self.cys*121.15 + self.asp*133.10 + self.glu*147.13 +\ 
    self.phe*165.19 + self.gly*75.07 + self.his*155.16 + self.ile*131.17 +\ 
    self.lys*146.19 + self.leu*131.17 + self.met*149.21 + self.asn*132.12 +\ 
    self.pro*115.13 + self.gln*146.15 + self.arg*174.20 + self.ser*105.09 +\ 
    self.thr*119.12 + self.val*117.15 + self.trp*204.23 + self.tyr*181.19 + 
self.x*136.9)-(self.total-1)*18.02 
   # x value for molecular weight is the average mw of all 20 amino acids 
   # this is in daltons.  it will be divided by 1000 when writing the data to get kDa 
   # subtract 18.02 for every protein bond - 1 H2O 
   self.start = self.sequence[0]  # save first amino acid 
   self.end  = self.sequence[self.total-1] # save last amino acid 
 
 def pi_calc(self, start_ph, end_ph, ph_step, save, slope): 
  # Calculate the estimated pI 
  # I use recursion to narrow down the pI (successive approximation) 
  # all pk values taken from Harpers Biochemistry (e-book) through HSLS 
  # these values compare very closely to Voet & Voet Biochemistry, 1990 
  #seq_list = ['A, 'C' 'D', 'E',  'F',  'G',  'H',  'I',  'K',  'L', 
  #    'M', 'N',  'P',  'Q',  'R',  'S',  'T',  'V',  'W',  'Y'] 
  pk_nh3 =  [ 9.69, 10.28, 9.60, 9.67, 9.00, 9.60, 9.17, 9.68, 8.95, 9.60, \ 
     9.21, 8.80, 10.96, 9.13, 9.04, 9.15, 9.62, 9.62, 9.39, 9.11] 
  pk_coo3 = [ 2.34, 1.96, 1.88, 2.19, 1.83, 2.34, 1.82, 2.36, 2.18, 2.36, \ 
     2.28, 2.02, 1.99, 2.17, 2.17, 2.21, 2.11, 2.32, 2.38, 2.20] 
  pk_side = [8.18, 3.65, 4.25, 10.07, 6.0, 10.53, 12.48] 
  # pk_side C, D, E, Y, H, K, R 
  low_ph = 0 
  ph = start_ph 
  while ph <= end_ph: 
   c_parts01 = 10**(ph - pk_side[0])   # cysteine 
   c_zi = c_parts01 /(c_parts01 + 1) 
   c_nzi = c_zi * self.cys 
 
   d_parts01 = 10**(ph - pk_side[1])   # aspartic acid 
   d_zi  = d_parts01 /(d_parts01 + 1) 
   d_nzi = d_zi * self.asp 
 
   e_parts01 = 10**(ph - pk_side[2])   # glutamic acid 
   e_zi  = e_parts01 /(e_parts01 + 1) 
   e_nzi = e_zi * self.glu 
 
   y_parts01 = 10**(ph - pk_side[3])   # tyrosine 
   y_zi  = y_parts01 /(y_parts01 + 1) 
   y_nzi = y_zi * self.tyr 
 
   neg_charge_sum = c_nzi + d_nzi + e_nzi + y_nzi # sum negative side chain aa 
 
   h_parts01 = 10**(ph - pk_side[4])   # histidine 
   h_zi = 1 /(h_parts01 + 1) 
   h_nzi = h_zi* self.his 
 
   k_parts01 = 10**(ph - pk_side[5])   # lysine 
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   k_zi = 1 /(k_parts01 + 1) 
   k_nzi = k_zi* self.lys 
 
   r_parts01 = 10**(ph - pk_side[6])   # arginine 
   r_zi = 1 /(r_parts01 + 1) 
   r_nzi = r_zi* self.arg 
 
   pos_charge_sum = h_nzi + k_nzi + r_nzi  # sum positive side chain aa 
   aa_list = ['A', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'K', 'L', 'M', 'N', 'P', 'Q', 'R', 'S', 'T', 'V', 'W', 'Y'] 
   start_zi = 0 
   end_zi = 0 
   count = 0 
   for aa in aa_list: 
    for start_aa in self.start: 
     if start_aa == aa:       
      # start amino acid - NH3 end 
      start_parts01 = 10**(ph - pk_nh3[count]) 
      start_zi = start_zi + 1 /(start_parts01 + 1) 
    count = count +1 
   count = 0 
   for aa in aa_list: 
    for end_aa in self.end: 
     if end_aa == aa:       
      # end amino acid - Carboxyl end 
      end_parts01 = 10**(ph - pk_coo3[count]) 
      end_zi = end_zi + end_parts01 /(end_parts01 + 1) 
    count = count + 1 
   # calculate charges (net, sum of squares, and total charges)     
   self.total_charge = (start_zi + pos_charge_sum - neg_charge_sum - end_zi) 
   # append charge values to respective lists 
   if save: 
    self.pk_list.append(str(self.total_charge) ) # add total (net) charge to list 
   if self.total_charge > 0: 
    low_ph = ph        
   # obtain lowest positive charge ph 
   ph = ph + ph_step        
  # increase pH to next step 
  if not slope: 
   if ph_step > 0.0001:        
    # don't calculate steps too small 
    self.pi_calc(low_ph, low_ph + ph_step, ph_step/2, 0, 0) 
   # recursion - will decrease the range of ph values to look at and decrease the step 
   else: 
    self.pi = low_ph 
 
 def pi_slope(self): 
  # this function is for calculating the slope around the pI 
  # pi_calc(self, start_ph, end_ph, ph_step, save, slope) 
  low_value  = self.pi - 0.1 
  high_value = self.pi + 0.1 
  self.slope_pi.append(str(low_value)) 
  self.slope_pi.append(str(high_value)) 
  self.pi_calc(low_value, high_value, 0.1, 1, 1) 
 
 def asa_calc(self): 
  # this function calculates the solvent accessible surface area of the structure 
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  # uses monomer equation (Miller Janin, Lesk, & Chothia (1987) JMB 196: 641656 
  # subtracts 'standard-size' interface of 1600 Angstroms squared per every additional chain  
#(Lo Conte, Chothia & Janin (1999) JMB 285: 2177-2198) 
  self.asa = 6.3*((self.mw)**0.73) - (self.num_chains-1)*1600 
 
 def write_data(self): 
 # this is my function to write the data to file 
  list = [self.id, '\t', self.subunit, '\t', self.type, '\t', self.num_chains, '\t', self.length, '\t', \ 
    self.sequence, '\t', self.ala, '\t', self.cys, '\t', self.asp, '\t', \ 
    self.glu, '\t', self.phe, '\t', self.gly, '\t', self.his, '\t', \ 
    self.ile, '\t', self.lys, '\t', self.leu, '\t', self.met, '\t', \ 
    self.asn, '\t', self.pro, '\t', self.gln, '\t', self.arg, '\t', \ 
    self.ser, '\t', self.thr, '\t', self.val, '\t', self.trp, '\t', \ 
    self.tyr, '\t', self.x, '\t', \ 
    self.pos_charge, '\t', self.neg_charge, '\t',\ 
    self.mw/1000, '\t', self.asa, '\t', self.start, '\t', self.end, '\t', self.pi, '\t',\ 
    self.protein, '\t', self.protein_het, '\t', self.nucleic, '\t', self.nucleic_het, '\t'] 
  for value in list: 
   output.writelines(str(value)) 
  for value in self.pk_list:   # write net charge (pk curve) values 
   output.writelines(str(value)) 
   output.writelines('\t') 
  for value in self.slope_pi:   # write values for calculation of the slope at the pI 
   output.writelines(str(value)) 
   output.writelines('\t') 
  output.writelines('\n') 
 
def title_parser(fasta_record): 
 #this function will break up the fasta title into parts found in the PDB seqres file 
 title = re.compile(r'(?P<pdb_id>[a-zA-Z0-9]+)_' 
       r'(?P<subunit>[a-zA-z\:0-9\!\_\-\+\#\=\:\>\<\|]+)?  ?mol:' 
       r'(?P<type>[a-zA-Z\-]+) length:' 
       r'(?P<length>[0-9]+) ? ? ? ? ?' 
       r'(?P<descrip>[a-zA-Z0-9,-:;\[\]\(\)\'_*=\.\/ ]+)') 
 result = title.search(fasta_record.title)  # search only in title line 
 pdb_id = result.group('pdb_id')   # PDB ID 
 subunit = result.group('subunit')   # protein subunit 
 if subunit == None:    # if no subunit set subunit to 99 
  subunit = "99" 
 type = result.group('type')    # type: protein, nucleic, et al. 
 length = result.group('length')   # LENGTH OF PROTEIN IN AMINO ACIDS 
 description = result.group('descrip')   # DESCRIPTION 
 outputList = []     # initialize a list named outputList - to return a list 
 outputList.append(pdb_id)      
 outputList.append(subunit)   # 1 
 outputList.append(type)    # 2 
 outputList.append(length)    # 3 
##  outputList.append(description)  # 4  # I don't save currently  
 outputList.append(fasta_record.sequence)  # 5 
 return(outputList)    # return a list for subunit parsing 
 
############################################################################################# 
###############################  Main Program ################################################ 
#############################################################################################    
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os.chdir(r'C:\Documents and Settings\dougalld\My Documents\School Material\PDB') # change directory to 
where PDB_SEQRES.txt file found 
# this is a list of all PDB files in fasta format - i.e. sequence information 
outputFile = os.path.join("c:\\", "Documents and Settings", "dougalld", "My Documents", "School Material", 
"PDB", "pdb_012006_aa_vector_protein.txt")   # set output file path 
output = open(outputFile, 'w+')   # open output file for fasta file parse 
#caption = "PDB_ID\tsubunit\tType\tTotal_charge\tPos_charge\tNeg_charge\tSS_charge\n"  
# for sum of square charge calc 
caption = 
"PDB_ID\tsubunit\tType\tnum_chains\taa_length\tSequence\tA\tC\tD\tE\tF\tG\tH\tI\tK\tL\tM\tN\tP\tQ\tR\tS\tT\tV\t
W\tY\tX\tpos_charge\tneg_charge\tmw\tasa\tstart_aa\tend_aa\ttheor_pi\tp_flag\tp-het_flag\tn_flag\tn-het_flag\t"    
 # make caption a string for writing 
output.writelines(caption)  # column headings printed to file 
a = 1.0 
line_list = [ ]   # this will containt column headings 
# net charge header 
while a <= 14: 
 line_list.append(('pk_' + str(a))) 
 line_list.append('\t') 
 a = a + 0.1 
line_list.append('net_low\tnet_pi\tnet_high\tph_low\tph_high\t') 
line_list.append('\n') 
for line in line_list:  # this method or below both work 
 output.write(line)             # column headings printed to file 
end_ph = 14   # initial maximum ph value 
start_ph = 1   # initial minimum ph value 
ph_step = 0.1   # original ph step 
parser = Fasta.RecordParser() 
file_name = open('pdb_seqres_013105.txt') # file with full list of fasta files# 
iterator = Fasta.Iterator(file_name, parser) 
#print file_name 
pdb_id = [ ]    # create empty list named pdb_id 
theor_pi = []    # initialize empty list named theor_pi 
prevPDB = PDB(0, 0, 0, 0, 0)  # initialize empty PDB file class 
save = 1 
slope = 0 
while 1: 
 cur_record = iterator.next() # obtain first FASTA record 
 if cur_record is None:  # after last fasta pdb_id will break 
  prevPDB.pi_calc(start_ph, end_ph, ph_step, save, slope) # calculate theoretical pI 
  prevPDB.pi_slope() # obtain values to calculate slope 
  prevPDB.asa_calc() # calculate the solvent accessible surface area 
  prevPDB.write_data() # save data to file 
  break 
 
 pdb_id = title_parser(cur_record) # sends current record for title parsing 
 # returns a list with [0-4] values 
 if pdb_id not in (0,'0'): 
  curPDB = PDB(pdb_id[0], pdb_id[1], pdb_id[2], pdb_id[3], pdb_id[4])#, pdb_id[5]) 
  curPDB.sequence_parser() 
  if (prevPDB.id == curPDB.id):  
# try to identify if subunits present by seeing multiple pdb_id entries 
   curPDB.subunit = prevPDB.subunit + curPDB.subunit   
# put subunits together into one value 
   if curPDB.type != prevPDB.type:  # see if different types 
    curPDB.type = prevPDB.type + curPDB.type  
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# put types together into one value 
   if curPDB.protein < prevPDB.protein: 
    curPDB.protein = prevPDB.protein   
# type = protein present in PDB entry 
   if curPDB.protein_het < prevPDB.protein_het: 
    curPDB.protein_het = prevPDB.protein_het  
# type = protein-het present in PDB entry 
   if curPDB.nucleic < prevPDB.nucleic: 
    curPDB.nucleic = prevPDB.nucleic   
# type = nucleic present in PDB entry 
   if curPDB.nucleic_het < prevPDB.nucleic_het: 
    curPDB.nucleic_het = prevPDB.nucleic_het  
# type = nucleic-het present in PDB entry 
   if curPDB.nucleic != 1 and curPDB.nucleic_het!= 1: 
    curPDB.length = int(curPDB.length) + int(prevPDB.length)  
# adjust length of protein by new subunit's aa length 
 ##  if curPDB.description != prevPDB.description: 
 ##   curPDB.description = prevPDB.description + curPDB.description 
   curPDB.sequence = prevPDB.sequence + curPDB.sequence  
# put aa sequences together into one value 
   curPDB.ala = prevPDB.ala + curPDB.ala  #ALA ALANINE 
   curPDB.cys = prevPDB.cys + curPDB.cys  #CYS CYSTEINE 
   curPDB.asp = prevPDB.asp + curPDB.asp  #ASP ASPARTIC ACID 
   curPDB.glu = prevPDB.glu + curPDB.glu  #GLU GLUTAMIC ACID 
   curPDB.phe = prevPDB.phe + curPDB.phe  #PHE PHENYLALANINE 
   curPDB.gly = prevPDB.gly + curPDB.gly  #GLY GLYCINE 
   curPDB.his = prevPDB.his + curPDB.his  #HIS HISTIDINE 
   curPDB.ile = prevPDB.ile + curPDB.ile  #ILE ISOLEUCINE 
   curPDB.lys = prevPDB.lys + curPDB.lys  #LYS LYSINE 
   curPDB.leu = prevPDB.leu + curPDB.leu  #LEU LEUCINE 
   curPDB.met = prevPDB.met + curPDB.met  #MET METHIONINE 
   curPDB.asn = prevPDB.asn + curPDB.asn  #ASN ASPARAGINE 
   curPDB.pro = prevPDB.pro + curPDB.pro  #PRO PROLINE 
   curPDB.gln = prevPDB.gln + curPDB.gln  #GLN GLUTAMINE 
   curPDB.arg = prevPDB.arg + curPDB.arg  #ARG ARGININE 
   curPDB.ser = prevPDB.ser + curPDB.ser  #SER SERINE 
   curPDB.thr = prevPDB.thr + curPDB.thr  #THR THREONINE 
   curPDB.val = prevPDB.val + curPDB.val  #VAL VALINE 
   curPDB.trp = prevPDB.trp + curPDB.trp  #TRP TRYPTOPHAN 
   curPDB.tyr = prevPDB.tyr + curPDB.tyr  #TYR TYROSINE 
   curPDB.x   = prevPDB.x   + curPDB.x       #Xaa    ANY AA 
#   curPDB.total = prevPDB.total + curPDB.total # adjust total aa length 
   curPDB.pos_charge = curPDB.pos_charge + prevPDB.pos_charge  
    # lysine + histidine + arginine 
   curPDB.neg_charge = curPDB.neg_charge + prevPDB.neg_charge  
# aspartic acid + glutamic acid + cysteine + tyrosine 
   curPDB.mw = curPDB.mw + prevPDB.mw 
   curPDB.start = curPDB.start + prevPDB.start # put start amino acids together 
   curPDB.end   = curPDB.end + prevPDB.end  # put end amino acids together 
   curPDB.num_chains = prevPDB.num_chains +1 # add 1 to number of chains 
   prevPDB = curPDB       
 # assign prev_id = pdb_id for adjustment of parameters 
  else: 
   if prevPDB.id not in (0, '0'):   # so initial value of prev_id not sent to seq_parser function 
    if prevPDB.protein_het < 1: 
     if prevPDB.nucleic < 1: 
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      if prevPDB.nucleic_het < 1: 
       prevPDB.pi_calc(start_ph, end_ph, ph_step, save, 
slope)  # calculate pI 
       prevPDB.pi_slope()  #obtain values to calculate slope 
       prevPDB.asa_calc()  
# calculate solvent accessible surface area 
       prevPDB.write_data() # save data to file 
   prevPDB = curPDB       
 # current pdb_id now becomes previous pdb_id - works 
output.close() 
file_name.close(). 
 
calc_charge.py 
# The purpose of this program is to calculate the slope of the pk_curve at the experimental ph of all pdb ids and  
# ALL OF THEIR SUBUNITS based on amino acid counts and starting and end amino acids 
import re, string, os 
class PDB:    # create a class PDB that represents one PDB file 
 def __init__(self): 
  self.id = 'X'  # PDB ID 
  self.mw = 0.0  # Molecular Weight 
  self.exp_ph = 0.0 # reported ph of crystallization value 
  self.ala = 0  #ALA ALANINE 
  self.cys = 0  #CYS CYSTEINE 
  self.asp = 0  #ASP ASPARTIC ACID 
  self.glu = 0  #GLU GLUTAMIC ACID 
  self.phe = 0  #PHE PHENYLALANINE 
  self.gly = 0  #GLY GLYCINE 
  self.his = 0  #HIS HISTIDINE 
  self.ile = 0  #ILE ISOLEUCINE 
  self.lys = 0  #LYS LYSINE 
  self.leu = 0  #LEU LEUCINE 
  self.met = 0  #MET METHIONINE 
  self.asn = 0  #ASN ASPARAGINE 
  self.pro = 0  #PRO PROLINE 
  self.gln = 0  #GLN GLUTAMINE 
  self.arg = 0  #ARG ARGININE 
  self.ser = 0  #SER SERINE 
  self.thr = 0  #THR THREONINE 
  self.val = 0  #VAL VALINE 
  self.trp = 0  #TRP TRYPTOPHAN 
  self.tyr = 0  #TYR TYROSINE 
  self.start = 'X'  # start amino acids 
  self.end = 'X'  # end amino acids 
##  self.slope = 0  # pk curve slope at the experimental pH 
  self.step = 0.1  # ph step to take 
  self.total_charge = 0.0 # list of total charge values for slope calculation 
  self.z_list = [ ]  # estimated net charge vs ph 
  self.zkda_list= [ ]  # estimated net charge/kDa vs pH 
  self.z = 0.0 # the protein's charge at the crystallization experimental pH 
  self.z_kda = 0.0 # estimated net charge/kDa at the reported pH of crystallization 
 
 def line_parser(self, pdb_record): 
  #this function will break up the lline into parts needed for the exp ph slope calculation 
  # all values needed to send to pk calculations 
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  sequence = re.compile(r'(?P<pdb_id>[a-zA-Z0-9\.]+)\t' 
         r'(?P<mw>[0-9.]+)\t' 
         r'(?P<pi>[0-9.]+)\t' 
         r'(?P<exp_ph>[0-9.]+)\t' 
         r'(?P<ala>[0-9]+)\t' 
         r'(?P<cys>[0-9]+)\t' 
         r'(?P<asp>[0-9]+)\t' 
         r'(?P<glu>[0-9]+)\t' 
         r'(?P<phe>[0-9]+)\t' 
         r'(?P<gly>[0-9]+)\t' 
         r'(?P<his>[0-9]+)\t' 
         r'(?P<ile>[0-9]+)\t' 
         r'(?P<lys>[0-9]+)\t' 
         r'(?P<leu>[0-9]+)\t' 
         r'(?P<met>[0-9]+)\t' 
         r'(?P<asn>[0-9]+)\t' 
         r'(?P<pro>[0-9]+)\t' 
         r'(?P<gln>[0-9]+)\t' 
         r'(?P<arg>[0-9]+)\t' 
         r'(?P<ser>[0-9]+)\t' 
         r'(?P<thr>[0-9]+)\t' 
         r'(?P<val>[0-9]+)\t' 
         r'(?P<trp>[0-9]+)\t' 
         r'(?P<tyr>[0-9]+)\t' 
         r'(?P<start>[A-Z]+)\t' 
         r'(?P<end>[A-Z]+)') 
  result = sequence.search(pdb_record) # search in every line 
  self.id = result.group('pdb_id')  # PDB ID 
  self.mw = float(result.group('mw'))  # molecular weight 
  self.pi = float(result.group('pi'))  # estimated pI 
  self.exp_ph = float(result.group('exp_ph')) # experimental ph 
  self.ala = int(result.group('ala'))  # ALA  ALANINE 
  self.cys = int(result.group('cys'))  #CYS CYSTEINE 
  self.asp = int(result.group('asp'))  #ASP ASPARTIC ACID 
  self.glu = int(result.group('glu'))  #GLU GLUTAMIC ACID 
  self.phe = int(result.group('phe'))  #PHE PHENYLALANINE 
  self.gly = int(result.group('gly'))  #GLY GLYCINE 
  self.his = int(result.group('his'))  #HIS HISTIDINE 
  self.ile = int(result.group('ile'))  #ILE ISOLEUCINE 
  self.lys = int(result.group('lys'))  #LYS LYSINE 
  self.leu = int(result.group('leu'))  #LEU LEUCINE 
  self.met = int(result.group('met'))  #MET METHIONINE 
  self.asn = int(result.group('asn'))  #ASN ASPARAGINE 
  self.pro = int(result.group('pro'))  #PRO PROLINE 
  self.gln = int(result.group('gln'))  #GLN GLUTAMINE 
  self.arg = int(result.group('arg'))  #ARG ARGININE 
  self.ser = int(result.group('ser'))  #SER SERINE 
  self.thr = int(result.group('thr'))  #THR THREONINE 
  self.val = int(result.group('val'))  #VAL VALINE 
  self.trp = int(result.group('trp'))  #TRP TRYPTOPHAN 
  self.tyr = int(result.group('tyr'))  #TYR TYROSINE 
  self.start = result.group('start')  # start list of first amino acids 
  self.end = result.group('end')  # end list of last amino acids 
##  self.start_ph = float(self.exp_ph) - 0.1 # lower pH value 
##  self.end_ph = float(self.exp_ph) + 0.1 # higher pH value 
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 def x_calc(self, start_ph, end_ph): 
  # this is my attempt to calculate theoretical pI 
  # I use recursion to narrow down the pI (successive approximation) 
  # all pk values taken from Harpers Biochemistry (e-book) through HSLS 
  # these values compare very closely to Voet & Voet Biochemistry, 1990 
  #seq_list = ['A, 'C' 'D', 'E',  'F',  'G',  'H',  'I',  'K',  'L', 
  #   'M', 'N',  'P',  'Q',  'R',  'S',  'T',  'V',  'W',  'Y'] 
  pk_nh3 =  [ 9.69, 10.28, 9.60, 9.67, 9.00, 9.60, 9.17, 9.68, 8.95, 9.60, \ 
    9.21, 8.80, 10.96, 9.13, 9.04, 9.15, 9.62, 9.62, 9.39, 9.11] 
  pk_coo3 = [2.34, 1.96, 1.88, 2.19, 1.83, 2.34, 1.82, 2.36, 2.18, 2.36, \ 
    2.28, 2.02, 1.99, 2.17, 2.17, 2.21, 2.11, 2.32, 2.38, 2.20] 
  pk_side = [8.18, 3.65, 4.25, 10.07, 6.0, 10.53, 12.48] 
  # pk_side C, D, E, Y, H, K, R 
##  low_ph = 0 
  ph = start_ph 
  while ph <= end_ph: 
   c_parts01 = 10**(ph - pk_side[0])   # cysteine 
   c_zi = c_parts01 /(c_parts01 + 1) 
   c_nzi = c_zi * self.cys 
   d_parts01 = 10**(ph - pk_side[1])   # aspartic acid 
   d_zi  = d_parts01 /(d_parts01 + 1) 
   d_nzi = d_zi * self.asp 
   e_parts01 = 10**(ph - pk_side[2])   # glutamic acid 
   e_zi  = e_parts01 /(e_parts01 + 1) 
   e_nzi = e_zi * self.glu 
   y_parts01 = 10**(ph - pk_side[3])   # tyrosine 
   y_zi  = y_parts01 /(y_parts01 + 1) 
   y_nzi = y_zi * self.tyr 
   neg_charge_sum = c_nzi + d_nzi + e_nzi + y_nzi # sum negative side chain aa 
   h_parts01 = 10**(ph - pk_side[4])   # histidine 
   h_zi = 1 /(h_parts01 + 1) 
   h_nzi = h_zi* self.his 
   k_parts01 = 10**(ph - pk_side[5])   # lysine 
   k_zi = 1 /(k_parts01 + 1) 
   k_nzi = k_zi* self.lys 
   r_parts01 = 10**(ph - pk_side[6])   # arginine 
   r_zi = 1 /(r_parts01 + 1) 
   r_nzi = r_zi* self.arg 
   pos_charge_sum = h_nzi + k_nzi + r_nzi  # sum positive side chain aa 
   aa_list = ['A', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'K', 'L', 'M', 'N', 'P', 'Q', 'R', 'S', 'T', 'V', 'W', 'Y'] 
   start_zi = 0 
   end_zi = 0 
   count = 0 
   for aa in aa_list: 
    for start_aa in self.start: 
     if start_aa == aa:  # start amino acid - NH3 end 
      start_parts01 = 10**(ph - pk_nh3[count]) 
      start_zi = start_zi + 1 /(start_parts01 + 1) 
    count = count +1 
   count = 0 
   for aa in aa_list: 
    for end_aa in self.end: 
     if end_aa == aa:  # end amino acid - Carboxyl end 
      end_parts01 = 10**(ph - pk_coo3[count]) 
      end_zi = end_zi + end_parts01 /(end_parts01 + 1) 
    count = count + 1 
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   # calculate charges (net, sum of squares, and total charges)     
   self.total_charge = (start_zi + pos_charge_sum - neg_charge_sum - end_zi) 
   if (round(ph,1) == round(self.exp_ph, 1)): 
     self.z = self.total_charge 
     self.z_kda = (self.z / self.mw) 
   # append charge values to respective lists 
   self.z_list.append(str(self.total_charge)) # add total (net) charge to list 
   z_kda = (self.total_charge/self.mw) 
   self.zkda_list.append(str(z_kda)) 
   ph = ph + self.step   # increase pH to next step 
 
 def write_data(self): 
  # this is my function to write the data to file 
  list = [self.id, '\t', self.mw, '\t', self.pi, '\t',self.exp_ph, '\t', \ 
    self.ala, '\t', self.cys, '\t', self.asp, '\t', \ 
    self.glu, '\t', self.phe, '\t', self.gly, '\t', self.his, '\t', \ 
    self.ile, '\t', self.lys, '\t', self.leu, '\t', self.met, '\t', \ 
    self.asn, '\t', self.pro, '\t', self.gln, '\t', self.arg, '\t', \ 
    self.ser, '\t', self.thr, '\t', self.val, '\t', self.trp, '\t', \ 
    self.tyr, '\t', self.start, '\t', self.end, '\t',\ 
    self.z, '\t', self.z_kda, '\t'] 
  for value in list: 
   output.writelines(str(value)) 
##  for value in self.z_list:  # write estimsted titration curve (z vs. pH) 
##   output.writelines(value) 
##   output.writelines('\t') 
  for value in self.zkda_list:  # write estimsted titration curve (z_kda vs. pH) 
   output.writelines(value) 
   output.writelines('\t') 
  output.writelines('\n')  
#################################################################################### 
########################  Main Program ################################################ 
####################################################################################     
os.chdir(r'C:\Documents and Settings\dougalld\My Documents\School Material\PDB')  
# change directory to where data file found 
# this is a list of all PDB files with a valid experimental pH and xrayed with amino acid sequence information 
outputFile = os.path.join("C:\\", "Documents and Settings", "dougalld", "My Documents", "School Material", 
"PDB", "pdb_110705_charge_calc_results.txt")    # set output file path 
##os.chdir(r'D:\Bioinformatics\PDB Files')   # change directory to where data file found 
### this is a list of all PDB files with a valid experimental pH and xrayed with amino acid sequence information 
##outputFile = os.path.join("d:\\", "Bioinformatics", "PDB Files", "pdb_040505_charge_at_ph.txt")     
# set output file path 
output = open(outputFile, 'w+')                      # open output file for fasta file parse 
caption = "PDB_ID\tmw\tpI\texp_ph\tA\tC\tD\tE\tF\tG\tH\tI\tK\tL\tM\tN\t"\ 
    "P\tQ\tR\tS\tT\tV\tW\tY\tstart_aa\tend_aa\tz\tz_kda\t"      # make caption a string for writing 
output.writelines(caption)                   # column headings printed to file 
a = 1.0    # initialize counter 
z_list = [ ]   # this will contain column headings 
# net charge header 
while a <= 14:   # create title line for titration curve 
 z_list.append(('z_' + str(a))) 
 z_list.append('\t') 
 a = a + 0.1 
z_list.append('\n') 
for line in z_list:   # this method or below both work 
 output.write(line)               # column headings printed to file 
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a = 1.0     # re-initialize counter 
zkda_list = [ ]   # this will containt column headings 
# net charge/kDa header 
while a <= 14:   # create title line for surface charge density curve 
 zkda_list.append(('z_' + str(a))) 
 zkda_list.append('\t') 
 a = a + 0.1 
#line_list.append('net_low\tnet_pi\tnet_high\tph_low\tph_high\t') 
zkda_list.append('\n') 
for line in zkda_list:    # this method or below both work 
 output.write(line)                 # column headings printed to file 
file_name = open('pdb_110705_input_charge_calc.txt') # file with full list of valid pdb ids 
start_ph =  1.0  # initial pH for titration curve calculation 
end_ph   = 14.0  # final pH for titration curve calculation 
for line in file_name: 
 line = line.rstrip() 
 curPDB = PDB()    # initialize a new instance of class PDB 
 curPDB.line_parser(line)   # sends current record for line parsing 
 if curPDB.id != 'X': 
  curPDB.x_calc(start_ph, end_ph) # sends current object for pk calculation 
  curPDB.write_data()  # sends current record for writing to file 
output.close() 
if not line: 
 file_name.close() 
  
nrpdb_testset.py 
The purpose of this program is to get a list of nrPDB ids with pH values 
# downloaded nrPDB and filtered out non-acceptable, non-x-ray, 
# with exp. pH, no membrane proteins, resolution <= 3.0, and no nucleic/hetero containing structures 
# sorted by blast group 80 and then rank blast 80 
import re, string, os 
class PDB:  # create a class PDB that represents one PDB chain 
    def __init__(self):         # initialize values required values: 
        self.id = 'aaaa'                # PDB ID 
        self.mmdb = 0                   # MMDB ID 
        self.group_80 = 0               # Group 80 Membership 
        self.rank_80 = 0                # Group 80 Membership Rank 
        self.exp_ph = 0.0               # Experimental pH 
 
    def line_parser(self, line): 
        # this function will parse the line into a list of variables 
        # the line should look like pdb_id..group_e80..rank_e80..exp_ph 
        title = re.compile(r'(?P<pdb_id>[a-zA-Z0-9]+)\t'\ 
                           r'(?P<mmdb>[0-9]+)\t'\ 
                            r'(?P<group_80>[0-9]+)\t'\ 
                            r'(?P<rank_80>[0-9]+)\t'\ 
                            r'(?P<exp_ph>[0-9.]+)\n') 
        result = title.search(line)                 # search in line 
        self.id                 = result.group('pdb_id') 
        self.mmdb               = result.group('mmdb') 
        self.group_80           = int(result.group('group_80')) 
        self.rank_80            = int(result.group('rank_80')) 
        self.exp_ph             = float(result.group('exp_ph')) 
 
    def write_data(self): 
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        # this is my function to write the data to file 
        list = [self.id, '\t', self.mmdb, '\t', self.group_80, '\t', self.rank_80, '\t', self.exp_ph, '\n'] 
        for value in list: 
            output.writelines(str(value)) 
 
##def train_parse(line): 
##    # this function will parse the line into a list of variables 
##    # the line should look like group_80\n 
##    title = re.compile(r'(?P<group_80>[0-9]+)\n') 
##    result = title.search(line)                   # search in line 
##    return(result.group('group_80')) 
################################################################################ 
#############################  Main Program ####################################### 
################################################################################ 
os.chdir(r'C:\Documents and Settings\dougalld\My Documents\School Material\PDB')              
# change directory to where nrpdb_with_ph.txt file found 
# set input file 
inputFile = os.path.join("c:\\", "Documents and Settings", "dougalld", "My Documents", "School Material", "PDB", 
"new_testset_nov_2005.txt") 
# sorted by group and then rank 
# this is a list of all nrPDB files that have a pH value (acceptable, xray method, no membranes, aa length >20) 
outputFile = os.path.join("c:\\", "Documents and Settings", "dougalld", "My Documents", "School Material", 
"PDB", "nrpdb_111405_testset.txt")    # set output file path 
output = open(outputFile, 'w+')                 # open output file for fasta file parse 
test_list = [ ]                      # list of new entries for test set 
line_list = [ ]  # this will contain column headings 
line_list.append('pdb_id\tmmdb_id\tgroup_80\trank_80\texp_ph\n')    # column headings 
output.writelines(line_list)   # write headings to ouput file 
input_file = open(inputFile)  # file with list of nrPDB entries ordered by group and rank 
curPDB  = PDB()                       # current line pdb entry 
prevPDB = PDB()                       # previous pdb entry with unique group_ni and highest ranking 
##uniquePDB = [ ]                        # list of unique PDB ids 
##mmdb_group_80 = [ ]                   # list of MMDB Group 80 members 
##mmdb_id = [ ]                          # list of MMDB IDs 
for line in input_file:             # read each line one at a time 
    curPDB.line_parser(line)        # parse line into PDB entry 
    if (curPDB.group_80 == prevPDB.group_80): 
        # see if same group number - if same group number and lower rank continue 
        curPDB.id = prevPDB.id 
        curPDB.mmdb = prevPDB.mmdb 
        curPDB.group_80 = prevPDB.group_80 
        curPDB.rank_80 = prevPDB.rank_80 
        curPDB.exp_ph = prevPDB.exp_ph       
    else:               # new group number blast 10e-80 replace previous PDB entry with current PDB entry 
        if prevPDB.id not in test_list: 
            test_list.append(prevPDB.id) 
            test_list.append('\n') 
        prevPDB.write_data() 
    prevPDB.id = curPDB.id 
    prevPDB.mmdb = curPDB.mmdb 
    prevPDB.group_80 = curPDB.group_80 
    prevPDB.rank_80 = curPDB.rank_80 
    prevPDB.exp_ph = curPDB.exp_ph 
print test_list 
input_file.close()              # close input  file 
output.close()                  # close output file 
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APPENDIX B: Commercial Crystallization Screens  
COMMERCIAL SCREENS 
Table B.1 lists the commercial screens examined from four commercial companies (Hampton 
Research, Emerald BioStructures, Jena Biosciences, and Molecular Dimensions).  Table B.2 lists 
the pH values of the buffers listed in the screens.   
 
Table B.1 Commercial screens examined for the reported pH of the buffer solutions. 
 
Vendor Screen N 
Hampton  Crystal Screen I 50 
Research Crystal Screen II 48 
 Index 96 
 Cryo 50 
 Lite 50 
MD* Structure Screen 1 & 2 96 
 Heavy & Light 96 
 PACT 96 
 Clear Strategy 1 96 
 Clear Strategy 2 96 
Jena 
Bioscience JBScreen Classic Kits 1-10 240 
Emerald 
BioStructures Wizard Screens 1 & 2 96 
Total  1110 
* MD = Molecular Dimensions Inc. 
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Table B.2 The reported buffer pH values for the commercial screens listed in Table B.1. 
 
pH Frequency Percent 
3.5 3 0.3 
4.0 4 0.4 
4.2 6 0.5 
4.5 14 1.3 
4.6 65 5.8 
5.0 10 0.9 
5.5 65 5.8 
5.6 34 3.1 
6.0 18 1.6 
6.2 5 0.4 
6.5 192 17.3 
7.0 43 3.9 
7.5 224 20.1 
8.0 35 3.1 
8.5 203 18.3 
9.0 15 1.3 
9.5 10 0.9 
10.5 4 0.4 
Not 
Listed 162 14.6 
Total 1112 100.0 
 
When the crystpH  values were obtained from the PDB were compared to the reported buffer pH 
values listed in the 18 different screens, an overlap was observed (Figure B.1), which can most 
likely explain this observed pattern.  Positive values indicate areas where the commercial screens 
may be over sampling.  Negative values indicate possible areas where commercial screens are 
under sampling.  It should be noted that ~15% of commercial screens do not list a pH value.  
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Figure B.1 (a) An overlap between the crystpH  distribution and the buffer pH as reported from four commercial 
protein crystallization companies (Emerald BioStructures, Hampton Research, Jena Biosciences, and Molecular 
Dimensions). (b) The difference between the (% pH of screens) - (% pH of training set). 
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APPENDIX C: Annotated Example  
ANNOTATED EXAMPLE 
In Chapter 2, the methods used for determining the three-dimensional (3D) structure of proteins 
and nucleic acids were discussed.  Current approaches, while rarely successful, need to be 
augmented to increase the throughput of crystallized structures.  This chapter describes an 
annotated example using three proteins from the independent test set to demonstrate the 
usefulness of the Features (pIest) to predict the Observables ( crystQ ) examined in this dissertation, 
which can then be used to suggest more probable pH ranges that are more likely to result in 
crystallization. 
C.1 INTRODUCTION 
One hypothesis of this dissertation was that the Q -related Observables, particularly crystQ , can 
be used as a proxy variables for the crystpH .  This offers researchers the possibility to 
intelligently select pH ranges for initial crystallization screens.  These methods in theory should 
increase the success rate of generating crystals suitable for diffraction studies by guiding the 
researcher to search areas in the crystallization search space that have a higher probability of 
success. 
For any protein undergoing crystallization attempts, the amino acid sequence should be 
known apriori, although the protein's function may remain unknown.  Thus, from the input of a 
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protein's amino acid sequence(s) (Figure C.1) an estimated titration curve (estimated net charge 
plotted as a function of solution pH) can be easily calculated (Figure C.2a).  By accounting for 
the molecular weight or estimated solvent accessible surface area, the estimated titration curve 
can be transformed into a Q  or σ  curve (Figure C.2b).  From these curves, prior Observable 
( crystQ ) probabilities derived from previously crystallized proteins in the PDB can be used to 
calculate the probability of crystallization for a test protein across the Q  or σ  curve, 
)|( PDBQQP cryst=  or )|( PDBP crystσσ =  (Figure C.3).  These probabilities can then be 
translated back into pH search space to estimate the probability that crystpHpH =  given that 
crystQQ = , ),|( PDBQQpHpHP crystcryst ==  , by matching the pH values that result in the given 
Q  value along the Q  curve.  The same kind of probabilities can be calculated for crystσσ = , 
),|( PDBpHpHP crystcryst σσ == .  The researcher is then able to rationalize the selection of 
solution pH values that have a higher probability in generating crystals.  Several methods are 
discussed in this dissertation on how to accomplish this, two of which are shown here.  The 
example proteins are selected from 'Acidic' proteins in the test set, '' AcidicpIest =  (Section 
6.1.1.2). 
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Figure C.1 Amino acid sequences of the three test set proteins in FASTA format. 
>1LRH_A mol:protein length:163  auxin-binding protein 1 
SCVRDNSLVRDISQMPQSSYGIEGLSHITVAGALNHGMKEVEVWLQTISPGQRTPIHRHSCEEVFTVLKGKGTLLM
GSSSLKYPGQPQEIPFFQNTTFSIPVNDPHQVWNSDEHEDLQVLVIISRPPAKIFLYDDWSMPHTAAVLKFPFVWD
EDCFEAAKEQL 
>1LRH_B mol:protein length:163  auxin-binding protein 1 
SCVRDNSLVRDISQMPQSSYGIEGLSHITVAGALNHGMKEVEVWLQTISPGQRTPIHRHSCEEVFTVLKGKGTLLM
GSSSLKYPGQPQEIPFFQNTTFSIPVNDPHQVWNSDEHEDLQVLVIISRPPAKIFLYDDWSMPHTAAVLKFPFVWD
EDCFEAAKEQL 
>1LRH_C mol:protein length:163  auxin-binding protein 1 
SCVRDNSLVRDISQMPQSSYGIEGLSHITVAGALNHGMKEVEVWLQTISPGQRTPIHRHSCEEVFTVLKGKGTLLM
GSSSLKYPGQPQEIPFFQNTTFSIPVNDPHQVWNSDEHEDLQVLVIISRPPAKIFLYDDWSMPHTAAVLKFPFVWD
EDCFEAAKEQL 
>1LRH_D mol:protein length:163  auxin-binding protein 1 
SCVRDNSLVRDISQMPQSSYGIEGLSHITVAGALNHGMKEVEVWLQTISPGQRTPIHRHSCEEVFTVLKGKGTLLM
GSSSLKYPGQPQEIPFFQNTTFSIPVNDPHQVWNSDEHEDLQVLVIISRPPAKIFLYDDWSMPHTAAVLKFPFVWD
EDCFEAAKEQL 
>1IMV_A mol:protein length:398  PIGMENT EPITHELIUM-DERIVED FACTOR 
MAHHHHHHMASLTVPAHVPSAAEDCEQLRSAFKGWGTNEKLIISILAHRTAAQRKLIRQTYAETFGEDLLKELDRE
LTHDFEKLVLVWTLDPSERDAHLAKEATKRWTKSNFVLVELACTRSPKELVLAREAYHARYKKSLEEDVAYHTTGD
HRKLLVPLVSSYRYGGEEVDLRLAKAESKILHEKISDKAYSDDEVIRILATRSKAQLNATLNHYKDEHGEDILKQL
EDGDEFVALLRATIKGLVYPEHYFVEVLRDAINRRGTEEDHLTRVIATRAEVDLKIIADEYQKRDSIPLGRAIAKD
TRGDYESMLLALLGQEED 
>1AVB_A mol:protein length:226     Arcelin-1 
SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAK
NIENSAYGLAFALVPVGSRPKLKGRYLGLFNTTNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNNGE
KAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNFI 
>1AVB_B mol:protein length:226     Arcelin-1 
SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAK
NIENSAYGLAFALVPVGSRPKLKGRYLGLFNTTNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNNGE
KAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNFI 
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Figure C.2 The (a) estimated titration curves and (b) Q  curves for the three proteins from the PDB test set, 1AVB, 
1IMV, and 1LRH. 
C.2 EXAMPLE PROTEINS FROM THE TEST SET 
A typical example demonstrating three possible scenarios using three '' AcidicpIest =  proteins 
(PDB IDs: 1LRH, 1IMV, and 1AVB) from the independent test set is discussed here, where 
‘Acidic’ proteins have a 5.0 < pIest ≤ 6.0.  These three proteins have 1-4 protein chains in the 
asymmetric unit, a molecular weight of 44-74 kDa, and a difflim between 1.9-2.9 Å (Table C.1).  
One of the goals of this research was to predict the solution pH ranges to search for growing 
crystals given the test protein’s sequence as input.  Because proteins denature at the extreme pH 
ranges and few proteins were found to crystallize at these extreme pH ranges, probabilities were 
calculated for the pH range from 3.0-11.0 in 0.5 unit increments.  It should be noted that the pH 
ranges < 4.0 (3.0 and 3.5) and > 10.0 (10.5 and 11.0) routinely have probabilities near zero. This 
was accomplished by calculating the Q  or σ  curve for the test protein and then using the 
probability density curve for previously crystallized proteins.  Examples are shown for (1) using 
the prior probabilities for all proteins in the training set, (2) a subgroup of proteins based upon 
the test protein’s pIest, and using the crystpH  priors based on the crystpH  distribution of all 
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proteins in the training set.  For reference, a ‘Random’ probability was also calculated, which 
assumes that each of the fourteen pH values between pH 4.0 and 10.0 (in 0.5 unit increments) 
examined has an equal chance of forming a crystal, i.e. 1/14 (7.7%).  A 10% threshold is used to 
represent areas of high probability and to compare the pH ranges selected by the different 
methods. 
 
Table C.1 The three example proteins used for the annotated example. 
 
ID # Chains in AU 
MW 
(kDa) pIest cryst
pH  pIest Group difflim 
1LRH 4 73.6 5.1 5.5 Acidic 1.9 
1IMV 1 44.3 5.7 6.2 Acidic 2.9 
1AVB 2 49.9 5.1 4.8 Acidic 1.9 
C.2.1 1LRH 
The first scenario, represented by 1LRH (Auxin-binding protein 1), is an example where the 
predicted crystpH  probability range was extremely accurate and could have significantly reduced 
the pH space to search.  Both methods using the Q  curve predicted a maximum pH probability 
between a pH of 5.5 and 6.0, which correctly captured the crystpH  for 1LRH, 5.5 (Figure C.3a).  
Using a 10% probability threshold suggests a pH range of 5.0-6.5 (All proteins) or 5.5-6.5 
( '' AcidicpIest = ).  However, using the crystpH  priors based on all proteins misses the listed 
crystpH  value, while suggesting a pH range of 6.5-7.5 for all target proteins.  Assuming all pH 
values with a probability above the 10% threshold should be searched, the priors based on ‘All’ 
proteins, ),|( 05.04.10nrPDBQQpHpHP crystcryst == , or the priors for '' AcidicpIest =  proteins, 
),'',|( 05.04.10nrPDBAcidicpIQQpHpHP estcrystcryst === , would reduce the initial screen 
conditions by 53%, only searching the solution conditions with a pH of 5.6 and 6.5 (Table C.2b).  
However, the pH probability distribution, based on '' AcidicpIest =  proteins gives a tighter pH 
range with a high probability to search, 5.5-6.0, reducing.  When such narrow distributions are 
predicted, a focused pH search (5.5-6.0) to concentrate the initial crystallization attempts would 
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be suggested.  This would allow the researcher greater flexibility in searching other parameters 
such as the salt or precipitating agent, while using the same number of experiments.  
C.2.2 1IMV 
The second scenario, represented by 1IMV (Pigment epithelium-derived factor), is an example 
where there is a relatively long stretch of pH values that have a similar probability (~10%).  The 
probability distribution based on ‘All’ proteins suggests a pH range of 6.5-7.5 should be searched 
(Figure C.3b), which all predict a probability near the 10% threshold.  The crystpH  for 1IMV was 
6.2, which falls near the peak stretch of this probability distribution.  By only choosing the pH 
values above 10%, the number of experiments can be reduced by 44%.  By using the priors for 
'' AcidicpIest =  proteins the reduction in experiments decreases only by 23%, removing all pH = 
4.6-5.6 experiments.  However, there is now a large drop-off in probability of crystals between 
pH 6.0 and 6.5, while an increase in probability is observed at more basic pH values, 8.5-9.0.  
The difflim for 1IMV was 2.9 Å (Table C.1).  It would be interesting to see if using a more 
neutral-basic pH solution could improve the resolution of the crystals. crystpH . 
C.2.3 1AVB 
The final example scenario was for 1AVB (Arcelin-1), which proved difficult, because this 
acidic protein (pIest 5.1) crystallized below its pIest, ( crystpH = 4.8).  Using prior probabilities from 
all proteins in the training set indicated an acidic range of pH values to search, 5.0-6.5.  This pH 
range does not capture the crystpH , but just misses.  However, this method eliminates 53% of the 
experiments, the experimental conditions with a pH value above 6.5 solutions.  When the priors 
are used for '' AcidicpIest =  proteins, a broader pH range, 5.5-8.0, is suggested.  However, the 
pH range from 5.0-6.5 still exhibits a much higher probability than the 7.0-8.0 range.  Using the 
prior for acidic proteins reduces the overall experiment by 30%.  Now, the crystpH  is not 
captured by the prediction, but a very large drop-off in prediction is observed between pH 5.0 
and 5.5.  The training data used for generating the probabilities had few 'Acidic' structures 
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(~17%) that crystallized below their pIest, which results in low probabilities for those pH ranges.  
However, it remains unknown whether the crystal structure of 1AVB (difflim 1.9 Å) could be 
improved, i.e. lower resolution, at more neutral pH values. 
C.3 SUMMARY 
This procedure of using a protein’s biophysical properties (Features), such as the protein’s pIest, 
to predict a crystQ  range (Hidden Observable) and thus a crystpHpH =  range (Controllable) 
appeared successful if the assumption holds true that the Q -related Observables ( crystQ ) can be 
used as proxy variables for the crystpH ..  These methods use a protein’s Q  curve to generate 
probabilities for the crystpH  based upon the crystQ  distribution of previously crystallized proteins.  
For some proteins, the pH search space for initial crystallization attempts is narrowed down to a 
pH unit or less.  This was the case with the protein 1LRH.  Conversely, there may be little to no 
reduction in the pH search space.  However, using the pH ranges above the 10% threshold for the 
initial screens should increase the chances of generating a well-ordered protein crystal.  It was 
not known whether there would be an increased chance of obtaining a 'hit' due to lack of 
available information. 
Reducing the time spent in searching for crystallization conditions in areas that are not 
likely to produce crystals should increase the chances of yielding a high quality crystal.  Without 
any prior knowledge, initial screens should attempt crystallization at a wide pH range of 4.0-9.0 
every 0.5 pH units.  Proteins have an increased tendency to denature outside of this pH range.  
Initial screens should be done with a sparse matrix screen varying all other ingredients, such as 
the salt and precipitant types and concentrations.  With no prior information, this would increase 
the initial conditions searched.  However, prior knowledge of a protein's Q  distribution 
(estimated specific charge curve) as a function of solution pH may allow the researcher to 
remove many of the solution pH values examined.  The prior knowledge could be encoded as 
Bayesian priors and used to generate probability distributions for various solution parameters.  
These probabilities can be further combined over multiple features as more data is collected and 
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analyzed to suggest regions in the crystallization search space more likely to produce well-
ordered crystals. 
 
Table C.2 (a) The distribution of pH values (buffers) searched by Crystal Screens 1 and 2 (Hampton Research; Aliso 
Viejo, CA). (b) Based on the 
crystpH  range prediction, certain screen wells can be removed. 
 
(a)    (b) Priors: All Proteins Priors: Acidic Proteins 
 pH Frequency Percent  1LRH 1IMV 1AVB 1LRH 1IMV 1AVB 
 4.6 12 12.2  - - - - - - 
 5.6 10 10.2  10 - 10 10 - 10 
 6.5 18 18.4  18 18 18 18 18 18 
 7.0 1 1.0  - 1 - - 1 1 
 7.5 21 21.4  - 21 - - 21 21 
 8.5 15 15.3  - - - - 15 - 
 9.0 3 3.1  - - - - 3 - 
 N/A* 18 18.4  18 18 18 18 18 18 
 Total 98 100.0  46 58 46 46 76 68 
 % of Total Experiments  46.9 56.1 46.9 46.9 77.6 69.4 
N/A = buffer pH not listed 
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Figure C.3 An example application using three 'Acidic' test set proteins to predict the 
),|( 05.04.10nrPDBQQpHpHP crystcryst == , ),'',|( 05.04.10nrPDBAcidicpIQQpHpHP estcrystcryst === , and 
)|( 05.04.10nrPDBpHpHP cryst= . 
 237 
APPENDIX D: Curve Fitting  
PRELIMINARY RESULTS OF CURVE FITTING 
D.1 INTRODUCTION 
Similar to Chapter 6, this section is based on the assumption (hypothesis) that the Q -related 
Observables, particularly crystQ , can be used as a proxy variables for the crystpH .  The 
preliminary results of using a cubic equation (Equation D.1) to fit the plot of the estpI  by crystQ  
(Figure D.1) is presented in this section.  A high correlation (Spearman’s rho) was observed 
between these two variables, 0.746, in Chapter 5 (Table 5.1).  In order to give an estimate of the 
error, five-fold cross-validation was used.  Five models (equations) were obtained by fitting a 
curve on four groups (4,288 proteins) and then testing the model on the remaining group of 
proteins (1,072 proteins).  The resulting five equations were used to give an estimate of the error 
and averaged to obtain a final equation for estimating the crystQ .  The Charge Range Test 
(Section 4.8.3) was then used to evaluate the model fit and compare the results to the other 
methods discussed previously. 
 
Equation D.1 dpIcpIbpIaQcryst +++= 32 ***  
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Figure D.1 Scatterplot of the estpI  versus the crystQ along with a cubic fit. 
D.2 RESULTS 
First, using five-fold cross-validation, five models were created using the random groupings to 
predict the crystQ  of proteins not used in the creation of the model.  The constants of the five 
cubic fit models are shown in Table D.1, while an example cubic fit using all of the data is 
shown in Figure D.1.  In each model, one of the five random groups was left out and used to test 
the resulting model.  The models were created by fitting the plot of the estpI  and crystQ  using a 
cubic equation, which resulted in a mean r2 of 0.547±0.007.  The resulting model using the 
average of the five coefficients from Equation D.1 is shown in Equation D.2.  Attempts were 
then made to use of this knowledge by using a target protein’s estpI  to predict the most probable 
Q  ranges for crystallization. 
Equation D.2.  230.6)(*015.0)(*324.0*455.2 32 −+−= estestestcryst pIpIpIQ   
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Table D.1 Cubic fit variables for the fit of Equation D.1. 
 
Fold* a b c d r2 
Not 5 2.48 -0.33 0.015 -6.31 0.547 
Not 4 2.45 -0.32 0.015 -6.21 0.552 
Not 3 2.51 -0.33 0.015 -6.36 0.548 
Not 2 2.45 -0.32 0.015 -6.22 0.550 
Not 1 2.38 -0.31 0.014 -6.05 0.535 
Mean 2.46 -0.32 0.015 -6.23 0.547 
SD 0.05 0.01 <0.001 0.12 0.006 
* Translates into modeling all groups, but the Group listed.  For example, Not 5 translates into modeling Groups 1-4 
and testing on Group 5. 
 
Using the Charge Range Test, the effectiveness of the five models and their error are 
reported in Table D.2.  This table shows that the cubic equation is correct in predicting the actual 
crystQ  approximately 20% of the time.  While 20% may not seem very accurate, it should noted 
that the success rate of obtaining a crystal suitable for diffraction studies has been listed as 
approximately 1-23% (Section 1.2).  Because proteins will often crystallize over a range of pH 
values, the area around the prediction was also examined.  When the Q  range was expanded to 
±0.1, 59% of the proteins crystQ  are correctly predicted.  When the range is expanded to the 
predicted crystQ  value ±0.2, 78% of the test set protein’s crystQ  values fell within this range.  An 
increase to 86% is observed when the range was expanded to ±0.3 e/kDa.  The results from all 
five models and the validation group behaved similarly. 
These results were then compared to those obtained earlier in the dissertation (Table 
D.3).  The cubic fit models performed similarly to the 2Step6 and SOM14x2 results on the training 
set at all levels (Table D.3a), but slightly better (2-4%) on the test set at the Mean±0.1 level 
(Table D.3b).  However, the other methods were not examined using five fold cross validation, 
which would allow for a more fair comparison between methods.  Statistical measures could then 
be performed to determine whether the observed differences were statistically significant. 
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Table D.2 Charge Range Test results for the (a) modelled or (b) test set proteins of the five cubic fit models. 
 
(a) Modelled 
 crystQ  Not 5 Not 4 Not 3 Not 2 Not 1 Mean SD 
Predicted 18.9 19.6 19.4 19.2 20.1 19.4 0.4 
Pred. ±0.1 58.5 57.9 58.0 58.4 60.0 58.6 0.9 
Pred. ±0.2 77.6 77.4 77.1 78.1 78.2 77.7 0.5 
Pred. ±0.3 86.3 86.5 86.1 86.1 86.4 86.3 0.2 
Model r2 0.547 0.552 0.548 0.550 0.535 0.547 0.006 
 
(b) Test Set 
 
 crystQ  Group 5 Group 4 Group 3 Group 2 Group 1 Mean SD 
Predicted 19.1 17.9 18.2 20.6 19.6 19.1 1.1 
Pred. ±0.1 57.6 59.7 59.0 60.0 56.3 58.5 1.5 
Pred. ±0.2 77.7 78.3 79.1 76.7 76.5 77.6 1.1 
Pred. ±0.3 86.4 85.5 87.1 86.3 85.5 86.2 0.7 
 
D.3 DISCUSSION 
Again it should be mentioned that these results are based on the assumption that the  crystQ  
variable can be used as a proxy variable for the crystpH .  Although these results are preliminary, 
the cubic fit seemed to result in predictions that were as good as the clustering methods in 
Chapter 6 (2Step and SOMs).  However, this method is much easier to calculate.  Based on the 
estpI  value, which can be calculated based on the AA sequence prior to any crystallization 
attempts, Equation D.2 can be used to estimate initial values for crystQQ = .  Similar to the 
previous methods, the estimated titration curve can then be used to more intelligently select (or 
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remove) initial pH values that have a higher probability in resulting in crystallization (or remove 
those pH values with a lower probability). 
  
Table D.3 Comparing the Cubic Fit results to the previous methods using the Charge Range Test. 
 
(a) Training      
 
pIest Bins 
Random 
Clusters 2Step6 SOM14x2 Cubic Fit 
Mean ±0.1 54.0 40.4±2.4 57.2 59.6 58.6±0.9 
Mean ±0.2 74.6 60.1±1.8 77.7 78.9 77.7±0.5 
Mean ±0.3 84.8 73.1±1.5 87.4 87.7 86.3±0.2 
 (b) Test      
 
pIest Bins 
Random 
Clusters 2Step6 SOM14x2 Cubic Fit 
Mean ±0.1 49.0 37.5 54.4 56.0 58.5±1.5 
Mean ±0.2 73.0 59.6 76.7 77.0 77.6±1.1 
Mean ±0.3 83.1 71.8 87.6 87.7 86.2±0.7 
crystQ
crystQ
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APPENDIX E: Linear Regression and Neural Networks  
PRELIMINARY RESULTS OF USING LINEAR REGRESSION AND NEURAL 
NETWORKS 
E.1 INTRODUCTION 
Similar to Appendix D, this section is also based on the assumption that the Q -related variables 
can be used as proxy variables for the crystpH . The preliminary results of using Linear 
Regression (LR) and Neural Networks (NN) to predict crystQ  ranges based on the amino acid 
(AA) composition is presented in this section.  Because the estpI  is based upon the charged AA 
composition (Arginine, Lysine, Histidine, Glutamic acid, Aspartic acid, and Tyrosine), a new 
hypothesis was tested: the composition of all twenty amino acids can predict the crystQ  better 
than the estpI  alone (Appendix D).  While LR assumes a linear relationship between variables, 
NN are able to handle non-linear problems. 
 
Equation E.1 221100 XbXbXbcY +++= , where  c= constant 
Equation E.2 compYcompCcompAcryst YbCbAbcQ ++++= ... , where Acomp = Alanine composition, Ccomp = Cysteine 
composition, etc. 
Using SPSS 14.0, stepwise linear regression, where the input was the amino acid 
composition (percentage) of all 20 amino acids, was used to determine if the amino acid 
composition could give insight into the crystQ . 
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Similar to modeling the estpI  and crystQ  relationship with a cubic fit in Appendix D, these 
two methods discussed in this section predict  a single crystQ  value as an outcome.  Because 
crystallization is thought to occur over a range of pH values (i.e. not a single pH value) the 
Charge Range Test was used to compare LR and NN to the previous methods.  In order to give 
an estimate of the error, five-fold cross-validation was used.  Therefore, five models (equations) 
were obtained by each method, modeling on four groups (4,288 proteins) and then testing the 
model on the remaining group of proteins (1,072 proteins).  The resulting five equations were 
used to give an estimate of the error for estimating the crystQ .  The Charge Range Test (Section 
4.8.3) was then used to evaluate the model fit and compare the results to the other methods 
discussed previously. 
E.2 RESULTS 
First, the zero-order correlations between the amino acid compositions and the estimated net 
charge variables were examined (Table E.1).  Again, the random number was used as a control.  
Little correlation was observed between any AA and the crystpH , with the largest correlation 
being Arginine at 0.074.  Much larger correlations were observed between the amino acids and 
the crystQ .  To no surprise, the charged amino acids (Arginine, Aspartic acid, Glutamic acid, and 
Lysine) had a much higher correlation to the crystQ .  However, both Histidine and Tyrosine had 
little correlation to the crystQ , <0.02.  It is also interesting to note that Alanine had a relatively 
high correlation to the crystQ , -0.108, compared to the other amino acids.  Only Aspartic acid, 
Glutamic acid, and Lysine had higher correlations with the crystQ . 
In order to account for size differences among proteins, the crystQ   was examined.  The 
Spearman’s correlations between the amino acid composition and the crystQ  are shown in Table 
E.1.  There wasn’t much difference in the AA correlations with crystQ  and crystQ .  While a few 
correlations were slightly reduced (greater than a 0.02 reduction), such as Alanine and 
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Methionine, only Arginine, Glutamic acid, and Aspartic acid increased their correlations by over 
0.04.  Again, no AA correlations with the Random Number approached statistical significance. 
 
Table E.1 Spearman’s rho correlations of amino acid composition and the Q  -related Observables. 
 
 crystpH  crystQ  crystQ  
Random 
Number 
% Alanine -0.002 -0.108 -0.088 0.006 
% Arginine 0.074 0.105 0.157 -0.009 
% Asparagine -0.033 0.053 0.059 -0.006 
% Aspartic Acid 0.021 -0.308 -0.352 0.004 
% Cysteine -0.016 0.019 0.007 -0.007 
% Glutamic Acid 0.025 -0.207 -0.252 0.001 
% Glutamine 0.019 0.005 0.007 0.002 
% Glycine -0.039 0.018 0.028 0.010 
% Histidine 0.042 -0.016 0.001 0.003 
% Isoleucine 0.021 0.004 0.021 -0.010 
% Leucine 0.044 -0.042 -0.025 0.004 
% Lysine 0.018 0.241 0.254 0.017 
% Methionine 0.019 -0.043 -0.004 0.012 
% Phenylalanine 0.034 -0.063 -0.070 -0.003 
% Proline -0.007 -0.003 0.012 -0.020 
% Serine -0.013 0.070 0.068 0.007 
% Threonine -0.043 -0.001 0.006 0.004 
% Tryptophan -0.012 0.007 0.018 -0.008 
% Tyrosine 0.017 -0.010 -0.020 0.001 
% Valine -0.046 0.002 0.008 -0.011 
 
After examining the correlations between the amino acid composition and the crystallization 
Observables ( crystpH , crystQ , and crystQ ), attempts were made to predict crystQ  using the amino acid 
composition.  Similar to Appendix D, five-fold cross-validation was used to give an estimate of 
the error for the models.  Five random groups of proteins were created with the model being 
developed on four, while being tested on the remaining group not used in the model creation.  
This results in five models for each method. 
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The LR equations of the five models are shown in Table E.2.  In each model, one of the five 
random groups was left out and used to test the resulting model.  The regression models were 
created by using the amino acid composition to predict the crystQ .  The resulting model using the 
average of the five coefficients from Equation E.1 is shown in Equation E.2.  Attempts were then 
made to use of this knowledge by using a target protein’s AA composition to predict the most 
probable Q  ranges for crystallization. 
 
Table E.2 The LR equations. 
 
Amino Acid LR1 LR2 LR3 LR4 LR5 Average 
Cysteine -0.962 -0.773 -0.478 -0.649 -0.753 -0.723 
Aspartic Acid -8.445 -8.456 -8.605 -8.668 -8.513 -8.537 
Glutamic Acid -7.723 -7.764 -7.940 -8.011 -7.964 -7.880 
Glycine 0.000 0.401 0.000 0.000 0.000 0.080 
Histidine 2.107 2.222 2.468 2.365 2.652 2.363 
Isoleucine -0.325 0.000 0.000 0.000 0.000 -0.065 
Lysine 8.385 8.615 8.508 8.440 8.601 8.510 
Leucine -0.535 0.000 0.000 -0.334 0.000 -0.174 
Asparagine 0.000 0.408 0.000 0.000 0.000 0.082 
Arginine 8.076 8.229 8.052 7.949 8.038 8.069 
Serine 0.000 0.000 0.313 0.000 0.443 0.151 
Valine 0.427 0.683 0.747 0.612 0.504 0.595 
Tryptophan 0.000 0.000 0.745 0.000 0.000 0.149 
Tyrosine -0.591 0.000 -0.538 0.000 -0.455 -0.317 
 Constant* 0.074 -0.100 0.000 0.000 0.000 -0.005 
*Constants with a 0.000 did not reach statistical significance (p<0.05) 
 
Using the Charge Range Test, the effectiveness of the five models and their error are 
reported in Table E.3.  This table shows that the LR model is correct in predicting the actual 
crystQ  approximately 21% of the time.  While 21% may not seem very accurate, it should again 
be noted that the success rate of obtaining a crystal suitable for diffraction studies has been listed 
as approximately 1-23% (Section 1.2).  Because proteins will often crystallize over a range of pH 
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values, the area around the prediction was also examined.  When the Q  range was expanded to 
±0.1, 65% of the proteins crystQ  are correctly predicted.  When the range is expanded to the 
predicted crystQ  value ±0.2, 82% of the test set protein’s crystQ  values fell within this range.  An 
increase to 90% is observed when the range was expanded to ±0.3 e/kDa.  The results from all 
five models and the validation group behaved similarly.  Similar values were obtained using NN 
(Table E.4). 
 
Table E.3 Charge Range Test results for the (a) modelled or (b) test set proteins of the five LR models. 
 
(a) Modelled 
 crystQ  Not 5 Not 4 Not 3 Not 2 Not 1 Mean SD 
Predicted 21.1 20.9 21.4 20.8 21.7 21.2 0.3 
Pred. ±0.1 64.9 65.1 64.9 65.3 65.6 65.1 0.3 
Pred. ±0.2 82.2 82.0 81.7 82.5 82.5 82.2 0.3 
Pred. ±0.3 90.1 89.8 89.6 90.0 90.0 89.9 0.2 
Model r2 0.630 0.640 0.645 0.643 0.641 0.640 0.006 
 
(b) Test Set 
 
 crystQ  Group 5 Group 4 Group 3 Group 2 Group 1 Mean SD 
Predicted 21.1 20.6 21.1 21.9 19.8 20.9 0.8 
Pred. ±0.1 65.4 64.5 65.3 67.0 61.8 64.8 1.9 
Pred. ±0.2 82.4 81.9 83.9 81.2 80.3 81.9 1.3 
Pred. ±0.3 89.1 89.8 91.3 89.9 88.6 89.8 1.0 
 
These results were then compared to those obtained earlier in the dissertation (Table E.5).  
The LR and NN models performed 5-7% better than the previous results at the Mean±0.1 and 
Mean±0.2 levels (Table E.5a), but slightly better (2-4%) on the test set at the Mean±0.3 level 
(Table E.5b).  However, most the other methods, including the 2Step6 and SOM14x2 results, were 
not examined using five fold cross validation, which would allow for statistical measures to be 
performed to determine the level of significance.  However, the NN and LR were statistically 
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better (p-value <0.01) than the Cubic fit models as judged by a Student’s t-test, which had 
similar values to those of unsupervised clustering (2Step6 and SOM14x2).  However, the LR and 
NN results were not statistically different from each other at all levels.  Therefore, due to the 
ease of use and interpretation, it would be recommended to use the LR models over the NN 
models. 
Both of these methods also give the “importance” of the variables (amino acid 
composition).  To no surprise, the charged amino acids were important in all models (10 in all). 
It should also be noted that the AA composition would be known for any target protein apriori to 
any crystallization attempts, while it’s crystQ  is unknown. 
 
Table E.4 Charge Range Test results for the (a) modelled or (b) test set proteins of the five NN models. 
 
(a) Modelled 
 crystQ  Not 5 Not 4 Not 3 Not 2 Not 1 Mean SD 
Predicted 21.2 21.2 22.4 19.3 20.8 21.0 1.1 
Pred. ±0.1 65.9 66.1 65.1 65.6 65.1 65.6 0.4 
Pred. ±0.2 82.9 82.6 81.6 81.8 81.9 82.2 0.5 
Pred. ±0.3 90.0 89.8 89.4 89.7 90.1 89.8 0.3 
Model r2 0.644 0.639 0.643 0.640 0.639 0.641 0.002 
 
(b) Test Set 
 
 crystQ  Group 5 Group 4 Group 3 Group 2 Group 1 Mean SD 
Predicted 20.7 21.7 22.0 20.0 20.9 21.1 0.8 
Pred. ±0.1 62.2 66.3 65.0 65.2 65.0 64.8 1.5 
Pred. ±0.2 81.1 81.1 83.8 81.9 81.6 81.9 1.1 
Pred. ±0.3 89.1 89.0 91.6 89.3 89.4 89.7 1.1 
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Table E.5 Comparing the LR and NN  results to the previous methods using the Charge Range Test. 
 
(a) Training        
 Random 
Clusters 
2Step6 SOM14x2 
crystQ  
Predicted 
Cubic Fit LR NN 
Mean ±0.1 40.4±2.4 57.2 59.6 ±0.1 58.6±0.9 65.1±0.3 65.6±0.4 
Mean ±0.2 60.1±1.8 77.7 78.9 ±0.2 77.7±0.5 82.2±0.3 82.2±0.5 
Mean ±0.3 73.1±1.5 87.4 87.7 ±0.3 86.3±0.2 89.9±0.2 89.8±0.3 
(b) Test           
 
 
Random 
Clusters 
2Step6 SOM14x2 
crystQ  
Predicted 
Cubic Fit LR NN 
Mean ±0.1 37.5 54.4 56.0 ±0.1 58.5±1.5 64.8±1.9 64.8±1.5 
Mean ±0.2 59.6 76.7 77.0 ±0.2 77.6±1.1 81.9±1.3 81.9±1.1 
Mean ±0.3 71.8 87.6 87.7 ±0.3 86.2±0.7 89.8±1.0 89.7±1.1 
 
E.3 DISCUSSION 
Again it should be mentioned that these results are based on the hypothesis (interpretation) that 
the  crystQ  variable can be used as s proxy variable for the 
cryspH
.  Although these results are 
preliminary, the LR and NN models resulted in better predictions than all previous methods.  An 
advantage of these models, is that the models allow for some interpretation, i.e. what amino acids 
are important for predicting the  crystQ . 
crystQ
crystQ
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Table E.6: The frequency of the amino acids in the LR and NN models. 
 
Abbreviation Amino Acid 
LR Models 
(n = 5) 
NN Models 
(n = 5) 
# Times in 
Model 
A (Ala) Alanine 0 1 1 
C (Cys) Cysteine 5 5 10 
D (Asp) Aspartic Acid 5 5 10 
E (Glu) Glutamic Acid 5 5 10 
F (Phe) Phenylalanine 0 1 1 
G (Gly) Glycine 1 3 4 
H (His) Histidine 5 5 10 
I (Ile) Isoleucine 1 0 1 
K (Lys) Lysine 5 5 10 
L (Leu) Leucine 2 2 4 
M (Met) Methionine 0 0 0 
N (Asn) Asparagine 1 3 4 
P (Pro) Proline 0 3 3 
Q (Gln) Glutamine 0 0 0 
R (Arg) Arginine 5 5 10 
S (Ser) Serine 2 3 5 
T (Thr) Threonine 0 2 2 
V (Val) Valine 5 3 8 
W (Trp) Tryptophan 1 1 2 
Y (Tyr) Tyrosine 3 4 7 
* Translates into modeling all groups, but the Group listed.  For example, Not 5 translates into modeling Groups 1-4 
and testing on Group 5. 
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